[
  {
    "id": "TCGA-UT-A97Y-01Z-00-DX1.19376AE8-F20F-49A8-BD6C-3998FD71628E-1",
    "image": "TCGA-MESO/TCGA-UT-A97Y-01Z-00-DX1.19376AE8-F20F-49A8-BD6C-3998FD71628E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelial type, TNM staging of T1M0N0, and IHC results showing strong positivity for CK7 and Calretinin, weak positivity for CK20 and CA125, WT1 positivity, and negative TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early TNM stage (T1M0N0), malignant mesothelioma generally has an aggressive nature and limited treatment options, contributing to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7OY-01Z-00-DX1.55585B4A-A419-42EF-80CF-ADD1A51854F1-1",
    "image": "TCGA-MESO/TCGA-TS-A7OY-01Z-00-DX1.55585B4A-A419-42EF-80CF-ADD1A51854F1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, biphasic type, TNM staging of T3MXN3, and IHC results showing positive Calretinin, CK5/6, and D2-40, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3MXN3) and the nature of biphasic mesothelioma, combined with positive markers for mesothelial origin, suggest a more aggressive disease with limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-3H-AB3L-01Z-00-DX1.AED33A7B-EEED-468B-8892-2B7F338C5471-1",
    "image": "TCGA-MESO/TCGA-3H-AB3L-01Z-00-DX1.AED33A7B-EEED-468B-8892-2B7F338C5471.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of epithelioid malignant mesothelioma, TNM staging of TXM0N2, and IHC results showing positive Keratin 5/6, WWT1, and Calretinin with negative MOC-31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of N2 (indicating significant lymph node involvement) suggests more advanced and potentially aggressive disease, despite the epithelioid subtype, which is generally less aggressive than other mesothelioma subtypes."
      }
    ]
  },
  {
    "id": "TCGA-3U-A98F-01Z-00-DX1.4D2C4E75-7D1A-40C3-AD67-BB5789EC9FB2-1",
    "image": "TCGA-MESO/TCGA-3U-A98F-01Z-00-DX1.4D2C4E75-7D1A-40C3-AD67-BB5789EC9FB2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of biphasic mesothelioma, TNM staging of T3M0N0, and immunohistochemistry results indicating positivity for calretinin, WT-1, cytokeratin (CAM 5.2), EMA, CAIX, Bcl2, D2-40, CK5/6, and focal positivity for TLE-1 and MOC31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Biphasic mesothelioma, especially with advanced local growth (T3), has a more aggressive course and limited treatment options, contributing to a generally poor outlook."
      }
    ]
  },
  {
    "id": "TCGA-UD-AAC7-01Z-00-DX1.A72102D3-0FEC-4F9B-AE49-5D6A5262A35F-1",
    "image": "TCGA-MESO/TCGA-UD-AAC7-01Z-00-DX1.A72102D3-0FEC-4F9B-AE49-5D6A5262A35F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of epithelioid malignant mesothelioma, TNM staging of T2N0M0, and IHC results showing positive Keratin broad spectrum (AE1/3), Calretinin, and WT-1 with negative TTF-1 and CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Epithelioid malignant mesothelioma is an aggressive cancer type, and despite the absence of metastasis (N0M0), the T2 stage still indicates a more advanced local tumor, contributing to a generally poor prognosis."
      }
    ]
  },
  {
    "id": "TCGA-3H-AB3M-01Z-00-DX1.9CD8A3B1-0F0F-418C-B54F-CBA22BB19469-1",
    "image": "TCGA-MESO/TCGA-3H-AB3M-01Z-00-DX1.9CD8A3B1-0F0F-418C-B54F-CBA22BB19469.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of malignant epithelioid mesothelioma, TNM staging of T3M0N2, and IHC results with strong positive staining for WT-1, Mesothelin, and Keratin 5/6, but negative staining for MOC-31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T3M0N2) indicates extensive local invasion and significant lymph node involvement, which are associated with a lower survival rate for malignant epithelioid mesothelioma."
      }
    ]
  },
  {
    "id": "TCGA-LK-A4O2-01Z-00-DX1.3CE365F3-3A3C-44A6-AEB9-ED8027459770-1",
    "image": "TCGA-MESO/TCGA-LK-A4O2-01Z-00-DX1.3CE365F3-3A3C-44A6-AEB9-ED8027459770.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant mesothelioma, epithelioid type, with TNM staging of T3N0M0, and IHC results showing positive Calretinin, WT-1, 02-40, and Cytokeratin 516, but negative CEA, Ber-EP4, 872.3, and TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, particularly with a T3 stage, indicates locally advanced disease, which is associated with a challenging prognosis despite the epithelioid subtype's relatively better outcome compared to other mesothelioma subtypes."
      }
    ]
  },
  {
    "id": "TCGA-LK-A4O5-01Z-00-DX1.826C5B0C-5F02-494E-8CB3-02E5DEAACCBC-1",
    "image": "TCGA-MESO/TCGA-LK-A4O5-01Z-00-DX1.826C5B0C-5F02-494E-8CB3-02E5DEAACCBC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of diffuse malignant mesothelioma, epithelial type, with a histologic grade G2, TNM staging of T3M0N0, and IHC results provided, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Diffuse malignant mesothelioma is inherently aggressive, and a T3 stage indicates advanced local disease. Additionally, the histologic grade G2 suggests moderately differentiated cells, further indicating a more challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-UD-AAC6-01Z-00-DX1.56D04FBC-2F26-4679-A597-C036E9CEDB37-1",
    "image": "TCGA-MESO/TCGA-UD-AAC6-01Z-00-DX1.56D04FBC-2F26-4679-A597-C036E9CEDB37.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of malignant mesothelioma (predominantly epithelioid and sarcomatoid), TNM staging of T2N0M0, and the specific immunohistochemistry results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, particularly with sarcomatoid differentiation, along with its T2 staging, generally indicates a more aggressive disease and a poorer outlook compared to other cancer types."
      }
    ]
  },
  {
    "id": "TCGA-UD-AAC1-01Z-00-DX1.787A89D0-C918-43CF-9D1B-80DB1686BA21-1",
    "image": "TCGA-MESO/TCGA-UD-AAC1-01Z-00-DX1.787A89D0-C918-43CF-9D1B-80DB1686BA21.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, TNM staging of T2N2M0, and IHC results showing strong staining for Cam5.2 and Calretinin with weaker staining for CD5/6, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging indicating significant lymph node involvement (N2) and the malignant nature of mesothelioma, known for its aggressive behavior and limited treatment options, contribute to a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-3U-A98G-01Z-00-DX1.5315FC96-F850-44EA-8480-04EDD64B1BAF-1",
    "image": "TCGA-MESO/TCGA-3U-A98G-01Z-00-DX1.5315FC96-F850-44EA-8480-04EDD64B1BAF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant biphasic mesothelioma, TNM staging of T4N0M0, and IHC results showing CAM5.2 positive in epithelioid cells and no venous or lymphatic invasion (CD34 negative), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4N0M0) indicates extensive local spread, and the diagnosis of biphasic mesothelioma, a more aggressive subtype, further contributes to a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-TS-A8AS-01Z-00-DX1.4278D910-79C3-44AB-A2A0-5B7CE54D64CB-1",
    "image": "TCGA-MESO/TCGA-TS-A8AS-01Z-00-DX1.4278D910-79C3-44AB-A2A0-5B7CE54D64CB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid type, TNM staging of T1AMXN0, and immunohistochemistry (IHC) results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally poor. Although staged at an early T1 level with no lymph node involvement (N0), malignant mesothelioma is typically aggressive and challenging to treat effectively, contributing to a less favorable overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-3H-AB3X-01Z-00-DX1.1EF5CB2E-61DF-4BB3-903C-D5F6488DE985-1",
    "image": "TCGA-MESO/TCGA-3H-AB3X-01Z-00-DX1.1EF5CB2E-61DF-4BB3-903C-D5F6488DE985.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of epithelioid malignant mesothelioma, TNM staging of T3M0N0, and IHC results positive for calretinin, WT-1, and D2-40, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Epithelioid malignant mesothelioma is an aggressive cancer, and the TNM stage of T3 indicates a locally advanced tumor, which collectively suggests a challenging outlook."
      }
    ]
  },
  {
    "id": "TCGA-UD-AABY-01Z-00-DX1.17CE3A58-EF84-424F-8BD0-7E0C2B93B901-1",
    "image": "TCGA-MESO/TCGA-UD-AABY-01Z-00-DX1.17CE3A58-EF84-424F-8BD0-7E0C2B93B901.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of malignant mesothelioma, TNM staging of T3N0M0, and IHC results showing positive Cytokeratin and EMA with negative CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of malignant mesothelioma combined with a T3 stage, indicating locally advanced disease, generally predicts a more aggressive clinical course despite the specific IHC markers."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88E-01Z-00-DX2.CC3E0AEE-61DE-46E0-B5B5-3387EC9A757C-1",
    "image": "TCGA-MESO/TCGA-UT-A88E-01Z-00-DX2.CC3E0AEE-61DE-46E0-B5B5-3387EC9A757C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant mesothelioma of epithelial type, TNM staging of T1M0N0, and positive IHC results for Calretinin, Thrombomodulin, CK5/6, and CK7, but negative for CK20 and TTF1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early-stage TNM (T1M0N0), malignant mesothelioma generally carries a poor prognosis due to its aggressive nature and limited effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88E-01Z-00-DX1.D4C533DB-FC2C-4E07-BC29-2C262E70FF96-1",
    "image": "TCGA-MESO/TCGA-UT-A88E-01Z-00-DX1.D4C533DB-FC2C-4E07-BC29-2C262E70FF96.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant mesothelioma of epithelial type, TNM staging of T1M0N0, and positive IHC results for Calretinin, Thrombomodulin, CK5/6, and CK7, but negative for CK20 and TTF1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early-stage TNM (T1M0N0), malignant mesothelioma generally carries a poor prognosis due to its aggressive nature and limited effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88E-01Z-00-DX3.B727FAE0-4562-4976-A896-6DAB791045AE-1",
    "image": "TCGA-MESO/TCGA-UT-A88E-01Z-00-DX3.B727FAE0-4562-4976-A896-6DAB791045AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant mesothelioma of epithelial type, TNM staging of T1M0N0, and positive IHC results for Calretinin, Thrombomodulin, CK5/6, and CK7, but negative for CK20 and TTF1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early-stage TNM (T1M0N0), malignant mesothelioma generally carries a poor prognosis due to its aggressive nature and limited effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7PB-01Z-00-DX1.1A1BCC79-0CE1-4CFB-B362-FDB766885FEE-1",
    "image": "TCGA-MESO/TCGA-TS-A7PB-01Z-00-DX1.1A1BCC79-0CE1-4CFB-B362-FDB766885FEE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of biphasic mesothelioma, TNM staging of T3N2MX, and IHC results showing positivity for CK5/6, Calretinin, D2-40, and WT-1, with negativity for TTF-1 and MOC-31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3N2) with significant lymph node involvement and the aggressive nature of biphasic mesothelioma contribute to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7P3-01Z-00-DX1.BE9B8EB9-9680-4F07-8248-5BE552C6AC9A-1",
    "image": "TCGA-MESO/TCGA-TS-A7P3-01Z-00-DX1.BE9B8EB9-9680-4F07-8248-5BE552C6AC9A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of biphasic mesothelioma, TNM staging of T3MXN2, and IHC results showing positivity for CK5/6, calretinin, and D2-40 with negativity for WT-1 and CD34, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3NXN2) and the biphasic nature of mesothelioma, which generally indicates a more aggressive and less favorable outcome, contribute to this assessment."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88D-01Z-00-DX1.45ED3296-2618-4CC3-BE69-78B0B097162C-1",
    "image": "TCGA-MESO/TCGA-UT-A88D-01Z-00-DX1.45ED3296-2618-4CC3-BE69-78B0B097162C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, with TNM staging of T2N0M0, and IHC results showing positive CK5/6 and HBME, along with negative TTF1, MOC31, and monoclonal CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the epithelioid subtype is the least aggressive form of malignant mesothelioma, the T2 stage indicates local tumor extension, which generally leads to a poorer outcome in this type of cancer."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88D-01Z-00-DX2.AE0B6725-767E-4E45-A34D-3BC8F1CBE923-1",
    "image": "TCGA-MESO/TCGA-UT-A88D-01Z-00-DX2.AE0B6725-767E-4E45-A34D-3BC8F1CBE923.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, with TNM staging of T2N0M0, and IHC results showing positive CK5/6 and HBME, along with negative TTF1, MOC31, and monoclonal CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the epithelioid subtype is the least aggressive form of malignant mesothelioma, the T2 stage indicates local tumor extension, which generally leads to a poorer outcome in this type of cancer."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88D-01Z-00-DX3.11C557F2-220F-4200-8003-90CAFCD5E1FC-1",
    "image": "TCGA-MESO/TCGA-UT-A88D-01Z-00-DX3.11C557F2-220F-4200-8003-90CAFCD5E1FC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, with TNM staging of T2N0M0, and IHC results showing positive CK5/6 and HBME, along with negative TTF1, MOC31, and monoclonal CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the epithelioid subtype is the least aggressive form of malignant mesothelioma, the T2 stage indicates local tumor extension, which generally leads to a poorer outcome in this type of cancer."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88C-01Z-00-DX4.70BC2CAA-E576-4D03-B996-B67F6ABDA950-1",
    "image": "TCGA-MESO/TCGA-UT-A88C-01Z-00-DX4.70BC2CAA-E576-4D03-B996-B67F6ABDA950.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, TNM staging of T3N2M0, and IHC results showing positivity for WT-1, Calretinin, CK5/6, and patchy CK7 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging with significant lymph node involvement (N2) and the nature of malignant mesothelioma indicate a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88C-01Z-00-DX1.A3206848-4B03-49CB-AF3C-720272E97AEE-1",
    "image": "TCGA-MESO/TCGA-UT-A88C-01Z-00-DX1.A3206848-4B03-49CB-AF3C-720272E97AEE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, TNM staging of T3N2M0, and IHC results showing positivity for WT-1, Calretinin, CK5/6, and patchy CK7 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging with significant lymph node involvement (N2) and the nature of malignant mesothelioma indicate a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88C-01Z-00-DX3.A761E40B-50C2-4157-BE06-52095FD4FAF6-1",
    "image": "TCGA-MESO/TCGA-UT-A88C-01Z-00-DX3.A761E40B-50C2-4157-BE06-52095FD4FAF6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, TNM staging of T3N2M0, and IHC results showing positivity for WT-1, Calretinin, CK5/6, and patchy CK7 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging with significant lymph node involvement (N2) and the nature of malignant mesothelioma indicate a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-UT-A88C-01Z-00-DX2.941278A1-EB79-4363-937F-6DB9B702510F-1",
    "image": "TCGA-MESO/TCGA-UT-A88C-01Z-00-DX2.941278A1-EB79-4363-937F-6DB9B702510F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid subtype, TNM staging of T3N2M0, and IHC results showing positivity for WT-1, Calretinin, CK5/6, and patchy CK7 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging with significant lymph node involvement (N2) and the nature of malignant mesothelioma indicate a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-SH-A7BH-01Z-00-DX1.5341A643-1358-4D60-9CB7-8252B5D7E2AC-1",
    "image": "TCGA-MESO/TCGA-SH-A7BH-01Z-00-DX1.5341A643-1358-4D60-9CB7-8252B5D7E2AC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of biphasic mesothelioma, TNM staging of T3M0N0, and IHC results showing variable positivity for MNF 116 and AE1AE3 in the epithelioid areas, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The biphasic nature of the mesothelioma, combined with an advanced T3 staging, typically indicates a more aggressive disease with limited treatment outcomes."
      }
    ]
  },
  {
    "id": "TCGA-MQ-A6BL-01Z-00-DX1.739C3B7A-6A6F-4EDA-9DC4-47ABD8634EAA-1",
    "image": "TCGA-MESO/TCGA-MQ-A6BL-01Z-00-DX1.739C3B7A-6A6F-4EDA-9DC4-47ABD8634EAA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of diffuse malignant mesothelioma, biphasic type (mixed epithelial and sarcomatoid type), TNM staging of T2M0N0, and IHC results showing positive Calretinin but negative TTF-1, CD34, and CK 5/6, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The biphasic type of mesothelioma is associated with a more aggressive clinical course, and the T2 stage indicates significant local invasion, contributing to a challenging overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-MQ-A6BQ-01Z-00-DX1.72BF21E4-17D6-436B-AAD9-7960342894F4-1",
    "image": "TCGA-MESO/TCGA-MQ-A6BQ-01Z-00-DX1.72BF21E4-17D6-436B-AAD9-7960342894F4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of malignant mesothelioma, epithelial type, TNM staging of T2MXN0, and IHC results showing positive Calretinin, WT-1, CK 5/6, and focally positive D2-40, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma generally has a poor prognosis, and the staging of T2 without specific information on distant metastasis (MX) further confirms the challenging nature of this disease."
      }
    ]
  },
  {
    "id": "TCGA-SC-A6LR-01Z-00-DX1.39A8C601-6445-4D04-B939-D5B860E558DD-1",
    "image": "TCGA-MESO/TCGA-SC-A6LR-01Z-00-DX1.39A8C601-6445-4D04-B939-D5B860E558DD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant mesothelioma, epitheliod type with TNM staging of T1BM0N2, and IHC results showing positivity for CK, WT-1, D2-40, Calretinin, and CK5/6, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, particularly with lymph node involvement (N2), typically indicates a more advanced stage and aggressive disease, which can limit treatment options and overall survival rates."
      }
    ]
  },
  {
    "id": "TCGA-NQ-A638-01Z-00-DX1.BBE8E433-E9CF-4D03-81AF-66D4EE33D51F-1",
    "image": "TCGA-MESO/TCGA-NQ-A638-01Z-00-DX1.BBE8E433-E9CF-4D03-81AF-66D4EE33D51F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated epithelial malignant mesothelioma, TNM staging of T2M0NX, and IHC results showing strong positivity for Calretinin, Cytokeratins, and WT-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma is generally aggressive, and the TNM staging of T2 suggests significant local tumor burden, while the NX indicates unknown nodal involvement, contributing to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-SC-A6LN-01Z-00-DX1.379BF588-5A65-4BF8-84CF-5136085D8A47-1",
    "image": "TCGA-MESO/TCGA-SC-A6LN-01Z-00-DX1.379BF588-5A65-4BF8-84CF-5136085D8A47.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant mesothelioma, biphasic type, with TNM staging T2N2M0 and IHC results showing positivity for AE1/AE3, Calretinin, and WT1, and negative for TTF1, CEA (p), and CD15, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Biphasic malignant mesothelioma generally has a less favorable outcome, and the TNM staging indicating significant lymph node involvement (N2) further worsens the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-TS-A8AV-01Z-00-DX1.39EFD486-8628-4C10-8D28-4AABE6BB661A-1",
    "image": "TCGA-MESO/TCGA-TS-A8AV-01Z-00-DX1.39EFD486-8628-4C10-8D28-4AABE6BB661A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of malignant mesothelioma, sarcomatoid type, with TNM staging of T2MXN2 and IHC results showing diffuse positivity for Cam8-2 and AE1-3, and focal positivity for several markers including D2-40, Calretinin, WT-1, and Thrombomodulin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, sarcomatoid type, is an aggressive tumor type, and the TNM staging indicating lymph node involvement (N2) further worsens the outlook."
      }
    ]
  },
  {
    "id": "TCGA-UD-AAC4-01Z-00-DX1.3485484D-1085-4FD5-B60E-FB3927BA0853-1",
    "image": "TCGA-MESO/TCGA-UD-AAC4-01Z-00-DX1.3485484D-1085-4FD5-B60E-FB3927BA0853.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of malignant mesothelioma, TNM staging of T2N2M0, and IHC results with CK7 and CK5/6 strongly positive, EMA demonstrated rim positivity, and negative CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging indicates significant regional lymph node involvement (N2), and malignant mesothelioma is generally an aggressive cancer with limited effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-NQ-A57I-01Z-00-DX1.274B053D-5E9D-4D31-8C1E-C036EB56BBC7-1",
    "image": "TCGA-MESO/TCGA-NQ-A57I-01Z-00-DX1.274B053D-5E9D-4D31-8C1E-C036EB56BBC7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma with a biphasic pattern, TNM staging of T1BMXNX, and IHC results showing positive mesothelin, TIF, WT1 (surface cells only), AE1/3, and KS, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, especially with a biphasic pattern, typically has an aggressive nature, and the TNM staging indicating possible spread (MXNX) complicates treatment outcomes."
      }
    ]
  },
  {
    "id": "TCGA-LK-A4O0-01Z-00-DX1.C174E1A1-0EB8-418A-91E3-A5282D6358D6-1",
    "image": "TCGA-MESO/TCGA-LK-A4O0-01Z-00-DX1.C174E1A1-0EB8-418A-91E3-A5282D6358D6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of diffuse malignant mesothelioma, predominantly fibrosarcomatous type, with TNM staging of T1AM0N0 and IHC results showing positive Calretinin, WT-1, D2-40, and CK5/6, but negative for Carcinoembryonic Antigen, B72.3, BER EP4, Lou-M1, TTF-1, BAS/PASD, and Mucicarmine, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Diffuse malignant mesothelioma, particularly the fibrosarcomatous type, is known for its aggressive nature and poor response to treatment, despite the early TNM stage and some positive prognostic markers in the IHC results."
      }
    ]
  },
  {
    "id": "TCGA-LK-A4O7-01Z-00-DX1.C097DA83-39E4-468C-98CB-8F7D8802E7D5-1",
    "image": "TCGA-MESO/TCGA-LK-A4O7-01Z-00-DX1.C097DA83-39E4-468C-98CB-8F7D8802E7D5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant epithelioid mesothelioma, TNM staging of T3N1M0, and IHC results showing positivity for Calretinin, CK5/6, WT-1, and D2-40, with Ber-EP4 implied negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3 with lymph node involvement N1) and the aggressive nature of malignant epithelioid mesothelioma indicate a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-3U-A98D-01Z-00-DX1.3CADC856-EEB0-410E-9881-B8188B91110D-1",
    "image": "TCGA-MESO/TCGA-3U-A98D-01Z-00-DX1.3CADC856-EEB0-410E-9881-B8188B91110D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of biphasic mesothelioma, TNM staging of T2N2M0, and IHC results showing positive Calretinin and WT-1 for the epithelioid component and weaker staining for mesothelial markers in the sarcomatoid component, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The biphasic nature of the mesothelioma, combined with the advanced TNM staging (N2 indicating significant lymph node involvement), suggests a more aggressive disease with a lower likelihood of favorable outcomes."
      }
    ]
  },
  {
    "id": "TCGA-TS-A8AY-01Z-00-DX1.EC2F69B8-D46B-45FA-8CE2-D6512EF19E02-1",
    "image": "TCGA-MESO/TCGA-TS-A8AY-01Z-00-DX1.EC2F69B8-D46B-45FA-8CE2-D6512EF19E02.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of epithelioid mesothelioma, TNM staging of T3MXN1, and immunohistochemistry results showing positive markers for D2-40, calretinin, AE1-3, CK 5/6, and WT1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with T3 indicating larger tumor size or chest wall invasion, N1 suggesting lymph node involvement, and the nature of epithelioid mesothelioma itself typically indicate a challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-3U-A98J-01Z-00-DX1.4594931A-DC81-4CD1-852C-DD9A5730111A-1",
    "image": "TCGA-MESO/TCGA-3U-A98J-01Z-00-DX1.4594931A-DC81-4CD1-852C-DD9A5730111A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of epithelial malignant mesothelioma, TNM staging of T3N2M0, and IHC results showing positive WT-1 and Calretinin, with negative MOC31 and BG8, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging with T3 primary tumor and N2 lymph node involvement indicates significant disease spread, typical of a more aggressive malignancy."
      }
    ]
  },
  {
    "id": "TCGA-SH-A9CT-01Z-00-DX1.B89F48C7-DB0F-4D4F-8731-A59AC2511F7A-1",
    "image": "TCGA-MESO/TCGA-SH-A9CT-01Z-00-DX1.B89F48C7-DB0F-4D4F-8731-A59AC2511F7A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of epithelioid malignant mesothelioma, TNM staging of T2M0N0, and IHC results with positive staining for MNF116, Calretinin, and WT1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Epithelioid malignant mesothelioma, even with no nodal (N0) or distant metastasis (M0), generally has a poor prognosis due to the aggressive nature of mesothelioma itself."
      }
    ]
  },
  {
    "id": "TCGA-SH-A7BD-01Z-00-DX1.9411F2E8-F569-46B2-86AC-EE4FCC459738-1",
    "image": "TCGA-MESO/TCGA-SH-A7BD-01Z-00-DX1.9411F2E8-F569-46B2-86AC-EE4FCC459738.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of epithelioid malignant mesothelioma, TNM staging of T2M1N0, and IHC results showing positive CKSV6, WT-1, and Calretinin, but negative CK7, CEA, and TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of distant metastasis (M1) in the TNM staging indicates an advanced stage of the disease, which is associated with a more aggressive course and lower overall survival rates."
      }
    ]
  },
  {
    "id": "TCGA-LK-A4NW-01Z-00-DX1.0A16E20B-1CFA-43B4-9C95-43BCFA6EC6A4-1",
    "image": "TCGA-MESO/TCGA-LK-A4NW-01Z-00-DX1.0A16E20B-1CFA-43B4-9C95-43BCFA6EC6A4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, TNM staging of T4N2M0, and IHC results showing positive Calretinin, Cytokeratin 5/6, Thrombomodulin, D2-40, and WT-1 with negative TTF-1 and CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T4N2M0) indicates extensive local invasion and significant lymph node involvement, suggesting aggressive disease behavior and limited treatment options typically associated with malignant mesothelioma."
      }
    ]
  },
  {
    "id": "TCGA-UD-AABZ-01Z-00-DX1.1F9761D0-1133-403D-B113-B04A0FFD4527-1",
    "image": "TCGA-MESO/TCGA-UD-AABZ-01Z-00-DX1.1F9761D0-1133-403D-B113-B04A0FFD4527.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, TNM staging of T2N0M0, and IHC results with positive markers for CALRETININ, CAM 5.2, CK 7, EMA, AE 1/3, and CK5/6, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma is an aggressive cancer, and even with a T2N0M0 stage, the disease is known for its poor response to treatment and low survival rates."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7P8-01Z-00-DX1.25E9AFA9-6C12-4F18-BE79-2F4F19887ECD-1",
    "image": "TCGA-MESO/TCGA-TS-A7P8-01Z-00-DX1.25E9AFA9-6C12-4F18-BE79-2F4F19887ECD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of epithelioid mesothelioma, TNM staging of TXMXN1, and IHC results showing CK7 positivity in a small cluster of cells with no tumor apparent in H&E sections, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The epithelioid mesothelioma diagnosis and lymph node involvement (N1) indicate a more challenging clinical course despite the limited detectable tumor in H&E sections."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7P1-01Z-00-DX1.7820F2FA-E75B-47D5-A2FF-1246A234FB1D-1",
    "image": "TCGA-MESO/TCGA-TS-A7P1-01Z-00-DX1.7820F2FA-E75B-47D5-A2FF-1246A234FB1D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelial type with focal sarcomatoid change, TNM staging of T1MXN0, and IHC results showing various markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma is generally aggressive, and the presence of focal sarcomatoid change further indicates a more challenging clinical course, despite the early TNM staging."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7P7-01Z-00-DX1.0EDCAFAC-38E5-4521-A0E3-25DD79FDBF26-1",
    "image": "TCGA-MESO/TCGA-TS-A7P7-01Z-00-DX1.0EDCAFAC-38E5-4521-A0E3-25DD79FDBF26.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of sarcomatoid mesothelioma, TNM staging of T3MXN2, and IHC results including positive calretinin, D2-40, and CK5/6, among others, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The sarcomatoid subtype of mesothelioma is associated with a more aggressive clinical course, and the TNM staging of T3MXN2 indicates advanced local tumor invasion and regional lymph node involvement, which are unfavorable prognostic factors."
      }
    ]
  },
  {
    "id": "TCGA-TS-A7P0-01Z-00-DX1.6CC0800C-C45C-4F50-B201-3975EBFD7970-1",
    "image": "TCGA-MESO/TCGA-TS-A7P0-01Z-00-DX1.6CC0800C-C45C-4F50-B201-3975EBFD7970.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid type, TNM staging of T3MXN0, and IHC results showing positive Calretinin, CK7, AE1/3 with focal positivity for CK5/6 and 2-40, but negative for CD16, TTF1, CEA, MOC31, and WT, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, particularly at T3 stage, generally indicates advanced local disease. Despite the epithelioid type, which is the less aggressive variant, the stage indicates a more challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-MQ-A6BS-01Z-00-DX1.B70332BE-BF97-45E5-B835-5158983ED6B5-1",
    "image": "TCGA-MESO/TCGA-MQ-A6BS-01Z-00-DX1.B70332BE-BF97-45E5-B835-5158983ED6B5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, epithelioid type, TNM staging of T2MXN0, and IHC results showing positivity for CK5/6 and D2-40, weak focal positivity for WT-1, and negativity for TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant mesothelioma, even of the epithelioid type and with limited staging information (T2MXN0), generally has an unfavorable prognosis due to its aggressive nature and limited effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-MQ-A6BR-01Z-00-DX1.89F49746-16A3-4862-BAFE-2933608202DB-1",
    "image": "TCGA-MESO/TCGA-MQ-A6BR-01Z-00-DX1.89F49746-16A3-4862-BAFE-2933608202DB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of diffuse malignant mesothelioma, epithelioid type, TNM staging of T1BMXN1, and IHC results showing positive Calretinin and CK5/6 with negative BerEP4 and B72.3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging showing lymph node involvement (N1) suggests a more advanced disease, and diffuse malignant mesothelioma generally has a poor prognosis despite being the epithelioid type, which is less aggressive compared to other mesothelioma subtypes."
      }
    ]
  },
  {
    "id": "TCGA-XT-AASU-01Z-00-DX1.FC2B9466-98D6-4AF8-89AB-F7409BEF789B-1",
    "image": "TCGA-MESO/TCGA-XT-AASU-01Z-00-DX1.FC2B9466-98D6-4AF8-89AB-F7409BEF789B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant mesothelioma, TNM staging of T3MXNX, and IHC results with strong positivity for EGFR in epithelioid parts while being weak and focal in the spindle component, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced local stage (T3) combined with uncertain metastatic and nodal status (MXNX), along with variable EGFR expression, indicates an aggressive and challenging disease with limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-MQ-A6BN-01Z-00-DX1.6DA0AD03-A9F5-4F77-B9F6-C5CD4904975B-1",
    "image": "TCGA-MESO/TCGA-MQ-A6BN-01Z-00-DX1.6DA0AD03-A9F5-4F77-B9F6-C5CD4904975B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of malignant epithelioid mesothelioma, TNM staging of T2MXN1, and IHC results showing diffuse positivity for Cytokeratin (AE1/AE3) and CKS/6, as well as focal positivity for Calretinin and WT1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Malignant epithelioid mesothelioma, combined with lymph node involvement (N1) and the complex IHC profile, typically indicates aggressive disease with limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-DD-A73D-01Z-00-DX1.455790BB-767B-458D-A90E-046FD47D0A92-1",
    "image": "TCGA-LIHC/TCGA-DD-A73D-01Z-00-DX1.455790BB-767B-458D-A90E-046FD47D0A92.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of well-differentiated hepatocellular carcinoma with TNM staging of T2MXNX and immunohistochemistry results showing positive Glypican-3 and absence of reticular framework in the tumor mass, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2 stage indicates a moderately advanced tumor size or number, and the absence of reticular framework, along with Glypican-3 positivity, suggests more aggressive tumor characteristics."
      }
    ]
  },
  {
    "id": "TCGA-DD-A73D-01Z-00-DX2.2492EB08-62D6-41F7-A612-4982F5360C64-1",
    "image": "TCGA-LIHC/TCGA-DD-A73D-01Z-00-DX2.2492EB08-62D6-41F7-A612-4982F5360C64.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of well-differentiated hepatocellular carcinoma with TNM staging of T2MXNX and immunohistochemistry results showing positive Glypican-3 and absence of reticular framework in the tumor mass, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2 stage indicates a moderately advanced tumor size or number, and the absence of reticular framework, along with Glypican-3 positivity, suggests more aggressive tumor characteristics."
      }
    ]
  },
  {
    "id": "TCGA-DD-A73C-01Z-00-DX2.616264EE-93CE-4E2F-A4DA-1CD3663A4F3C-1",
    "image": "TCGA-LIHC/TCGA-DD-A73C-01Z-00-DX2.616264EE-93CE-4E2F-A4DA-1CD3663A4F3C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated hepatocellular carcinoma with TNM staging of T3AM0N0 and the provided IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3A stage indicates a larger tumor with vascular invasion but no metastasis, which complicates treatment and decreases overall survival rates despite the well-differentiated status."
      }
    ]
  },
  {
    "id": "TCGA-DD-A73C-01Z-00-DX1.B31DD97B-0C66-4404-9521-4CE5661CA0C4-1",
    "image": "TCGA-LIHC/TCGA-DD-A73C-01Z-00-DX1.B31DD97B-0C66-4404-9521-4CE5661CA0C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated hepatocellular carcinoma with TNM staging of T3AM0N0 and the provided IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3A stage indicates a larger tumor with vascular invasion but no metastasis, which complicates treatment and decreases overall survival rates despite the well-differentiated status."
      }
    ]
  },
  {
    "id": "TCGA-DD-AADB-01Z-00-DX1.F708320D-E595-4196-B133-E097E9C8FC80-1",
    "image": "TCGA-LIHC/TCGA-DD-AADB-01Z-00-DX1.F708320D-E595-4196-B133-E097E9C8FC80.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma with predominantly grade II differentiation and areas of grade IV differentiation, TNM staging of T1N0M0, and negative CD34 immunohistochemistry results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early stage (T1N0M0), the presence of areas with grade IV differentiation indicates a more aggressive behavior, which negatively impacts the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-G3-A25Y-01Z-00-DX1.C6BF2202-9030-4460-B0F5-E846C8A44C1E-1",
    "image": "TCGA-LIHC/TCGA-G3-A25Y-01Z-00-DX1.C6BF2202-9030-4460-B0F5-E846C8A44C1E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Grade III/IV hepatocellular carcinoma, TNM staging of T1N0M0, and IHC results showing positive CAM 5.2 and focal positivity for alpha fetoprotein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (III/IV) of the hepatocellular carcinoma indicates aggressive tumor behavior despite the low TNM stage, suggesting a higher risk of progression and recurrence."
      }
    ]
  },
  {
    "id": "TCGA-EP-A2KA-01Z-00-DX1.2B69485D-AE0F-4E14-B90E-2B040ABAD497-1",
    "image": "TCGA-LIHC/TCGA-EP-A2KA-01Z-00-DX1.2B69485D-AE0F-4E14-B90E-2B040ABAD497.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, grade 3 of 4, TNM staging of T3AMXNX, and IHC results with negative CK7, CK20, CK8, HepPar 1, and loss of reticulin staining with usual canalicular spotty staining for CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor stage (T3A), higher grade (3 of 4), and notable loss of reticulin staining suggest a more aggressive and potentially less manageable form of hepatocellular carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-BC-A69H-01Z-00-DX1.22CA7EA4-B8EC-444C-90AA-33095CC53585-1",
    "image": "TCGA-LIHC/TCGA-BC-A69H-01Z-00-DX1.22CA7EA4-B8EC-444C-90AA-33095CC53585.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated carcinoma, favoring hepatocellular carcinoma, TNM staging of T2M0NX, and IHC results showing positive Cytokeratin AE1/AE3, CK8/18, and HepPar1 with patchy moderate staining for MOC-31 and negative CD10, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates a more aggressive cancer, and the T2 stage suggests a larger tumor size without clear lymph node involvement, contributing to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-BC-A112-01Z-00-DX1.4CC4A845-25F1-4DC2-8142-9990A66E9C1B-1",
    "image": "TCGA-LIHC/TCGA-BC-A112-01Z-00-DX1.4CC4A845-25F1-4DC2-8142-9990A66E9C1B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma with TNM staging of T3MXNX and IHC results showing HepPar-1 positivity, CK7 positivity, and CK20 and PSA negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging of T3 suggests an advanced primary tumor, while the moderate differentiation indicates intermediate tumor behavior, all pointing towards a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-XR-A8TE-01Z-00-DX1.BAA09A5C-74E3-4BF2-B08F-743886222E1B-1",
    "image": "TCGA-LIHC/TCGA-XR-A8TE-01Z-00-DX1.BAA09A5C-74E3-4BF2-B08F-743886222E1B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of well-differentiated hepatocellular carcinoma, TNM staging of T3MXN0, and IHC results showing positive cytokeratin of low weight and polyclonal CEA but negative HSA and CK7, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the well-differentiated nature of the carcinoma, the T3 staging indicates a larger tumor size or multiple tumors within the liver, suggesting more advanced disease."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9H3-01Z-00-DX1.813C14D8-DBBC-43AF-9E3A-9EFC1D1AFC98-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9H3-01Z-00-DX1.813C14D8-DBBC-43AF-9E3A-9EFC1D1AFC98.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated hepatocellular carcinoma, TNM staging of T2MXNX, and IHC findings indicating vascular invasion highlighted by CD31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the cancer being well-differentiated, the TNM staging indicating a second stage tumor and the presence of vascular invasion highlight a higher risk of disease progression."
      }
    ]
  },
  {
    "id": "TCGA-WX-AA46-01Z-00-DX1.30A83B36-A242-4846-86D5-F9BA48E42B72-1",
    "image": "TCGA-LIHC/TCGA-WX-AA46-01Z-00-DX1.30A83B36-A242-4846-86D5-F9BA48E42B72.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of well-differentiated hepatocellular carcinoma, TNM staging of T2MXNX, and the immunohistochemistry results provided, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging (T2MXNX) indicates a tumor that is more than one but less than two centimeters in size with possible lymphatic involvement, and the varied IHC findings suggest mixed cellular behavior, which complicates treatment."
      }
    ]
  },
  {
    "id": "TCGA-RC-A6M6-01Z-00-DX1.02120025-8890-45C8-AD77-5E8C4711BC70-1",
    "image": "TCGA-LIHC/TCGA-RC-A6M6-01Z-00-DX1.02120025-8890-45C8-AD77-5E8C4711BC70.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated carcinoma consistent with hepatocellular carcinoma, TNM staging of T2M0NX, and IHC results showing nonreactive CK20 and HSA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates a more aggressive cancer, and the TNM staging of T2 suggests a relatively advanced local disease, compounded by the indeterminate lymph node status (NX)."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9H5-01Z-00-DX1.08348C3C-A16F-45F6-8AE9-D0613268D703-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9H5-01Z-00-DX1.08348C3C-A16F-45F6-8AE9-D0613268D703.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, TNM staging of T1MXN0, and IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early-stage tumor (T1) without regional lymph node involvement (N0) and the IHC profile confirming hepatocellular carcinoma with positive markers like alpha-fetoprotein suggest a potentially better outcome if managed appropriately."
      }
    ]
  },
  {
    "id": "TCGA-FV-A4ZP-01Z-00-DX1.4B78C21C-8033-4870-82D9-5B127D3AF228-1",
    "image": "TCGA-LIHC/TCGA-FV-A4ZP-01Z-00-DX1.4B78C21C-8033-4870-82D9-5B127D3AF228.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma with TNM staging of T3M0NX and IHC results showing negative Hapa, Mela-A, and S-100, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor stage (T3) without distant metastasis but unknown nodal status suggests local aggressiveness, and the negative IHC markers do not provide specific therapeutic targets."
      }
    ]
  },
  {
    "id": "TCGA-UB-AA0V-01Z-00-DX1.FB59AF14-B425-488D-94FD-E999D4057468-1",
    "image": "TCGA-LIHC/TCGA-UB-AA0V-01Z-00-DX1.FB59AF14-B425-488D-94FD-E999D4057468.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of focal nodular hyperplasia, TNM staging of T0MXNX, and IHC results showing positive findings for Glutamine synthetase and L-FABP in normal patterns with patchy CD34 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. Focal nodular hyperplasia is a benign liver lesion, typically non-progressive and asymptomatic, with IHC results confirming this benign diagnosis."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9HB-01Z-00-DX1.ECF68E86-4D45-4545-A1D2-184D5ED38C3C-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9HB-01Z-00-DX1.ECF68E86-4D45-4545-A1D2-184D5ED38C3C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of well to moderately differentiated hepatocellular carcinoma, TNM staging of T1MXNX, and IHC results showing positive HepPar-1 and Glypican 3 with negative AFP, Cytokeratin 7, and Cytokeratin 20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The well to moderately differentiated status and low TNM stage (T1) suggest early-stage disease, and the IHC results support a hepatocellular origin, which can be associated with better treatment outcomes."
      }
    ]
  },
  {
    "id": "TCGA-UB-A7MB-01Z-00-DX1.974C60BF-CDDF-4F34-8056-385A1E352628-1",
    "image": "TCGA-LIHC/TCGA-UB-A7MB-01Z-00-DX1.974C60BF-CDDF-4F34-8056-385A1E352628.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of hepatocellular carcinoma, TNM staging of T2MXNX, and IHC results showing positive Arginase-1, negative CK19, negative Mucicarmine stain, and abnormal Reticulin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T2 stage suggests a larger tumor or multiple tumors within the liver, and the abnormal Reticulin stain indicates disrupted liver architecture, both of which suggest a more advanced and aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-CC-5261-01Z-00-DX1.475D05D8-FC25-4B9F-B601-6AD5208FE8EE-1",
    "image": "TCGA-LIHC/TCGA-CC-5261-01Z-00-DX1.475D05D8-FC25-4B9F-B601-6AD5208FE8EE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, TNM staging of T2M0N0, and IHC results showing negative ER, PR, Her-2/neu, B-Cell Marker, and T-Cell Marker, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T2 stage indicates the presence of a solitary tumor with vascular invasion, and the lack of positive immunohistochemical markers limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-RC-A7S9-01Z-00-DX1.B8EF745F-94C1-4115-9B27-EB0C08C053E2-1",
    "image": "TCGA-LIHC/TCGA-RC-A7S9-01Z-00-DX1.B8EF745F-94C1-4115-9B27-EB0C08C053E2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, TNM staging of T1M0N0, and IHC findings with positive Hepatocyte staining in tumor cells, negative Cytokeratin 19, negative Cytokeratin 7 (block Ad), and negative Iron, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low TNM stage (T1M0N0) indicates an early-stage tumor with no lymph node or distant metastasis, which often correlates with a better outcome."
      }
    ]
  },
  {
    "id": "TCGA-CC-A9FV-01Z-00-DX1.CAD4920E-4EE4-45C3-950C-DB2B8A824D28-1",
    "image": "TCGA-LIHC/TCGA-CC-A9FV-01Z-00-DX1.CAD4920E-4EE4-45C3-950C-DB2B8A824D28.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, TNM staging of T3N0M0, and IHC results showing negative hormone receptors but positive HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor size (T3) and lack of hormone receptor positivity limit effective hormonal therapies, while HER-2/neu positivity suggests a more aggressive cancer but allows for targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-RC-A7SH-01Z-00-DX1.96A1F4A5-ACE6-4EE6-9D41-9018F235A629-1",
    "image": "TCGA-LIHC/TCGA-RC-A7SH-01Z-00-DX1.96A1F4A5-ACE6-4EE6-9D41-9018F235A629.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of hepatocellular carcinoma, TNM staging of T2M0N0, and IHC results showing negative Iron, Cytokeratin 7 positivity in bile ducts and focal positivity in other areas, negative Cytokeratin 19, and positive Hepatocyte staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The stage T2 indicates a single tumor with vascular invasion or multiple tumors none larger than 5 cm, which typically suggests a higher risk of tumor progression and aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-RC-A7SF-01Z-00-DX1.F37E60B9-A340-4758-BE3C-C4675F6F5671-1",
    "image": "TCGA-LIHC/TCGA-RC-A7SF-01Z-00-DX1.F37E60B9-A340-4758-BE3C-C4675F6F5671.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma with a TNM staging of T1N0M0 and immunohistochemistry results showing negative iron and positive cytokeratin 7 in bile duct, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early TNM stage (T1N0M0) indicates a localized tumor without lymph node involvement or metastasis, which generally suggests a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-G3-AAV4-01Z-00-DX1.D62F997C-F97A-47FB-BE0D-1A2B18E861A0-1",
    "image": "TCGA-LIHC/TCGA-G3-AAV4-01Z-00-DX1.D62F997C-F97A-47FB-BE0D-1A2B18E861A0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of well-differentiated hepatocellular carcinoma with TNM staging of T1M0N0 and IHC results showing focal positivity for Hepatitis B core and surface antigens but negative for alpha-fetoprotein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The well-differentiated histology and early-stage TNM classification (T1M0N0) suggest a less aggressive tumor with better potential treatment outcomes."
      }
    ]
  },
  {
    "id": "TCGA-G3-A25S-01Z-00-DX1.52D3A6BB-A728-4651-A394-EACBEE29B106-1",
    "image": "TCGA-LIHC/TCGA-G3-A25S-01Z-00-DX1.52D3A6BB-A728-4651-A394-EACBEE29B106.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated (Grade II/III) hepatocellular carcinoma, TNM staging of T1N0M0, and IHC results showing positive CEA (canalicular stain) and strongly positive Hep-par-1 with negative CK7, CK20, Synaptophysin, and AFP, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer is moderately differentiated and confined to the liver without lymph node or distant metastasis (T1N0M0), suggesting a better outlook with potentially effective local treatments."
      }
    ]
  },
  {
    "id": "TCGA-K7-AAU7-01Z-00-DX1.70CA5190-7978-4BC5-851B-7B31D20116BC-1",
    "image": "TCGA-LIHC/TCGA-K7-AAU7-01Z-00-DX1.70CA5190-7978-4BC5-851B-7B31D20116BC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of combined hepatocellular-cholangiocarcinoma, moderately differentiated, with TNM staging of T2AMXNX and IHC results showing positive CK7, CK19, and focal positivity for Heppar, Arginase-1, and Glypican-3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Moderately differentiated combined hepatocellular-cholangiocarcinoma and staging indicating larger tumor size (T2A) are associated with a challenging and typically more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-MR-A520-01Z-00-DX1.2F323BAC-56C9-4A0C-9C1B-2B4F776056B4-1",
    "image": "TCGA-LIHC/TCGA-MR-A520-01Z-00-DX1.2F323BAC-56C9-4A0C-9C1B-2B4F776056B4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of well-differentiated hepatocellular carcinoma with adenoma-like features, TNM staging of T1MXNX, and the provided immunohistochemistry results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The well-differentiated status and early-stage T1 indicate a lower-grade tumor with limited spread, contributing positively to the overall outlook despite some uncertainty in nodal and metastatic status."
      }
    ]
  },
  {
    "id": "TCGA-FV-A3R3-01Z-00-DX1.29EDF32A-C679-427B-8A04-A601A6E92BE2-1",
    "image": "TCGA-LIHC/TCGA-FV-A3R3-01Z-00-DX1.29EDF32A-C679-427B-8A04-A601A6E92BE2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated grade I hepatocellular carcinoma, TNM staging of T1NXMX, and IHC results showing positive Keratin CAM5.2 and Hepar, CK7 positive in a focus, CK20 negative, with a disruption of reticulin fibers in the neoplasm, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The well-differentiated, low-grade nature (Grade I) and the confined T1 staging indicate less aggressive disease, though the lack of lymph node and metastatic information (NX and MX) must be considered cautiously."
      }
    ]
  },
  {
    "id": "TCGA-CC-5263-01Z-00-DX1.9CB478BC-3470-4930-976B-0419B180D57F-1",
    "image": "TCGA-LIHC/TCGA-CC-5263-01Z-00-DX1.9CB478BC-3470-4930-976B-0419B180D57F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of undifferentiated carcinoma with TNM staging of T3N0M0 and IHC results showing negative for ER, PR, and Her-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The undifferentiated status indicates an aggressive cancer type, the T3 stage suggests a larger tumor, and the triple-negative IHC profile limits the available targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BC-4072-01Z-00-DX1.8D27B669-CD01-4018-828E-1B87AA1649B5-1",
    "image": "TCGA-LIHC/TCGA-BC-4072-01Z-00-DX1.8D27B669-CD01-4018-828E-1B87AA1649B5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of hepatocellular carcinoma, TNM staging of T3M0N0, and IHC results showing strong positive AFP staining and thickened hepatocyte trabeculae, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T3 suggests a more advanced primary tumor without lymph node involvement or distant metastasis, and the strong AFP positivity indicates aggressive tumor biology."
      }
    ]
  },
  {
    "id": "TCGA-EP-A3JL-01Z-00-DX1.E53B8DA5-DD45-43FA-981F-4B793D4EDD33-1",
    "image": "TCGA-LIHC/TCGA-EP-A3JL-01Z-00-DX1.E53B8DA5-DD45-43FA-981F-4B793D4EDD33.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T1MXNX, and IHC results confirming HCC, with positive Heppar1 staining and negative CK7, CK20, and CDX-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status and the early-stage cancer (T1) indicate a potentially favorable outcome, although the unknown lymph node and metastasis status require cautious optimism."
      }
    ]
  },
  {
    "id": "TCGA-RC-A6M4-01Z-00-DX1.94EFD979-FEEF-406D-8253-EC9969682615-1",
    "image": "TCGA-LIHC/TCGA-RC-A6M4-01Z-00-DX1.94EFD979-FEEF-406D-8253-EC9969682615.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T3MXNX, and IHC findings of positive CEA(p) and negative CD10 (canalicular pattern), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status and TNM staging indicating a larger tumor (T3) with unknown lymph node and metastasis status suggest a potentially aggressive disease with uncertain spread."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9H7-01Z-00-DX1.E61F4D00-5D48-412C-A6EB-DD731C5A3ECE-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9H7-01Z-00-DX1.E61F4D00-5D48-412C-A6EB-DD731C5A3ECE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma with TNM staging of T1MXN0 and IHC results showing positive Hep-Par 1 and negative CK7, CK20, CK19, and Chromogranin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status and low TNM stage (T1, no lymph node involvement) indicate a less aggressive tumor with a better potential outcome."
      }
    ]
  },
  {
    "id": "TCGA-CC-5262-01Z-00-DX1.B750BE18-3C41-4355-A8CE-20FCEB1CB2C9-1",
    "image": "TCGA-LIHC/TCGA-CC-5262-01Z-00-DX1.B750BE18-3C41-4355-A8CE-20FCEB1CB2C9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of hepatocellular carcinoma, TNM staging of T4M0N0, and IHC results indicating negative ER, PR, HER-2/neu, and T-cell markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging of T4 indicates advanced local disease, while the negative results for common markers suggest limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-UB-A7MA-01Z-00-DX1.13804B83-8203-4A32-B8DE-5D1823EEC027-1",
    "image": "TCGA-LIHC/TCGA-UB-A7MA-01Z-00-DX1.13804B83-8203-4A32-B8DE-5D1823EEC027.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated mixed hepatocellular/cholangiocarcinoma, TNM staging of T2BM0N0, and the IHC results including strong CK19 positivity and brisk MIB1 proliferation, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of mixed hepatocellular/cholangiocarcinoma, moderate differentiation, TNM staging of T2B, and high MIB1 proliferation index indicate a more aggressive tumor with intermediate stage disease."
      }
    ]
  },
  {
    "id": "TCGA-UB-AA0U-01Z-00-DX1.FB596ABD-A3B0-4EC8-B154-D751C7BFE0CE-1",
    "image": "TCGA-LIHC/TCGA-UB-AA0U-01Z-00-DX1.FB596ABD-A3B0-4EC8-B154-D751C7BFE0CE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T2MXNX, and IHC results showing positive Arginase-1 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status and T2 staging, indicating multiple tumors or a single tumor with vascular invasion, contribute to a more concerning outlook, even though precise lymph node involvement and metastasis status are unclear."
      }
    ]
  },
  {
    "id": "TCGA-UB-A7MF-01Z-00-DX1.BED80F46-51CB-4453-B094-DA6B812D1A1A-1",
    "image": "TCGA-LIHC/TCGA-UB-A7MF-01Z-00-DX1.BED80F46-51CB-4453-B094-DA6B812D1A1A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T3aMXNX, and IHC results showing CD34 positivity and loss of MSH6 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3a) indicates significant tumor size or multifocal involvement, and the loss of MSH6 suggests potential genomic instability, both of which are associated with more aggressive disease and poorer outcomes."
      }
    ]
  },
  {
    "id": "TCGA-DD-A3A8-01Z-00-DX1.94F0BAEE-80BC-4B2D-AA75-63EE77100A7E-1",
    "image": "TCGA-LIHC/TCGA-DD-A3A8-01Z-00-DX1.94F0BAEE-80BC-4B2D-AA75-63EE77100A7E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of grade 2 hepatocellular carcinoma with TNM staging of T2M0N0 and IHC results showing negative insulin staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The grade 2 hepatocellular carcinoma and TNM staging of T2 (indicating a larger or multiple tumors) are associated with a more challenging disease course, despite the absence of metastasis (M0) and lymph node involvement (N0)."
      }
    ]
  },
  {
    "id": "TCGA-DD-A3A6-01Z-00-DX1.FCF4A7E7-A0F9-4B5D-B751-D990703EA261-1",
    "image": "TCGA-LIHC/TCGA-DD-A3A6-01Z-00-DX1.FCF4A7E7-A0F9-4B5D-B751-D990703EA261.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Grade 2 hepatocellular carcinoma, TNM staging of T2N0M0, and IHC results showing positivity for CAM 5.2, vimentin, alpha fetoprotein, and HMB-45, with negative p-CEA, S-100, and actin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2 stage indicates a larger tumor with possible blood vessel invasion, and Grade 2 suggests moderate differentiation, which may lead to a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9H1-01Z-00-DX1.FE4D124E-AB92-4083-8D09-F025B0C637EB-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9H1-01Z-00-DX1.FE4D124E-AB92-4083-8D09-F025B0C637EB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of hepatocellular carcinoma with TNM staging of T1MXNX and IHC results showing positive AFP, Hep-Par1, CEA-p (canalicular pattern), CK7, and CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early TNM stage (T1) indicates a localized tumor without confirmed lymph node involvement or metastasis. Positive AFP and Hep-Par1 support the diagnosis and can guide effective treatment."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9H6-01Z-00-DX1.B805A8D8-B75D-449F-8D1A-8E948ED12757-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9H6-01Z-00-DX1.B805A8D8-B75D-449F-8D1A-8E948ED12757.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T1MXNX, and IHC results showing positive HepPar-1 and negative Alpha Fetoprotein, Cytokeratin 7, and Cytokeratin 20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The tumor is moderately differentiated and localized (T1), indicating a less aggressive disease and potentially effective local treatment options. However, the uncertainty in nodal and metastatic status (MXNX) should be clarified for a more comprehensive prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BC-A5W4-01Z-00-DX1.57017E96-B611-420D-BEED-021B928A1BA8-1",
    "image": "TCGA-LIHC/TCGA-BC-A5W4-01Z-00-DX1.57017E96-B611-420D-BEED-021B928A1BA8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of hepatocellular carcinoma, TNM staging of T3aM0NX, and IHC results showing positive Glypican 3 and HEPAR-1 in certain areas, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3a) suggests significant tumor size and/or nodularity, which is associated with a more aggressive disease and less favorable outcomes."
      }
    ]
  },
  {
    "id": "TCGA-2Y-A9H8-01Z-00-DX1.1993AB53-D47B-4E15-BC97-B9E4B1F40A80-1",
    "image": "TCGA-LIHC/TCGA-2Y-A9H8-01Z-00-DX1.1993AB53-D47B-4E15-BC97-B9E4B1F40A80.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of pT2MXNX, and IHC results showing positivity for AFP, HepPar1, and canalicular pattern of CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of vascular invasion (pT2 stage), moderately differentiated status, and cirrhosis are indicative of more aggressive disease and potential for poor outcomes."
      }
    ]
  },
  {
    "id": "TCGA-FV-A2QR-01Z-00-DX1.2A2C52AC-8A5F-4E8E-95FE-C653D424FC21-1",
    "image": "TCGA-LIHC/TCGA-FV-A2QR-01Z-00-DX1.2A2C52AC-8A5F-4E8E-95FE-C653D424FC21.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of grade I hepatocellular carcinoma with TNM staging of T1N0M0 and IHC results showing positive CK7, CK20, HepPar-1, CK8/18, Vimentin, and Alpha-1 antitrypsin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low histologic grade (grade I) and early TNM stage (T1N0M0) suggest limited disease involvement and a higher likelihood of favorable outcomes."
      }
    ]
  },
  {
    "id": "TCGA-DD-A1EK-01Z-00-DX1.676881B7-C16A-4097-9859-97B0340A64D1-1",
    "image": "TCGA-LIHC/TCGA-DD-A1EK-01Z-00-DX1.676881B7-C16A-4097-9859-97B0340A64D1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T4M1N0, and IHC results showing positive Polyclonal CEA and Hep-1 but negative AFP and Cytokeratin 7, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging of T4M1N0 indicates extensive local disease with distant metastasis, which generally correlates with a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-BC-A10W-01Z-00-DX1.93D364F9-1161-4D75-952F-D7F3167CB7BF-1",
    "image": "TCGA-LIHC/TCGA-BC-A10W-01Z-00-DX1.93D364F9-1161-4D75-952F-D7F3167CB7BF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated hepatocellular carcinoma, TNM staging of T4MXNX, and IHC results showing positive cytoplasmic positivity for Cytokeratin 20 and negative for Cytokeratin 7 and EMA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status, advanced T4 staging, and uncertain metastatic (MX) and nodal (NX) status indicate an aggressive disease with a high likelihood of poor outcomes."
      }
    ]
  },
  {
    "id": "TCGA-RC-A7SB-01Z-00-DX1.2F9AD3F0-68C1-443F-9E4C-47DB92302543-1",
    "image": "TCGA-LIHC/TCGA-RC-A7SB-01Z-00-DX1.2F9AD3F0-68C1-443F-9E4C-47DB92302543.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of hepatocellular carcinoma with focal sarcomatoid differentiation, TNM staging of T2N0M0, and immunohistochemistry results showing positive Hepatocyte, focal positive Cytokeratin 7 and Vimentin, and positive Can5.2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of sarcomatoid differentiation, indicating a more aggressive tumor phenotype coupled with the intermediate TNM stage (T2N0M0), suggests a more challenging treatment and survival outlook."
      }
    ]
  },
  {
    "id": "TCGA-K7-A5RF-01Z-00-DX1.0B1FE587-D6F7-40E4-8F18-B37948336845-1",
    "image": "TCGA-LIHC/TCGA-K7-A5RF-01Z-00-DX1.0B1FE587-D6F7-40E4-8F18-B37948336845.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated hepatocellular carcinoma, TNM staging of T1MXNX, and IHC results showing positive GLYPICAN-3 and CEA (canalicular pattern), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The well-differentiated status and early TNM stage (T1) suggest a less aggressive disease, while positive markers such as GLYPICAN-3 and CEA in a canalicular pattern support the hepatocellular carcinoma diagnosis."
      }
    ]
  },
  {
    "id": "TCGA-ED-A627-01Z-00-DX1.B3E203DC-0ECB-4819-A9CF-6670FE3753BC-1",
    "image": "TCGA-LIHC/TCGA-ED-A627-01Z-00-DX1.B3E203DC-0ECB-4819-A9CF-6670FE3753BC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated hepatocellular carcinoma, TNM staging of T1M0NX, and IHC results showing positivity for CD10, Hepart, and AFP, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer's moderately differentiated status and early-stage (T1) suggest less aggressive behavior, and the positive IHC markers confirm the diagnosis, aiding in targeted management strategies."
      }
    ]
  },
  {
    "id": "TCGA-MR-A8JO-01Z-00-DX1.FB4668E2-B5EA-402F-AB15-8C22C724E002-1",
    "image": "TCGA-LIHC/TCGA-MR-A8JO-01Z-00-DX1.FB4668E2-B5EA-402F-AB15-8C22C724E002.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, fibrolamellar variant, TNM staging of T1MXN0, and IHC results showing positivity for CK7 and CD68, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The fibrolamellar variant generally has a better prognosis compared to typical hepatocellular carcinoma, and the early TNM stage (T1, no node involvement) suggests limited disease spread."
      }
    ]
  },
  {
    "id": "TCGA-2V-A95S-01Z-00-DX1.9DFA6FC7-87A6-4C14-9A39-E3F12B01C4D4-1",
    "image": "TCGA-LIHC/TCGA-2V-A95S-01Z-00-DX1.9DFA6FC7-87A6-4C14-9A39-E3F12B01C4D4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, TNM staging of T2MXNX, and IHC results showing strong positivity for Glypican 3 with negative CK, CK20, and Hepar-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T2 suggests a larger tumor with possible vascular invasion, and the undetermined MX and NX statuses complicate a clear assessment of metastasis and lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-DD-AACU-01Z-00-DX1.6E322E50-8576-4D09-9480-1D2880317178-1",
    "image": "TCGA-LIHC/TCGA-DD-AACU-01Z-00-DX1.6E322E50-8576-4D09-9480-1D2880317178.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of hepatocellular carcinoma, TNM staging of T1N0M0, and IHC results showing CD34 positivity in the tumor but negative in the liver, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early TNM staging (T1N0M0) indicates a smaller, localized tumor without metastasis, and CD34 positivity helps in confirming the diagnosis of hepatocellular carcinoma, supporting potential effective local treatment approaches."
      }
    ]
  },
  {
    "id": "TCGA-ZP-A9D4-01Z-00-DX1.306ADF14-E71A-4E44-BF28-F7733A1937EC-1",
    "image": "TCGA-LIHC/TCGA-ZP-A9D4-01Z-00-DX1.306ADF14-E71A-4E44-BF28-F7733A1937EC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis for a patient with well-differentiated hepatocellular carcinoma, TNM staging of T1MXNX, and IHC findings showing focal positivity for Glypican-3 good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The well-differentiated status and low TNM stage (T1) suggest early-stage disease with a potentially favorable outcome, though accurate assessment of metastasis and lymph nodes is limited due to MX and NX status."
      }
    ]
  },
  {
    "id": "TCGA-ZS-A9CF-01Z-00-DX1.34B7DB68-24A7-46A0-B7D6-EE3344D4919A-1",
    "image": "TCGA-LIHC/TCGA-ZS-A9CF-01Z-00-DX1.34B7DB68-24A7-46A0-B7D6-EE3344D4919A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated hepatocellular carcinoma (grade 2), TNM staging of T2MXNX, and IHC results showing positive HepPar1, positive CD10 with a distinct canalicular pattern, and a high proportion of MIB1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated grade (grade 2), the T2 status indicating a larger tumor, and the high MIB1 suggesting increased cell proliferation indicate a more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-WQ-A9G7-01Z-00-DX1.45C6F0D2-3477-410A-B0E7-FF6B2069E7A1-1",
    "image": "TCGA-LIHC/TCGA-WQ-A9G7-01Z-00-DX1.45C6F0D2-3477-410A-B0E7-FF6B2069E7A1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated hepatocellular carcinoma, TNM staging of T3AM0NX, and IHC results including positive Glypican 3 and MOC-31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status, advanced TNM stage (T3A), and specific IHC markers suggest a more aggressive disease with lower chances for curative treatment."
      }
    ]
  },
  {
    "id": "TCGA-BC-A3KF-01Z-00-DX1.F3B071B2-8C62-4867-8F60-6E207BE1EDF4-1",
    "image": "TCGA-LIHC/TCGA-BC-A3KF-01Z-00-DX1.F3B071B2-8C62-4867-8F60-6E207BE1EDF4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, TNM staging of T1M0NX, and IHC results showing positive HepPar-1 and CD31 (outlining blood vessels), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early TNM stage (T1M0NX) indicates the tumor is small and has not metastasized, and the positive HepPar-1 confirms the diagnosis of hepatocellular carcinoma, facilitating targeted treatment."
      }
    ]
  },
  {
    "id": "TCGA-DD-AACN-01Z-00-DX1.A52D7AD1-DBEE-4AD7-8965-6ABCD224A643-1",
    "image": "TCGA-LIHC/TCGA-DD-AACN-01Z-00-DX1.A52D7AD1-DBEE-4AD7-8965-6ABCD224A643.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of hepatocellular carcinoma, poorly differentiated with cholangiocytic differentiation, TNM staging of T1N0M0, and IHC results showing focal positivity for CK7 and CK19, general positivity for CK and Hepatocyte, and negative AFP, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status signifies a more aggressive tumor despite early TNM staging (T1N0M0), and cholangiocytic differentiation can complicate the disease course."
      }
    ]
  },
  {
    "id": "TCGA-DD-AACG-01Z-00-DX1.7B625854-0DEF-4CD1-9D01-EE685671DE84-1",
    "image": "TCGA-LIHC/TCGA-DD-AACG-01Z-00-DX1.7B625854-0DEF-4CD1-9D01-EE685671DE84.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated hepatocellular carcinoma, TNM staging of T2N0M0, and IHC results with negative CD86, positive Hepatocyte, and negative CK7, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates a more aggressive cancer, and while the TNM staging shows no lymph node involvement or metastasis, the T2 classification suggests larger or multiple tumors, contributing to the overall poorer outlook."
      }
    ]
  },
  {
    "id": "TCGA-50-8457-01Z-00-DX1.F4B6ECCE-F22B-43FC-9A08-4366A24A67A4-1",
    "image": "TCGA-LUAD/TCGA-50-8457-01Z-00-DX1.F4B6ECCE-F22B-43FC-9A08-4366A24A67A4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive adenocarcinoma, TNM staging of T1AM0N0, and IHC results showing reactivity to TTF-1 and Napsin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status and early-stage TNM classification (T1AM0N0) indicate a less aggressive disease, while the positive TTF-1 and Napsin suggest a primary lung origin, aiding in targeted treatment approaches."
      }
    ]
  },
  {
    "id": "TCGA-50-8459-01Z-00-DX1.24D876E7-5265-4C5D-A215-0BAE5450EEF3-1",
    "image": "TCGA-LUAD/TCGA-50-8459-01Z-00-DX1.24D876E7-5265-4C5D-A215-0BAE5450EEF3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated mucinous adenocarcinoma, TNM staging of T3N0M0, and IHC results showing positive TTF-1, negative p63, and negative Cytokeratin 5/6, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate to poor. The moderately differentiated status and T3 stage indicate a significant tumor size without lymph node involvement or metastasis, suggesting a more advanced disease that can still be managed but may be more challenging."
      }
    ]
  },
  {
    "id": "TCGA-73-4677-01Z-00-DX1.b557785c-9ccc-42a7-bb54-7bb47638ddfc-1",
    "image": "TCGA-LUAD/TCGA-73-4677-01Z-00-DX1.b557785c-9ccc-42a7-bb54-7bb47638ddfc.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2AM0N0, and IHC results showing negative stains for microorganisms, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status and lack of lymph node involvement (N0) suggest a less aggressive disease, and the absence of microorganisms indicates no complicating infections."
      }
    ]
  },
  {
    "id": "TCGA-50-6597-01Z-00-DX1.ec7fc0b2-78a1-4384-bddd-e89f02ee5eb6-1",
    "image": "TCGA-LUAD/TCGA-50-6597-01Z-00-DX1.ec7fc0b2-78a1-4384-bddd-e89f02ee5eb6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive adenocarcinoma with components of typical carcinoid, moderately differentiated, and angiolymphatic and visceral pleural invasion, with TNM staging of T2N0M0 and IHC results showing positive TTF-1 and Synaptophysin, and negative COX2 and Calcitonin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of angiolymphatic and visceral pleural invasion, along with moderately differentiated cancer and T2 staging, suggests a higher potential for aggressive disease despite the absence of lymph node involvement (N0)."
      }
    ]
  },
  {
    "id": "TCGA-95-7944-01Z-00-DX1.E66A3565-7B0D-412B-9C0C-81D7397E8B87-1",
    "image": "TCGA-LUAD/TCGA-95-7944-01Z-00-DX1.E66A3565-7B0D-412B-9C0C-81D7397E8B87.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1AM0N0, and IHC results showing negative TTI-1, p63, and CkS, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status indicates a more aggressive tumor, and the negative IHC markers limit potential targeted therapy options, despite the early TNM stage."
      }
    ]
  },
  {
    "id": "TCGA-86-8076-01Z-00-DX1.e7378b2f-e20e-4d2f-a86c-3a8ead08a385-1",
    "image": "TCGA-LUAD/TCGA-86-8076-01Z-00-DX1.e7378b2f-e20e-4d2f-a86c-3a8ead08a385.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated papillary adenocarcinoma, TNM staging of T1N0M0, and IHC results showing TTF1+ and CD15+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The well-differentiated nature of the adenocarcinoma, along with early-stage TNM (T1N0M0) and positive TTF1, generally indicate a less aggressive cancer with favorable outcomes."
      }
    ]
  },
  {
    "id": "TCGA-55-8510-01Z-00-DX1.BB1EAC72-6215-400B-BCBF-E3D51A60182D-1",
    "image": "TCGA-LUAD/TCGA-55-8510-01Z-00-DX1.BB1EAC72-6215-400B-BCBF-E3D51A60182D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated adenocarcinoma, TNM staging of T2AMXN0, and IHC results showing positive CK7, MOC-31, Napsin-A, TTF-1, and a low Ki-67 proliferative index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of poorly differentiated adenocarcinoma and the T2 stage imply a more aggressive and advanced disease, although a low Ki-67 index might slightly mitigate the overall prediction."
      }
    ]
  },
  {
    "id": "TCGA-55-6642-01Z-00-DX1.0487cfc6-8216-4da3-aae1-a35452e9e4f6-1",
    "image": "TCGA-LUAD/TCGA-55-6642-01Z-00-DX1.0487cfc6-8216-4da3-aae1-a35452e9e4f6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of grade 2 adenocarcinoma with TNM staging of T2MXN0 and IHC results showing TTF-1 positive tumor cells, synaptophysin positive spindle cell tumor, and chromogranin positive spindle cell tumor, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate. The intermediate grade (histologic grade 2) and the TNM stage suggesting a primary lung tumor with no confirmed metastasis (MXN0) imply a reasonably balanced outlook, though the presence of neuroendocrine differentiation (synaptophysin and chromogranin positivity) can vary prognostically."
      }
    ]
  },
  {
    "id": "TCGA-55-5899-01Z-00-DX1.faa65b08-150c-4c74-95aa-1e8743f0152c-1",
    "image": "TCGA-LUAD/TCGA-55-5899-01Z-00-DX1.faa65b08-150c-4c74-95aa-1e8743f0152c.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, TNM staging of T1AM0N1, and IHC results showing positive CK7 and TTF-1, negative CK20, high molecular weight keratin SK, and p63, and weak positivity for synaptophysin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of lymph node involvement (N1) and weak positivity for synaptophysin suggest more aggressive disease behavior despite the early tumor stage (T1A)."
      }
    ]
  },
  {
    "id": "TCGA-78-7159-01Z-00-DX1.399d865f-f4f9-4602-b15b-908be0afe459-1",
    "image": "TCGA-LUAD/TCGA-78-7159-01Z-00-DX1.399d865f-f4f9-4602-b15b-908be0afe459.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of adenocarcinoma, TNM staging of T1M0NX, and IHC results showing positive CK7 and TTF-1 with negative CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is uncertain. The early TNM stage (T1M0) is favorable, but the unknown lymph node status (NX) limits a definitive prognosis. Positive CK7 and TTF-1 suggest a lung origin, generally associated with a better outlook if confined early."
      }
    ]
  },
  {
    "id": "TCGA-L4-A4E6-01Z-00-DX1.1B537DE0-2CE3-4B90-9ED3-71F1F8747EE9-1",
    "image": "TCGA-LUAD/TCGA-L4-A4E6-01Z-00-DX1.1B537DE0-2CE3-4B90-9ED3-71F1F8747EE9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1N0M0, and IHC results showing TTF1 positive and P63 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status indicates a more aggressive and less predictable behavior, despite the early TNM stage. The TTF1 positivity suggests a likely lung origin, which also influences disease management."
      }
    ]
  },
  {
    "id": "TCGA-62-A471-01Z-00-DX1.51A235BB-7F67-4C0D-8B15-2E26116D8822-1",
    "image": "TCGA-LUAD/TCGA-62-A471-01Z-00-DX1.51A235BB-7F67-4C0D-8B15-2E26116D8822.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of grade 3 adenocarcinoma (NOS), TNM staging of T2BM0N1, and IHC results showing CK7 positivity and Ki-67 index of 40%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The grade 3 classification, TNM staging indicating lymph node involvement (N1), and high Ki-67 index suggest a more aggressive tumor behavior and higher likelihood of disease progression."
      }
    ]
  },
  {
    "id": "TCGA-05-4427-01Z-00-DX1.36CF4E93-3FBB-4346-A26B-85F0D9D0575D-1",
    "image": "TCGA-LUAD/TCGA-05-4427-01Z-00-DX1.36CF4E93-3FBB-4346-A26B-85F0D9D0575D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of mixed large-cell and polymorphocellular adenocarcinoma, predominantly undifferentiated, with TNM staging of T2N1M0, and IHC results showing high positivity for low molecular weight cytokeratins and TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The undifferentiated nature of the adenocarcinoma and TNM staging with lymph node involvement (N1) indicate a more aggressive disease, despite the high TTF-1 positivity."
      }
    ]
  },
  {
    "id": "TCGA-86-6851-01Z-00-DX1.0b13e600-fd7b-44a2-9ec2-26e9938fb7bc-1",
    "image": "TCGA-LUAD/TCGA-86-6851-01Z-00-DX1.0b13e600-fd7b-44a2-9ec2-26e9938fb7bc.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient\u2019s diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1BM0N1, and IHC results showing positivity for Cytokeratin 7, TTF-1, and Napsin-A with negative Cytokeratin 5/6 and rare focal positivity for p63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status and TNM stage indicating lymph node involvement (N1), combined with the IHC profile, suggest a more aggressive cancer type likely originating in the lung."
      }
    ]
  },
  {
    "id": "TCGA-MN-A4N5-01Z-00-DX1.D0FBA0D2-6245-4EFD-AF2B-849215600DBE-1",
    "image": "TCGA-LUAD/TCGA-MN-A4N5-01Z-00-DX1.D0FBA0D2-6245-4EFD-AF2B-849215600DBE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive poorly differentiated adenocarcinoma, TNM staging of T1AM0N0, and IHC results showing positivity for CK7, TTF-1, Chromogranin, and Synaptophysin with negativity for CK20 and ALK protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated nature of the adenocarcinoma suggests a more aggressive disease course, although the low TNM staging indicates limited spread."
      }
    ]
  },
  {
    "id": "TCGA-55-7227-01Z-00-DX1.e1a9e09c-4a50-4ee5-b1e4-2c7ae34dc913-1",
    "image": "TCGA-LUAD/TCGA-55-7227-01Z-00-DX1.e1a9e09c-4a50-4ee5-b1e4-2c7ae34dc913.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive moderately differentiated adenocarcinoma, TNM staging of T3MXN1, and IHC results showing positive Cytokeratin OSCAR and TTF-1 with visceral pleural invasion indicated by elastin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The moderately differentiated adenocarcinoma with T3 staging, lymph node involvement (N1), and evidence of visceral pleural invasion indicate a more advanced and aggressive disease state."
      }
    ]
  },
  {
    "id": "TCGA-49-AARN-01Z-00-DX1.E13AA041-978E-427D-AFA5-D3180224A03A-1",
    "image": "TCGA-LUAD/TCGA-49-AARN-01Z-00-DX1.E13AA041-978E-427D-AFA5-D3180224A03A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of infiltrating moderately differentiated adenocarcinoma, TNM staging of T1MXN0, and IHC results showing positive TTF-1 with negative estrogen, progesterone receptors, and gross cystic disease fluid protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The low TNM stage (T1NXN0) indicates minimal disease spread, and moderately differentiated adenocarcinomas generally have a better outlook compared to poorly differentiated ones."
      }
    ]
  },
  {
    "id": "TCGA-44-7669-01Z-00-DX1.34d0c9ac-d3dc-4a5e-b99c-a8c1c1e120d1-1",
    "image": "TCGA-LUAD/TCGA-44-7669-01Z-00-DX1.34d0c9ac-d3dc-4a5e-b99c-a8c1c1e120d1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive poorly differentiated adenocarcinoma, TNM staging of T1BMXN1, and IHC results showing TTF-1 and CEA positivity with negative P63 and Mucicarmine, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma and the nodal involvement (N1) suggest a more aggressive cancer with a higher risk of recurrence and metastasis."
      }
    ]
  },
  {
    "id": "TCGA-99-7458-01Z-00-DX1.10ea0b2c-c763-40d1-83a4-3d4ae957fdb0-1",
    "image": "TCGA-LUAD/TCGA-99-7458-01Z-00-DX1.10ea0b2c-c763-40d1-83a4-3d4ae957fdb0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of well-differentiated adenocarcinoma with bronchioloalveolar features, TNM staging of T4N0M0, and IHC results showing positivity for chromogranin and synaptophysin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging of T4 indicates a large, locally advanced tumor, despite the well-differentiated status, which typically suggests less aggressive behavior. Positivity for chromogranin and synaptophysin confirms the presence of neuroendocrine features, which can complicate the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-69-7978-01Z-00-DX1.90a2bf2f-18e2-4bfe-b858-d2de619e2493-1",
    "image": "TCGA-LUAD/TCGA-69-7978-01Z-00-DX1.90a2bf2f-18e2-4bfe-b858-d2de619e2493.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, mixed type, TNM staging of T2BMxN1, and IHC results showing positive TTF-1 and negative P63 with EGFR mutation analysis pending, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a significant tumor size and lymph node involvement, and the uncertain metastatic status (Mx) complicates the prognosis despite the positive TTF-1 marker."
      }
    ]
  },
  {
    "id": "TCGA-55-8204-01Z-00-DX1.30ba69f3-53f1-41cc-826c-20dce3cfe86b-1",
    "image": "TCGA-LUAD/TCGA-55-8204-01Z-00-DX1.30ba69f3-53f1-41cc-826c-20dce3cfe86b.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated non-small cell carcinoma (adenocarcinoma), TNM staging of T2AMXN0, and IHC results with positivity for TTF-1, CK7, and p63, and negativity for CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and the T2A stage indicate a more aggressive tumor, while the TNM staging with an undefined metastasis status (MX) further complicates prognosis clarity."
      }
    ]
  },
  {
    "id": "TCGA-50-7109-01Z-00-DX1.08f6420c-baa2-4e79-908e-ebbdeec503a6-1",
    "image": "TCGA-LUAD/TCGA-50-7109-01Z-00-DX1.08f6420c-baa2-4e79-908e-ebbdeec503a6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis good or poor for the patient with a diagnosis of moderately differentiated adenocarcinoma, TNM staging of T1N0M0, and IHC results showing positive TTF-1, rare cells positive for p63, and negative Cytokeratin 5/6?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated status and early TNM stage (T1N0M0) suggest a localized and potentially less aggressive tumor, while the IHC profile supports a specific diagnosis that could respond well to treatment."
      }
    ]
  },
  {
    "id": "TCGA-05-4410-01Z-00-DX1.E5B66334-4949-4F45-9200-296B1A2F1AD5-1",
    "image": "TCGA-LUAD/TCGA-05-4410-01Z-00-DX1.E5B66334-4949-4F45-9200-296B1A2F1AD5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma with TNM staging of T2N0M0 and IHC results showing positive Cytokeratin 7 and TTF-1 but negative Cytokertin 20 and CDX-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate to relatively good. The T2N0M0 stage indicates that the cancer is locally advanced but has not spread to lymph nodes or distant organs, and the positive Cytokeratin 7 and TTF-1 suggest a likely lung origin, which may respond to targeted treatments effectively."
      }
    ]
  },
  {
    "id": "TCGA-55-6983-01Z-00-DX1.8f940a64-1f1b-4e6e-99ea-418175be2b3f-1",
    "image": "TCGA-LUAD/TCGA-55-6983-01Z-00-DX1.8f940a64-1f1b-4e6e-99ea-418175be2b3f.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of mucinous adenocarcinoma, TNM staging of T2N1M0, and IHC results showing positivity for CK7 and TTF-1, but negativity for CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates tumor invasion and nodal involvement (N1), which suggests a more advanced disease and higher potential for recurrence and metastasis."
      }
    ]
  },
  {
    "id": "TCGA-86-7954-01Z-00-DX1.0a063ee6-18b7-4b66-9726-04fb452156cb-1",
    "image": "TCGA-LUAD/TCGA-86-7954-01Z-00-DX1.0a063ee6-18b7-4b66-9726-04fb452156cb.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive poorly differentiated adenocarcinoma, TNM staging of T2N0M0, and IHC results showing CK7 positivity, focal CK20 positivity, TTF-1 positivity, CDX2 negativity, and Napsin A positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma suggests a more aggressive tumor, and despite the TNM staging of T2N0M0 indicating no lymph node involvement, the prognosis remains unfavorable due to the high-grade pathology."
      }
    ]
  },
  {
    "id": "TCGA-55-6984-01Z-00-DX1.d53e387a-9618-4486-98f3-a75604f25a7d-1",
    "image": "TCGA-LUAD/TCGA-55-6984-01Z-00-DX1.d53e387a-9618-4486-98f3-a75604f25a7d.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2N1M0, and IHC results showing CK7 positive, CK20 negative, and very focally positive TTF1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status, along with TNM staging indicating lymph node involvement (N1), suggests a more advanced disease with a higher risk of recurrence and spread."
      }
    ]
  },
  {
    "id": "TCGA-NJ-A4YQ-01Z-00-DX1.56C29975-77E9-4822-A9E1-83AD70D6C5F7-1",
    "image": "TCGA-LUAD/TCGA-NJ-A4YQ-01Z-00-DX1.56C29975-77E9-4822-A9E1-83AD70D6C5F7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive poorly differentiated adenocarcinoma (grade 3), TNM staging of T1BM0N0, and IHC results showing positivity for CK7, weak focal positivity for TTF-1, and negative CK5/6 and P63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (poorly differentiated), even with early TNM stage (T1BM0N0), suggests more aggressive tumor behavior and potential for poorer outcomes."
      }
    ]
  },
  {
    "id": "TCGA-64-5775-01Z-00-DX1.9A338C1A-CDB6-41AF-B6D5-EDE608B5E3E1-1",
    "image": "TCGA-LUAD/TCGA-64-5775-01Z-00-DX1.9A338C1A-CDB6-41AF-B6D5-EDE608B5E3E1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of adenocarcinoma, TNM staging of T4N0M0, and IHC results showing positivity for CK7, TTF-1, Cam 5.2, cytokeratin AE1/AE3, and vimentin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high TNM stage (T4) indicates advanced local disease, which significantly impacts overall prognosis despite the lack of lymph node involvement (N0) and no distant metastasis (M0)."
      }
    ]
  },
  {
    "id": "TCGA-05-4434-01Z-00-DX1.f3f5c89c-306f-4876-98fa-f7bd231f2e10-1",
    "image": "TCGA-LUAD/TCGA-05-4434-01Z-00-DX1.f3f5c89c-306f-4876-98fa-f7bd231f2e10.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of histologically mixed adenocarcinoma grade 3 (G3), TNM staging of T4M1N1, and IHC results showing positivity for low molecular weight keratins, high molecular weight keratins, and TTF1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (G3), advanced TNM stage with metastasis (T4M1N1), and immunohistochemistry results indicating a high degree of cellular differentiation suggest an aggressive disease with limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-55-6978-01Z-00-DX1.2ef6d6aa-2a19-4bce-b845-cc83ac81a1c3-1",
    "image": "TCGA-LUAD/TCGA-55-6978-01Z-00-DX1.2ef6d6aa-2a19-4bce-b845-cc83ac81a1c3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of non-small cell carcinoma, poorly differentiated, TNM staging of T2BMXN0, and IHC results showing patchy positive THF-1 and negative for p63, CK5/6, CK7, and CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status indicates aggressive behavior, and the TNM staging suggests a larger primary tumor with indeterminate metastatic status, which complicates the disease management."
      }
    ]
  },
  {
    "id": "TCGA-55-8619-01Z-00-DX1.46C7678A-6032-4C95-B535-85C87B92B6ED-1",
    "image": "TCGA-LUAD/TCGA-55-8619-01Z-00-DX1.46C7678A-6032-4C95-B535-85C87B92B6ED.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated adenocarcinoma with mucinous features, TNM staging of T3MXN0, and IHC results showing positive CK7 and patchy positivity for CDX2 and Villin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The well-differentiated tumor indicates a more favorable outlook, but the T3 staging suggests a locally advanced disease, which could complicate treatment and management."
      }
    ]
  },
  {
    "id": "TCGA-95-7043-01Z-00-DX1.AE0FD8AA-9B88-45FE-B247-402BED1285EF-1",
    "image": "TCGA-LUAD/TCGA-95-7043-01Z-00-DX1.AE0FD8AA-9B88-45FE-B247-402BED1285EF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenocarcinoma, mixed subtype; TNM staging of T1aMXN0; and IHC results showing CK7 positivity, TTF positivity, Napsin positivity, and mixed CK20 results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated nature of the adenocarcinoma indicates a more aggressive cancer, and the TNM staging with uncertain metastasis (MX) complicates the assessment further, suggesting a need for cautious optimism."
      }
    ]
  },
  {
    "id": "TCGA-44-8119-01Z-00-DX1.1EBEBFA7-22DB-4365-9DF8-C4E679C11312-1",
    "image": "TCGA-LUAD/TCGA-44-8119-01Z-00-DX1.1EBEBFA7-22DB-4365-9DF8-C4E679C11312.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated adenocarcinoma, TNM staging of T3N0M0, and IHC results showing positive CEA and TTF-1 with negative CK 5/6 and P63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates an aggressive tumor, and the TNM stage T3 implies a larger tumor size without lymph node involvement. Despite positive CEA and TTF-1, these factors collectively suggest a more challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-97-A4M5-01Z-00-DX1.283AFBA6-A349-425F-A18E-5CA186084C23-1",
    "image": "TCGA-LUAD/TCGA-97-A4M5-01Z-00-DX1.283AFBA6-A349-425F-A18E-5CA186084C23.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive mucinous adenocarcinoma, TNM staging of T1BM0N0, and IHC results showing positive CK7, TTF-1, and Napsin-A with negative CK20 and CDX-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated cancer, early TNM stage (T1BM0N0) with no lymph node involvement, and the IHC profile suggest a less aggressive disease and a more favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-55-7913-01Z-00-DX1.2295fcc5-70b0-412e-a1fd-b5366fce0739-1",
    "image": "TCGA-LUAD/TCGA-55-7913-01Z-00-DX1.2295fcc5-70b0-412e-a1fd-b5366fce0739.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated adenocarcinoma with TNM staging T1BMxN0 and IHC results showing positive TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The well-differentiated status, low T stage (T1), and absence of lymph node involvement (N0) indicate a less aggressive disease course, and positive TTF-1 is consistent with a lung primary, which often has better outcomes when detected early."
      }
    ]
  },
  {
    "id": "TCGA-55-7574-01Z-00-DX1.09639e6a-d85f-4d84-abbc-0f5a6d679683-1",
    "image": "TCGA-LUAD/TCGA-55-7574-01Z-00-DX1.09639e6a-d85f-4d84-abbc-0f5a6d679683.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenocarcinoma, TNM staging of T2AM0N0, and IHC results showing positive TTF-1, Napsin-A, CK7, and negative CK20, ER, and CDX-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated nature of the adenocarcinoma and the T2A staging indicate a more aggressive tumor type, while the absence of lymph node or distant metastases provides some balance to the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-44-A47A-01Z-00-DX1.62448803-3A7B-41EC-9794-67916DA0792E-1",
    "image": "TCGA-LUAD/TCGA-44-A47A-01Z-00-DX1.62448803-3A7B-41EC-9794-67916DA0792E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2AMXN0, and IHC results showing positive TTF-1, negative CK5/6, and weakly positive P63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The moderately differentiated adenocarcinoma suggests a better outcome than poorly differentiated forms, and the absence of lymph node involvement (N0) is positive, despite the current uncertainty in the MX status."
      }
    ]
  },
  {
    "id": "TCGA-69-A59K-01Z-00-DX1.01EAF520-9AC1-4ECC-8EF3-B9122924A1E3-1",
    "image": "TCGA-LUAD/TCGA-69-A59K-01Z-00-DX1.01EAF520-9AC1-4ECC-8EF3-B9122924A1E3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of adenocarcinoma, TNM staging of T3N0M0, and IHC results showing strong TTF-1 reactivity and no p63 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T3 indicates a larger primary tumor size without metastasis, and while strong TTF-1 reactivity suggests a primary lung origin, the overall prognosis is affected by the tumor's advanced local stage."
      }
    ]
  },
  {
    "id": "TCGA-49-6743-01Z-00-DX4.5ea81023-1372-48ed-88a8-374e2394d7f7-1",
    "image": "TCGA-LUAD/TCGA-49-6743-01Z-00-DX4.5ea81023-1372-48ed-88a8-374e2394d7f7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1MXN2, and IHC results showing positive TTF-1 and p53 with negative EGFR and KRAS mutations, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma and significant lymph node involvement (N2) suggest aggressive disease behavior, and the lack of EGFR and KRAS mutations limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-49-6743-01Z-00-DX1.ddae5601-6ffa-4a70-8755-8645d5e45135-1",
    "image": "TCGA-LUAD/TCGA-49-6743-01Z-00-DX1.ddae5601-6ffa-4a70-8755-8645d5e45135.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1MXN2, and IHC results showing positive TTF-1 and p53 with negative EGFR and KRAS mutations, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma and significant lymph node involvement (N2) suggest aggressive disease behavior, and the lack of EGFR and KRAS mutations limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-49-6743-01Z-00-DX2.f6b71e89-19ff-4d9b-a3f1-3a52949f1dc7-1",
    "image": "TCGA-LUAD/TCGA-49-6743-01Z-00-DX2.f6b71e89-19ff-4d9b-a3f1-3a52949f1dc7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1MXN2, and IHC results showing positive TTF-1 and p53 with negative EGFR and KRAS mutations, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma and significant lymph node involvement (N2) suggest aggressive disease behavior, and the lack of EGFR and KRAS mutations limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-49-6743-01Z-00-DX3.d391f3ab-e954-4f4f-996d-cd0420933ccf-1",
    "image": "TCGA-LUAD/TCGA-49-6743-01Z-00-DX3.d391f3ab-e954-4f4f-996d-cd0420933ccf.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1MXN2, and IHC results showing positive TTF-1 and p53 with negative EGFR and KRAS mutations, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma and significant lymph node involvement (N2) suggest aggressive disease behavior, and the lack of EGFR and KRAS mutations limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-NJ-A55O-01Z-00-DX1.8E23C821-B8BB-4D89-9E38-E97424A685CE-1",
    "image": "TCGA-LUAD/TCGA-NJ-A55O-01Z-00-DX1.8E23C821-B8BB-4D89-9E38-E97424A685CE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive adenocarcinoma, grade 1, with mucinous features, TNM staging of T1BM0N1, and IHC results showing positivity for CK7 and TTF-1 but negativity for CK20 and COX-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate. The well-differentiated (grade 1) status and the early T stage (T1B) are favorable, but the presence of lymph node involvement (N1) suggests a higher risk for disease spread, which tempers the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-97-A4LX-01Z-00-DX1.B2334672-A626-4E74-B4D1-A79F70F65909-1",
    "image": "TCGA-LUAD/TCGA-97-A4LX-01Z-00-DX1.B2334672-A626-4E74-B4D1-A79F70F65909.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of adenocarcinoma, mixed subtype, with a TNM staging of T2AM0N0 and IHC results showing TTF-1 and Napsin-A positivity and p63 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The absence of lymph node involvement (N0) and distant metastasis (M0), along with positivity for TTF-1 and Napsin-A, markers typically associated with better outcomes in lung adenocarcinomas, suggest a somewhat favorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-NJ-A55A-01Z-00-DX1.42C356FE-52A3-4A60-886B-75F84ADBC534-1",
    "image": "TCGA-LUAD/TCGA-NJ-A55A-01Z-00-DX1.42C356FE-52A3-4A60-886B-75F84ADBC534.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2N0M0, and IHC results showing TTF-1 positivity, CK7 positivity, and CK20 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The moderately differentiated adenocarcinoma and absence of lymph node metastasis (N0) are positive indicators, though the T2 staging suggests a larger tumor size."
      }
    ]
  },
  {
    "id": "TCGA-55-7994-01Z-00-DX1.a0858080-c471-4337-bc57-7af57e9d92d8-1",
    "image": "TCGA-LUAD/TCGA-55-7994-01Z-00-DX1.a0858080-c471-4337-bc57-7af57e9d92d8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenocarcinoma, histologic grade 3, TNM staging of T3MXN0, and IHC results showing positive CD68 and negative AE1/AE3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status (grade 3) and advanced local tumor size (T3) indicate aggressive disease, and the uncertainty in distant metastasis (MX) adds to the unfavorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-95-7948-01Z-00-DX1.FF1AEF38-19E5-4475-87C8-B318204FEF1D-1",
    "image": "TCGA-LUAD/TCGA-95-7948-01Z-00-DX1.FF1AEF38-19E5-4475-87C8-B318204FEF1D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, mixed subtype, TNM staging of T2AM0N0, and IHC results indicating visceral pleural invasion but compatible with a lung primary, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of visceral pleural invasion (T2A) indicates a more advanced local disease, which can be associated with a higher risk of recurrence and worse outcomes."
      }
    ]
  },
  {
    "id": "TCGA-95-A4VP-01Z-00-DX1.1B145AC0-2471-4974-BBB6-C88BDF0BE8BD-1",
    "image": "TCGA-LUAD/TCGA-95-A4VP-01Z-00-DX1.1B145AC0-2471-4974-BBB6-C88BDF0BE8BD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2BM0N2, and IHC results showing diffusely positive TTF-1 and focally positive synaptophysin in the tumor, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated adenocarcinoma and TNM staging indicating multiple regional lymph node involvements (N2) suggest a more advanced disease, which typically correlates with a less favorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-86-8279-01Z-00-DX1.fd12b60e-d181-454b-a655-298a973a849d-1",
    "image": "TCGA-LUAD/TCGA-86-8279-01Z-00-DX1.fd12b60e-d181-454b-a655-298a973a849d.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated carcinoma, TNM staging of T2aN1M0, and IHC results showing positivity for CD15, CK7, TTF1, CEA and negativity for CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status and TNM staging with lymph node involvement (N1) indicate a more aggressive cancer with a higher likelihood of spreading."
      }
    ]
  },
  {
    "id": "TCGA-55-7995-01Z-00-DX1.fef24d04-35a0-4f57-8f51-7ad602a78871-1",
    "image": "TCGA-LUAD/TCGA-55-7995-01Z-00-DX1.fef24d04-35a0-4f57-8f51-7ad602a78871.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1BM0N0, and IHC results showing TTF-1 positive and P40 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates a more aggressive cancer, despite the low TNM stage and absence of lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-67-6217-01Z-00-DX1.3fa5c69b-60d1-41fb-a86f-48f77d81285f-1",
    "image": "TCGA-LUAD/TCGA-67-6217-01Z-00-DX1.3fa5c69b-60d1-41fb-a86f-48f77d81285f.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma with a TNM staging of T2AM0N1 and IHC results showing positive Cytokeratin 5/6 and negative Synaptophysin and Chromogranin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T2AM0N1 indicates a primary tumor with regional lymph node involvement, which suggests a more advanced stage and potentially aggressive cancer behavior."
      }
    ]
  },
  {
    "id": "TCGA-86-8278-01Z-00-DX1.6500afef-f0f0-4e7c-a6c0-60da81993641-1",
    "image": "TCGA-LUAD/TCGA-86-8278-01Z-00-DX1.6500afef-f0f0-4e7c-a6c0-60da81993641.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated mucinous adenocarcinoma, TNM staging of T2N1M0, and IHC results showing CK7 positive and TTF1 positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status and TNM staging with T2 and N1 suggest a significant tumor size with lymph node involvement, which typically indicates a higher risk of disease progression."
      }
    ]
  },
  {
    "id": "TCGA-55-8513-01Z-00-DX1.E21776FE-DF49-48D1-90D6-6F71D0764492-1",
    "image": "TCGA-LUAD/TCGA-55-8513-01Z-00-DX1.E21776FE-DF49-48D1-90D6-6F71D0764492.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated invasive mucinous adenocarcinoma, TNM staging of T3MXN0, and IHC results showing CK7 positivity, weak Napsin-A positivity, and negative results for CK20, CDX2, Villin, and TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T3 stage indicates a locally advanced tumor, and the MX status implies uncertainty about metastasis, which complicates the outlook despite the well-differentiated nature of the tumor."
      }
    ]
  },
  {
    "id": "TCGA-55-7903-01Z-00-DX1.40fc5dcb-b5bb-46b4-90bd-2eeb3ea880f5-1",
    "image": "TCGA-LUAD/TCGA-55-7903-01Z-00-DX1.40fc5dcb-b5bb-46b4-90bd-2eeb3ea880f5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1BMXN0, and IHC results showing negative CK8/6 and p63, but positive TTF1 and CK7, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates a more aggressive tumor, and while the TNM staging shows a small tumor size and no regional lymph node involvement, the high potential for aggressive behavior remains concerning."
      }
    ]
  },
  {
    "id": "TCGA-MP-A4TK-01Z-00-DX1.57494698-D9D9-4C04-AAB2-16616CCFDCC9-1",
    "image": "TCGA-LUAD/TCGA-MP-A4TK-01Z-00-DX1.57494698-D9D9-4C04-AAB2-16616CCFDCC9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma with sarcomatoid differentiation, grade 4, TNM staging of T2MXN1, and IHC results showing positive CD20 and CD3 with mixed kappa and lambda staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade (grade 4) adenocarcinoma with sarcomatoid differentiation and lymph node involvement (N1) suggest a highly aggressive disease, while the IHC results indicate complex immunophenotypic characteristics."
      }
    ]
  },
  {
    "id": "TCGA-95-7947-01Z-00-DX1.44291078-2D8E-4E79-8FAB-439E52BAAD60-1",
    "image": "TCGA-LUAD/TCGA-95-7947-01Z-00-DX1.44291078-2D8E-4E79-8FAB-439E52BAAD60.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, mixed subtype, with TNM staging of T1aN0M0, and IHC results indicating positive CK7, negative CK20, positive TTF-1, negative Napsin A and Pax8, and focal positive Mucicarmine, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated adenocarcinoma and early TNM stage (T1aN0M0) suggest a localized tumor with no lymph node involvement or metastasis, indicating a better prognosis."
      }
    ]
  },
  {
    "id": "TCGA-NJ-A55R-01Z-00-DX1.2E2B3642-4E1C-47DB-AF7B-988D586C0986-1",
    "image": "TCGA-LUAD/TCGA-NJ-A55R-01Z-00-DX1.2E2B3642-4E1C-47DB-AF7B-988D586C0986.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive adenocarcinoma, TNM staging of T1BMXN0, and IHC results showing positivity for cytokeratin 7 and TTF-1 and negativity for cytokeratin 5,6 and P63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The early TNM stage (T1B, N0) suggests limited tumor size and no lymph node involvement, and the IHC profile supports a primary lung adenocarcinoma, which usually responds well to treatment at this early stage."
      }
    ]
  },
  {
    "id": "TCGA-44-2655-01Z-00-DX1.ee255271-780c-461c-ab23-5cd3504b5e4a-1",
    "image": "TCGA-LUAD/TCGA-44-2655-01Z-00-DX1.ee255271-780c-461c-ab23-5cd3504b5e4a.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T1N0M0, and IHC result showing TTF1 strongly positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated adenocarcinoma with early-stage TNM staging (T1N0M0) indicates limited disease spread and the strong positivity for TTF1 suggests a primary lung origin, both of which are favorable factors."
      }
    ]
  },
  {
    "id": "TCGA-69-7974-01Z-00-DX1.e4282067-fc3d-4fee-bae7-fe99000979d4-1",
    "image": "TCGA-LUAD/TCGA-69-7974-01Z-00-DX1.e4282067-fc3d-4fee-bae7-fe99000979d4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of adenocarcinoma with TNM staging of T2aN2M0 and IHC results showing diffuse positivity for TTF-1, focal positivity for p-63, and Cytokeratin CAM 5.2 highlighting tumor cells within lymphatic spaces, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging showing lymph node involvement (N2) indicates more advanced disease, and the presence of tumor cells within lymphatic spaces suggests a higher risk of metastasis."
      }
    ]
  },
  {
    "id": "TCGA-69-7973-01Z-00-DX1.aefb015a-cb51-425f-a80f-cd51091a0ee3-1",
    "image": "TCGA-LUAD/TCGA-69-7973-01Z-00-DX1.aefb015a-cb51-425f-a80f-cd51091a0ee3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of adenocarcinoma with TNM staging of T2AM0N0 and IHC results showing positive CAM 5.2 and TTF-1, focal positivity for Synaptophysin, and negative Chromogranin, p63, and CD56, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally intermediate. The T2A stage indicates a moderately advanced local tumor, while the absence of lymph node (N0) and distant metastasis (M0) is favorable. Positive TTF-1 suggests a lung origin, which impacts prognosis depending on other factors."
      }
    ]
  },
  {
    "id": "TCGA-97-8177-01Z-00-DX1.4c2ddf48-40d3-4fa0-8b5f-0485e8270ac7-1",
    "image": "TCGA-LUAD/TCGA-97-8177-01Z-00-DX1.4c2ddf48-40d3-4fa0-8b5f-0485e8270ac7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2AM0N0, and IHC results showing TTF1 positivity, EGFR L858R mutation, and wild-type KRAS, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status and early TNM stage (T2AM0N0) indicate less aggressive disease, and the presence of the EGFR L858R mutation opens up potential effective targeted therapy options, improving outcomes."
      }
    ]
  },
  {
    "id": "TCGA-38-7271-01Z-00-DX1.EF258BEB-8DEA-483E-823A-1E0B90AAA392-1",
    "image": "TCGA-LUAD/TCGA-38-7271-01Z-00-DX1.EF258BEB-8DEA-483E-823A-1E0B90AAA392.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T1N0M0, and IHC results showing immunoreactivity for TTF-1 and HER2 but no reactivity for GCDFP and ER, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The early TNM stage (T1N0M0) indicates localized disease with no lymph node involvement or metastases, which contributes to a favorable outlook despite moderate differentiation and HER2 positivity."
      }
    ]
  },
  {
    "id": "TCGA-55-8299-01Z-00-DX1.6F652EC5-EBB8-499C-A66D-E0951FBFCAA2-1",
    "image": "TCGA-LUAD/TCGA-55-8299-01Z-00-DX1.6F652EC5-EBB8-499C-A66D-E0951FBFCAA2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenocarcinoma with a TNM staging of T1BMXN0 and IHC results including strong positivity for CK7 and MOC-31 but focal weak positivity for ER and evidence of lymphovascular invasion, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and the presence of lymphovascular invasion are indicators of a more aggressive disease, despite the early TNM stage (T1B)."
      }
    ]
  },
  {
    "id": "TCGA-05-4425-01Z-00-DX1.82B093EE-49BC-4FD9-91AC-4CC89944309D-1",
    "image": "TCGA-LUAD/TCGA-05-4425-01Z-00-DX1.82B093EE-49BC-4FD9-91AC-4CC89944309D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of adenocarcinoma, TNM staging of T2N0M1, and IHC results showing CK7 positivity, CK20 negativity, TTF-1 positivity in a smaller focus, and isolated tumor cells with surfactant protein B staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with distant metastasis (M1) significantly indicates an advanced disease with a generally unfavorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-49-AAR3-01Z-00-DX1.B4D85F13-CEB4-46DA-BF39-0200B9E55835-1",
    "image": "TCGA-LUAD/TCGA-49-AAR3-01Z-00-DX1.B4D85F13-CEB4-46DA-BF39-0200B9E55835.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated adenocarcinoma (Grade 3), TNM staging of T2MXN1, and IHC results showing positive TIF-1 and CK7, but negative CK20, S-100, and Calretinin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated grade and TNM staging with lymph node involvement (N1) suggest a more aggressive disease, while the specific IHC profile helps confirm the diagnosis."
      }
    ]
  },
  {
    "id": "TCGA-MN-A4N1-01Z-00-DX1.07CD10C3-73A7-47E5-AD45-45458CE33107-1",
    "image": "TCGA-LUAD/TCGA-MN-A4N1-01Z-00-DX1.07CD10C3-73A7-47E5-AD45-45458CE33107.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive adenocarcinoma, TNM staging of T2aN1M0, and negative ALK immunostaining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma, along with lymph node involvement (N1) and the absence of ALK protein expression, are associated with aggressive disease and limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-MN-A4N1-01Z-00-DX2.9B0852C4-16BF-4962-B86F-E2570E48A89E-1",
    "image": "TCGA-LUAD/TCGA-MN-A4N1-01Z-00-DX2.9B0852C4-16BF-4962-B86F-E2570E48A89E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive adenocarcinoma, TNM staging of T2aN1M0, and negative ALK immunostaining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenocarcinoma, along with lymph node involvement (N1) and the absence of ALK protein expression, are associated with aggressive disease and limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-97-7554-01Z-00-DX1.4107ca63-4642-42b9-b6f2-13778ecaf9a7-1",
    "image": "TCGA-LUAD/TCGA-97-7554-01Z-00-DX1.4107ca63-4642-42b9-b6f2-13778ecaf9a7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2AN2M0, and IHC results showing positive Cytokeratins AE1/AE3, CK7, and TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The moderately differentiated status and TNM staging indicating significant lymph node involvement (N2) suggest a more advanced and potentially aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-55-8615-01Z-00-DX1.928CFCA6-059D-4901-8D6A-BC7D9486C29F-1",
    "image": "TCGA-LUAD/TCGA-55-8615-01Z-00-DX1.928CFCA6-059D-4901-8D6A-BC7D9486C29F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T3N2Mx, and IHC results showing positive TTF1 and CK7 with negative CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The moderately differentiated adenocarcinoma with advanced TNM staging (T3 and N2) indicates a higher tumor burden and significant lymph node involvement, which are associated with a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-55-1595-01Z-00-DX1.6270c9cf-cd18-4fa5-b313-33350ad55f89-1",
    "image": "TCGA-LUAD/TCGA-55-1595-01Z-00-DX1.6270c9cf-cd18-4fa5-b313-33350ad55f89.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of adenocarcinoma with a clear cell carcinoma component, moderately to poorly differentiated, TNM staging of T1N0M0, and IHC results showing strong nuclear positivity for TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of a moderately to poorly differentiated clear cell carcinoma component indicates a more aggressive disease, despite the early TNM stage (T1N0M0), and strong TTF-1 positivity is often associated with primary lung adenocarcinoma but does not significantly improve prognosis."
      }
    ]
  },
  {
    "id": "TCGA-55-A4DF-01Z-00-DX1.C945E1AD-BEF4-403F-BB11-BAC831D24CDA-1",
    "image": "TCGA-LUAD/TCGA-55-A4DF-01Z-00-DX1.C945E1AD-BEF4-403F-BB11-BAC831D24CDA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma and poorly differentiated squamous carcinoma, TNM staging of T1BMXN0, and IHC results showing varying positivity for markers in different lobe specimens, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The combination of adenocarcinoma and poorly differentiated squamous carcinoma, alongside certain IHC results indicating different expression profiles and the uncertain metastatic status (MX), suggests a more complex and potentially aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-62-A46O-01Z-00-DX1.39B361AD-ED1D-4C0C-8611-0E8CCBDBD252-1",
    "image": "TCGA-LUAD/TCGA-62-A46O-01Z-00-DX1.39B361AD-ED1D-4C0C-8611-0E8CCBDBD252.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated grade 3 adenocarcinoma, TNM staging of T2N0M0, and IHC results showing CK7 and CEA positivity with a Ki-67 index of 40-50%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated (grade 3) status and high Ki-67 index suggest aggressive tumor behavior, while the TNM stage T2N0M0 indicates a moderately advanced local disease without metastasis."
      }
    ]
  },
  {
    "id": "TCGA-55-8614-01Z-00-DX1.043DE2B5-A453-4570-8830-99170450658C-1",
    "image": "TCGA-LUAD/TCGA-55-8614-01Z-00-DX1.043DE2B5-A453-4570-8830-99170450658C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated carcinoma with features of adenosquamous carcinoma, TNM staging of T2AMXN0, and IHC results showing strong positivity for CK5/6 and CK7, with majority positivity for p63 and occasional positivity for TTF1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poor differentiation of the carcinoma, along with its features of adenosquamous carcinoma and TNM staging, suggests a more aggressive disease behavior typically associated with worse outcomes."
      }
    ]
  },
  {
    "id": "TCGA-L9-A5IP-01Z-00-DX1.E699D989-8BB8-41DF-9B95-A880858653E6-1",
    "image": "TCGA-LUAD/TCGA-L9-A5IP-01Z-00-DX1.E699D989-8BB8-41DF-9B95-A880858653E6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated adenocarcinoma, TNM staging of T3M1BN2, and IHC results showing CK7 positive, TTF1 negative, CK5/6 negative, and P63 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status, advanced TNM stage with distant metastasis (M1), and regional lymph node involvement (N2) indicate aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-55-8089-01Z-00-DX1.da4d99ff-4a7c-45a3-b79c-039c0c9e9712-1",
    "image": "TCGA-LUAD/TCGA-55-8089-01Z-00-DX1.da4d99ff-4a7c-45a3-b79c-039c0c9e9712.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1aN0M0, and IHC results showing a strongly positive CK7, negative TTF-1, CK5/6, and p63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status indicates a more aggressive and less predictable tumor behavior, despite the early-stage TNM classification."
      }
    ]
  },
  {
    "id": "TCGA-97-7546-01Z-00-DX1.dad9871f-cdfb-424d-a5b2-4e0905c29137-1",
    "image": "TCGA-LUAD/TCGA-97-7546-01Z-00-DX1.dad9871f-cdfb-424d-a5b2-4e0905c29137.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive adenocarcinoma, TNM staging of T1MXN0, and IHC results showing positive Cytokeratin-7 and TTF-1 and negative CK-20 and CDX-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The moderately differentiated status and the low TNM stage (T1, no lymph node involvement) are favorable indicators, while the IHC profile supports a less aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-73-4666-01Z-00-DX1.dd9c8922-ddd1-4674-8124-9e334532e47e-1",
    "image": "TCGA-LUAD/TCGA-73-4666-01Z-00-DX1.dd9c8922-ddd1-4674-8124-9e334532e47e.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1M1N0, and IHC results showing positive mucin stain in tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates aggressive cancer behavior, and the presence of metastasis (M1) despite a small primary tumor (T1) significantly worsens the outlook."
      }
    ]
  },
  {
    "id": "TCGA-55-7570-01Z-00-DX1.9020ae67-cf60-4bac-8c60-403c8891c4a3-1",
    "image": "TCGA-LUAD/TCGA-55-7570-01Z-00-DX1.9020ae67-cf60-4bac-8c60-403c8891c4a3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T1aMXN0, and IHC results showing CK5/6 negative, CK7 focal positive, p63 negative, and TTF-1 rare positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status indicates aggressive cancer, and while the TNM staging is low, the IHC results suggest limited information for targeted therapies, further contributing to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-55-7727-01Z-00-DX1.0c7a4953-16dc-41e0-845b-b89167ec17d7-1",
    "image": "TCGA-LUAD/TCGA-55-7727-01Z-00-DX1.0c7a4953-16dc-41e0-845b-b89167ec17d7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, grade 2, TNM staging of T1aMXN2, and IHC results showing positivity for Cytokeratin-OSCAR, TTF-1, Napsin-A, and MOC-31, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated adenocarcinoma (grade 2) combined with TNM staging indicating significant lymph node involvement (N2) suggests a more advanced disease with a higher risk of metastasis."
      }
    ]
  },
  {
    "id": "TCGA-55-A493-01Z-00-DX1.1CF94B85-7A64-4213-9B04-16504512DE2E-1",
    "image": "TCGA-LUAD/TCGA-55-A493-01Z-00-DX1.1CF94B85-7A64-4213-9B04-16504512DE2E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, TNM staging of T2AM0N0, and IHC results with strongly positive TTF-1 and negative P63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The absence of lymph node involvement (N0) and metastasis (M0), along with the T2 staging, suggests a localized disease, and the strongly positive TTF-1 supports a favorable response to certain therapies."
      }
    ]
  },
  {
    "id": "TCGA-55-8506-01Z-00-DX1.A908E3D2-91F7-4DE2-98C9-95D1038B9F49-1",
    "image": "TCGA-LUAD/TCGA-55-8506-01Z-00-DX1.A908E3D2-91F7-4DE2-98C9-95D1038B9F49.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated adenocarcinoma, TNM staging of T3MXN0, and IHC results showing positive TTF1 and focal positive mCEA with negative CK5/6 and p63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status suggests aggressive behavior, and the TNM staging indicates a larger tumor (T3) with an unknown metastatic status (MX), pointing to a higher likelihood of adverse outcomes."
      }
    ]
  },
  {
    "id": "TCGA-55-7728-01Z-00-DX1.1d47a5fe-cab5-4d5a-a62b-16f345334d25-1",
    "image": "TCGA-LUAD/TCGA-55-7728-01Z-00-DX1.1d47a5fe-cab5-4d5a-a62b-16f345334d25.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of well-differentiated mucinous adenocarcinoma, TNM staging of T2AMXN0, and IHC results showing strongly positive CK7 and scattered focal positive CK20, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally favorable. The well-differentiated nature of the tumor and absence of lymph node involvement, as indicated by the staging, contribute to a better outlook despite the T2 classification."
      }
    ]
  },
  {
    "id": "TCGA-05-4384-01Z-00-DX1.CA68BF29-BBE3-4C8E-B48B-554431A9EE13-1",
    "image": "TCGA-LUAD/TCGA-05-4384-01Z-00-DX1.CA68BF29-BBE3-4C8E-B48B-554431A9EE13.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of bronchopulmonary adenocarcinoma, TNM staging of T2M0N2, and IHC results with Cytokeratin 7 and TTF-1 positive, Cytokeratin 20 focally positive, and CDX2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T2M0N2 indicates significant lymph node involvement, which generally suggests a more advanced disease and potentially poorer outcomes."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2DO-01Z-00-DX1.60817A51-93B7-483D-ABC9-8ED6341C6660-1",
    "image": "TCGA-BRCA/TCGA-GM-A2DO-01Z-00-DX1.60817A51-93B7-483D-ABC9-8ED6341C6660.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, well-differentiated, Modified Black\u2019s nuclear grade 1, TNM staging of M0T1CN0 (I-), and IHC results showing high positivity for estrogen and progesterone receptors, negative HER-2/neu overexpression, but high Ki-67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The well-differentiated status and low TNM stage indicate a favorable outcome, and high hormone receptor positivity suggests the effectiveness of hormonal therapies. However, the high Ki-67 index may indicate a higher proliferative rate, which is a factor to be considered."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XJ-01Z-00-DX1.660DDF8D-6816-4EBE-AF37-6F7A374F4E9E-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XJ-01Z-00-DX1.660DDF8D-6816-4EBE-AF37-6F7A374F4E9E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal and partially mucinous carcinoma, NHG2 with TNM staging of T3N1MX, and IHC results indicating high expression of estrogen receptors, moderate progesterone receptors, and positive HER2 (3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3 stage with lymph node involvement (N1) and HER2 positivity suggest aggressive disease, although hormone receptor positivity provides potential therapeutic avenues."
      }
    ]
  },
  {
    "id": "TCGA-AQ-A54N-01Z-00-DX1.E53271E9-AFD2-4071-9B1E-CD05F63B8136-1",
    "image": "TCGA-BRCA/TCGA-AQ-A54N-01Z-00-DX1.E53271E9-AFD2-4071-9B1E-CD05F63B8136.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham combined histologic grade 3, TNM staging of M0T2N0, and negative Cytokeratin immunostain (AE1/AE3), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (Nottingham grade 3) is associated with a more aggressive and less differentiated tumor, and although there is no metastasis or lymph node involvement (M0T2N0), the aggressive nature of the cancer still warrants a more guarded outlook."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989-1",
    "image": "TCGA-BRCA/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of high nuclear grade invasive ductal carcinoma, Nottingham Grade 3, TNM staging of M0T1CN0 (I+), and IHC results showing low positive estrogen receptor, negative progesterone receptor, and high Ki-67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high nuclear grade, Nottingham Grade 3, and high Ki-67 indicate aggressive tumor behavior, while low hormone receptor positivity limits effective hormone therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XM-01Z-00-DX1.5F6A140E-5D20-45F6-B76F-0F98AB27AD08-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XM-01Z-00-DX1.5F6A140E-5D20-45F6-B76F-0F98AB27AD08.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, TNM staging of T1N0M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early stage (T1N0M0) and high hormone receptor positivity suggest responsiveness to hormonal therapies, while negative HER2 indicates a lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0J7-01Z-00-DX1.DBA7BA24-CEEF-4636-87BB-D12D8DF016A3-1",
    "image": "TCGA-BRCA/TCGA-AO-A0J7-01Z-00-DX1.DBA7BA24-CEEF-4636-87BB-D12D8DF016A3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with focal mucinous carcinoma, moderately differentiated, with a total Nottingham Grade II, TNM staging of T2N1M0, and IHC results showing positive estrogen receptor but negative progesterone receptor and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate to poor. The moderately differentiated status and the TNM stage indicating lymph node involvement (N1) suggest a risk of disease spread, despite the positive estrogen receptor which may allow for hormonal therapy. The negative HER2/neu status indicates limited options for targeted therapy."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XD-01Z-00-DX1.E500D561-1F49-4F08-99AE-E8345F21B406-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XD-01Z-00-DX1.E500D561-1F49-4F08-99AE-E8345F21B406.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of T1N2M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite high hormone receptor positivity, indicating potential benefit from hormonal therapy, the N2 stage shows significant lymph node involvement, suggesting a higher risk of disease spread."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XC-01Z-00-DX1.E7494388-838B-4D35-9CA1-77017CBE77F2-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XC-01Z-00-DX1.E7494388-838B-4D35-9CA1-77017CBE77F2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive mucinous carcinoma, Nottingham Histologic Grade 2, TNM staging of M0T4BN1A, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. While hormone receptor positivity suggests potential treatment responsiveness, the high T4B stage and N1 nodal involvement indicate a more advanced disease, affecting overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XC-01Z-00-DX2.10BA8536-D6AF-460E-9796-EB77FFE3EF5B-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XC-01Z-00-DX2.10BA8536-D6AF-460E-9796-EB77FFE3EF5B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive mucinous carcinoma, Nottingham Histologic Grade 2, TNM staging of M0T4BN1A, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. While hormone receptor positivity suggests potential treatment responsiveness, the high T4B stage and N1 nodal involvement indicate a more advanced disease, affecting overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-EW-A3U0-01Z-00-DX1.526F60F9-D1EB-4613-B428-18A1FC0BAAE2-1",
    "image": "TCGA-BRCA/TCGA-EW-A3U0-01Z-00-DX1.526F60F9-D1EB-4613-B428-18A1FC0BAAE2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated invasive ductal carcinoma, Nottingham Grade 2, with negative estrogen, progesterone receptors, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The lack of hormone receptor expression limits treatment options, and the absence of HER2 overexpression further reduces targeted therapy possibilities, despite the moderate differentiation."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2DF-01Z-00-DX1.CD0BE6D7-2DB3-4193-84CC-F9BE7BF18CC2-1",
    "image": "TCGA-BRCA/TCGA-GM-A2DF-01Z-00-DX1.CD0BE6D7-2DB3-4193-84CC-F9BE7BF18CC2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of high nuclear grade invasive ductal carcinoma, TNM staging of T1CN1A, and IHC results showing negative hormone receptors and negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high nuclear grade and lymph node involvement, along with triple-negative status (ER, PR, and HER-2), suggest a more aggressive disease with limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14N-01Z-00-DX1.15F5644F-CA9F-4688-B56E-BCC00CA4769B-1",
    "image": "TCGA-BRCA/TCGA-E2-A14N-01Z-00-DX1.15F5644F-CA9F-4688-B56E-BCC00CA4769B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBA Grade II, TNM staging of T2N1M0, and IHC results showing negative hormone receptors and HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate grade (SBA Grade II), lymph node involvement (N1), and negative hormone receptor and HER2 status limit treatment options and suggest a more challenging clinical course."
      }
    ]
  },
  {
    "id": "TCGA-LD-A66U-01Z-00-DX1.AEC25C62-0519-47ED-A85B-2A964BA2BA87-1",
    "image": "TCGA-BRCA/TCGA-LD-A66U-01Z-00-DX1.AEC25C62-0519-47ED-A85B-2A964BA2BA87.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma with TNM staging of MXT2N1MI and IHC findings of positive Cytokeratin stain indicating micrometastasis in a sentinel lymph node, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T2N1MI stage indicates regional lymph node metastasis and potential distant involvement, suggesting more advanced disease. Positive Cytokeratin staining confirms micrometastasis, further complicating the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XQ-01Z-00-DX1.1A17A5C7-F14B-4AD2-AD5F-D3400D86A366-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XQ-01Z-00-DX1.1A17A5C7-F14B-4AD2-AD5F-D3400D86A366.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, basal-like, Nottingham Histologic Grade 3 (NHG3), TNM staging of T2N0M0, and IHC results showing no estrogen receptors, less than 10% progesterone receptor positivity, and negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The tumor's high grade (Nottingham Grade 3) and its basal-like subtype suggest aggressive behavior, the TNM stage indicates a moderate tumor size without lymph node involvement, and the lack of significant hormone receptor positivity limits the effectiveness of hormonal therapy options, while negative HER2/neu overexpression reduces targeted therapy choices."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0IP-01Z-00-DX1.3723A250-AA4B-4AFE-A692-C1311E9BA268-1",
    "image": "TCGA-BRCA/TCGA-B6-A0IP-01Z-00-DX1.3723A250-AA4B-4AFE-A692-C1311E9BA268.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of infiltrating lobular carcinoma, TNM staging of T1CN0M0 (I-), and IHC results showing positive estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early TNM stage (T1CN0M0) and strong positivity for hormone receptors suggest effective hormonal treatment options, with no metastatic spread, indicating a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-D8-A141-01Z-00-DX1.10F6EEB2-C920-43FF-B5A7-B5A651CBDBE3-1",
    "image": "TCGA-BRCA/TCGA-D8-A141-01Z-00-DX1.10F6EEB2-C920-43FF-B5A7-B5A651CBDBE3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging M0T1CN1, and IHC results showing negative estrogen receptors, 75% positivity for progesterone receptors, and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the moderate grade and early tumor size, lymph node involvement (N1) and negative estrogen receptors limit hormonal therapy options, leading to a more challenging disease outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A141-01Z-00-DX2.DBD0D81E-28FC-4466-BDE3-94753BD6CBEB-1",
    "image": "TCGA-BRCA/TCGA-D8-A141-01Z-00-DX2.DBD0D81E-28FC-4466-BDE3-94753BD6CBEB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging M0T1CN1, and IHC results showing negative estrogen receptors, 75% positivity for progesterone receptors, and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the moderate grade and early tumor size, lymph node involvement (N1) and negative estrogen receptors limit hormonal therapy options, leading to a more challenging disease outlook."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5S0-01Z-00-DX1.49A7AC9D-C186-406C-BA67-2D73DE82E13B-1",
    "image": "TCGA-BRCA/TCGA-OL-A5S0-01Z-00-DX1.49A7AC9D-C186-406C-BA67-2D73DE82E13B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, grade I/II, TNM staging of MXT2N1A, and IHC results showing weak ER expression, negative PR expression, a 50% Ki-67 proliferation rate, and amplified Her2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of lymph node involvement (N1), high Ki-67 proliferation rate, and Her2/neu amplification indicate a more aggressive cancer behavior and higher potential for metastasis, which negatively impacts the overall prognosis despite the intermediate histologic grade."
      }
    ]
  },
  {
    "id": "TCGA-A2-A25D-01Z-00-DX1.41DADDB8-3E3F-4F8F-8BE7-C43F8FBCFD2B-1",
    "image": "TCGA-BRCA/TCGA-A2-A25D-01Z-00-DX1.41DADDB8-3E3F-4F8F-8BE7-C43F8FBCFD2B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of poorly differentiated pleomorphic invasive lobular carcinoma, TNM staging of T2N3A, and IHC results showing positive estrogen receptors and negative progesterone and HER2/neu receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade tumor and advanced TNM stage with significant lymph node involvement indicate aggressive behavior, while the limited hormone receptor positivity reduces therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A2LE-01Z-00-DX1.E8E1FC5C-9A4A-463F-81D7-E9A8AF43EAD9-1",
    "image": "TCGA-BRCA/TCGA-AR-A2LE-01Z-00-DX1.E8E1FC5C-9A4A-463F-81D7-E9A8AF43EAD9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating lobular carcinoma, TNM staging of T1N0M0, and IHC results showing positive estrogen receptors but negative progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early stage (T1N0M0) and positive estrogen receptor status suggest responsiveness to hormonal therapy, indicating a favorable outcome despite the negative progesterone receptor."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JI-01Z-00-DX1.4DCDA545-B7E3-49DF-AB10-963E84BEB105-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JI-01Z-00-DX1.4DCDA545-B7E3-49DF-AB10-963E84BEB105.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, histologic Grade III/III, TNM staging of T1N1M0, and IHC results showing 98% estrogen receptor positivity, 0% progesterone receptor positivity, and negative HER2-NEU, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status (Grade III) and lymph node involvement (N1) are associated with more aggressive disease, though the high estrogen receptor positivity offers some potential for effective hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XV-01Z-00-DX1.D0D78B02-2A0D-4107-8083-D2FE1D3F1207-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XV-01Z-00-DX1.D0D78B02-2A0D-4107-8083-D2FE1D3F1207.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive mucinous carcinoma and ductal carcinoma in situ, TNM staging of T2N0M0, and IHC results showing over 75% positivity for estrogen and progesterone receptors with a HER2 score of 2+ and no HER2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The strong positivity for hormone receptors suggests that hormonal therapies could be effective, and the lack of HER2 gene amplification reduces the likelihood of aggressive disease behavior. However, the T2 stage does indicate a larger tumor size, which warrants caution."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XV-01Z-00-DX2.D1988E01-5FDC-4F50-8183-F0CCE74D0CB2-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XV-01Z-00-DX2.D1988E01-5FDC-4F50-8183-F0CCE74D0CB2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive mucinous carcinoma and ductal carcinoma in situ, TNM staging of T2N0M0, and IHC results showing over 75% positivity for estrogen and progesterone receptors with a HER2 score of 2+ and no HER2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The strong positivity for hormone receptors suggests that hormonal therapies could be effective, and the lack of HER2 gene amplification reduces the likelihood of aggressive disease behavior. However, the T2 stage does indicate a larger tumor size, which warrants caution."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14R-01Z-00-DX1.DDE62ED5-1FC0-4B3B-A874-95C08B33AB20-1",
    "image": "TCGA-BRCA/TCGA-E2-A14R-01Z-00-DX1.DDE62ED5-1FC0-4B3B-A874-95C08B33AB20.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, grade III (SBR grade III) with a total score of 9 out of 9, TNM staging of T2N0M0, and IHC results showing negative for ER, PR, and HER-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The cancer's high grade (SBR grade III) suggests aggressive behavior, and the absence of hormone receptor positivity (ER and PR) along with negative HER-2 status limits treatment options, leading to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-AC-A6IW-01Z-00-DX1.C4514189-E64F-4603-8970-230FA2BB77FC-1",
    "image": "TCGA-BRCA/TCGA-AC-A6IW-01Z-00-DX1.C4514189-E64F-4603-8970-230FA2BB77FC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade 3 (score 9 of 9), TNM staging of T2N0MX, and IHC results showing negative hormone receptors and HER2 with high Ki67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high Nottingham grade and elevated Ki67 indicate aggressive tumor behavior, while the lack of hormone and HER2 receptor positivity limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A2FR-01Z-00-DX1.FF521BBF-F5BA-4B03-9CA1-101A337F4B45-1",
    "image": "TCGA-BRCA/TCGA-EW-A2FR-01Z-00-DX1.FF521BBF-F5BA-4B03-9CA1-101A337F4B45.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T1BN3A, and IHC results showing negative hormone receptors and HER2 amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade, significant lymph node involvement (N3A), negative hormone receptors, and positive HER2 amplification indicate aggressive cancer characteristics and limited hormone therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14U-01Z-00-DX1.F788A244-6C96-4CDC-AD9A-157DE951A723-1",
    "image": "TCGA-BRCA/TCGA-E2-A14U-01Z-00-DX1.F788A244-6C96-4CDC-AD9A-157DE951A723.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, SBR grade 2, TNM staging of M0T1CN0, and IHC results showing positive estrogen and progesterone receptors (Allred Score 8) while HER2 status is pending, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low TNM stage and positive hormone receptor status suggest responsiveness to hormone therapy, and the moderate SBR grade indicates intermediate aggressiveness, contributing to a favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-GM-A3XL-01Z-00-DX1.CCE8AA1D-9194-4E49-9546-DBF25A35847C-1",
    "image": "TCGA-BRCA/TCGA-GM-A3XL-01Z-00-DX1.CCE8AA1D-9194-4E49-9546-DBF25A35847C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of high-grade invasive ductal carcinoma with TNM staging of T2N0M0 and IHC results showing rare cytokeratin-positive cells in some lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham grade 3) suggests aggressive cancer behavior, and the presence of rare cytokeratin-positive cells in lymph nodes may indicate minimal metastatic involvement, affecting prognosis negatively."
      }
    ]
  },
  {
    "id": "TCGA-BH-A42U-01Z-00-DX1.130D060A-3DD8-407E-B8B0-EBBF743491AE-1",
    "image": "TCGA-BRCA/TCGA-BH-A42U-01Z-00-DX1.130D060A-3DD8-407E-B8B0-EBBF743491AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, TNM staging M0T2N0, and negative Cadherin on IHC, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The T2 stage suggests a tumor of moderate size, but N0 indicates no lymph node involvement, which is favorable. The negative Cadherin may indicate a more aggressive tumor subtype, affecting prognosis slightly negatively."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0W5-01Z-00-DX1.84EA3913-667B-4694-A0F0-E629CAC615C8-1",
    "image": "TCGA-BRCA/TCGA-BH-A0W5-01Z-00-DX1.84EA3913-667B-4694-A0F0-E629CAC615C8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of infiltrating duct carcinoma with a Nottingham score of 6/9 and grade 2, TNM staging of T1cN1aM0, and IHC results showing positive estrogen and progesterone receptors with equivocal HER-2/neu status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is cautiously optimistic. The moderate grade (Nottingham 6/9) and TNM staging indicating a small tumor size but some lymph node involvement are challenging factors. However, the strong positivity for hormone receptors suggests that hormonal therapies could be effective, tempering the overall risk."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1P0-01Z-00-DX1.6C75EEBD-CE05-4DE2-8C43-8B6435F1379F-1",
    "image": "TCGA-BRCA/TCGA-EW-A1P0-01Z-00-DX1.6C75EEBD-CE05-4DE2-8C43-8B6435F1379F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with mucinous differentiation, Nottingham Histologic Grade 2, TNM staging of MXT2N1B, and IHC results showing ER positive, PR negative, and HER2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately poor. The intermediate histologic grade and presence of lymph node involvement (N1B) suggest a need for closer management. The ER positivity is favorable, but the PR negativity and HER2 negativity limit some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-A7-A0DC-01Z-00-DX2.795FD529-D7C2-407D-9E8A-5DCE1EF49029-1",
    "image": "TCGA-BRCA/TCGA-A7-A0DC-01Z-00-DX2.795FD529-D7C2-407D-9E8A-5DCE1EF49029.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive ductal carcinoma, Nottingham Histologic Grade 2, TNM staging of M0T1CN0 (I-), and immunohistochemistry results showing 80% positivity for estrogen receptor, 0% for progesterone receptor, and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated grade, low TNM stage, and high estrogen receptor positivity suggest favorable responses to hormonal therapy, despite the lack of progesterone receptor expression and negative HER2/neu status."
      }
    ]
  },
  {
    "id": "TCGA-A7-A0DC-01Z-00-DX1.C770781E-83E4-47DD-B658-25BBBBB32066-1",
    "image": "TCGA-BRCA/TCGA-A7-A0DC-01Z-00-DX1.C770781E-83E4-47DD-B658-25BBBBB32066.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive ductal carcinoma, Nottingham Histologic Grade 2, TNM staging of M0T1CN0 (I-), and immunohistochemistry results showing 80% positivity for estrogen receptor, 0% for progesterone receptor, and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated grade, low TNM stage, and high estrogen receptor positivity suggest favorable responses to hormonal therapy, despite the lack of progesterone receptor expression and negative HER2/neu status."
      }
    ]
  },
  {
    "id": "TCGA-AR-A2LQ-01Z-00-DX1.2F579E62-69A8-40F4-A516-542C7C808628-1",
    "image": "TCGA-BRCA/TCGA-AR-A2LQ-01Z-00-DX1.2F579E62-69A8-40F4-A516-542C7C808628.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Nottingham grade I infiltrating lobular carcinoma, TNM staging of T3N0M0, and IHC confirmation of sentinel lymph node involvement via cytokeratin staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The low histological grade suggests less aggressive cancer, but the T3 stage indicates a larger tumor size, affecting the overall outlook despite no lymph node involvement and no metastasis."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1PF-01Z-00-DX1.9420D058-65CE-4DF8-815F-EB407003096E-1",
    "image": "TCGA-BRCA/TCGA-EW-A1PF-01Z-00-DX1.9420D058-65CE-4DF8-815F-EB407003096E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T1CN0, and pending IHC results showing 21% immunoreactive tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The tumor's moderate differentiation and early TNM stage indicate a favorable outcome, despite the pending IHC results."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XB-01Z-00-DX1.DA8E2FA4-DBBA-4157-8052-B90FB3BB58F1-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XB-01Z-00-DX1.DA8E2FA4-DBBA-4157-8052-B90FB3BB58F1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma with ductal carcinoma in situ, Nottingham grade 3, TNM staging of T2N1M0, and IHC showing high estrogen and progesterone receptor positivity with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease, despite the high hormone receptor positivity, which offers some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XB-01Z-00-DX2.B262C269-F22B-4306-8195-079C0874EF8E-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XB-01Z-00-DX2.B262C269-F22B-4306-8195-079C0874EF8E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma with ductal carcinoma in situ, Nottingham grade 3, TNM staging of T2N1M0, and IHC showing high estrogen and progesterone receptor positivity with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease, despite the high hormone receptor positivity, which offers some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14O-01Z-00-DX1.432DB252-35D4-4B02-B0A7-39BF85A38F89-1",
    "image": "TCGA-BRCA/TCGA-E2-A14O-01Z-00-DX1.432DB252-35D4-4B02-B0A7-39BF85A38F89.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with focal micropapillary features, poorly differentiated, Modified Scarff-Bloom-Richardson Grade 3, TNM staging of M0T3N1A, and IHC results showing positive estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status, high grade, and staging indicating a large tumor size with some lymph node involvement suggest a more aggressive disease. The positive hormone receptors offer some therapeutic options, but the overall outlook is influenced by the advanced disease characteristics."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0J6-01Z-00-DX1.D0C003CE-E112-4375-953D-78404C9D62DA-1",
    "image": "TCGA-BRCA/TCGA-AO-A0J6-01Z-00-DX1.D0C003CE-E112-4375-953D-78404C9D62DA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma with a Nottingham grade of 3, TNM staging of M0T2N0, and IHC showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) indicates aggressive cancer, despite hormone receptor positivity, as the negative HER2/neu limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A576-01Z-00-DX1.2E045763-7EB0-48F5-8C47-E4B84287D739-1",
    "image": "TCGA-BRCA/TCGA-E2-A576-01Z-00-DX1.2E045763-7EB0-48F5-8C47-E4B84287D739.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive lobular carcinoma, Nottingham grade 2, TNM staging of MXT1CN0, and IHC showing negative E-cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (Nottingham grade 2) and absence of distant metastasis (MX) suggest a less aggressive form, but negative E-cadherin indicates potential for diffuse spread, which requires careful consideration."
      }
    ]
  },
  {
    "id": "TCGA-AQ-A54O-01Z-00-DX1.85AB0AC4-47BB-4CD8-B7FB-5928108864AC-1",
    "image": "TCGA-BRCA/TCGA-AQ-A54O-01Z-00-DX1.85AB0AC4-47BB-4CD8-B7FB-5928108864AC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with Nottingham combined histologic grade 3, TNM staging of T2N0M0, and IHC results showing CD20 highlights small lymphocytes in a nodular distribution and CD3 highlights majority of lymphocytes with focal paracortex expansion, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham grade 3) of the tumor indicates a more aggressive cancer, and the TNM staging of T2N0M0 shows a moderate tumor size without lymph node involvement or distant metastasis, which still suggests a higher risk profile due to the tumor's aggressive nature."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XL-01Z-00-DX2.FDE2C80D-5DC4-4743-A180-C5AFC5BB0BE2-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XL-01Z-00-DX2.FDE2C80D-5DC4-4743-A180-C5AFC5BB0BE2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with Nottingham Histologic Grade 3 (NHG3) and a TNM staging of MXT2N1A, alongside IHC results showing over 75% positivity for estrogen and progesterone receptors, and HER-2 gene amplification not found, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) and the TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease, although strong hormone receptor positivity offers some favorable response to hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XL-01Z-00-DX1.FDF07020-8F40-4C00-9023-E5F40E0D8A7C-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XL-01Z-00-DX1.FDF07020-8F40-4C00-9023-E5F40E0D8A7C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with Nottingham Histologic Grade 3 (NHG3) and a TNM staging of MXT2N1A, alongside IHC results showing over 75% positivity for estrogen and progesterone receptors, and HER-2 gene amplification not found, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) and the TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease, although strong hormone receptor positivity offers some favorable response to hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0IM-01Z-00-DX1.E2CBD42F-D933-4446-BE7C-C2F8B5AFB976-1",
    "image": "TCGA-BRCA/TCGA-B6-A0IM-01Z-00-DX1.E2CBD42F-D933-4446-BE7C-C2F8B5AFB976.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma with prominent cribriform pattern, TNM staging of M0T3N0, and IHC results showing positive estrogen receptor activity and borderline progesterone receptor activity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The tumor size (T3) indicates a potentially locally advanced cancer, but the positive estrogen receptor status may allow for effective hormonal therapy, improving outcomes."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1PH-01Z-00-DX1.77e0f907-fe59-4dc2-b582-6f10330a9c01-1",
    "image": "TCGA-BRCA/TCGA-EW-A1PH-01Z-00-DX1.77e0f907-fe59-4dc2-b582-6f10330a9c01.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of poorly differentiated invasive mammary carcinoma, Nottingham Grade 3, TNM staging of T1CN1A, and negative IHC results for ER, PR, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and lymph node involvement (N1A) indicate a more aggressive disease, while the triple-negative status limits targeted hormonal or HER2 therapies, often contributing to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14T-01Z-00-DX1.61B4C988-6D75-447B-A5F4-9DE92CEACC9F-1",
    "image": "TCGA-BRCA/TCGA-E2-A14T-01Z-00-DX1.61B4C988-6D75-447B-A5F4-9DE92CEACC9F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated invasive ductal carcinoma with micropapillary features, Nottingham Histologic Grade 2 (NHG2) with a total score of 7, TNM staging of T2N0M0, and IHC results showing positive estrogen receptor with Allred score 8, positive progesterone receptor with Allred score 4, and HER-2 not amplified, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate differentiation and Nottingham Grade 2 suggest a balanced behavior of the disease. The positive hormone receptors provide beneficial hormonal therapy options, while the non-amplified HER-2 reduces the aggressiveness compared to HER-2 positive cases."
      }
    ]
  },
  {
    "id": "TCGA-OK-A5Q2-01Z-00-DX4.83B45D6C-E350-4436-812F-4155D9F7D331-1",
    "image": "TCGA-BRCA/TCGA-OK-A5Q2-01Z-00-DX4.83B45D6C-E350-4436-812F-4155D9F7D331.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive lobular carcinoma, focally pleomorphic type, with Nottingham Grade II, TNM staging of T2N1MX, and IHC results showing strong ER positivity and partial PR positivity with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and lymph node involvement suggest a significant disease risk, but the strong ER positivity allows for effective hormonal therapies, providing potential treatment benefits."
      }
    ]
  },
  {
    "id": "TCGA-OK-A5Q2-01Z-00-DX1.0D169898-37C6-44CA-AC87-27887123AA6F-1",
    "image": "TCGA-BRCA/TCGA-OK-A5Q2-01Z-00-DX1.0D169898-37C6-44CA-AC87-27887123AA6F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive lobular carcinoma, focally pleomorphic type, with Nottingham Grade II, TNM staging of T2N1MX, and IHC results showing strong ER positivity and partial PR positivity with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and lymph node involvement suggest a significant disease risk, but the strong ER positivity allows for effective hormonal therapies, providing potential treatment benefits."
      }
    ]
  },
  {
    "id": "TCGA-OK-A5Q2-01Z-00-DX3.5F9215C3-E407-46F8-968E-503D7D14605C-1",
    "image": "TCGA-BRCA/TCGA-OK-A5Q2-01Z-00-DX3.5F9215C3-E407-46F8-968E-503D7D14605C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive lobular carcinoma, focally pleomorphic type, with Nottingham Grade II, TNM staging of T2N1MX, and IHC results showing strong ER positivity and partial PR positivity with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and lymph node involvement suggest a significant disease risk, but the strong ER positivity allows for effective hormonal therapies, providing potential treatment benefits."
      }
    ]
  },
  {
    "id": "TCGA-OK-A5Q2-01Z-00-DX2.C828A160-87DF-4625-A8C5-2057F61D54F4-1",
    "image": "TCGA-BRCA/TCGA-OK-A5Q2-01Z-00-DX2.C828A160-87DF-4625-A8C5-2057F61D54F4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive lobular carcinoma, focally pleomorphic type, with Nottingham Grade II, TNM staging of T2N1MX, and IHC results showing strong ER positivity and partial PR positivity with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and lymph node involvement suggest a significant disease risk, but the strong ER positivity allows for effective hormonal therapies, providing potential treatment benefits."
      }
    ]
  },
  {
    "id": "TCGA-EW-A2FS-01Z-00-DX1.A01C9183-2AC8-456A-B5A6-85C5BB0361D8-1",
    "image": "TCGA-BRCA/TCGA-EW-A2FS-01Z-00-DX1.A01C9183-2AC8-456A-B5A6-85C5BB0361D8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with extensive intraductal component, Nottingham Histologic Grade III, TNM staging of MXT2N1MI, and IHC results showing ER positivity, PR negativity, and HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham Grade III) and TNM staging indicating a large tumor size with lymph node involvement (T2N1) and possible distant metastasis (MX) are factors associated with aggressive disease behavior, despite the ER positivity."
      }
    ]
  },
  {
    "id": "TCGA-B6-A2IU-01Z-00-DX1.3C7DF701-4ED9-4989-AA63-A6B7B105F6EE-1",
    "image": "TCGA-BRCA/TCGA-B6-A2IU-01Z-00-DX1.3C7DF701-4ED9-4989-AA63-A6B7B105F6EE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating lobular carcinoma with a nuclear grade of 2, TNM staging of T2N0M0, and positive estrogen and progesterone receptor status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The intermediate nuclear grade and absence of lymph node or distant metastasis (N0M0) indicate a less aggressive disease. Positive hormone receptor status suggests potential benefit from hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0YM-01Z-00-DX1.A48B4C96-2CC5-464C-98B7-F0F92AE56533-1",
    "image": "TCGA-BRCA/TCGA-A2-A0YM-01Z-00-DX1.A48B4C96-2CC5-464C-98B7-F0F92AE56533.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrative duct carcinoma, Bloom-Richardson Grade III, with a TNM staging of M0T2N0 (I-), and IHC results showing negative Cytokeratin staining in lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Bloom-Richardson grade (III) indicates aggressive cancer behavior despite the absence of lymph node involvement and distant metastasis, reflected in the TNM staging."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JF-01Z-00-DX1.3277D13C-F257-4D4C-AB5C-BEBA2E1A63D8-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JF-01Z-00-DX1.3277D13C-F257-4D4C-AB5C-BEBA2E1A63D8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of M0T1CN1A, and IHC results showing 95% nuclear staining for estrogen receptors, 70% nuclear staining with moderate intensity for progesterone receptors, and negative (2+) HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is cautious. The early tumor size (T1) and absence of distant metastasis (M0) are favorable, but lymph node involvement (N1) and moderate HER-2/neu negativity suggest a higher risk for recurrence. The high positivity for hormone receptors indicates potentially effective hormonal therapy options, offering a positive aspect amidst the more challenging factors."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XY-01Z-00-DX1.AC051FB4-1D51-449B-BF2D-9DDB4382414C-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XY-01Z-00-DX1.AC051FB4-1D51-449B-BF2D-9DDB4382414C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM stage MXT2N0, with positive estrogen and progesterone receptors and HER2 protein overexpression (score 3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (NHG2) and T2 stage suggest a more advanced disease, while strong hormone receptor positivity offers favorable treatment options. However, HER2 overexpression indicates potential aggressive behavior, affecting prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XY-01Z-00-DX2.33D96E5C-5291-4864-B282-8BACA2043586-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XY-01Z-00-DX2.33D96E5C-5291-4864-B282-8BACA2043586.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM stage MXT2N0, with positive estrogen and progesterone receptors and HER2 protein overexpression (score 3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (NHG2) and T2 stage suggest a more advanced disease, while strong hormone receptor positivity offers favorable treatment options. However, HER2 overexpression indicates potential aggressive behavior, affecting prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X5-01Z-00-DX2.E4D28EE2-9C87-4613-BD2E-89FBEF960DEE-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X5-01Z-00-DX2.E4D28EE2-9C87-4613-BD2E-89FBEF960DEE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma with partially signet ring cell carcinoma, Nottingham Histologic Grade 2 with a total score of 7 (3+3+1), TNM staging of MXT2N3A, and IHC results showing high positivity for estrogen and progesterone receptors, and strong HER2 protein overexpression (Score  3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate differentiation (NHG2), significant lymph node involvement (N3A), and strong HER2 overexpression indicate an aggressive tumor likely requiring intensive treatment. Despite high hormone receptor positivity, the advanced stage and HER2 status contribute to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X5-01Z-00-DX1.81B10B43-0D99-44D0-A245-D652041B8FEE-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X5-01Z-00-DX1.81B10B43-0D99-44D0-A245-D652041B8FEE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma with partially signet ring cell carcinoma, Nottingham Histologic Grade 2 with a total score of 7 (3+3+1), TNM staging of MXT2N3A, and IHC results showing high positivity for estrogen and progesterone receptors, and strong HER2 protein overexpression (Score  3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate differentiation (NHG2), significant lymph node involvement (N3A), and strong HER2 overexpression indicate an aggressive tumor likely requiring intensive treatment. Despite high hormone receptor positivity, the advanced stage and HER2 status contribute to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B-1",
    "image": "TCGA-BRCA/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating carcinoma, TNM staging of M0T2N0 (I+), and IHC results showing positive estrogen and progesterone receptors with equivocal HER-2/neu and FISH analysis, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The positive hormone receptor status may allow effective hormone-based treatments despite the T2 stage. However, equivocal HER-2/neu status introduces some uncertainty in targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14S-01Z-00-DX1.5C332E99-7296-473A-9917-7EFC38A8251D-1",
    "image": "TCGA-BRCA/TCGA-E2-A14S-01Z-00-DX1.5C332E99-7296-473A-9917-7EFC38A8251D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma (SBR grade 2), TNM staging of T1cN0M0, and IHC results showing ER and PR positivity with high Allred scores and non-amplified HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The moderately differentiated grade and early-stage TNM status indicate a favorable outlook, while the high ER and PR positivity suggests responsiveness to hormonal therapies, and the lack of HER2 amplification signals a lower risk of aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-AR-A2LM-01Z-00-DX1.CB64A062-2E35-41F9-97C7-07BB60754799-1",
    "image": "TCGA-BRCA/TCGA-AR-A2LM-01Z-00-DX1.CB64A062-2E35-41F9-97C7-07BB60754799.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of infiltrating lobular carcinoma, Nottingham grade I, TNM staging of T1N1M0, and positive immunohistochemical cytokeratin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The low Nottingham grade suggests less aggressive cancer, and the absence of distant metastasis (M0) is positive. However, node involvement (N1) indicates a moderate risk, thus influencing the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-BH-A28Q-01Z-00-DX1.C6D1CA93-6B2A-4722-9270-5D56592D833D-1",
    "image": "TCGA-BRCA/TCGA-BH-A28Q-01Z-00-DX1.C6D1CA93-6B2A-4722-9270-5D56592D833D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Nottingham grade 3 invasive carcinoma, TNM staging M0T2N1a, and positive IHC results for estrogen and progesterone receptors but negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade and lymph node involvement (N1) indicate aggressive disease. Although hormone receptor positivity offers therapeutic options, the negative HER2 status limits targeted treatments."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JA-01Z-00-DX1.E3DDBAAF-6FFA-40BE-83FF-942857CFED5D-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JA-01Z-00-DX1.E3DDBAAF-6FFA-40BE-83FF-942857CFED5D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with focal lobular growth pattern, moderately differentiated (histologic grade II/III), TNM staging of M0T2N3, and IHC results showing 90% positivity for estrogen receptor, negative progesterone receptor, and moderate HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated grade, significant lymph node involvement (N3), and moderate HER2/neu overexpression suggest a more aggressive disease course despite high estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0W3-01Z-00-DX1.38DCA2B7-1A54-4FFA-BABA-29F80974BB17-1",
    "image": "TCGA-BRCA/TCGA-BH-A0W3-01Z-00-DX1.38DCA2B7-1A54-4FFA-BABA-29F80974BB17.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Grade 2 (total score 6/9), TNM staging of M0T1CN1A, and IHC findings with high estrogen receptor positivity, low progesterone receptor positivity, and equivocal HER-2/neu without amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The low tumor size (T1) and no distant metastasis (M0) are positive factors, though moderate lymph node involvement (N1A) and mixed hormone receptor status suggest careful management. The absence of HER-2/neu amplification means limited targeted therapy options for HER-2/neu."
      }
    ]
  },
  {
    "id": "TCGA-C8-A138-01Z-00-DX1.845A0680-23A4-4A58-A9C4-2EE17BDBD371-1",
    "image": "TCGA-BRCA/TCGA-C8-A138-01Z-00-DX1.845A0680-23A4-4A58-A9C4-2EE17BDBD371.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenocarcinoma, TNM staging of T2N2M0, and IHC results showing negativity for estrogen, progesterone, and HER-2/neu receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status, TNM staging indicating significant lymph node involvement (N2), and triple-negative receptor status suggest a more aggressive disease with limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1P6-01Z-00-DX1.A8024C26-6336-4858-88FD-5679795899BA-1",
    "image": "TCGA-BRCA/TCGA-EW-A1P6-01Z-00-DX1.A8024C26-6336-4858-88FD-5679795899BA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with a Nottingham Histologic Grade 2 (NHG2), TNM staging of T2N1M0, and IHC results showing 21% estrogen receptor positivity, 1% progesterone receptor positivity, and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate to poor. The moderate differentiation (NHG2) and the TNM staging indicating some lymph node involvement (N1) suggest a higher risk for aggressive disease, while the limited hormone receptor positivity and negative HER2 status reduce targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A147-01Z-00-DX1.159094F2-BB78-4910-B7AE-3D7CAAB1DAD9-1",
    "image": "TCGA-BRCA/TCGA-D8-A147-01Z-00-DX1.159094F2-BB78-4910-B7AE-3D7CAAB1DAD9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma and ductal carcinoma in situ, Nottingham grade 3, TNM staging of T2N0M0, and IHC results showing no hormone receptor presence and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade (NHG3) and lack of hormone receptor expression indicate aggressive tumor behavior, and the absence of HER2 limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XW-01Z-00-DX1.10187A1F-086B-4CD9-AC01-ADA2E435CD34-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XW-01Z-00-DX1.10187A1F-086B-4CD9-AC01-ADA2E435CD34.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing lack of estrogen receptors, low progesterone receptor positivity, and negative HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The lack of estrogen and low progesterone receptor positivity, combined with negative HER2 status, limits hormone and targeted therapy options, and the T2 stage indicates a larger primary tumor size."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XW-01Z-00-DX2.9849E503-BE3E-417C-ABE8-93A39583DDE0-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XW-01Z-00-DX2.9849E503-BE3E-417C-ABE8-93A39583DDE0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing lack of estrogen receptors, low progesterone receptor positivity, and negative HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The lack of estrogen and low progesterone receptor positivity, combined with negative HER2 status, limits hormone and targeted therapy options, and the T2 stage indicates a larger primary tumor size."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0YC-01Z-00-DX1.F01F2268-17D8-45FD-8917-FD89454D0709-1",
    "image": "TCGA-BRCA/TCGA-A2-A0YC-01Z-00-DX1.F01F2268-17D8-45FD-8917-FD89454D0709.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of moderately differentiated infiltrating ductal carcinoma, Scarff-Bloom-Richardson Grade II, TNM staging of M0T2N1MI, and IHC results positive for metastatic adenocarcinoma with Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status and intermediate grade (Grade II) combined with TNM staging indicating lymph node involvement (N1) and the presence of micrometastasis (MI) suggest a more challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-AC-A2FF-01Z-00-DX1.012DAC86-E05C-44FA-81C2-FE4C754F409C-1",
    "image": "TCGA-BRCA/TCGA-AC-A2FF-01Z-00-DX1.012DAC86-E05C-44FA-81C2-FE4C754F409C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating lobular carcinoma, TNM staging of MXT2N1, and IHC results showing 3% ER positivity, favorable PR status, normal HER-2/neu levels, and a Ki-67 index of 18.8%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2N1 staging suggests a notable tumor size and lymph node involvement, while low ER positivity (3%) and a borderline Ki-67 index indicate limited hormone responsiveness and potential for more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14Z-01Z-00-DX1.A1344A78-1842-4578-8CDE-921E50656891-1",
    "image": "TCGA-BRCA/TCGA-E2-A14Z-01Z-00-DX1.A1344A78-1842-4578-8CDE-921E50656891.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 3, TNM staging of T1N0M0, and HER2 negativity by IHC, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) suggests aggressive tumor behavior despite the early TNM stage and absence of HER2 overexpression, which limits certain targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1P8-01Z-00-DX1.E9852193-8CDD-49EF-B49B-DA6931198F0D-1",
    "image": "TCGA-BRCA/TCGA-EW-A1P8-01Z-00-DX1.E9852193-8CDD-49EF-B49B-DA6931198F0D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive poorly differentiated ductal carcinoma, Nottingham Grade 3, TNM staging of T2N3bM0, and IHC results showing minimal hormone receptor positivity and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade, advanced nodal involvement (N3b), and lack of hormone receptor expression or HER2/neu overexpression suggest a more aggressive disease with limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A1FZ-01Z-00-DX1.0BAAEF41-DCA4-4677-9A27-09E990033FA6-1",
    "image": "TCGA-BRCA/TCGA-A2-A1FZ-01Z-00-DX1.0BAAEF41-DCA4-4677-9A27-09E990033FA6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated infiltrating duct carcinoma, TNM staging M0T2N0, and IHC results showing negative Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status suggests aggressive behavior, and the staging indicates a moderately advanced tumor size (T2) with no metastasis, but negative Cytokeratin could complicate further treatment identification."
      }
    ]
  },
  {
    "id": "TCGA-D8-A140-01Z-00-DX1.5B9382C0-332C-4FBF-82CD-B9453D02B815-1",
    "image": "TCGA-BRCA/TCGA-D8-A140-01Z-00-DX1.5B9382C0-332C-4FBF-82CD-B9453D02B815.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Grade 3 (3+3+3), TNM staging of T2N1M0, and IHC results showing strong positivity for estrogen receptors, lower positivity for progesterone receptors, and overexpression of HER2 (Score  3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status (Grade 3) and TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease. Although the cancer is positive for estrogen receptors, the overexpression of HER2 is associated with a more aggressive subtype."
      }
    ]
  },
  {
    "id": "TCGA-D8-A140-01Z-00-DX2.0C0A62BB-1FB8-47D8-8FAF-112D221F18BE-1",
    "image": "TCGA-BRCA/TCGA-D8-A140-01Z-00-DX2.0C0A62BB-1FB8-47D8-8FAF-112D221F18BE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Grade 3 (3+3+3), TNM staging of T2N1M0, and IHC results showing strong positivity for estrogen receptors, lower positivity for progesterone receptors, and overexpression of HER2 (Score  3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status (Grade 3) and TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease. Although the cancer is positive for estrogen receptors, the overexpression of HER2 is associated with a more aggressive subtype."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0SV-01Z-00-DX1.F5645E47-3540-4753-AF5D-F5709BD8DFC1-1",
    "image": "TCGA-BRCA/TCGA-A2-A0SV-01Z-00-DX1.F5645E47-3540-4753-AF5D-F5709BD8DFC1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 3 (NHG3) with a total score of 9 out of 9, TNM staging of M1T2N2A, and immunohistochemistry results showing positive estrogen and progesterone receptors with weakly positive HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade and advanced TNM staging with distant metastasis (M1) indicate an aggressive cancer. Although hormone receptor positivity provides some therapeutic options, the weakly positive HER2/neu result further complicates the management and overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2D9-01Z-00-DX1.AF4BF2DD-05FB-400B-A1BC-6E7C9B9DDF05-1",
    "image": "TCGA-BRCA/TCGA-GM-A2D9-01Z-00-DX1.AF4BF2DD-05FB-400B-A1BC-6E7C9B9DDF05.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated invasive ductal carcinoma, TNM staging of T1N0M0, and immunohistochemistry results showing negative neuroendocrine markers, low Ki-67 proliferation index, and negative HER-2/neu gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer's well-differentiated status, low TNM stage, and low Ki-67 proliferation index indicate a less aggressive disease, while the negative HER-2/neu gene amplification is associated with a lower likelihood of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49-1",
    "image": "TCGA-BRCA/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of grade 3 invasive ductal carcinoma, TNM staging of T2N1M1(I+), and IHC results with positive E-cadherin, p63, and calponin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and TNM stage indicating metastasis (M1) suggest aggressive disease. Despite positive IHC markers, the metastatic status heavily impacts the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-E2-A2P6-01Z-00-DX1.9D8060AA-881F-49FF-AEF5-B40A3625A44A-1",
    "image": "TCGA-BRCA/TCGA-E2-A2P6-01Z-00-DX1.9D8060AA-881F-49FF-AEF5-B40A3625A44A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, Nottingham Grade 2 with a TNM staging of T2N1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2 by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The grade and TNM stage indicate intermediate aggression with some lymph node involvement, but positive hormone receptor status suggests responsiveness to hormonal therapy, balancing the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069-1",
    "image": "TCGA-BRCA/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Nottingham grade III infiltrating ductal carcinoma, TNM staging of T2N0M0, and IHC results showing negative HER2/neu, estrogen, and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of high-grade (Nottingham grade III) invasive cancer and TNM staging indicating tumor size without lymph node involvement, along with negative hormone receptors and HER2/neu, limits therapeutic options and suggests more aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA10-01Z-00-DX1.C0468882-0DD8-4FC5-8C2F-E18BE8000F69-1",
    "image": "TCGA-BRCA/TCGA-S3-AA10-01Z-00-DX1.C0468882-0DD8-4FC5-8C2F-E18BE8000F69.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of high-grade invasive ductal carcinoma (NHG3, total score 9/9), TNM stage of T2N0M0, and IHC results with negative hormone receptors and HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade, combined with negative hormone receptors and HER-2/neu, suggests aggressive cancer with limited options for targeted hormonal or HER-2 therapies."
      }
    ]
  },
  {
    "id": "TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720-1",
    "image": "TCGA-BRCA/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of high-grade invasive lobular carcinoma, TNM staging of T2N0M0, and IHC results showing strong ER and PR positivity with HER2 overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade nature and HER2 overexpression suggest a more aggressive disease, despite the positive hormone receptor status that indicates some responsiveness to hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade II, with TNM staging of T1N0M0, and IHC results showing positive Cytokeratin and H&E indicating isolated tumor cell clusters, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The lower TNM stage (T1N0M0) and moderate Nottingham grade II indicate a less advanced disease, and absence of metastasis (M0) suggests a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0WS-01Z-00-DX1.020ED7BF-9497-4F13-AA07-FE0E839F9A06-1",
    "image": "TCGA-BRCA/TCGA-B6-A0WS-01Z-00-DX1.020ED7BF-9497-4F13-AA07-FE0E839F9A06.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating ductal carcinoma, histologic and nuclear grade 2 of 3, with TNM staging MXT1CNX, and IHC results showing positive estrogen receptor and negative progesterone receptor, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate histologic and nuclear grades combined with T1 tumor size suggest less aggressive characteristics, but the undetermined regional lymph nodes and mixed hormone receptor status add uncertainty to the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0WZ-01Z-00-DX1.6CFB236E-36F5-43D6-8DE3-C4ECBD3C14C6-1",
    "image": "TCGA-BRCA/TCGA-B6-A0WZ-01Z-00-DX1.6CFB236E-36F5-43D6-8DE3-C4ECBD3C14C6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma (tubulolobular subtype) with NSABP histologic grade 1-2, TNM staging of T2N1M0, and IHC results showing positivity for estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The cancer's low to intermediate histologic grade and positive hormone receptor status suggest it can respond well to hormonal therapies, although some lymph node involvement (N1) indicates a need for careful management."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LH-01Z-00-DX1.F85384B7-1EBF-4F57-A45B-4A668B68E535-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LH-01Z-00-DX1.F85384B7-1EBF-4F57-A45B-4A668B68E535.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with lobular extension, poorly differentiated (SBR Grade 3), TNM staging of T1CN0, and IHC results showing 0% ER, PR, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated grade and triple-negative status, combined with T1 stage, indicate aggressive tumor behavior and limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24V-01Z-00-DX1.E749C2FE-E26B-4306-80B4-8269EEB23270-1",
    "image": "TCGA-BRCA/TCGA-AR-A24V-01Z-00-DX1.E749C2FE-E26B-4306-80B4-8269EEB23270.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating ductal carcinoma, Nottingham grade II with a TNM staging of T2N1M0, along with positive Cytokeratin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (Nottingham grade II) and TNM staging indicating lymph node involvement (N1) suggest a moderate risk of aggressive behavior, influencing overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24Q-01Z-00-DX1.69DC7E35-DC0D-4F20-88DA-04C25F28628C-1",
    "image": "TCGA-BRCA/TCGA-AR-A24Q-01Z-00-DX1.69DC7E35-DC0D-4F20-88DA-04C25F28628C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade III, TNM staging of T3N0M0, and pending HER-2/neu IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham grade III) and the T3 stage indicate a more aggressive and advanced local disease, despite no lymph node or distant metastasis involvement (N0, M0)."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IK-01Z-00-DX1.25C554BB-AA90-4FF4-9D68-EEC899B8A27D-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IK-01Z-00-DX1.25C554BB-AA90-4FF4-9D68-EEC899B8A27D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 2 with mucinous features and signet ring cells, TNM staging of M0T1CN1MI, and IHC results showing positivity for Cytokeratin AE1/3, ER, and PR, but negativity for HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The intermediate SBR Grade 2 and early TNM stage (T1 and M0) are favorable, while the positive hormone receptor status (ER and PR) suggests effective hormonal therapy options, despite some lymph node involvement indicated by N1."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0C1-01Z-00-DX1.21FE357E-B182-4397-BFEF-7E96E994236A-1",
    "image": "TCGA-BRCA/TCGA-BH-A0C1-01Z-00-DX1.21FE357E-B182-4397-BFEF-7E96E994236A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, nuclear grade 3, with a Nottingham score of 8/9, TNM staging of T3N2aM0, and IHC results showing positivity for estrogen and progesterone receptors but negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high nuclear grade and Nottingham score indicate aggressive disease, and the TNM staging suggests significant tumor size and lymph node involvement. Although hormone receptor positivity offers therapeutic options, the absence of HER-2/neu overexpression limits targeted treatment possibilities."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JE-01Z-00-DX2.CCF3DFEF-E851-425A-BCD0-0F7B377A00BC-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JE-01Z-00-DX2.CCF3DFEF-E851-425A-BCD0-0F7B377A00BC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2, TNM staging of T1N1M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The middle-grade tumor and nodal involvement (N1) suggest intermediate risk, but high hormone receptor positivity supports effective hormonal therapies. Negative HER2 indicates lower aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JE-01Z-00-DX1.714805A1-E337-46DA-88D9-6CE4B4E3C2D0-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JE-01Z-00-DX1.714805A1-E337-46DA-88D9-6CE4B4E3C2D0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2, TNM staging of T1N1M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The middle-grade tumor and nodal involvement (N1) suggest intermediate risk, but high hormone receptor positivity supports effective hormonal therapies. Negative HER2 indicates lower aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1L6-01Z-00-DX1.AFE87067-2BFD-42C2-9334-9DDE8AB61B49-1",
    "image": "TCGA-BRCA/TCGA-E2-A1L6-01Z-00-DX1.AFE87067-2BFD-42C2-9334-9DDE8AB61B49.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of well-differentiated infiltrating ductal carcinoma (NHG1), TNM staging of T1N1M0, and IHC results showing strong positivity for both estrogen and progesterone receptors with negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer\u2019s well-differentiated grade and strong hormone receptor positivity indicate a less aggressive disease and effective hormonal therapy options, while the TNM stage T1N1M0 suggests limited spread, thereby supporting a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JB-01Z-00-DX1.6CF48257-066C-4B8C-91AA-30A6B4AD4307-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JB-01Z-00-DX1.6CF48257-066C-4B8C-91AA-30A6B4AD4307.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma and ductal carcinoma in situ, Nottingham Histologic Grade 2, TNM staging of M0T2N1A, and IHC results showing high estrogen receptor positivity, moderate progesterone receptor positivity, and negative for HER-2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (Nottingham Grade 2) and TNM staging indicating regional lymph node involvement (N1) suggest a need for careful management, though high estrogen receptor positivity can allow effective hormone therapy options. The absence of HER-2 gene amplification reduces the risk of highly aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IL-01Z-00-DX1.46B6AA99-C7CE-4573-B15D-2C56A708B082-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IL-01Z-00-DX1.46B6AA99-C7CE-4573-B15D-2C56A708B082.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, modified Scarff-Bloom-Richardson grade 2 (total score: 6 out of 9), TNM staging of M0T1CN1A, and IHC results showing ER positive, PR positive, and HER2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The intermediate grade (grade 2), low primary tumor size (T1), and absence of distant metastasis (M0), along with positive hormone receptors (ER and PR), suggest favorable response to hormonal therapies, despite the involvement of one lymph node (N1)."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JK-01Z-00-DX1.3190C919-A403-460D-9F6C-D2AB5FD3FD05-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JK-01Z-00-DX1.3190C919-A403-460D-9F6C-D2AB5FD3FD05.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, Nottingham Grade 3, TNM staging of T2N0M0, and IHC results showing no estrogen receptors, low progesterone receptor expression, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (NHG3), coupled with hormone receptor negativity and absence of HER2 overexpression, suggests a more aggressive disease with limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24M-01Z-00-DX1.D81F1BDF-00DD-42A3-AFFE-55655A877213-1",
    "image": "TCGA-BRCA/TCGA-AR-A24M-01Z-00-DX1.D81F1BDF-00DD-42A3-AFFE-55655A877213.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive mammary carcinoma with mixed ductal and lobular features (Nottingham grade II), TNM staging of T2N2M0, and pending Her-2/Neu results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate grade and advanced nodal involvement (N2) suggest a more aggressive disease with potential for recurrence, while the pending Her-2/Neu results could impact treatment strategies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IE-01Z-00-DX1.D6BF29A7-4FBD-4F7D-B093-991FA0F49FE8-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IE-01Z-00-DX1.D6BF29A7-4FBD-4F7D-B093-991FA0F49FE8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive ductal carcinoma (SBR Grade 2), TNM staging of T2N1M0, and IHC results showing positive ER and PR with equivocal HER-2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and lymph node involvement suggest moderate risk, while the positive hormone receptors are favorable for hormonal therapy. The equivocal HER-2 status may require further testing to determine targeted therapy eligibility."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LS-01Z-00-DX1.9a43a58a-df40-4375-8456-ef0071bc9eb9-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LS-01Z-00-DX1.9a43a58a-df40-4375-8456-ef0071bc9eb9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, SBR Grade 3, TNM staging of T1CN0, and IHC results showing negative ER, PR, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (SBR Grade 3) with triple-negative IHC results indicates a more aggressive cancer and fewer hormone or targeted therapy options available, despite the early TNM stage."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0D0-01Z-00-DX1.4FF6B8E5-703B-400F-920A-104F56E0F874-1",
    "image": "TCGA-BRCA/TCGA-A2-A0D0-01Z-00-DX1.4FF6B8E5-703B-400F-920A-104F56E0F874.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham grade 3 infiltrating ductal carcinoma with a TNM staging of T2N0M0 and IHC results showing negative estrogen, progesterone, and HER2/neu receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (Nottingham grade 3) indicates aggressive behavior, and the lack of hormone and HER2 receptor positivity limits targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1L8-01Z-00-DX1.842BF73D-2D64-4ABA-880D-DBE8F4C2AA19-1",
    "image": "TCGA-BRCA/TCGA-E2-A1L8-01Z-00-DX1.842BF73D-2D64-4ABA-880D-DBE8F4C2AA19.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 2, with TNM staging of M0T2N1A, and IHC results showing ER positive (Allred Score 8), PR positive (Allred Score 6), and HER2 negative by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The SBR Grade 2 indicates a moderately differentiated tumor, and the TNM staging (T2N1A) shows a tumor size with some lymph node involvement. The positive hormone receptors (high Allred Scores for ER and PR) are favorable, but the HER2 negativity reduces targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-A7-A4SF-01Z-00-DX1.CDCFD4BC-4363-4CF2-95F5-4922E04C3B9D-1",
    "image": "TCGA-BRCA/TCGA-A7-A4SF-01Z-00-DX1.CDCFD4BC-4363-4CF2-95F5-4922E04C3B9D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated invasive ductal carcinoma (NHG2), TNM staging of T2N0M0, and IHC results with negative Cytokeratin stains on lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is fair to good. The moderately differentiated status (NHG2) and TNM staging indicating no nodal involvement (N0) suggest a localized disease with potentially effective treatment outcomes."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24P-01Z-00-DX1.08BE8830-C55E-4E2B-9378-371A670C75FD-1",
    "image": "TCGA-BRCA/TCGA-AR-A24P-01Z-00-DX1.08BE8830-C55E-4E2B-9378-371A670C75FD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of Nottingham grade II infiltrating ductal carcinoma with associated ductal carcinoma in situ, intermediate nuclear grade, TNM staging of M0T1N0, and positive Cytokeratin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The intermediate Nottingham grade and low TNM stage (T1N0M0) suggest less aggressive disease with no metastasis, indicating a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LI-01Z-00-DX1.503dd2fa-23ef-4b11-8aab-301e069eaa88-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LI-01Z-00-DX1.503dd2fa-23ef-4b11-8aab-301e069eaa88.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of ductal carcinoma, SBR Grade III, TNM staging of M0T2N1, and IHC results with 0% ER, pending PR, and borderline HER2 results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (SBR Grade III) and TNM staging reflecting lymph node involvement (N1) suggest aggressive disease, while the lack of hormone receptor positivity limits effective hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD-1",
    "image": "TCGA-BRCA/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, moderately differentiated NHG2, TNM staging of T2N0M0, and IHC showing high positivity for estrogen and progesterone receptors with negative HER2/neu amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The moderate differentiation, lack of lymph node involvement, and strong hormone receptor positivity suggest favorable treatment options, while the negative HER2/neu amplification indicates a less aggressive disease profile."
      }
    ]
  },
  {
    "id": "TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C-1",
    "image": "TCGA-BRCA/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of poorly differentiated grade 3 infiltrating ductal carcinoma, TNM staging M0T2N1a, and IHC results showing negative hormone receptors and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated and high-grade tumor, combined with lymph node involvement and negative hormone receptor and HER2 status, suggests a more aggressive disease and limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A7-A26I-01Z-00-DX1.0077D012-BC14-4E96-84F7-A1A6A3A778DF-1",
    "image": "TCGA-BRCA/TCGA-A7-A26I-01Z-00-DX1.0077D012-BC14-4E96-84F7-A1A6A3A778DF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Elston\u2019s SBR grade 2, TNM staging of T2N0M0, and IHC results showing no metastatic tumor identified with Pan cytokeratin AEL/AE3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The intermediate grade and the absence of lymph node involvement or distant metastasis suggest a less aggressive disease and better overall outcome prospects."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AX-01Z-00-DX1.2389D54F-545E-499E-B392-DD731834460A-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AX-01Z-00-DX1.2389D54F-545E-499E-B392-DD731834460A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham grade II infiltrating ductal carcinoma, TNM staging of T1N0M0, and IHC results confirming the H&E impression with positive cytokeratin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low TNM stage (T1N0M0) indicates limited disease spread and early detection, while the moderate grade (Nottingham grade II) suggests an intermediate growth rate."
      }
    ]
  },
  {
    "id": "TCGA-A2-A3XS-01Z-00-DX1.867925C0-91D8-40A0-9FEA-25A635AC31E7-1",
    "image": "TCGA-BRCA/TCGA-A2-A3XS-01Z-00-DX1.867925C0-91D8-40A0-9FEA-25A635AC31E7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating and intraductal carcinoma, comedo-type, Bloom-Richardson Grade 9 (3+3+3), TNM staging of M0T1N2A, and IHC results showing weakly positive (2+) HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Bloom-Richardson grade indicates aggressive tumor behavior, and the TNM staging with significant lymph node involvement (N2) also suggests a more advanced disease, despite the absence of distant metastasis (M0). Weakly positive HER2 status adds complexity to treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A0TS-01Z-00-DX1.2DB81A2E-16C1-4EE0-8175-65FA46768277-1",
    "image": "TCGA-BRCA/TCGA-AR-A0TS-01Z-00-DX1.2DB81A2E-16C1-4EE0-8175-65FA46768277.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, Nottingham grade III, TNM staging of T2N1M0, and positive cytokeratin stain in sentinel node 3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade and TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease course with a higher risk of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-HN-A2OB-01Z-00-DX1.14F1FBFB-4540-43CE-9D79-5BC628640424-1",
    "image": "TCGA-BRCA/TCGA-HN-A2OB-01Z-00-DX1.14F1FBFB-4540-43CE-9D79-5BC628640424.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, Scarff-Bloom-Richardson Grade 1, TNM staging of M0T2N1, and IHC results showing positive ER and PR, and negative HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The low grade and positive hormone receptor status suggest responsiveness to hormonal therapies, although some lymph node involvement (N1) indicates a potential for metastasis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0E2-01Z-00-DX1.5F6FA19C-D59F-45BE-80CE-F738CAB1EF0B-1",
    "image": "TCGA-BRCA/TCGA-BH-A0E2-01Z-00-DX1.5F6FA19C-D59F-45BE-80CE-F738CAB1EF0B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nFor a patient with invasive ductal carcinoma, Nottingham Grade 3, TNM staging of T2N2M0, and IHC results showing positive estrogen and progesterone receptors but negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and TNM staging indicating significant lymph node involvement (N2) associate with aggressive disease, though positive hormone receptors offer some potential for hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LG-01Z-00-DX1.8ff0fdd8-e5d5-4ff8-8707-4a760aaa5d36-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LG-01Z-00-DX1.8ff0fdd8-e5d5-4ff8-8707-4a760aaa5d36.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nFor a patient diagnosed with pleomorphic invasive lobular carcinoma, SBR Grade 3, TNM stage T2N0M0, and negative HER-2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The combination of a high grade (SBR Grade 3), the type of lobular carcinoma, and intermediate tumor size, despite no nodal involvement and negative HER-2/neu, indicate a more aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of NHG3 invasive ductal carcinoma with TNM staging M0T2N1A and IHC results showing low estrogen receptor positivity, no progesterone receptors, and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3), lymph node involvement (N1), low hormone receptor positivity, and negative HER2 status indicate a more aggressive disease with fewer treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24K-01Z-00-DX1.3A56BAEC-484E-4F9B-BCB4-360ABF6DDB4B-1",
    "image": "TCGA-BRCA/TCGA-AR-A24K-01Z-00-DX1.3A56BAEC-484E-4F9B-BCB4-360ABF6DDB4B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, Nottingham grade III, with TNM staging of T2N0M0, and IHC results confirming cytokeratin positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high Nottingham grade indicates aggressive tumor behavior, and while the TNM staging shows no lymph node involvement, the T2 status suggests a larger primary tumor contributing to the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-AC-A2QJ-01Z-00-DX1.48C303BB-5A23-4037-BD28-77629A8CD9DA-1",
    "image": "TCGA-BRCA/TCGA-AC-A2QJ-01Z-00-DX1.48C303BB-5A23-4037-BD28-77629A8CD9DA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive metaplastic carcinoma with Nottingham Grade 3, TNM staging of T4BN0M0, and IHC results showing no hormone receptor expression and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade, aggressive nature of metaplastic carcinoma, advanced T stage, and lack of hormone receptor expression limit treatment options, indicating a more challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1L9-01Z-00-DX1.F2CC1036-8EEE-4664-962E-541B8ACB10DE-1",
    "image": "TCGA-BRCA/TCGA-E2-A1L9-01Z-00-DX1.F2CC1036-8EEE-4664-962E-541B8ACB10DE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR grade 2 with focal necrosis, TNM staging of T1CN1M0, and IHC results showing positive ER and PR with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The T1 stage and hormone receptor positivity are favorable factors, but lymph node involvement (N1) and focal necrosis suggest a more intermediate risk profile."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0RV-01Z-00-DX1.C46C2937-868D-47B7-B9B9-E51F5433BE97-1",
    "image": "TCGA-BRCA/TCGA-B6-A0RV-01Z-00-DX1.C46C2937-868D-47B7-B9B9-E51F5433BE97.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with a prominent lobular component, histologic grade 3, nuclear grade 2, TNM staging of M0T3N2, and positive estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The advanced TNM stage with significant lymph node involvement (N2) and high histologic grade indicate a more aggressive cancer, although hormone receptor positivity suggests potential benefit from hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JJ-01Z-00-DX1.a986b48f-b295-4d7a-b778-ce829cdf9c38-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JJ-01Z-00-DX1.a986b48f-b295-4d7a-b778-ce829cdf9c38.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with Nottingham Histologic Grade 3 (NHG3), TNM staging of T2N0M0, and IHC results showing high estrogen receptor positivity, moderate progesterone receptor positivity, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) indicates aggressive tumor behavior, and the TNM staging of T2N0M0 suggests a locally advanced disease without metastasis. Although the strong estrogen receptor positivity offers potential hormonal therapy options, the overall aggressive nature of the cancer impacts the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with Nottingham Histologic Grade 3 (NHG3), TNM staging of T2N0M0, and IHC results showing high estrogen receptor positivity, moderate progesterone receptor positivity, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) indicates aggressive tumor behavior, and the TNM staging of T2N0M0 suggests a locally advanced disease without metastasis. Although the strong estrogen receptor positivity offers potential hormonal therapy options, the overall aggressive nature of the cancer impacts the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AJ-01Z-00-DX1.34B9FCF0-74D8-4328-9B5A-698AD57EDA85-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AJ-01Z-00-DX1.34B9FCF0-74D8-4328-9B5A-698AD57EDA85.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, Nottingham grade III, TNM staging of T1N0M0, and IHC results showing positive Cytokeratin stain and negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low TNM stage (T1N0M0), the high grade (Nottingham grade III) indicates a more aggressive disease, and the negative HER2/neu overexpression limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1L7-01Z-00-DX1.BE796CD2-2E81-44E8-8CA2-85B4D2A31B64-1",
    "image": "TCGA-BRCA/TCGA-E2-A1L7-01Z-00-DX1.BE796CD2-2E81-44E8-8CA2-85B4D2A31B64.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with a Modified Scarff Bloom Richardson Grade 3, TNM stage M0T2N2, and IHC results showing triple-negative status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high SBR grade and advanced TNM stage with regional lymph node involvement suggest aggressive disease, and the triple-negative status limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0EB-01Z-00-DX1.70D7BBA0-214D-4D1A-933C-7CFCDA5416A3-1",
    "image": "TCGA-BRCA/TCGA-BH-A0EB-01Z-00-DX1.70D7BBA0-214D-4D1A-933C-7CFCDA5416A3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, TNM staging of M0T1CN0 (I-), and IHC results showing positive estrogen and progesterone receptors with negative HER-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early TNM stage (T1N0M0) combined with positive hormone receptor status indicates a favorable response to hormonal therapies, and the negative HER-2 results suggest lower aggression of the disease."
      }
    ]
  },
  {
    "id": "TCGA-AC-A62V-01Z-00-DX1.2D8994FD-58B8-43C1-B99D-AA964E7DFD60-1",
    "image": "TCGA-BRCA/TCGA-AC-A62V-01Z-00-DX1.2D8994FD-58B8-43C1-B99D-AA964E7DFD60.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham grade 3 with focal micropapillary features, TNM stage M1T2N1A, and IHC findings of 100% estrogen receptor positivity but low progesterone receptor and HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis (M1), high grade, and aggressive features outweigh the benefits of hormone receptor positivity, suggesting a challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JD-01Z-00-DX2.C6A7667E-25C9-48BD-A4E7-F4BB740FE589-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JD-01Z-00-DX2.C6A7667E-25C9-48BD-A4E7-F4BB740FE589.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham grade 2 invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results showing high estrogen receptor positivity, moderate progesterone receptor positivity, and negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade and lymph node involvement (N1) suggest some tumor aggressiveness, but high estrogen receptor positivity provides beneficial hormonal therapy options, balancing the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JD-01Z-00-DX1.6D215B14-DD90-4635-8645-AF06EBD9BA3F-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JD-01Z-00-DX1.6D215B14-DD90-4635-8645-AF06EBD9BA3F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham grade 2 invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results showing high estrogen receptor positivity, moderate progesterone receptor positivity, and negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade and lymph node involvement (N1) suggest some tumor aggressiveness, but high estrogen receptor positivity provides beneficial hormonal therapy options, balancing the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0C0-01Z-00-DX1.2D32D35A-EB7E-4D0E-BE5F-E56F7B930463-1",
    "image": "TCGA-BRCA/TCGA-BH-A0C0-01Z-00-DX1.2D32D35A-EB7E-4D0E-BE5F-E56F7B930463.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with Nottingham Grade 3 and admixed DCIS, TNM staging of M0T1CN1A, and positive estrogen and progesterone receptors with weakly positive HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade (Grade 3 with a total score of 9 out of 9) and nodal involvement (N1A) indicate aggressive tumor behavior, despite the positive hormone receptor status and weak HER2/neu positivity."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0EE-01Z-00-DX1.872EA586-25C8-4835-A138-152DFA1EBF30-1",
    "image": "TCGA-BRCA/TCGA-BH-A0EE-01Z-00-DX1.872EA586-25C8-4835-A138-152DFA1EBF30.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating ductal carcinoma with papillary features, Nottingham Histologic Grade 3 with a score of 8 out of 9, TNM staging of M0T3N0 (I-), and IHC results showing ER negative, PR negative, and HER-2/neu positive with a score of 3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham Histologic Grade 3) and large tumor size (T3) suggest aggressive disease, while the triple negative hormonal receptor status limits hormonal therapy options, and HER-2/neu positivity typically indicates a more aggressive cancer, though targeted therapies may provide some benefit."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27R-01Z-00-DX2.31F47D8F-DFD7-42AE-BBBA-7DBBA12FA97D-1",
    "image": "TCGA-BRCA/TCGA-D8-A27R-01Z-00-DX2.31F47D8F-DFD7-42AE-BBBA-7DBBA12FA97D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 with a total score of 9 out of 9, TNM staging of T2N3A M0, and IHC results showing high positivity for estrogen receptors, moderate positivity for progesterone receptors, and HER2 protein score of 2+ with FISH verification recommended, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade of the tumor (NHG3) and advanced TNM staging with significant lymph node involvement (N3A) indicate a more aggressive disease course, despite the high estrogen receptor positivity. FISH verification for HER2 is critical for determining further therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27R-01Z-00-DX1.F6E2FD1C-0666-4788-8D95-A76D15907270-1",
    "image": "TCGA-BRCA/TCGA-D8-A27R-01Z-00-DX1.F6E2FD1C-0666-4788-8D95-A76D15907270.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 with a total score of 9 out of 9, TNM staging of T2N3A M0, and IHC results showing high positivity for estrogen receptors, moderate positivity for progesterone receptors, and HER2 protein score of 2+ with FISH verification recommended, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade of the tumor (NHG3) and advanced TNM staging with significant lymph node involvement (N3A) indicate a more aggressive disease course, despite the high estrogen receptor positivity. FISH verification for HER2 is critical for determining further therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86-1",
    "image": "TCGA-BRCA/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive tubulolobular carcinoma, Nottingham Grade I, with TNM staging MXT1BN1A, and IHC results showing positive ER/PR and negative Her2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer\u2019s low grade and positive hormone receptors suggest responsiveness to hormonal therapies, while the negative Her2 and minimal nodal involvement (N1a) indicate a less aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BV-01Z-00-DX1.3C9CD4F7-A001-430D-AA8D-80CAD61C344E-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BV-01Z-00-DX1.3C9CD4F7-A001-430D-AA8D-80CAD61C344E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 2 with a total score of 7 out of 9, TNM staging of M0T2N1A, and IHC results showing ER positive, PR positive, and HER-2/neu negative (score 0), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. Although there is lymph node involvement (N1A), the intermediate grade and positive hormone receptor status (ER and PR positive) provide options for effective hormonal therapy, which can positively impact outcomes."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DO-01Z-00-DX1.1684557E-A5D4-4828-B2D5-FA899993A019-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DO-01Z-00-DX1.1684557E-A5D4-4828-B2D5-FA899993A019.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis for this patient, with a diagnosis of Nottingham grade 2 invasive ductal carcinoma, TNM staging of T1cN0M0, and positive hormone receptors but negative HER2, good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated grade, early TNM stage, and positive hormone receptors suggest effective hormonal therapy, with negative HER2 indicating a lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-OL-A66J-01Z-00-DX1.661F7F70-E4D4-4875-B8C4-556F7927F3BA-1",
    "image": "TCGA-BRCA/TCGA-OL-A66J-01Z-00-DX1.661F7F70-E4D4-4875-B8C4-556F7927F3BA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive lobular carcinoma, TNM staging of MXT1CN0, and IHC results showing strong ER and PR expression with low HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The presence of strong hormone receptor positivity (ER and PR) provides effective hormonal therapy options, and the low HER2/neu expression suggests a less aggressive tumor profile."
      }
    ]
  },
  {
    "id": "TCGA-3C-AALK-01Z-00-DX1.4E6EB156-BB19-410F-878F-FC0EA7BD0B53-1",
    "image": "TCGA-BRCA/TCGA-3C-AALK-01Z-00-DX1.4E6EB156-BB19-410F-878F-FC0EA7BD0B53.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, TNM staging of T1CN0M0 (I+), and IHC results showing various hormone receptor positivity and a HER2 score ranging from equivocal to positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The low TNM stage (T1CN0M0) and presence of hormone receptor positivity are favorable, but the HER2 positivity in one of the samples indicates a potential for more aggressive disease, which may affect overall outcomes."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55-1",
    "image": "TCGA-BRCA/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of infiltrating ductal carcinoma with Nottingham grade 3, TNM staging of T2N1M0, and IHC findings showing negative hormone receptors and HER2/neu score of 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade and lymph node involvement (N1) suggest aggressive disease. Negative hormone receptors and low HER2/neu expression limit targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AO-A03M-01Z-00-DX1.9998A9A0-D0A6-48FC-80FB-AE597CB9E8AA-1",
    "image": "TCGA-BRCA/TCGA-AO-A03M-01Z-00-DX1.9998A9A0-D0A6-48FC-80FB-AE597CB9E8AA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated, histologic grade III invasive ductal carcinoma, TNM staging of T1CN0M0 (I-), and IHC results showing positive ER and PR with high HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated histologic grade III suggests aggressive tumor behavior, and the high HER2/neu overexpression also indicates a more aggressive disease, despite the small tumor size and hormone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-AQ-A04L-01Z-00-DX1.F35BF4DD-896A-43C2-8DA6-C67945C003BE-1",
    "image": "TCGA-BRCA/TCGA-AQ-A04L-01Z-00-DX1.F35BF4DD-896A-43C2-8DA6-C67945C003BE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of grade 3 invasive ductal carcinoma, TNM staging of MXT2N0 (I-), and IHC results showing positive ER but negative PR with HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high tumor grade and HER2/neu overexpression translate to more aggressive disease, despite some hormone receptor positivity, indicating a complex therapeutic landscape."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EW-01Z-00-DX1.F24495CB-63D8-483F-9834-F761E3F16BF0-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EW-01Z-00-DX1.F24495CB-63D8-483F-9834-F761E3F16BF0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive lobular carcinoma, Nottingham grade 1, TNM staging of T1BN3A, and IHC results with positive estrogen and progesterone receptors and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the low grade and hormone receptor positivity, the TNM stage indicates extensive lymph node involvement (N3), which complicates treatment outcomes and suggests more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18P-01Z-00-DX1.C66642D3-BE44-4D65-B4AE-C1C3D959D22C-1",
    "image": "TCGA-BRCA/TCGA-BH-A18P-01Z-00-DX1.C66642D3-BE44-4D65-B4AE-C1C3D959D22C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 2 with associated ductal carcinoma in situ (nuclear grade 2), TNM staging of T1N0M0, and IHC results showing positive estrogen receptor, negative progesterone receptor, and weakly positive HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally favorable. The intermediate grade (Nottingham Histologic Grade 2), early stage (T1N0M0), and positive estrogen receptor status suggest a reasonable response to hormonal therapy. However, the weak HER-2/neu positivity and negative progesterone receptor may indicate a need for careful consideration in the therapeutic approach."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1J2-01Z-00-DX1.F1D8E593-2DF4-44C3-873D-FD3C910011E4-1",
    "image": "TCGA-BRCA/TCGA-EW-A1J2-01Z-00-DX1.F1D8E593-2DF4-44C3-873D-FD3C910011E4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of well-differentiated invasive lobular carcinoma, Nottingham grade 1, TNM staging MXT1CN1MI, and IHC results showing positive ER and PR with negative HER-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer\u2019s well-differentiated nature, low Nottingham grade, positive hormone receptor status, and negative HER-2 suggest favorable treatment options and a lower likelihood of aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-AC-A23H-01Z-00-DX1.8E0AE339-1047-4CA5-BFC5-37A3B10FD8B5-1",
    "image": "TCGA-BRCA/TCGA-AC-A23H-01Z-00-DX1.8E0AE339-1047-4CA5-BFC5-37A3B10FD8B5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, grade 2, with TNM staging M0T2NX, and IHC results showing low estrogen receptor positivity, negative progesterone receptor, and positive HER2/neu amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate to poor. The intermediate grade and HER2/neu positivity suggest a potentially aggressive cancer, while limited hormone receptor positivity reduces hormone therapy effectiveness."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2-1",
    "image": "TCGA-BRCA/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma (left) and moderately differentiated invasive ductal carcinoma (Nottingham grade 2) (right), TNM staging of T3N0M0, and IHC results showing 21% positivity for estrogen and progesterone receptors with positive HER2 (Score 3), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The larger tumor size (T3), moderate differentiation (Nottingham grade 2), and positive HER2 status (Score 3) indicate a higher risk of aggressive disease progression despite the hormone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EP-01Z-00-DX1.1180C406-5C18-4373-8621-1B7B70875113-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EP-01Z-00-DX1.1180C406-5C18-4373-8621-1B7B70875113.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating lobular carcinoma, moderately differentiated with a Bloom-Richardson Score of 6, TNM staging of M0T1N0 (I+), and IHC results showing positive estrogen receptor, negative progesterone receptor, and not amplified HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status, low TNM stage, and positivity for estrogen receptors suggest favorable outcomes with hormonal therapy, despite the negative progesterone receptor and lack of HER2/neu amplification."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0AW-01Z-00-DX1.9D50A0D2-B103-411C-831E-8520C3D50173-1",
    "image": "TCGA-BRCA/TCGA-BH-A0AW-01Z-00-DX1.9D50A0D2-B103-411C-831E-8520C3D50173.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive carcinoma, Nottingham Grade 2, TNM staging of M0T1CN1A, and immunohistochemistry results showing weak estrogen receptor positivity, negative progesterone receptor, and positive HER-1/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the tumor is moderately differentiated (Nottingham Grade 2) and the TNM staging indicates no distant metastasis (M0) with a small tumor size (T1), lymph node involvement (N1) and positive HER-1/neu overexpression suggest a more aggressive disease and potential for faster progression."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Nottingham grade 2 ductal carcinoma, TNM staging of T2N1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2 overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and lymph node involvement suggest a moderate risk, while the positive hormone receptor status offers favorable treatment options, and the negative HER2 indicates a lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DS-01Z-00-DX1.38E82A1F-21B9-4B97-A304-15B886EA68A0-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DS-01Z-00-DX1.38E82A1F-21B9-4B97-A304-15B886EA68A0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T2N2M0, and positive estrogen and progesterone receptors with negative HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. While hormone receptor positivity offers therapeutic options, the TNM stage with significant lymph node involvement (N2) and the grade suggest a more challenging outlook compared to lower-stage disease."
      }
    ]
  },
  {
    "id": "TCGA-AC-A5EI-01Z-00-DX1.A174D91A-730E-460C-AE73-46CA1E5B177B-1",
    "image": "TCGA-BRCA/TCGA-AC-A5EI-01Z-00-DX1.A174D91A-730E-460C-AE73-46CA1E5B177B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with concomitant malignant phyllodes tumor, TNM staging of MXT1CN1MI, and IHC results showing strong positivity for estrogen and progesterone receptors, HER2 score of 0, and low Ki67 proliferation index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of malignant phyllodes tumor alongside invasive ductal carcinoma, involvement of axillary lymph nodes (N1), and the TNM staging all indicate a more complex and potentially aggressive clinical course despite the favorable hormone receptor status and low proliferation index."
      }
    ]
  },
  {
    "id": "TCGA-OL-A6VQ-01Z-00-DX1.E3B81163-0239-47C3-B53F-064405B58685-1",
    "image": "TCGA-BRCA/TCGA-OL-A6VQ-01Z-00-DX1.E3B81163-0239-47C3-B53F-064405B58685.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, SBR grade II, TNM staging of MXT2N0, and IHC results showing strong ER expression, weak PR expression, non-amplified HER2, and a Ki67 index of 10%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate grade (SBR grade II) and the TNM staging indicating no lymph node involvement (N0) are relatively positive. Strong ER expression suggests effectiveness of hormonal therapy, although weak PR expression and non-amplified HER2 slightly temper the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BM-01Z-00-DX1.8BD324F2-60F5-4F59-AF2D-533A5FB230BF-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BM-01Z-00-DX1.8BD324F2-60F5-4F59-AF2D-533A5FB230BF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Nottingham grade I infiltrating ductal carcinoma, TNM staging of T2N1M0, and IHC results showing ER positive, PR negative, and HER-2/neu negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The low histologic grade suggests a less aggressive tumor, and the ER positivity indicates potential benefit from hormonal therapies. However, the TNM staging indicates moderate tumor size and some lymph node involvement, while the negative HER-2/neu reduces options for targeted HER2 therapies."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0H3-01Z-00-DX1.C6D4DFB9-A4FA-40B2-90EF-75294CBC4523-1",
    "image": "TCGA-BRCA/TCGA-BH-A0H3-01Z-00-DX1.C6D4DFB9-A4FA-40B2-90EF-75294CBC4523.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 1 (NHG1) with a total score of 4 out of 9, TNM staging of T1CN0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low histologic grade, early TNM stage, and positive hormone receptor status suggest that the cancer is less aggressive and more likely to respond well to hormonal therapies, while the negative HER2/neu status indicates a lower risk of aggressive disease progression."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1OZ-01Z-00-DX1.9639BB06-FF02-475F-A89D-773BE12721CC-1",
    "image": "TCGA-BRCA/TCGA-EW-A1OZ-01Z-00-DX1.9639BB06-FF02-475F-A89D-773BE12721CC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of high-grade invasive ductal carcinoma, Nottingham Histologic Grade III, TNM staging of T2N0M0, and IHC results showing strong positivity for ER/PR and HER-2/neu (pending FISH confirmation), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (III) indicates aggressive tumor behavior, and although the TNM staging shows no lymph node involvement, the strong HER-2/neu positivity suggests a more aggressive disease course, despite potential responsiveness to targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-GM-A3NW-01Z-00-DX1.3B0324F0-4007-4390-AF26-3789A50684E5-1",
    "image": "TCGA-BRCA/TCGA-GM-A3NW-01Z-00-DX1.3B0324F0-4007-4390-AF26-3789A50684E5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive lobular carcinoma, modified Black\u2019s nuclear grade 1-2, TNM staging of T2N0M0, and negative cytokeratin staining in sentinel lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer's well to moderately differentiated status, absence of lymph node involvement (N0), and absence of metastasis (M0) contribute to a favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T1CN1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) and lymph node involvement (N1) suggest aggressive disease potential, despite hormone receptor positivity providing some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A256-01Z-00-DX1.950D4546-4BF4-4380-9877-51D86A93D755-1",
    "image": "TCGA-BRCA/TCGA-AR-A256-01Z-00-DX1.950D4546-4BF4-4380-9877-51D86A93D755.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 2, TNM staging of T2N0M0, and IHC results showing negativity for estrogen and progesterone receptors with sentinel lymph nodes negative for metastasis, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite a moderate grade and no lymph node involvement (N0), the negativity for hormone receptors limits effective hormonal therapy options, which can impact overall outcomes."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HQ-01Z-00-DX1.0921FCEF-20A2-4D4B-A198-91AF9F6C814C-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HQ-01Z-00-DX1.0921FCEF-20A2-4D4B-A198-91AF9F6C814C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, TNM staging of T2N0M0 (I+), and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The absence of lymph node involvement (N0), hormone receptor positivity, and negative HER-2/neu suggest effective options for hormonal therapy and a less aggressive cancer behavior."
      }
    ]
  },
  {
    "id": "TCGA-EW-A6S9-01Z-00-DX1.4A8CD2D4-D528-465C-82DC-9CAE35DD424B-1",
    "image": "TCGA-BRCA/TCGA-EW-A6S9-01Z-00-DX1.4A8CD2D4-D528-465C-82DC-9CAE35DD424B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Grade 2, TNM staging M0T1CN1, with 50% ER positivity, HER2 score 3+, and negative keratin staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of poorly differentiated cells, lymph node involvement (N1), and high HER2 positivity indicates a more aggressive disease and may complicate treatment efficacy."
      }
    ]
  },
  {
    "id": "TCGA-GM-A3NY-01Z-00-DX1.BEED8B8F-5A1B-4CE2-BB5D-A7ED40551AE4-1",
    "image": "TCGA-BRCA/TCGA-GM-A3NY-01Z-00-DX1.BEED8B8F-5A1B-4CE2-BB5D-A7ED40551AE4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, TNM staging of T2N1M0, and IHC results showing negative HER2 overexpression, positive estrogen receptor, low positive progesterone receptor, and low Ki-67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The positive estrogen receptor status suggests hormonal therapy effectiveness, but lymph node involvement (N1) and low progesterone receptor positivity indicate a more guarded outlook."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DZ-01Z-00-DX1.138BAEC2-589E-4960-B94E-DF48DDAA5490-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DZ-01Z-00-DX1.138BAEC2-589E-4960-B94E-DF48DDAA5490.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated infiltrating ductal carcinoma, TNM staging of T2N1M0, and IHC results showing positive ER, PR, and HER2/neu amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated grade and lymph node involvement (N1) pose challenges, but positive hormone receptors and HER2/neu amplification suggest effective targeted therapies, potentially improving outcomes."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BC-01Z-00-DX1.7A91831D-9625-49FC-B783-C633F80F898C-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BC-01Z-00-DX1.7A91831D-9625-49FC-B783-C633F80F898C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T2N3M0, and IHC results showing positive estrogen and progesterone receptors with equivocal HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high lymph node involvement (N3) suggests advanced regional spread, which is concerning, despite positive hormone receptor status that may offer some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-AQ-A04J-01Z-00-DX1.6A4E16D4-2696-4E5F-BCA8-708556FC3A8C-1",
    "image": "TCGA-BRCA/TCGA-AQ-A04J-01Z-00-DX1.6A4E16D4-2696-4E5F-BCA8-708556FC3A8C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T2N0M0, and negative IHC results for estrogen, progesterone, and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade and lack of hormone receptor and HER2/neu expression suggest aggressive disease behavior and limited options for targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18V-01Z-00-DX1.7797760A-05CD-436E-97DA-31D6201F943B-1",
    "image": "TCGA-BRCA/TCGA-BH-A18V-01Z-00-DX1.7797760A-05CD-436E-97DA-31D6201F943B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated carcinoma, TNM staging of T2N1M0, and IHC findings, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated carcinoma, along with lymph node involvement (N1), indicates an aggressive disease. Additionally, the negative status for ER, PR, and HER-2/neu limits therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-LL-A6FR-01Z-00-DX1.107010FD-8EDD-406D-B4DE-DEC9E85576FF-1",
    "image": "TCGA-BRCA/TCGA-LL-A6FR-01Z-00-DX1.107010FD-8EDD-406D-B4DE-DEC9E85576FF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, poorly differentiated (Nottingham grade 3), TNM staging MXT2N0, and IHC results with equivocal HER2 but amplified and weakly positive PR, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and T2 stage suggest aggressive behavior, while limited hormone receptor positivity and HER2 amplification indicate potentially aggressive disease with limited hormonal therapy efficacy."
      }
    ]
  },
  {
    "id": "TCGA-LL-A73Y-01Z-00-DX1.50C20931-3AA9-40B4-8A73-56B1976423A8-1",
    "image": "TCGA-BRCA/TCGA-LL-A73Y-01Z-00-DX1.50C20931-3AA9-40B4-8A73-56B1976423A8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 3 (total score 8/9), TNM staging of T1CN0MX, and IHC results indicating negative estrogen, progesterone, and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade suggests aggressive tumor characteristics, while the triple-negative IHC profile limits hormone and targeted therapy options, increasing the likelihood of a challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1B1-01Z-00-DX1.7C8DF153-B09B-44C7-87B8-14591E319354-1",
    "image": "TCGA-BRCA/TCGA-E2-A1B1-01Z-00-DX1.7C8DF153-B09B-44C7-87B8-14591E319354.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated infiltrating ductal carcinoma, Modified Scarff-Bloom-Richardson Grade 1, with TNM staging of T2N1M0, and IHC results showing positive ER and PR, and HER2 amplification by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The well-differentiated nature and hormone receptor positivity suggest favorable treatment response, although the TNM staging indicates some nodal involvement, and HER2 amplification points to a more aggressive tumor but also provides opportunities for targeted HER2 therapy."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HK-01Z-00-DX1.019036F5-647A-4EC4-8479-F2C100291AEF-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HK-01Z-00-DX1.019036F5-647A-4EC4-8479-F2C100291AEF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating mammary carcinoma, predominantly lobular, Nottingham Histologic Grade 2 (NHG2) with a total score of 6 out of 9, TNM staging of T2N1M0, and IHC results showing positive estrogen receptor, negative progesterone receptor, and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade (NHG2) and TNM staging indicating some lymph node involvement (N1) suggest a moderately aggressive disease, while the positive estrogen receptor status provides beneficial hormonal therapy options, despite the negative progesterone receptor and HER-2/neu results."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1IW-01Z-00-DX1.0DE87057-951F-4887-A2D5-485736D66E4E-1",
    "image": "TCGA-BRCA/TCGA-EW-A1IW-01Z-00-DX1.0DE87057-951F-4887-A2D5-485736D66E4E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of intermediate-grade invasive lobular carcinoma with TNM staging of MXT2N1A and IHC results showing 21% positivity for estrogen and progesterone receptors, equivocal HER2/neu status with CISH indicating amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate nuclear and histologic grade along with the TNM staging indicating regional lymph node involvement (N1A) suggest a more aggressive disease course. Moreover, the low hormone receptor positivity and HER2/neu amplification are associated with less favorable outcomes."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18Q-01Z-00-DX1.E89E49C7-D62A-4408-A3D9-19E79FCB249E-1",
    "image": "TCGA-BRCA/TCGA-BH-A18Q-01Z-00-DX1.E89E49C7-D62A-4408-A3D9-19E79FCB249E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of infiltrating poorly differentiated ductal adenocarcinoma, a TNM staging of T2N1M0, and IHC results showing negative hormone receptors and weakly positive HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high Nottingham grade, lymph node involvement (N1), and absence of hormone receptors with only weakly positive HER-2/neu suggest limited therapeutic options and aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A-1",
    "image": "TCGA-BRCA/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated invasive carcinoma with lobular features, TNM staging of T1CN0, and IHC results showing positivity for estrogen and progesterone receptors with HER2/neu score 3+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is somewhat intermediate. The moderately differentiated status and low TNM stage are favorable, but the HER2/neu positivity indicates a more aggressive potential, although it allows for targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CO-01Z-00-DX1.B191DADE-7DEA-4575-AED7-1C52BE15B8D5-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CO-01Z-00-DX1.B191DADE-7DEA-4575-AED7-1C52BE15B8D5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating lobular carcinoma, TNM staging of T3N0M0, and IHC results showing HER2/neu amplification (5.0), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3 stage indicates a larger tumor size, and although there is no lymph node involvement, the HER2/neu amplification suggests a more aggressive cancer type."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EV-01Z-00-DX1.EA8C5594-BA4F-47A8-949B-D536E00E62C9-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EV-01Z-00-DX1.EA8C5594-BA4F-47A8-949B-D536E00E62C9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated infiltrating ductal carcinoma (NHG2), TNM staging of T1N0M0, and the IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated grade, low TNM stage, and high hormone receptor positivity suggest responsive hormonal therapy, while negative HER-2/neu indicates lower aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DG-01Z-00-DX1.D3C4F57F-608F-46AA-A978-B558117C9DFB-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DG-01Z-00-DX1.D3C4F57F-608F-46AA-A978-B558117C9DFB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Grade 2 with a score of 7 out of 9, TNM staging of T2N0M0, and IHC results showing positive estrogen receptor, negative progesterone receptor, and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The intermediate grade (Nottingham Grade 2) and the absence of lymph node involvement (N0) are favorable factors. The positive estrogen receptor status allows for possible hormonal therapy, although negative progesterone receptor and HER-2/neu suggest fewer targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1B6-01Z-00-DX1.8CD458BE-C4F9-4AF3-A927-18C042E9B4B7-1",
    "image": "TCGA-BRCA/TCGA-E2-A1B6-01Z-00-DX1.8CD458BE-C4F9-4AF3-A927-18C042E9B4B7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated invasive ductal carcinoma, Scarff-Bloom-Richardson Grade 3, TNM staging of M0T2N0, and IHC results showing negative ER and PR with equivocal HER-2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated Grade 3 status and TNM staging of T2 without lymph node involvement (N0) indicates aggressive cancer behavior, while the negative hormone receptors and equivocal HER-2 status limit targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-LL-A5YO-01Z-00-DX1.B5B6DFDB-1020-41FF-AA50-9C633E17DE5F-1",
    "image": "TCGA-BRCA/TCGA-LL-A5YO-01Z-00-DX1.B5B6DFDB-1020-41FF-AA50-9C633E17DE5F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, TNM staging MXT1BN0, and IHC results showing ER, PR, and HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The triple-negative status (ER, PR, and HER2 negative) limits targeted treatment options, and while the current staging suggests no lymph node involvement, the overall lack of hormone or HER2-driven treatments makes it challenging."
      }
    ]
  },
  {
    "id": "TCGA-EW-A6SA-01Z-00-DX1.DE032DD7-169D-4AA2-A4E0-1EFC158431FA-1",
    "image": "TCGA-BRCA/TCGA-EW-A6SA-01Z-00-DX1.DE032DD7-169D-4AA2-A4E0-1EFC158431FA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of MXT2N0 (I+), and IHC results showing ER positivity, PR negativity, and HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade and T2 classification suggest more aggressive disease, despite the ER positivity, which offers some potential for hormonal therapy. HER2 negativity limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1IY-01Z-00-DX1.3FD00274-C2CD-491A-915B-23FD535A4723-1",
    "image": "TCGA-BRCA/TCGA-EW-A1IY-01Z-00-DX1.3FD00274-C2CD-491A-915B-23FD535A4723.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with an intermediate histologic grade (Nottingham grade 2), TNM staging of MXT1CN0, and IHC results showing positive ER and PR but negative HER2-neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate histologic grade (Nottingham grade 2) and TNM staging indicating a small tumor size without clear nodal or distant metastasis suggest a less aggressive form of cancer, and the positive ER and PR status implies potential effectiveness of hormone therapy."
      }
    ]
  },
  {
    "id": "TCGA-OL-A66K-01Z-00-DX1.C1DC85F1-4FAE-4411-9886-11DCB5E70CC3-1",
    "image": "TCGA-BRCA/TCGA-OL-A66K-01Z-00-DX1.C1DC85F1-4FAE-4411-9886-11DCB5E70CC3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, SBR grade II, TNM staging of MXT2N0, and IHC results showing moderate expression of ER and strong expression of PR with equivocal Her2/neu antigen status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated (SBR grade II) tumor and greater than T2 primary tumor size suggest a need for cautious optimism. However, the strong hormone receptor positivity provides potential for effective hormonal therapy, although the pending Her2/neu status might influence further treatment considerations."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive ductal carcinoma, Nottingham Histologic Grade 2 (NHG2) with a total score of 6 out of 9, TNM staging of M0T1CN0 (I-), and IHC results showing positive estrogen and progesterone receptors with HER2/neu score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The moderate differentiation (NHG2), low TNM stage (T1CN0), and positive hormone receptor status indicate a likely positive response to hormonal therapy, although the equivocal HER2/neu status may require further clarification."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BP-01Z-00-DX1.63A87C1D-87FA-494D-9836-74290B5DC30D-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BP-01Z-00-DX1.63A87C1D-87FA-494D-9836-74290B5DC30D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with a Nottingham Score of 6/9 (Grade 2), TNM staging of T1cN0M0, and IHC results showing positive P63 and Smooth Muscle Myosin Heavy Chain with HER2/neu expression at 0 or 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The grade 2 classification, early local stage (T1c) without nodal involvement (N0) or distant metastasis (M0), and low HER2/neu expression suggest a less aggressive form of cancer and better overall outcomes."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated infiltrating lobular carcinoma, TNM staging of T3N0M0 with isolated tumor cells (I+), and IHC results showing negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite moderate differentiation, the T3 stage indicates a larger tumor size, and the presence of isolated tumor cells suggests potential dissemination. Negative HER2/neu limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-AO-A03P-01Z-00-DX1.D34DA321-D8E3-4D68-BCE2-4A8B72B3D0AE-1",
    "image": "TCGA-BRCA/TCGA-AO-A03P-01Z-00-DX1.D34DA321-D8E3-4D68-BCE2-4A8B72B3D0AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of grade III invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results with high ER positivity, moderate PR positivity, and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histological and nuclear grades, along with lymph node involvement (N1), suggest a more aggressive disease. However, the high ER positivity offers some favorable aspects for hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18M-01Z-00-DX1.56E6935A-62CB-4CBE-BDCA-60DA56422CE0-1",
    "image": "TCGA-BRCA/TCGA-BH-A18M-01Z-00-DX1.56E6935A-62CB-4CBE-BDCA-60DA56422CE0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of ductal carcinoma with focal lobular features, TNM staging of M0T3N1, and IHC results showing positive estrogen and progesterone receptors (Score 3+) and nearly positive HER-2/neu (Score 2+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The advanced TNM staging (T3N1) indicates a larger tumor and some lymph node involvement, which are associated with a more aggressive disease. Although positive hormone receptors may offer some treatment options, the nearly positive HER-2/neu status suggests potential for higher aggressiveness without clear benefit from HER-2 targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27F-01Z-00-DX1.C1A87F27-49F1-46BA-B2E2-A89293F7FD0C-1",
    "image": "TCGA-BRCA/TCGA-D8-A27F-01Z-00-DX1.C1A87F27-49F1-46BA-B2E2-A89293F7FD0C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma (NHG3) with a total score of 9, TNM staging of T2N0M0, and IHC results showing absence of estrogen and progesterone receptors with negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade indicates aggressive cancer, absence of hormone receptors limits endocrine therapy options, and negative HER2 status suggests fewer targeted treatments."
      }
    ]
  },
  {
    "id": "TCGA-AR-A0U4-01Z-00-DX1.DE722DC5-859D-4866-ADCC-ED98EDBFB588-1",
    "image": "TCGA-BRCA/TCGA-AR-A0U4-01Z-00-DX1.DE722DC5-859D-4866-ADCC-ED98EDBFB588.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient's diagnosis of Nottingham grade III infiltrating ductal carcinoma, TNM staging of T2N0M0, and IHC results showing negative ER, PR, and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade tumor, T2 stage, and triple-negative status (ER, PR, HER2/neu) suggest a more aggressive cancer with fewer treatment options, impacting overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-OL-A66P-01Z-00-DX1.5ADD0D6D-37C6-4BC9-8C2B-64DB18BE99B3-1",
    "image": "TCGA-BRCA/TCGA-OL-A66P-01Z-00-DX1.5ADD0D6D-37C6-4BC9-8C2B-64DB18BE99B3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade II, TNM staging of MXT2N0, and IHC results showing no expression of ER and PR, non-amplified HER2, and high Ki-67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate grade (SBR Grade II) and the TNM staging indicating a tumor size greater than 2 cm (T2) suggest a more aggressive disease. The lack of hormone receptor expression and HER2 amplification limits treatment options, while a high Ki-67 index indicates a higher proliferation rate."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0GZ-01Z-00-DX1.9AD4F493-A0A9-499D-B667-B33333FC1A51-1",
    "image": "TCGA-BRCA/TCGA-BH-A0GZ-01Z-00-DX1.9AD4F493-A0A9-499D-B667-B33333FC1A51.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of Nottingham Grade 2 invasive ductal carcinoma, TNM staging of T1CN1M0, and IHC results indicating positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (Nottingham Grade 2) and lymph node involvement (N1) suggest a need for caution, but positive hormone receptor status offers potential for effective hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-AR-A0U3-01Z-00-DX1.9BB87F9D-459F-4A18-B591-29822EA5AE18-1",
    "image": "TCGA-BRCA/TCGA-AR-A0U3-01Z-00-DX1.9BB87F9D-459F-4A18-B591-29822EA5AE18.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal adenocarcinoma, Nottingham grade III, TNM staging of T2N1M0, and IHC results showing estrogen positivity greater than 10% and focal progesterone positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade III indicates aggressive cancer, and the TNM staging shows some lymph node involvement (N1). Although estrogen positivity is a favorable factor, the overall indicators point to a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CZ-01Z-00-DX1.A433A414-4F1B-4F99-8FD9-E64803F5E042-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CZ-01Z-00-DX1.A433A414-4F1B-4F99-8FD9-E64803F5E042.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with lobular features, a Nottingham Histologic Grade 2, TNM staging of T2N0M0, and IHC results showing high estrogen receptor positivity and low progesterone receptor positivity with negative HER-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The moderate differentiation (NHG2) and TNM staging with no lymph node of metastasis involvement (T2N0M0) indicate a less aggressive disease, and the high estrogen receptor positivity represents a favorable hormonal therapy response, despite low progesterone receptor positivity and negative HER-2 status."
      }
    ]
  },
  {
    "id": "TCGA-Z7-A8R6-01Z-00-DX1.CE4ED818-D762-4324-9DEA-2ACB38B9B0B9-1",
    "image": "TCGA-BRCA/TCGA-Z7-A8R6-01Z-00-DX1.CE4ED818-D762-4324-9DEA-2ACB38B9B0B9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating lobular carcinoma, pleomorphic type, poorly differentiated, with a modified Bloom-Richardson score of 8/9, TNM staging of M0T1CN0, and IHC results showing positive estrogen and progesterone receptors with high Ki-67 and negative HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status and high proliferation rate (Ki-67) indicate aggressive tumor behavior, despite the small tumor size (T1) and hormone receptor positivity, which are favorable factors."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27H-01Z-00-DX1.BE9DFDD4-97C5-4327-B1DA-4B34A6F267C5-1",
    "image": "TCGA-BRCA/TCGA-D8-A27H-01Z-00-DX1.BE9DFDD4-97C5-4327-B1DA-4B34A6F267C5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing no hormone receptor expression and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade indicates aggressive cancer, and the absence of hormone receptors along with negative HER2 limits effective targeted therapies, despite no lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-AC-A5EH-01Z-00-DX1.DF59B26B-379F-4047-B7AE-4493810D30A0-1",
    "image": "TCGA-BRCA/TCGA-AC-A5EH-01Z-00-DX1.DF59B26B-379F-4047-B7AE-4493810D30A0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham grade 2, with TNM staging of T2N1MX, and IHC results showing positive estrogen receptor, negative progesterone receptor, negative HER2, and high Ki67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate grade, lymph node involvement (N1), and high Ki67 indicate aggressive disease, while hormone receptor positivity offers some hormonal therapy options despite low estrogen receptor expression."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T1C0M0, and IHC results showing positive estrogen receptors, negative progesterone receptors, and positive HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The early TNM stage (T1 and N0) and Nottingham Grade 2 indicate a relatively early-stage and moderately differentiated tumor. The positive HER-2/neu overexpression allows for targeted HER-2 therapies, although the negative progesterone receptor and intermediate grade temper the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0H5-01Z-00-DX1.28F24D4D-EE80-4EDA-BC30-A194E22FD61C-1",
    "image": "TCGA-BRCA/TCGA-BH-A0H5-01Z-00-DX1.28F24D4D-EE80-4EDA-BC30-A194E22FD61C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis good or poor for a patient diagnosed with invasive ductal carcinoma, TNM staging of T1N0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu by FISH?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early-stage cancer (T1N0M0) and positive hormone receptors suggest effective hormonal therapy options, while the negative HER-2/neu indicates a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-E2-A10F-01Z-00-DX1.18F9324C-A38F-478E-95DF-B8E172D0DD07-1",
    "image": "TCGA-BRCA/TCGA-E2-A10F-01Z-00-DX1.18F9324C-A38F-478E-95DF-B8E172D0DD07.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive lobular carcinoma, TNM stage M0T2N0, and IHC findings supporting lobular differentiation with negative E-cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated status and absence of nodal involvement (N0) indicate a less aggressive form of the disease. The lack of distant metastasis (M0) further supports this positive outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y1-01Z-00-DX1.477390C8-2141-4ADD-813E-25220D2A71FC-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y1-01Z-00-DX1.477390C8-2141-4ADD-813E-25220D2A71FC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 with a TNM staging of MXT3N1A, and IHC results showing 10-75% estrogen receptor positivity, over 75% progesterone receptor positivity, and negative HER2 protein expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham histologic grade (Grade 3) and the TNM staging, which suggests advanced local tumor size (T3) with lymph node involvement (N1A), indicate a more aggressive disease. Despite hormone receptor positivity, the negative HER2 protein limits certain treatment options, contributing to the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y1-01Z-00-DX2.B58DC955-F864-4E78-8B1A-8156E2F7D554-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y1-01Z-00-DX2.B58DC955-F864-4E78-8B1A-8156E2F7D554.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 with a TNM staging of MXT3N1A, and IHC results showing 10-75% estrogen receptor positivity, over 75% progesterone receptor positivity, and negative HER2 protein expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham histologic grade (Grade 3) and the TNM staging, which suggests advanced local tumor size (T3) with lymph node involvement (N1A), indicate a more aggressive disease. Despite hormone receptor positivity, the negative HER2 protein limits certain treatment options, contributing to the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-A8-A0A4-01Z-00-DX1.06C38F98-F34B-49F0-AFB5-7F0086188346-1",
    "image": "TCGA-BRCA/TCGA-A8-A0A4-01Z-00-DX1.06C38F98-F34B-49F0-AFB5-7F0086188346.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, classical differentiation (G I), TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with negative c-erb B-2 oncoprotein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer is well-differentiated, has no lymph node involvement (N0), and has positive hormone receptors, indicating responsiveness to hormonal therapy. The negative c-erb B-2 oncoprotein suggests a lower likelihood of aggressive disease progression."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15P-01Z-00-DX1.4C7F95DC-B319-4A78-8F34-8CB9166EA6A8-1",
    "image": "TCGA-BRCA/TCGA-E2-A15P-01Z-00-DX1.4C7F95DC-B319-4A78-8F34-8CB9166EA6A8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 2 (Score 6), TNM staging of T1CN0M0, and IHC results showing ER positive with an Allred Score of 8, PR positive with an Allred Score of 4, and HER2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer\u2019s moderate differentiation (SBR Grade 2), low TNM stage, and strong positivity for estrogen and progesterone receptors suggest favorable outcomes with hormonal therapy, while the negative HER2 status indicates a lower risk of aggressive disease progression."
      }
    ]
  },
  {
    "id": "TCGA-D8-A73X-01Z-00-DX2.1ABCCE71-A70C-48C3-924E-2C8F5F71E269-1",
    "image": "TCGA-BRCA/TCGA-D8-A73X-01Z-00-DX2.1ABCCE71-A70C-48C3-924E-2C8F5F71E269.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive tubular carcinoma with Nottingham Histologic Grade 1, TNM staging of T2N0M0, and IHC results showing 75% positivity for estrogen and progesterone receptors, negative HER2, and a Ki-67 index of 10%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low Nottingham grade and absence of lymph node involvement indicate a less aggressive tumor, and the high hormone receptor positivity allows for effective hormonal therapy. Additionally, the negative HER2 status and low Ki-67 index suggest a lower proliferation rate and reduced aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-D8-A73X-01Z-00-DX1.5F0DF75C-594C-42DF-BE3F-E00E5E01DCD6-1",
    "image": "TCGA-BRCA/TCGA-D8-A73X-01Z-00-DX1.5F0DF75C-594C-42DF-BE3F-E00E5E01DCD6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive tubular carcinoma with Nottingham Histologic Grade 1, TNM staging of T2N0M0, and IHC results showing 75% positivity for estrogen and progesterone receptors, negative HER2, and a Ki-67 index of 10%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low Nottingham grade and absence of lymph node involvement indicate a less aggressive tumor, and the high hormone receptor positivity allows for effective hormonal therapy. Additionally, the negative HER2 status and low Ki-67 index suggest a lower proliferation rate and reduced aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-E2-A10A-01Z-00-DX1.98B19EF1-0DAE-4DC6-8B0E-963CFABC6724-1",
    "image": "TCGA-BRCA/TCGA-E2-A10A-01Z-00-DX1.98B19EF1-0DAE-4DC6-8B0E-963CFABC6724.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, multifocal, SBR Grade II, TNM staging of M0T3N0 (I-), and IHC results showing positive estrogen and progesterone receptors with an Allred score of 7 and 8 respectively, and HER-2 not amplified, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate SBR Grade II and the larger tumor size (T3) suggest moderately aggressive disease, but the absence of lymph node involvement (N0) and positive hormone receptors indicate responsive hormonal therapies and a lower likelihood of metastasis defined by the M0 status."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1EN-01Z-00-DX1.F535657F-E2FA-4283-87AE-7DAB663B196B-1",
    "image": "TCGA-BRCA/TCGA-BH-A1EN-01Z-00-DX1.F535657F-E2FA-4283-87AE-7DAB663B196B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma with signet ring features, TNM staging of T2NXM0, and IHC results showing positive estrogen and progesterone receptors along with positive HER2/neu (Score 3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate tumor size (T2), unknown lymph node status (NX), and aggressive histology with signet ring features indicate a higher risk profile, despite the positive hormone receptors and HER2/neu, which may provide additional therapeutic options but also indicate a potentially more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-E2-A152-01Z-00-DX1.B0860DEB-D34B-4C5D-97F5-C1C646437424-1",
    "image": "TCGA-BRCA/TCGA-E2-A152-01Z-00-DX1.B0860DEB-D34B-4C5D-97F5-C1C646437424.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR Grade 3, with TNM staging of T1CN0, and IHC results showing ER-positive, PR-negative, and HER2-positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) signifies aggressive behavior, and while the tumor is small (T1) and with no distant metastasis (M0) or confirmed lymph node involvement (N0), the HER2-positive status indicates a more aggressive cancer type despite targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-C8-A12Y-01Z-00-DX1.A15CB3E2-E145-4C75-8FEA-1DD503CD7C20-1",
    "image": "TCGA-BRCA/TCGA-C8-A12Y-01Z-00-DX1.A15CB3E2-E145-4C75-8FEA-1DD503CD7C20.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated infiltrating ductal carcinoma, TNM staging of T2N1M0, and IHC findings negative for ER, PR, HER2/neu, and other markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The moderately differentiated cancer with lymph node involvement (N1) and triple-negative status (ER, PR, HER2) indicates limited targeted therapy options and a potentially aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-E2-A155-01Z-00-DX1.A5AF232A-61BB-4FDC-ABF9-2FE9BA461BDC-1",
    "image": "TCGA-BRCA/TCGA-E2-A155-01Z-00-DX1.A5AF232A-61BB-4FDC-ABF9-2FE9BA461BDC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of invasive ductal carcinoma, SBR Grade 3 with micropapillary features, TNM staging of M0T2N1A, and IHC results showing ER-positive, PR-negative, and HER2-negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade (SBR Grade 3), the presence of micropapillary features, and lymph node involvement (N1A) suggest more aggressive disease behavior, while the negative HER2 status reduces targeted therapy options despite the ER positivity."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5RY-01Z-00-DX1.AE4E9D74-FC1C-4C1E-AE6D-5DF38899BBA6-1",
    "image": "TCGA-BRCA/TCGA-OL-A5RY-01Z-00-DX1.AE4E9D74-FC1C-4C1E-AE6D-5DF38899BBA6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of high-grade invasive ductal carcinoma with an SBR grade score of 8 out of 9, TNM staging of MXT1CN1, and IHC results indicating weak ER expression, no PR expression, and amplified HER2/neu antigen, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high SBR grade and TNM staging indicating lymph node involvement suggest aggressive disease. Additionally, weak ER and absent PR expression limit hormonal therapy options, while amplified HER2/neu indicates more aggressive cancer, albeit with potential for targeted HER2 therapies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15K-01Z-00-DX1.9F424BE2-9BFE-4DFF-8CC9-10D2DADBBEA7-1",
    "image": "TCGA-BRCA/TCGA-E2-A15K-01Z-00-DX1.9F424BE2-9BFE-4DFF-8CC9-10D2DADBBEA7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR Grade 3, TNM staging of T2N1M0, and IHC results showing ER positive with an Allred score of 8 and PR positive with an Allred score of 4, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) and the TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease. However, the positive estrogen receptor status offers some potential for effective hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-C8-A12K-01Z-00-DX1.D71C7974-65F7-4EF0-8FFB-9F27CEC85242-1",
    "image": "TCGA-BRCA/TCGA-C8-A12K-01Z-00-DX1.D71C7974-65F7-4EF0-8FFB-9F27CEC85242.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma, TNM staging of T2N1M0, and IHC results showing negativity for estrogen receptor, progesterone receptor, HER-2/neu, and other markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging of T2N1M0 suggests a tumor size of more than 2 cm with regional lymph node involvement, and the triple-negative status (negative for ER, PR, and HER-2/neu) is associated with a more aggressive disease and fewer targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A04Y-01Z-00-DX1.4DC97AD6-4806-4A3A-A998-FD36F93590A4-1",
    "image": "TCGA-BRCA/TCGA-A2-A04Y-01Z-00-DX1.4DC97AD6-4806-4A3A-A998-FD36F93590A4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated infiltrating ductal carcinoma, TNM staging of T2N1M0, and IHC results showing high estrogen receptor positivity, low progesterone receptor positivity, and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (NHG3) and lymph node involvement (N1) indicate aggressive disease, while negative HER2 status limits targeted therapy options, despite high estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-A2-A3KD-01Z-00-DX1.E400D529-A0D1-4C78-AD5C-33EB0508B128-1",
    "image": "TCGA-BRCA/TCGA-A2-A3KD-01Z-00-DX1.E400D529-A0D1-4C78-AD5C-33EB0508B128.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of well-differentiated infiltrating mucinous (colloid) carcinoma with Nottingham Histologic Grade 1, TNM staging of T3N1MI, and IHC results showing positive Cytokeratin, high positivity for estrogen and progesterone receptors, and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the well-differentiated and hormone receptor-positive status, the advanced TNM stage with T3 primary tumor size, some lymph node metastasis (N1), and presence of micrometastasis (MI) suggest a more serious progression of the disease."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SN-01Z-00-DX1.5E9B85AE-AFB7-41DC-8A1B-BD6DA39B6540-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SN-01Z-00-DX1.5E9B85AE-AFB7-41DC-8A1B-BD6DA39B6540.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrative ductal carcinoma, SBR grade 2, TNM staging of MXT1CN1, and IHC results showing strong positivity for both estrogen and progesterone receptors, along with positive HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. While hormone receptor positivity suggests potential effectiveness of hormonal therapy, the involvement of lymph nodes (N1) and positive HER2/neu overexpression indicate a more aggressive disease with higher risk of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-A2-A04W-01Z-00-DX1.F7E7B945-2ADC-4741-8FCE-ACEA657DB9C7-1",
    "image": "TCGA-BRCA/TCGA-A2-A04W-01Z-00-DX1.F7E7B945-2ADC-4741-8FCE-ACEA657DB9C7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated invasive ductal carcinoma (NHG2) and TNM staging of T2N1M0, alongside IHC results showing HER2/neu positive (3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately positive. The intermediate grade and lymph node involvement suggest moderate risk, but the HER2/neu positivity allows for targeted therapy, which can improve outcomes."
      }
    ]
  },
  {
    "id": "TCGA-E2-A108-01Z-00-DX1.B110ED43-08A4-476A-A658-1CA75F7C0DDE-1",
    "image": "TCGA-BRCA/TCGA-E2-A108-01Z-00-DX1.B110ED43-08A4-476A-A658-1CA75F7C0DDE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of Grade 3 invasive ductal carcinoma, TNM staging of T2N2M0, and IHC results showing positive estrogen and progesterone receptors but negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and TNM staging indicating significant lymph node involvement (N2) suggest aggressive disease. However, the positive hormone receptors may offer some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A13Z-01Z-00-DX1.517140BB-D34C-42F8-952C-340EF16D382F-1",
    "image": "TCGA-BRCA/TCGA-D8-A13Z-01Z-00-DX1.517140BB-D34C-42F8-952C-340EF16D382F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of mixed invasive carcinoma with invasive ductal carcinoma features, TNM staging of T2N2M0, and IHC results showing negative estrogen and progesterone receptors with negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The mixed invasive carcinoma with significant lymph node involvement (N2) and lack of hormone receptor and HER2 expression limits treatment options, indicating more aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-BH-A201-01Z-00-DX1.6D6E3224-50A0-45A2-B231-EEF27CA7EFD2-1",
    "image": "TCGA-BRCA/TCGA-BH-A201-01Z-00-DX1.6D6E3224-50A0-45A2-B231-EEF27CA7EFD2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T1N0M0, and IHC results showing positive ER and PR with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderate grade, early-stage TNM, and positive hormone receptor status suggest potential responsiveness to hormonal therapies, while negative HER-2/neu indicates a lower risk of aggressive progression."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SI-01Z-00-DX1.AB717348-F964-4F29-BBE2-972B7C640432-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SI-01Z-00-DX1.AB717348-F964-4F29-BBE2-972B7C640432.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of SBR grade II invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate. The intermediate SBR grade and lymph node involvement (N1) suggest a more challenging outlook, but the presence of hormone receptors provides opportunities for effective hormonal therapy, supporting a more favorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5RX-01Z-00-DX1.15A0D4F4-2744-4D44-8883-27FF83D9C824-1",
    "image": "TCGA-BRCA/TCGA-OL-A5RX-01Z-00-DX1.15A0D4F4-2744-4D44-8883-27FF83D9C824.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR grade 1, TNM staging of MXT1CN0, and strong expression of ER and PR with non-amplified Her2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low histological grade (SBR grade 1), strong hormone receptor positivity, and non-amplified Her2/neu indicate a less aggressive cancer with effective options for hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-E9-A3X8-01Z-00-DX1.D1532F80-F5F8-47AF-8A1B-B59E345F5D70-1",
    "image": "TCGA-BRCA/TCGA-E9-A3X8-01Z-00-DX1.D1532F80-F5F8-47AF-8A1B-B59E345F5D70.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of lobular carcinoma, TNM staging of T2N1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The positive hormone receptors suggest responsiveness to hormonal therapy, but the tumor size and lymph node involvement (N1) indicate an intermediate risk for disease progression."
      }
    ]
  },
  {
    "id": "TCGA-AQ-A7U7-01Z-00-DX1.AB5629A1-399E-402B-AD3D-DAF9F97D8300-1",
    "image": "TCGA-BRCA/TCGA-AQ-A7U7-01Z-00-DX1.AB5629A1-399E-402B-AD3D-DAF9F97D8300.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma with a Nottingham combined histologic grade of 2, TNM staging of T2N2M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately positive. Although the TNM staging indicates significant lymph node involvement (N2), the moderate histologic grade and high hormone receptor positivity suggest a favorable response to hormonal therapies, and the negative HER2/neu overexpression indicates a less aggressive disease profile."
      }
    ]
  },
  {
    "id": "TCGA-E2-A153-01Z-00-DX1.CA994467-E541-4131-A9FC-DCD9944F29C4-1",
    "image": "TCGA-BRCA/TCGA-E2-A153-01Z-00-DX1.CA994467-E541-4131-A9FC-DCD9944F29C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, intermediate nuclear grade, SBR Grade 2, TNM staging of T2N1M0, and IHC results showing ER and PR positive but HER2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade and TNM stage indicating lymph node involvement (N1) suggest a potential for progression, though positive hormone receptors offer some therapeutic options while negative HER2 reduces aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-AC-A3W5-01Z-00-DX1.522F702C-776E-45F1-84D3-1648DF04137C-1",
    "image": "TCGA-BRCA/TCGA-AC-A3W5-01Z-00-DX1.522F702C-776E-45F1-84D3-1648DF04137C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of pleomorphic invasive lobular carcinoma, high grade (Nottingham Grade 3), TNM stage T2MXN0, and IHC results showing positive hormone receptors and HER2 overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade status and HER2 overexpression suggest aggressive disease. Despite positive hormone receptors, the pleomorphic type adds complexity to the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5RV-01Z-00-DX1.920AC243-1DAC-4854-BEB6-1CBCC950F26B-1",
    "image": "TCGA-BRCA/TCGA-OL-A5RV-01Z-00-DX1.920AC243-1DAC-4854-BEB6-1CBCC950F26B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR grade II, with TNM staging MXT2N3, and IHC results showing strong ER and PR expression but non-amplified Her2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of extensive lymph node involvement (N3) and advanced tumor size (T2) outweigh the favorable hormonal receptor status, indicating a more aggressive disease and challenging management."
      }
    ]
  },
  {
    "id": "TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA-1",
    "image": "TCGA-BRCA/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, Nottingham Histologic Grade 1, TNM staging of T2N3A, and IHC results showing 75% positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor due to the significant lymph node involvement (N3) despite the low histologic grade and positive hormone receptor status, which are generally favorable factors."
      }
    ]
  },
  {
    "id": "TCGA-D8-A3Z5-01Z-00-DX1.4DBF937F-623C-4212-8493-ECE3C8F555E3-1",
    "image": "TCGA-BRCA/TCGA-D8-A3Z5-01Z-00-DX1.4DBF937F-623C-4212-8493-ECE3C8F555E3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, Nottingham Histologic Grade 1, TNM staging of T2N3A, and IHC results showing 75% positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor due to the significant lymph node involvement (N3) despite the low histologic grade and positive hormone receptor status, which are generally favorable factors."
      }
    ]
  },
  {
    "id": "TCGA-D8-A3Z5-01Z-00-DX2.6196B9FF-F09E-4D44-873D-E53BFB2BF4E1-1",
    "image": "TCGA-BRCA/TCGA-D8-A3Z5-01Z-00-DX2.6196B9FF-F09E-4D44-873D-E53BFB2BF4E1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, Nottingham Histologic Grade 1, TNM staging of T2N3A, and IHC results showing 75% positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor due to the significant lymph node involvement (N3) despite the low histologic grade and positive hormone receptor status, which are generally favorable factors."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1EO-01Z-00-DX1.0E624888-D7E4-48DF-B51A-9AD8F75A66B7-1",
    "image": "TCGA-BRCA/TCGA-BH-A1EO-01Z-00-DX1.0E624888-D7E4-48DF-B51A-9AD8F75A66B7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of multifocal infiltrating ductal carcinoma mixed with lobular carcinoma, moderate grade, with TNM staging of T1CN1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The presence of hormone receptors (positive for estrogen and progesterone) is favorable for hormonal treatment options, and the absence of distant metastasis (M0) is positive. However, the involvement of lymph nodes (N1) and mixed histology raise some concerns, indicating the need for more aggressive initial treatment."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y0-01Z-00-DX1.10F40197-4174-43CC-AAD3-8CB85154FB2D-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y0-01Z-00-DX1.10F40197-4174-43CC-AAD3-8CB85154FB2D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with ductal carcinoma in situ, moderately differentiated as Nottingham grade 2, TNM stage T1N2MX, and IHC showing high positivity for estrogen and progesterone receptors with negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The nodal involvement (N2) suggests a more advanced stage of disease despite favorable hormone receptor status and moderate differentiation, which typically assist in treatment responsiveness."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y0-01Z-00-DX2.7C25E941-12A6-46CE-B1A5-488D08E35684-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y0-01Z-00-DX2.7C25E941-12A6-46CE-B1A5-488D08E35684.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with ductal carcinoma in situ, moderately differentiated as Nottingham grade 2, TNM stage T1N2MX, and IHC showing high positivity for estrogen and progesterone receptors with negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The nodal involvement (N2) suggests a more advanced stage of disease despite favorable hormone receptor status and moderate differentiation, which typically assist in treatment responsiveness."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1FG-01Z-00-DX1.DA665FB6-9DD9-4B18-A925-2EFD9BC4C43B-1",
    "image": "TCGA-BRCA/TCGA-BH-A1FG-01Z-00-DX1.DA665FB6-9DD9-4B18-A925-2EFD9BC4C43B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient's diagnosis of invasive ductal carcinoma, TNM staging of T1CNM0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low tumor size (T1), positive hormone receptor status suggests responsiveness to hormonal therapy, and negative HER-2/neu indicates a lower risk of aggressive disease progression."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SH-01Z-00-DX1.90E71B08-E1D9-4FC2-85AC-062E56DDF17C-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SH-01Z-00-DX1.90E71B08-E1D9-4FC2-85AC-062E56DDF17C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma with a total score of 6 out of 9 (grade 2), TNM staging M0T2N0 (I-), and IHC results showing negative estrogen receptors, positive progesterone receptors (strong nuclear staining in >95% of tumor cells), and indeterminate HER2/neu status (staining intensity score of 2), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated grade and TNM staging suggest a somewhat aggressive disease, but the strong positivity for progesterone receptors is a favorable factor. The indeterminate HER2/neu status limits clarity on potential targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A109-01Z-00-DX1.FCF5E9FC-F9FE-4F5F-96DD-5628E2609BEF-1",
    "image": "TCGA-BRCA/TCGA-E2-A109-01Z-00-DX1.FCF5E9FC-F9FE-4F5F-96DD-5628E2609BEF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with varying SBR grades, TNM staging of M0T2N0 (I-), and immunohistochemistry results showing high estrogen receptor positivity, equivocal HER2 status, and mixed progesterone receptor results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate to poor. The high SBR Grade III for the larger tumor focus and the TNM stage indicating a moderately sized tumor without lymph node or distant metastasis contribute to a more cautious outlook, despite strong estrogen receptor positivity suggesting potential benefits from hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15C-01Z-00-DX1.26E13415-1D37-43C7-9EBB-4411BE7FCE10-1",
    "image": "TCGA-BRCA/TCGA-E2-A15C-01Z-00-DX1.26E13415-1D37-43C7-9EBB-4411BE7FCE10.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 2 with associated cribriform type DCIS, TNM staging of T1cN0M0, and IHC results showing positive estrogen and progesterone receptors with pending HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early stage (T1cN0M0), intermediate grade, and strong positivity for estrogen and progesterone receptors suggest good response to hormonal therapies, which is favorable for the patient's overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4-1",
    "image": "TCGA-BRCA/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated infiltrating ductal carcinoma, TNM staging M0T1N0 (I-), and IHC results showing negative progesterone receptors and weakly positive HER2 by IHC but not amplified by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status suggests aggressive behavior, and the lack of progesterone receptors limits hormone therapy options. The non-amplified HER2 status reduces targeted treatment avenues."
      }
    ]
  },
  {
    "id": "TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6-1",
    "image": "TCGA-BRCA/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, modified Black's nuclear grade of 1-2, TNM staging of T3N3A M0, and IHC results showing positive Cytokeratin for metastatic carcinoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The advanced TNM stage (T3N3A) indicates a large primary tumor and significant lymph node involvement, despite the lower modified Black's nuclear grade. Positive Cytokeratin further confirms metastatic disease, which complicates the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15M-01Z-00-DX1.6E4671E5-18EA-4464-BE7C-C94767136E5C-1",
    "image": "TCGA-BRCA/TCGA-E2-A15M-01Z-00-DX1.6E4671E5-18EA-4464-BE7C-C94767136E5C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, SBR grade 2, TNM staging of T2N0M0, and IHC results showing positive ER and PR with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The cancer\u2019s intermediate grade and TNM staging with no lymph node involvement suggest a controlled disease, while positive hormone receptor status provides effective treatment avenues, despite HER2 negativity."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0T3-01Z-00-DX1.5E96BC87-F4FB-4ABA-8D81-FAB7F4A80661-1",
    "image": "TCGA-BRCA/TCGA-A2-A0T3-01Z-00-DX1.5E96BC87-F4FB-4ABA-8D81-FAB7F4A80661.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma with high-grade ductal carcinoma in situ, TNM staging of M0T1CN1MI, and IHC results showing positive cytokeratin in the sentinel lymph node but negative for metastatic disease in the second axillary lymph node, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status of the invasive ductal carcinoma, high histological grade, and lymph node involvement (N1) indicate a more aggressive disease course, despite the absence of metastatic disease in the second axillary lymph node."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1ET-01Z-00-DX1.05C126CD-CC10-44BF-9A68-6CDDE97272B2-1",
    "image": "TCGA-BRCA/TCGA-BH-A1ET-01Z-00-DX1.05C126CD-CC10-44BF-9A68-6CDDE97272B2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated infiltrating duct carcinoma, TNM staging of T1N0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated status, early TNM stage, and positive hormone receptors suggest favorable outcomes with hormonal therapy, while negative HER-2/neu indicates reduced aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-E2-A107-01Z-00-DX1.3BFCCC24-7286-488D-A9E9-98E498AD0767-1",
    "image": "TCGA-BRCA/TCGA-E2-A107-01Z-00-DX1.3BFCCC24-7286-488D-A9E9-98E498AD0767.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, SBR Grade 2, TNM staging of T3N2A, and IHC results showing ER positive, PR negative, and HER2 negative by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM stage suggests larger tumor size and significant lymph node involvement (N2A), which indicates a more advanced disease, although ER positivity provides some hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-A7-A5ZX-01Z-00-DX2.02F586FE-4775-480B-8035-D6AD3386F45D-1",
    "image": "TCGA-BRCA/TCGA-A7-A5ZX-01Z-00-DX2.02F586FE-4775-480B-8035-D6AD3386F45D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, histologic grade 2, TNM staging of T2N3A, and IHC results showing high estrogen receptor positivity, weak progesterone positivity, and negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of extensive lymph node involvement (N3A) and moderate histologic grade are associated with a more aggressive disease course, despite hormone receptor positivity providing some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A7-A5ZX-01Z-00-DX1.A4C651F0-DB8E-4534-84A2-AD875F62209F-1",
    "image": "TCGA-BRCA/TCGA-A7-A5ZX-01Z-00-DX1.A4C651F0-DB8E-4534-84A2-AD875F62209F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, histologic grade 2, TNM staging of T2N3A, and IHC results showing high estrogen receptor positivity, weak progesterone positivity, and negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of extensive lymph node involvement (N3A) and moderate histologic grade are associated with a more aggressive disease course, despite hormone receptor positivity providing some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SF-01Z-00-DX1.7F252D89-EA78-419F-A969-1B7313D77499-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SF-01Z-00-DX1.7F252D89-EA78-419F-A969-1B7313D77499.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, SBR grade 2, with a TNM staging of M0T2N0 and immunohistochemistry results showing positive estrogen and progesterone receptors and negative HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderate grade of cancer, lack of metastatic disease, and no lymph node involvement, combined with high positive hormone receptor status, suggest effective hormonal therapy options, while HER2/neu negativity indicates a lower likelihood of aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0T4-01Z-00-DX1.AC61ED08-2E42-4D4A-BB81-746D3FEBB653-1",
    "image": "TCGA-BRCA/TCGA-A2-A0T4-01Z-00-DX1.AC61ED08-2E42-4D4A-BB81-746D3FEBB653.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating lobular carcinoma with in situ components, TNM staging of M0T2N0 (I-), and IHC results showing no evidence of metastatic disease in any tested lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The absence of metastatic disease in lymph nodes and a TNM stage indicating a tumor limited to T2 with no lymph node involvement (N0) and no distant metastasis (M0) suggest a lower risk of aggressive disease progression."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15J-01Z-00-DX1.BF7901D1-30B1-4A76-B0A5-E9B8B36EF4C9-1",
    "image": "TCGA-BRCA/TCGA-E2-A15J-01Z-00-DX1.BF7901D1-30B1-4A76-B0A5-E9B8B36EF4C9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade I, TNM staging of T1CN0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer's low grade (SBR Grade I), early stage, and positive hormone receptors indicate that it is likely to respond well to hormonal therapies, and the negative HER2 reduces the likelihood of aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-LL-A442-01Z-00-DX1.9275EDBD-1C89-4AF3-B02B-19F613A4E083-1",
    "image": "TCGA-BRCA/TCGA-LL-A442-01Z-00-DX1.9275EDBD-1C89-4AF3-B02B-19F613A4E083.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with a Nottingham Histologic Grade 2, TNM staging of MXT2N0, and IHC results showing 100% positivity for both estrogen and progesterone receptors, equivocal HER-2/neu immunoperoxidase studies, and not amplified HER-2/neu by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The intermediate grade (Nottingham Grade 2) and TNM staging indicating no lymph node involvement (N0) are favorable factors, and the strong hormone receptor positivity suggests responsiveness to hormonal therapies, although the equivocal HER-2/neu status does not provide advantage from HER-2 targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JJ-01Z-00-DX1.D5B636F5-1B47-4033-9938-9DC8CD48CEE9-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JJ-01Z-00-DX1.D5B636F5-1B47-4033-9938-9DC8CD48CEE9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, classical type, TNM staging of T2N1M0, and IHC results with positive BR and PR but negative ER and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM stage indicates significant involvement (T2N1), especially with lymph node positivity, and the absence of ER and HER2 positivity limits therapeutic options, suggesting a more challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-D8-A145-01Z-00-DX2.B834BF47-1CD6-45EA-BB88-D8ECE1FDDC6A-1",
    "image": "TCGA-BRCA/TCGA-D8-A145-01Z-00-DX2.B834BF47-1CD6-45EA-BB88-D8ECE1FDDC6A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2 with a total score of 7, TNM staging of M0T1CN1A, and IHC results of 75% estrogen receptor positivity, 10% progesterone receptor positivity, and a HER2 score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The Nottingham Histologic Grade 2 indicates moderate differentiation, the low TNM stage (T1CN1A) shows relatively limited spread, and the high positivity for estrogen receptors implies potential responsiveness to hormonal therapy. However, the lower progesterone receptor positivity and ambiguous HER2 status (2+) may necessitate further evaluation."
      }
    ]
  },
  {
    "id": "TCGA-D8-A145-01Z-00-DX1.34D4EC27-7FD7-4BE2-95A4-CA521CB5590E-1",
    "image": "TCGA-BRCA/TCGA-D8-A145-01Z-00-DX1.34D4EC27-7FD7-4BE2-95A4-CA521CB5590E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2 with a total score of 7, TNM staging of M0T1CN1A, and IHC results of 75% estrogen receptor positivity, 10% progesterone receptor positivity, and a HER2 score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The Nottingham Histologic Grade 2 indicates moderate differentiation, the low TNM stage (T1CN1A) shows relatively limited spread, and the high positivity for estrogen receptors implies potential responsiveness to hormonal therapy. However, the lower progesterone receptor positivity and ambiguous HER2 status (2+) may necessitate further evaluation."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X9-01Z-00-DX1.28CE7849-EEC5-4ABB-A319-A977A1FD3CD1-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X9-01Z-00-DX1.28CE7849-EEC5-4ABB-A319-A977A1FD3CD1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, moderately differentiated (NHG2), TNM staging of T2N1M0, and IHC results with strong positivity for hormone receptors and no HER2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated nature, lymph node involvement (N1), and hormone receptor positivity offer effective treatment opportunities, although the N1 stage indicates some disease spread, affecting the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14X-01Z-00-DX1.24ADDA43-F127-4A6B-9AAD-2FAD982A853D-1",
    "image": "TCGA-BRCA/TCGA-E2-A14X-01Z-00-DX1.24ADDA43-F127-4A6B-9AAD-2FAD982A853D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, SBR Grade 3, TNM staging of T2N2M0, and IHC results showing negative ER, PR, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (SBR Grade 3), TNM staging indicating significant lymph node involvement (N2), and triple-negative status suggest a more aggressive disease with fewer targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XR-01Z-00-DX2.A103FB8B-4397-4DD4-8587-90A736407484-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XR-01Z-00-DX2.A103FB8B-4397-4DD4-8587-90A736407484.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2 with a total score of 6, TNM staging of T2N1M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate histologic grade (NHG2), moderate TNM stage (T2N1), and high hormone receptor positivity suggest responsiveness to hormonal therapy, though some lymph node involvement and negative HER2 status indicate a more cautious outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XR-01Z-00-DX1.7F443346-C564-47B6-9736-6944230CAF46-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XR-01Z-00-DX1.7F443346-C564-47B6-9736-6944230CAF46.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2 with a total score of 6, TNM staging of T2N1M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate histologic grade (NHG2), moderate TNM stage (T2N1), and high hormone receptor positivity suggest responsiveness to hormonal therapy, though some lymph node involvement and negative HER2 status indicate a more cautious outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A142-01Z-00-DX1.F6D58989-9120-40C9-918D-6B1650C1A8E8-1",
    "image": "TCGA-BRCA/TCGA-D8-A142-01Z-00-DX1.F6D58989-9120-40C9-918D-6B1650C1A8E8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of poorly differentiated invasive ductal carcinoma with Nottingham Histologic Grade 3, TNM staging of T3N0M0, and IHC results showing absence of hormone receptors and equivocal HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade, advanced tumor size without node involvement, lack of hormone receptors, and uncertain HER2 status suggest aggressive disease with limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AC-A8OP-01Z-00-DX1.A2AF501D-7DCD-4BE7-93A4-EBCAF0C0D54E-1",
    "image": "TCGA-BRCA/TCGA-AC-A8OP-01Z-00-DX1.A2AF501D-7DCD-4BE7-93A4-EBCAF0C0D54E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham grade 2, with TNM staging of MXT1CN0 (I-) and IHC results showing positive estrogen and progesterone receptors, negative HER2/neu, and a K-67 proliferative index of 20%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally fair. The intermediate grade (Nottingham grade 2) and lack of confirmed distant metastasis (MX) indicate a moderately aggressive disease. The positive hormone receptors are favorable for hormonal therapy, though the 20% K-67 index reflects a moderate proliferative activity."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JM-01Z-00-DX1.94E75EFD-E5F5-4DF8-93A0-ED94CB4D203A-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JM-01Z-00-DX1.94E75EFD-E5F5-4DF8-93A0-ED94CB4D203A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging of T2N1M0, and IHC results showing HER2 positivity with moderate ER and weak PR expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately poor. The intermediate histologic grade and lymph node involvement (N1) contribute to a more serious outlook, despite potential targeted therapy for HER2 positivity. Moderate ER and weak PR expression indicate limited hormone response."
      }
    ]
  },
  {
    "id": "TCGA-A2-A1FX-01Z-00-DX1.35B93F3A-9959-4D72-A702-08B27563D24F-1",
    "image": "TCGA-BRCA/TCGA-A2-A1FX-01Z-00-DX1.35B93F3A-9959-4D72-A702-08B27563D24F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating carcinoma, TNM stage M0T3N2A, and IHC results showing positive Cytokeratin and E-cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM stage indicates a large tumor size (T3) and significant lymph node involvement (N2), which are associated with a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-XX-A89A-01Z-00-DX1.671E2AD6-4D1A-4579-88C1-5B0B15818126-1",
    "image": "TCGA-BRCA/TCGA-XX-A89A-01Z-00-DX1.671E2AD6-4D1A-4579-88C1-5B0B15818126.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated invasive lobular carcinoma, Nottingham Histologic Grade 2, TNM staging of MXT3N0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status and TNM stage T3 indicate a larger tumor size, which suggests a more advanced disease, despite the favorable hormonal receptor status and negative HER-2/neu overexpression."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14V-01Z-00-DX1.D6274B5E-644C-478C-817F-B8BB9262D6F4-1",
    "image": "TCGA-BRCA/TCGA-E2-A14V-01Z-00-DX1.D6274B5E-644C-478C-817F-B8BB9262D6F4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results showing positive ER, PR, and HER2 (3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated nature and TNM staging with lymph node involvement (N1) indicate a more aggressive cancer, although positive hormone receptors and HER2 status could provide effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X7-01Z-00-DX2.F0631B8C-EB75-4995-8ED7-1A8972BE8997-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X7-01Z-00-DX2.F0631B8C-EB75-4995-8ED7-1A8972BE8997.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive mucinous carcinoma partim ductal carcinoma, TNM staging of T2N0MX, and IHC showing over 75% positivity for estrogen and progesterone receptors with HER2 negative (score 0), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The hormone receptor positivity suggests responsiveness to hormonal therapies, and the absence of lymph node involvement (N0) with HER2 negativity indicates a less aggressive disease profile."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X7-01Z-00-DX1.3529AEED-2827-4D94-9A8B-32F116EE49D5-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X7-01Z-00-DX1.3529AEED-2827-4D94-9A8B-32F116EE49D5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive mucinous carcinoma partim ductal carcinoma, TNM staging of T2N0MX, and IHC showing over 75% positivity for estrogen and progesterone receptors with HER2 negative (score 0), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The hormone receptor positivity suggests responsiveness to hormonal therapies, and the absence of lymph node involvement (N0) with HER2 negativity indicates a less aggressive disease profile."
      }
    ]
  },
  {
    "id": "TCGA-BH-A42V-01Z-00-DX1.B6D78256-05D1-45FA-826A-1B8554D60B7D-1",
    "image": "TCGA-BRCA/TCGA-BH-A42V-01Z-00-DX1.B6D78256-05D1-45FA-826A-1B8554D60B7D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of Nottingham grade 2 infiltrating ductal carcinoma, TNM staging of T1N1M0, and IHC results showing positive estrogen and progesterone receptors with HER2 positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade and some lymph node involvement present challenges, but positive hormone receptors and HER2 status offer effective targeted treatment options, potentially improving outcomes."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1P3-01Z-00-DX1.EF69B964-57D6-4F8E-A183-A3022AF6E835-1",
    "image": "TCGA-BRCA/TCGA-EW-A1P3-01Z-00-DX1.EF69B964-57D6-4F8E-A183-A3022AF6E835.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, Nottingham grade II, TNM staging MXT2N0, and negative immunohistochemistry for Keratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated grade and TNM stage with a tumor size in T2 imply a potential for manageable treatment outcomes, but the negative Keratin IHC findings require careful consideration of treatment strategies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14Q-01Z-00-DX1.C19BA7FD-D986-4E3B-9A79-F3531A78F05D-1",
    "image": "TCGA-BRCA/TCGA-E2-A14Q-01Z-00-DX1.C19BA7FD-D986-4E3B-9A79-F3531A78F05D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results showing positive E-cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a medium-sized tumor with some lymph node involvement (T2N1), which suggests a higher risk for disease spread, despite the positive E-cadherin indicating some degree of cellular adhesion."
      }
    ]
  },
  {
    "id": "TCGA-A2-A1FV-01Z-00-DX1.F70ACD9A-7819-4296-BD28-4D24BBA8AFF4-1",
    "image": "TCGA-BRCA/TCGA-A2-A1FV-01Z-00-DX1.F70ACD9A-7819-4296-BD28-4D24BBA8AFF4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive lobular carcinoma, TNM staging of T3N0M0 (I+), and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is fair. While positive hormone receptors suggest potential hormonal therapy effectiveness, the larger tumor size (T3) without lymph node involvement indicates a more cautious outlook. Negative HER2/neu reduces aggressive treatment options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D-1",
    "image": "TCGA-BRCA/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, Nottingham Grade II, TNM staging of T2N0M0, and IHC results showing triple negative status with positive HLA-DR, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The triple negative status (ER, PR, HER2 negative) limits targeted therapy options, and the intermediate grade II suggests a moderate proliferation rate, despite no current lymph node involvement (N0)."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0I1-01Z-00-DX1.86BEC5E4-A2D1-4039-8D08-0598FA8BCC2B-1",
    "image": "TCGA-BRCA/TCGA-B6-A0I1-01Z-00-DX1.86BEC5E4-A2D1-4039-8D08-0598FA8BCC2B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of grade 3 infiltrating carcinoma according to N.S.A.B.P grading, TNM staging of T2N0M0, and IHC results showing negative estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade and lack of hormone receptor positivity suggest a more aggressive disease with limited hormonal therapy options, despite no metastasis or lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0IO-01Z-00-DX1.D8898C30-4016-4983-9359-5C1507C01715-1",
    "image": "TCGA-BRCA/TCGA-B6-A0IO-01Z-00-DX1.D8898C30-4016-4983-9359-5C1507C01715.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive carcinoma, Nottingham Histologic Grade 2, TNM staging of T2N0M0, and IHC results showing positive estrogen receptor, borderline progesterone receptor, no HER2/neu overexpression, and a high proliferation index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The moderately differentiated status and TNM staging without lymph node involvement are favorable, but the high proliferation index indicates a higher likelihood of aggressive behavior, and the borderline progesterone receptor status provides limited hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2DL-01Z-00-DX1.1CE6992E-B1CE-45AB-B2EB-75338B6FEE9D-1",
    "image": "TCGA-BRCA/TCGA-GM-A2DL-01Z-00-DX1.1CE6992E-B1CE-45AB-B2EB-75338B6FEE9D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated invasive ductal carcinoma and DCIS, TNM stage M0T1CN0, with IHC results showing high hormone receptor positivity and negative HER-2/neu overexpression but a high Ki-67 index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately poor. Despite the favorable low TNM stage and high hormone receptor positivity, the poor differentiation and high Ki-67 index suggest a more aggressive potential for tumor growth."
      }
    ]
  },
  {
    "id": "TCGA-E2-A573-01Z-00-DX1.D6633BC2-524D-4153-952F-6B1D8D067370-1",
    "image": "TCGA-BRCA/TCGA-E2-A573-01Z-00-DX1.D6633BC2-524D-4153-952F-6B1D8D067370.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 3, TNM staging of M0T1CN0, and IHC results showing negative estrogen and progesterone receptors with equivocal HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) indicates aggressive disease. Additionally, the lack of hormone receptor positivity and equivocal HER2 status limit the options for targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1PD-01Z-00-DX1.6F6A0122-A50B-4D00-9A3F-7A2502D44E38-1",
    "image": "TCGA-BRCA/TCGA-EW-A1PD-01Z-00-DX1.6F6A0122-A50B-4D00-9A3F-7A2502D44E38.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham grade II infiltrating ductal carcinoma, TNM staging of T1N1M0, and IHC results showing 21% estrogen receptor positivity, equivocal progesterone receptor status, and HER2 amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate to poor. The grade II status and low primary tumor size are somewhat favorable; however, lymph node involvement (N1) and HER2 amplification indicate a more aggressive disease with potential for targeted HER2 therapy, though the intermediate hormone receptor status may limit hormonal therapy effectiveness."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0WA-01Z-00-DX1.C0EB7B73-5529-49EC-B660-3F849B041963-1",
    "image": "TCGA-BRCA/TCGA-BH-A0WA-01Z-00-DX1.C0EB7B73-5529-49EC-B660-3F849B041963.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, metaplastic type, Nottingham Histologic Grade 3 with a total score of 9 out of 9, TNM staging of M0T1CN0 (I-), and IHC results showing negative estrogen and progesterone receptors and HER2/neu score of 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metaplastic subtype, high histologic grade (3 with a total score of 9 out of 9), and negative hormone receptor status, along with a low HER2/neu score, indicate a more aggressive cancer with limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A259-01Z-00-DX1.7289CD72-CB74-41D4-B4AC-4EA5FDFEC666-1",
    "image": "TCGA-BRCA/TCGA-A2-A259-01Z-00-DX1.7289CD72-CB74-41D4-B4AC-4EA5FDFEC666.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of moderately differentiated invasive ductal carcinoma (Nottingham Histologic Grade 2), TNM staging of M0T1CN0 (I-), and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated grade, early TNM stage, and positive hormone receptors indicate a favorable outlook and potential efficacy of hormonal therapies, while the negative HER2/neu status reduces the likelihood of aggressive tumor behavior."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8-1",
    "image": "TCGA-BRCA/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, TNM staging of M0T1CN0 (I-), and IHC results showing 0% nuclear staining for estrogen and progesterone receptors with no evidence of metastatic disease, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early stage (T1N0M0), the lack of hormone receptor expression limits hormonal therapy options, potentially leading to a more challenging treatment pathway."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1PC-01Z-00-DX1.45369705-AD49-419F-A0F0-EC51473BBAB9-1",
    "image": "TCGA-BRCA/TCGA-EW-A1PC-01Z-00-DX1.45369705-AD49-419F-A0F0-EC51473BBAB9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma with Nottingham Histologic Grade 3 and TNM staging of MXT3N0 (I-), along with mixed hormone receptor positivity and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade and the T3 classification suggest aggressive disease. While ER and PR positivity can benefit from hormonal therapy, the negative HER2 limits targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2DB-01Z-00-DX1.9EE36AA6-2594-44C7-B05C-91A0AEC7E511-1",
    "image": "TCGA-BRCA/TCGA-GM-A2DB-01Z-00-DX1.9EE36AA6-2594-44C7-B05C-91A0AEC7E511.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with a TNM staging of T2N0M0 and IHC results showing negativity for estrogen and progesterone receptors and no HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The lack of hormone receptor positivity and HER-2/neu overexpression limits targeted treatment options, despite the absence of metastasis and lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-EW-A2FW-01Z-00-DX1.4F948681-81F3-46C5-A4E8-FDE8A4116F7A-1",
    "image": "TCGA-BRCA/TCGA-EW-A2FW-01Z-00-DX1.4F948681-81F3-46C5-A4E8-FDE8A4116F7A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Grade 3 with a TNM staging of MXT2N0, and all sentinel nodes negative for keratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high tumor grade (Nottingham Grade 3) and stage T2 indicate aggressive disease characteristics, despite no detected lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14P-01Z-00-DX1.663B02FF-C64B-41A6-8685-FD61CD76F9C6-1",
    "image": "TCGA-BRCA/TCGA-E2-A14P-01Z-00-DX1.663B02FF-C64B-41A6-8685-FD61CD76F9C6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma with SBR grade 3, TNM staging of T2N3M0, and IHC results showing negative hormone receptors but positive HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high SBR grade, significant lymph node involvement (N3), and negative hormone receptor status suggest a more aggressive cancer, although positive HER2 offers opportunities for targeted therapy."
      }
    ]
  },
  {
    "id": "TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8-1",
    "image": "TCGA-BRCA/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of Nottingham grade II infiltrating lobular carcinoma, TNM staging of T2N0M0, and IHC results confirming the H&E impression with Cytokeratin stain, would you say the prognosis is good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The mid-range Nottingham grade (II) and lack of lymph node involvement (N0) suggest a less aggressive disease course, leading to a somewhat better outlook."
      }
    ]
  },
  {
    "id": "TCGA-A2-A1FW-01Z-00-DX1.DC2BC5D7-E57B-444E-833F-9A1B6E11DE6D-1",
    "image": "TCGA-BRCA/TCGA-A2-A1FW-01Z-00-DX1.DC2BC5D7-E57B-444E-833F-9A1B6E11DE6D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Scarff-Bloom-Richardson Grade 3 with a score of 9 (3+3+3), TNM staging of M0T3N2A, and IHC results showing 90% ER positivity, no PR immunoreactive cells, and negative PanKeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade (Scarff-Bloom-Richardson Grade 3) and TNM staging (T3N2A) indicating significant tumor size and lymph node involvement suggest aggressive disease. Despite the high ER positivity, the lack of PR and PanKeratin expression complicates the outlook."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B-1",
    "image": "TCGA-BRCA/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive ductal carcinoma with Nottingham Grade 2, TNM staging of T2N1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The cancer's moderate differentiation and TNM staging with lymph node involvement indicate an intermediate risk, while positive hormone receptors suggest that hormonal therapies could be effective, which can improve outcomes despite the negative HER-2/neu status."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JB-01Z-00-DX1.250FE098-345B-4981-9236-0519E1C9058E-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JB-01Z-00-DX1.250FE098-345B-4981-9236-0519E1C9058E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with extensive ductal carcinoma in situ, high nuclear grade, TNM staging of T3N1M0, and IHC results showing moderate positivity for estrogen and progesterone receptors with a positive HER2 (1+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high nuclear grade, advanced TNM stage indicating larger tumor size and lymph node involvement, and the relatively low positivity of HER2 suggest a more aggressive disease with limited response to targeted HER2 therapies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14W-01Z-00-DX1.2AF665A9-F582-4C41-B2B8-1982648CDEC7-1",
    "image": "TCGA-BRCA/TCGA-E2-A14W-01Z-00-DX1.2AF665A9-F582-4C41-B2B8-1982648CDEC7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T2N0M0, and IHC showing positivity for ER, PR, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Grade 3) indicates aggressive disease, and HER2 positivity, while offering targeted therapy options, is associated with more aggressive cancer behavior despite the hormone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0W7-01Z-00-DX1.93F11232-A1FB-4682-B744-3531D4DF11AF-1",
    "image": "TCGA-BRCA/TCGA-BH-A0W7-01Z-00-DX1.93F11232-A1FB-4682-B744-3531D4DF11AF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of invasive ductal carcinoma, TNM staging of T1CN0 (I-), and IHC results showing positive ER and PR with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low TNM stage and positive hormone receptor status suggest favorable outcomes and effective hormonal therapy options, while the negative HER-2/neu indicates a lower risk of more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X6-01Z-00-DX1.ABF237D4-708C-46A5-AEF8-58712E5DCC04-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X6-01Z-00-DX1.ABF237D4-708C-46A5-AEF8-58712E5DCC04.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive carcinoma with Nottingham Histologic Grade 3 (NHG3), TNM staging of MXT3N2A, and IHC results showing high positivity for estrogen and progesterone receptors but negative HER2 expression (Score  1+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) indicates aggressive tumor behavior, and the TNM staging (T3N2A) reflects significant tumor size and lymph node involvement, which are associated with a worse outcome despite the high hormone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X6-01Z-00-DX2.F36D68F2-70C3-4E0E-ABE6-6969170BA6DC-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X6-01Z-00-DX2.F36D68F2-70C3-4E0E-ABE6-6969170BA6DC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive carcinoma with Nottingham Histologic Grade 3 (NHG3), TNM staging of MXT3N2A, and IHC results showing high positivity for estrogen and progesterone receptors but negative HER2 expression (Score  1+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) indicates aggressive tumor behavior, and the TNM staging (T3N2A) reflects significant tumor size and lymph node involvement, which are associated with a worse outcome despite the high hormone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XZ-01Z-00-DX1.8E51A61D-B01C-4A52-8F5D-44D2ABCA46FC-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XZ-01Z-00-DX1.8E51A61D-B01C-4A52-8F5D-44D2ABCA46FC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with Nottingham Histologic Grade 3, TNM staging of MXT1CN2A, and IHC results showing high positivity for estrogen receptors, negative progesterone receptors, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham Grade 3) and significant lymph node involvement (N2) suggest a more aggressive and advanced disease, despite the high expression of estrogen receptors which might provide some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XZ-01Z-00-DX2.73D59546-C003-4DED-80D5-866E7055EC79-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XZ-01Z-00-DX2.73D59546-C003-4DED-80D5-866E7055EC79.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with Nottingham Histologic Grade 3, TNM staging of MXT1CN2A, and IHC results showing high positivity for estrogen receptors, negative progesterone receptors, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham Grade 3) and significant lymph node involvement (N2) suggest a more aggressive and advanced disease, despite the high expression of estrogen receptors which might provide some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-AC-A2FB-01Z-00-DX1.A4D93E32-BBD7-45E4-8ACF-3724B059ECBC-1",
    "image": "TCGA-BRCA/TCGA-AC-A2FB-01Z-00-DX1.A4D93E32-BBD7-45E4-8ACF-3724B059ECBC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive lobular carcinoma, pleomorphic variant, Nottingham Histologic Grade 2, TNM staging MXT2N0, and IHC results showing ER 2+, PR 3+, HER2/neu 3+, and negative E-cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The pleomorphic variant is typically more aggressive, the TNM staging indicates a sizable primary tumor with unknown distant metastasis status (MX), and HER2/neu overexpression suggests a more aggressive disease course despite the presence of hormone receptors."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0JL-01Z-00-DX1.473CC200-221A-4777-B19E-ADC41D10FC94-1",
    "image": "TCGA-BRCA/TCGA-AO-A0JL-01Z-00-DX1.473CC200-221A-4777-B19E-ADC41D10FC94.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, TNM staging M0T2N2A, and IHC results showing negative ER, PR, and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM stage indicates significant lymph node involvement (N2), and the triple-negative status (ER, PR, HER2/neu) suggests limited treatment options and more aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XS-01Z-00-DX1.E5C78E5A-947C-499D-9E95-619FEEC63E69-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XS-01Z-00-DX1.E5C78E5A-947C-499D-9E95-619FEEC63E69.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated invasive ductal carcinoma with focal micropapillary features, TNM staging of T2N3A, and IHC results showing high positivity for estrogen and progesterone receptors as well as HER2 (3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the hormone receptor positivity and HER2 overexpression offer treatment options, the high lymph node involvement (N3A) and moderate differentiation suggest a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XS-01Z-00-DX2.ED8BBDB4-CEA6-4E47-8214-4666F3CC6E44-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XS-01Z-00-DX2.ED8BBDB4-CEA6-4E47-8214-4666F3CC6E44.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated invasive ductal carcinoma with focal micropapillary features, TNM staging of T2N3A, and IHC results showing high positivity for estrogen and progesterone receptors as well as HER2 (3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the hormone receptor positivity and HER2 overexpression offer treatment options, the high lymph node involvement (N3A) and moderate differentiation suggest a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-GM-A3XG-01Z-00-DX1.68FFB600-8573-451F-8100-D11DB091F457-1",
    "image": "TCGA-BRCA/TCGA-GM-A3XG-01Z-00-DX1.68FFB600-8573-451F-8100-D11DB091F457.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive lobular carcinoma with Nottingham grade 2, TNM staging of T3N1M0, and IHC results showing positive Cytokeratin immunostaining in lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate histologic grade, higher tumor size (T3), and lymph node involvement (N1) suggest a more aggressive disease with increased risk for further progression."
      }
    ]
  },
  {
    "id": "TCGA-AC-A7VB-01Z-00-DX1.62D7FDB3-280D-43B2-92EA-AB810384B0B7-1",
    "image": "TCGA-BRCA/TCGA-AC-A7VB-01Z-00-DX1.62D7FDB3-280D-43B2-92EA-AB810384B0B7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of multifocal invasive ductal carcinoma, Nottingham grades 2-3, TNM staging MXT1CN1A, and pending HER2 results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis tends to be poor. The multifocality, higher Nottingham grades, and lymph node involvement (N1) suggest more aggressive cancer characteristics, even with HER2 status pending."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1X8-01Z-00-DX1.DDA3866E-C7CC-4650-BE2B-5C9A98A2D531-1",
    "image": "TCGA-BRCA/TCGA-D8-A1X8-01Z-00-DX1.DDA3866E-C7CC-4650-BE2B-5C9A98A2D531.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, Nottingham Histologic Grade 2 with TNM staging of M0T1CN2A and IHC results showing high estrogen and progesterone receptor positivity, but no HER-2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate to poor. The mid-grade (NHG2) and TNM staging with lymph node involvement (N2) indicate a more advanced disease, despite the high hormone receptor positivity providing potential responsiveness to hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XT-01Z-00-DX1.9E4DEEEB-AB0A-45F6-A69B-65B3E6F22D46-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XT-01Z-00-DX1.9E4DEEEB-AB0A-45F6-A69B-65B3E6F22D46.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with a Nottingham Histologic Grade of 3, TNM staging of M0T1CN1A, and IHC results showing negative for estrogen and progesterone receptors but positive for HER2/neu overexpression (score 3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade, lymph node involvement indicated by N1, and lack of hormone receptor positivity suggest more aggressive disease. However, the positive HER2/neu status provides options for targeted therapies, which may improve outcomes."
      }
    ]
  },
  {
    "id": "TCGA-AC-A2FE-01Z-00-DX1.C036AE58-3C0D-4DBF-B658-296D03FD6701-1",
    "image": "TCGA-BRCA/TCGA-AC-A2FE-01Z-00-DX1.C036AE58-3C0D-4DBF-B658-296D03FD6701.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of infiltrating carcinoma with a lobular phenotype, Nottingham grade II, TNM staging MXT3N3A, and IHC results showing ER and PR favorable with Her2/neu within normal limits, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T3N3A) indicating significant tumor size and extensive lymph node involvement outweighs the moderately favorable hormone receptor status, suggesting an overall aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-E2-A14Y-01Z-00-DX1.804A22A3-FD8D-4C8A-A766-48D28434DE22-1",
    "image": "TCGA-BRCA/TCGA-E2-A14Y-01Z-00-DX1.804A22A3-FD8D-4C8A-A766-48D28434DE22.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR Grade 3, with TNM staging of T2N0M0 and IHC results showing positive ER, PR, and HER2 by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high SBR grade indicates aggressive behavior, but the presence of positive hormone receptors and HER2 allows for targeted therapies, which might moderate the outlook."
      }
    ]
  },
  {
    "id": "TCGA-A2-A25A-01Z-00-DX1.6D311E39-9F96-4775-B9DA-8D034D1AD1DC-1",
    "image": "TCGA-BRCA/TCGA-A2-A25A-01Z-00-DX1.6D311E39-9F96-4775-B9DA-8D034D1AD1DC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of lobular carcinoma in situ with extensive atypical hyperplasia, TNM staging of T2N0M0, and IHC results showing negative estrogen receptors and positive progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. While the absence of distant metastasis and lymph node involvement is favorable, the negative estrogen receptor status and presence of large tumor size (T2) suggest a more challenging treatment approach."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1PB-01Z-00-DX1.B2E9B88F-C371-4821-9B7B-8A63BB120D95-1",
    "image": "TCGA-BRCA/TCGA-EW-A1PB-01Z-00-DX1.B2E9B88F-C371-4821-9B7B-8A63BB120D95.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Grade 3, TNM staging of T3N1MX, and IHC results showing negative hormone receptors and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and stage with lymph node involvement, along with negative hormone receptors and HER2/neu, indicate aggressive disease and limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XA-01Z-00-DX1.36A807F0-2D35-4CE3-8A27-CC59181B1A3D-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XA-01Z-00-DX1.36A807F0-2D35-4CE3-8A27-CC59181B1A3D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIn light of the diagnosis of invasive ductal carcinoma, with TNM staging M0T1CN0, and IHC results showing high positivity for estrogen and progesterone receptors along with negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early stage of the disease (T1N0M0), combined with high positivity for hormone receptors, suggests effective hormonal therapy options, while negative HER2 indicates a lower risk of aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-GM-A2DD-01Z-00-DX1.01332FF3-7488-41B7-A515-7841715DE92B-1",
    "image": "TCGA-BRCA/TCGA-GM-A2DD-01Z-00-DX1.01332FF3-7488-41B7-A515-7841715DE92B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of poorly differentiated invasive ductal carcinoma, TNM stage M0T1CN0, and IHC results showing low estrogen receptor positivity, negative progesterone receptor, and negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and limited hormonal receptor positivity, alongside negative HER-2/neu, suggest more aggressive behavior with fewer targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B-1",
    "image": "TCGA-BRCA/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating lobular carcinoma with focal signet ring morphology, Nottingham Histologic Grade 2 (NHG2) with a total score of 5 out of 9, TNM staging of T1N2MX, and IHC results showing positive estrogen and progesterone receptors but negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the positive hormone receptor status offering potential hormonal therapy options, the presence of significant lymph node involvement (N2) and the uncertain metastatic status (MX) are concerning and indicative of more advanced disease."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890-1",
    "image": "TCGA-BRCA/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive lobular carcinoma and lobular carcinoma in situ, TNM staging of T2N1M0, and IHC results showing Ki67 positive in 5% of cell nuclei, negative E-cadherin, and positive CK7, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM stage of T2N1M0 indicates a tumor size greater than 2 cm with regional lymph node involvement, and the Ki67 index of 5% suggests a relatively low proliferation rate, but the presence of lymph node metastasis worsens the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0IN-01Z-00-DX1.5C1CBEF7-0C4A-4B22-A85B-6F6FD9435573-1",
    "image": "TCGA-BRCA/TCGA-B6-A0IN-01Z-00-DX1.5C1CBEF7-0C4A-4B22-A85B-6F6FD9435573.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of intermediate-grade ductal carcinoma in situ with TNM staging MXT1CNX and IHC results showing positive estrogen receptor, negative progesterone receptor, and a HER2/neu score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The positive estrogen receptor status offers some hormonal therapy options, but the HER2/neu 2+ score suggests potential for more aggressive disease due to overexpression, contributing to mixed prognosis indicators."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5D6-01Z-00-DX1.6B11331B-4A0D-4E13-B054-A5C7A6FC3AAC-1",
    "image": "TCGA-BRCA/TCGA-OL-A5D6-01Z-00-DX1.6B11331B-4A0D-4E13-B054-A5C7A6FC3AAC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of high-grade intraductal carcinoma with associated moderately differentiated invasive ductal carcinoma (Nottingham Histologic Grade III, score 8/9), TNM staging of MXT2N0, and IHC results showing no expression of ER and PR with HER2/neu results pending, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (Nottingham Grade III) and TNM staging indicating a sizable primary tumor (T2) without known metastasis or lymph node involvement, combined with negative hormone receptor status, suggest more aggressive disease without the benefit of hormone therapy."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JA-01Z-00-DX1.BD43F94A-D5A8-490E-AED4-5F3AB24080FA-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JA-01Z-00-DX1.BD43F94A-D5A8-490E-AED4-5F3AB24080FA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of M0T4BNX, and IHC findings showing less than 10% estrogen receptor positivity, no progesterone receptors, and a positive HER2 protein (Score  3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor size (T4), absence of significant hormone receptor expression, and positive HER2 status suggest a more aggressive disease and limited effectiveness of hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IO-01Z-00-DX1.C812D02F-3B40-496B-9EF5-7F68ADE64962-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IO-01Z-00-DX1.C812D02F-3B40-496B-9EF5-7F68ADE64962.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with Scarff-Bloom-Richardson Grade 3, TNM staging of T1CN0, and IHC results showing positivity for estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is cautiously optimistic. Despite the high grade indicating a more aggressive cancer, the low TNM stage and positive hormone receptors suggest favorable response to hormone therapy, pending HER2 results for further clarification."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IH-01Z-00-DX1.816F0C54-D87E-4E23-891B-98169F5B439B-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IH-01Z-00-DX1.816F0C54-D87E-4E23-891B-98169F5B439B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive lobular carcinoma, SBR grade 2, TNM staging M0T1CN0, and positive ER and PR while HER2 is pending, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The early-stage (T1), no metastasis (M0), and no clinical lymph node involvement (CN0) along with positive hormone receptors suggest favorable outcomes with hormonal therapy, despite awaiting HER2 status."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JF-01Z-00-DX1.224EDA43-F822-4A88-814A-BA7D4C60F8CC-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JF-01Z-00-DX1.224EDA43-F822-4A88-814A-BA7D4C60F8CC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, poorly differentiated (Nottingham Histologic Grade 3) with TNM staging of M0T1CN2A, and IHC results showing no estrogen or progesterone receptors and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and high Nottingham Histologic Grade indicate aggressive disease, while the TNM staging with extensive lymph node involvement (N2) and negative hormone receptor status limit treatment options and suggest a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0D3-01Z-00-DX1.D18CE1C0-291D-41C1-8F71-2A0551F8C661-1",
    "image": "TCGA-BRCA/TCGA-A2-A0D3-01Z-00-DX1.D18CE1C0-291D-41C1-8F71-2A0551F8C661.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated infiltrating ductal carcinoma, TNM staging of T1N0M0, and IHC findings with positive estrogen and progesterone receptors and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The well-differentiated, low-grade tumor with early-stage TNM status and positive hormone receptors suggests favorable outcomes, while negative HER2/neu indicates a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5D8-01Z-00-DX1.C0A75731-1DDC-4FAF-A2C5-2E2ECB23DC13-1",
    "image": "TCGA-BRCA/TCGA-OL-A5D8-01Z-00-DX1.C0A75731-1DDC-4FAF-A2C5-2E2ECB23DC13.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nFor a patient diagnosed with invasive ductal carcinoma, Nottingham Grade II, TNM staging MXT3N0, and IHC results showing strong ER and PR expression but pending Her2/neu results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. Although the strong ER and PR expression indicates responsiveness to hormonal therapy, the T3 staging suggests a larger tumor size, and the MX stage indicates unknown metastasis status, which complicates the outlook."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JH-01Z-00-DX1.4A4F2502-612C-421D-9F64-444BF2C85620-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JH-01Z-00-DX1.4A4F2502-612C-421D-9F64-444BF2C85620.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 1, TNM staging of T1CN0M0, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low-grade tumor, TNM staging without lymph node involvement, and strong hormone receptor positivity suggest favorable responses to hormone therapy, while negative HER2 expression indicates lower aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0D4-01Z-00-DX1.35E43827-DABC-4685-A62A-333672923349-1",
    "image": "TCGA-BRCA/TCGA-A2-A0D4-01Z-00-DX1.35E43827-DABC-4685-A62A-333672923349.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated infiltrating ductal carcinoma, TNM staging M0T2N1A, and IHC results showing high positivity for estrogen and progesterone receptors with equivocal HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The moderately differentiated grade and some lymph node involvement indicate an intermediate outlook. High hormone receptor positivity suggests responsiveness to hormonal therapies, while equivocal HER2/neu expression requires further analysis for clarification."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24N-01Z-00-DX1.563E9160-9E09-4E3F-8CE9-FFED0AA52927-1",
    "image": "TCGA-BRCA/TCGA-AR-A24N-01Z-00-DX1.563E9160-9E09-4E3F-8CE9-FFED0AA52927.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of infiltrating ductal carcinoma, Nottingham grade II, TNM staging of T1N0M0, and pending Her-2/NEU results, is the prognosis likely to be good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low TNM stage (T1N0M0) and intermediate grade (Nottingham II) suggest less aggressive disease, although Her-2/NEU results will provide further prognostic information."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0EI-01Z-00-DX1.929E126A-C9F8-4240-BF00-B6C4A57B7FF6-1",
    "image": "TCGA-BRCA/TCGA-BH-A0EI-01Z-00-DX1.929E126A-C9F8-4240-BF00-B6C4A57B7FF6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Grade 1, TNM staging of T1N1M0, and IHC results showing positive estrogen and progesterone receptors with HER2/neu score of zero or 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer\u2019s low grade (Nottingham Grade 1) and positive hormone receptors indicate better responsiveness to hormonal therapy, and the absence of distant metastasis is favorable. However, the involvement of one lymph node (N1) suggests some spread, moderating the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IF-01Z-00-DX1.51F5B0AC-E4D6-439D-8168-34934471FA06-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IF-01Z-00-DX1.51F5B0AC-E4D6-439D-8168-34934471FA06.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 2, TNM staging of T1CN0M0, and immunohistochemistry results showing positive estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderate grade of the cancer (SBR Grade 2), low TNM stage with no lymph node involvement, and strong positivity for both estrogen and progesterone receptors indicate favorable outcomes and responsiveness to hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AH-01Z-00-DX1.5D5D7774-77BB-4EA0-9E8E-A8D28F70A575-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AH-01Z-00-DX1.5D5D7774-77BB-4EA0-9E8E-A8D28F70A575.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of infiltrating ductal carcinoma, Nottingham grade III, TNM staging T2N1M0, and IHC results showing focal estrogen positivity, negative progesterone, and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and TNM staging indicating lymph node involvement suggest a more aggressive disease, while limited hormone receptor positivity and negative HER2/neu reduce potential treatment options."
      }
    ]
  },
  {
    "id": "TCGA-PE-A5DE-01Z-00-DX1.88B354F2-5485-44AA-A057-89E40B988F69-1",
    "image": "TCGA-BRCA/TCGA-PE-A5DE-01Z-00-DX1.88B354F2-5485-44AA-A057-89E40B988F69.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma and lobular carcinoma in situ with TNM staging of T2N0M0 and IHC results showing negative Cytokeratin AE1/AE3, positive ER and PR, and negative HER-2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The positive ER and PR status suggest responsiveness to hormonal therapies, and the absence of metastasis (M0) along with no lymph node involvement (N0) are favorable factors despite the T2 tumor size."
      }
    ]
  },
  {
    "id": "TCGA-D8-A4Z1-01Z-00-DX1.D39D38B5-FC9F-4298-8720-016407DC6591-1",
    "image": "TCGA-BRCA/TCGA-D8-A4Z1-01Z-00-DX1.D39D38B5-FC9F-4298-8720-016407DC6591.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma and lobular carcinoma in situ, TNM staging of T1CN0M0, and IHC results indicating 75% estrogen receptor positivity, 10-75% progesterone receptor positivity, negative HER2 protein, and 10% Ki 67 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low TNM stage (T1CN0M0), high estrogen receptor positivity, and moderate progesterone receptor positivity suggest potential effectiveness of hormone therapies. The negative HER2 protein and low Ki 67 expression further indicate a less aggressive cancer behavior."
      }
    ]
  },
  {
    "id": "TCGA-A7-A3J1-01Z-00-DX1.92895B92-5F95-4EA3-9237-4CAF63CDE3FF-1",
    "image": "TCGA-BRCA/TCGA-A7-A3J1-01Z-00-DX1.92895B92-5F95-4EA3-9237-4CAF63CDE3FF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, TNM staging of T1N0MX, and IHC results showing positive CK5/6 and mixed E-cadherin results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low TNM stage (T1N0) indicates early-stage disease with no lymph node involvement, which is typically associated with a better outcome despite mixed E-cadherin results."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0E7-01Z-00-DX1.7FEE54C4-3795-403C-85B9-FF932BE56788-1",
    "image": "TCGA-BRCA/TCGA-BH-A0E7-01Z-00-DX1.7FEE54C4-3795-403C-85B9-FF932BE56788.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging M0T2N1A, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. Grade 2 indicates intermediate aggressiveness. Positive hormone receptors suggest effective hormonal treatment options, but lymph node involvement (N1) presents a higher risk for spread."
      }
    ]
  },
  {
    "id": "TCGA-AO-A1KP-01Z-00-DX1.612442AB-24E2-489B-9838-7CEE82BCD605-1",
    "image": "TCGA-BRCA/TCGA-AO-A1KP-01Z-00-DX1.612442AB-24E2-489B-9838-7CEE82BCD605.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated invasive ductal carcinoma with a TNM staging of T1N1M0 and IHC results showing positive estrogen and progesterone receptors and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The moderate differentiation and TNM staging with lymph node involvement (N1) suggest a somewhat aggressive behavior, but positive ER and PR indicate hormone therapy effectiveness, balancing the outlook."
      }
    ]
  },
  {
    "id": "TCGA-LL-A7T0-01Z-00-DX1.B03BBA63-ACF4-4BCA-9F2B-F631F0C6A25C-1",
    "image": "TCGA-BRCA/TCGA-LL-A7T0-01Z-00-DX1.B03BBA63-ACF4-4BCA-9F2B-F631F0C6A25C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of high-grade invasive ductal carcinoma, TNM staging M0T2N1A, and IHC results showing strong estrogen receptor positivity, weak progesterone receptor positivity, and positive HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade and lymph node involvement (N1A) suggest aggressive disease. However, positive HER2 status may allow for effective targeted therapy, partially offsetting the negative factors."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5DA-01Z-00-DX1.1B1E9CC4-7B42-43BB-A1D7-A26F1D1F8557-1",
    "image": "TCGA-BRCA/TCGA-OL-A5DA-01Z-00-DX1.1B1E9CC4-7B42-43BB-A1D7-A26F1D1F8557.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, modified SBR grade II, TNM staging of MXT2N0, and IHC results showing 68% ER positivity, 66% PR positivity, and non-amplified HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The grade II status and TNM staging indicating a medium-sized tumor without clear metastatic status (MX) suggest an intermediate severity, while hormone receptor positivity indicates potential responsiveness to hormone therapy."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LB-01Z-00-DX1.B4AFDB08-BA09-4F6E-806E-4054B790AB8E-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LB-01Z-00-DX1.B4AFDB08-BA09-4F6E-806E-4054B790AB8E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated (SBR Grade 3) invasive ductal carcinoma with apocrine features, TNM staging of T2N1M0, and IHC results showing negative ER and PR but positive HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) and TNM staging with lymph node involvement (N1) suggest a more aggressive disease, but the positive HER2 status provides an opportunity for targeted therapy, which could potentially improve outcomes."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA14-01Z-00-DX1.000A865F-19E6-4018-9352-BFA54EF0CE31-1",
    "image": "TCGA-BRCA/TCGA-S3-AA14-01Z-00-DX1.000A865F-19E6-4018-9352-BFA54EF0CE31.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, grade 3, Nottingham histologic score 8 (3+3+2), TNM staging of CM0 (I+)T1N0 (I+), and IHC results showing positive HER2/NEU (Score 3+) and positive estrogen and progesterone receptors (75%), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (3) and Nottingham score (8) indicate aggressive disease, despite early-stage TNM. Positive HER2/NEU (3+) suggests a more aggressive clinical course, although hormone receptor positivity offers potential treatment avenues."
      }
    ]
  },
  {
    "id": "TCGA-B6-A1KF-01Z-00-DX1.2E08E830-4216-4CD0-9646-1F489300E11D-1",
    "image": "TCGA-BRCA/TCGA-B6-A1KF-01Z-00-DX1.2E08E830-4216-4CD0-9646-1F489300E11D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with histologic and nuclear grades of 3, TNM staging of T2N1M0, and IHC results showing negative estrogen and progesterone receptors but positive HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic and nuclear grades indicate aggressive disease, the TNM staging shows lymph node involvement (N1), and the negative hormone receptors limit hormonal therapy options. The positive HER2/neu, while aggressive, allows for targeted HER2 therapy."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0E0-01Z-00-DX1.01E88024-83DF-4282-ABAF-F4E35807DA06-1",
    "image": "TCGA-BRCA/TCGA-BH-A0E0-01Z-00-DX1.01E88024-83DF-4282-ABAF-F4E35807DA06.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Histologic Grade 3, TNM staging of T3N3aM0, and IHC results showing negative hormonal receptors and HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and TNM stage indicate aggressive cancer with significant lymph node involvement, and the negative hormonal and HER-2/neu status limits treatment options."
      }
    ]
  },
  {
    "id": "TCGA-LL-A740-01Z-00-DX1.757D94A5-EF0F-4A0E-99A9-8809B66438DA-1",
    "image": "TCGA-BRCA/TCGA-LL-A740-01Z-00-DX1.757D94A5-EF0F-4A0E-99A9-8809B66438DA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with TNM staging MXT1CN0 (I-) and IHC results showing negative ER and PR, equivocal HER2 immunoperoxidase, and non-amplified HER2 in situ hybridization, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The negative hormone receptor status and lack of HER2 amplification suggest limited treatment options and a more aggressive tumor behavior, despite the low TNM stage."
      }
    ]
  },
  {
    "id": "TCGA-E2-A2P5-01Z-00-DX1.375B5E5D-D8D0-425C-9163-6DF26E31BBE1-1",
    "image": "TCGA-BRCA/TCGA-E2-A2P5-01Z-00-DX1.375B5E5D-D8D0-425C-9163-6DF26E31BBE1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of ductal carcinoma in situ (DCIS), cribriform type, intermediate grade, with necrosis and microcalcifications, TNM staging of M0T2N3, and IHC results showing positive estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the positive hormone receptors, the intermediate grade with necrosis and high TNM stage (T2N3) indicates a locally advanced disease with significant lymph node involvement, which is often linked with a higher risk of recurrence and spread."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LL-01Z-00-DX1.D1AA1613-902C-4579-9612-48A76042B0AE-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LL-01Z-00-DX1.D1AA1613-902C-4579-9612-48A76042B0AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, SBR Grade 3 with squamous features and necrosis, TNM staging of T3N2MX, and IHC results showing triple-negative status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade, presence of necrosis, and significant lymph node involvement (N2) indicate aggressive disease, while the triple-negative status limits targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AT-01Z-00-DX1.6ED69002-2CC1-4AD4-9573-B245D7C2D060-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AT-01Z-00-DX1.6ED69002-2CC1-4AD4-9573-B245D7C2D060.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of infiltrating mammary carcinoma, solid variant, Nottingham grade III, TNM staging of T2N0M0, and IHC findings showing lack of E-cadherin staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade indicates aggressive tumor behavior, and the T2 stage suggests a sizable tumor. The lack of E-cadherin staining, supporting a lobular phenotype, may also influence treatment responses."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0E9-01Z-00-DX1.5FC4A5E1-3984-4869-9FFB-C0C7F9EAF5FE-1",
    "image": "TCGA-BRCA/TCGA-BH-A0E9-01Z-00-DX1.5FC4A5E1-3984-4869-9FFB-C0C7F9EAF5FE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, pleomorphic type, Nottingham Grade 2, TNM staging M0T2N1A, and IHC showing positive estrogen and progesterone receptors with HER2NEU score of 0 or 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The TNM stage shows lymph node involvement (N1), and pleomorphic subtype is more aggressive, but positive hormone receptors support treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92-1",
    "image": "TCGA-BRCA/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 3 (NHG3), TNM staging of T2N0M0, and IHC results showing negative estrogen, progesterone receptors, and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high Nottingham grade indicates a more aggressive tumor, the T2 staging reflects a larger tumor size, and the lack of hormone receptor and HER2/neu expression limits potential targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D-1",
    "image": "TCGA-BRCA/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging M0T2N1, and IHC results showing strong estrogen receptor positivity with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The grade 2 status and estrogen receptor positivity suggest favorable outcomes with hormonal therapy, despite some lymph node involvement. The negative HER2 indicates a slightly less aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1J8-01Z-00-DX2.5DCB3447-548D-442C-86B1-CEF79B8689DF-1",
    "image": "TCGA-BRCA/TCGA-D8-A1J8-01Z-00-DX2.5DCB3447-548D-442C-86B1-CEF79B8689DF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging M0T2N1, and IHC results showing strong estrogen receptor positivity with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The grade 2 status and estrogen receptor positivity suggest favorable outcomes with hormonal therapy, despite some lymph node involvement. The negative HER2 indicates a slightly less aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JT-01Z-00-DX2.8DB9BB5B-17F3-4D80-835D-872BA275FD3B-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JT-01Z-00-DX2.8DB9BB5B-17F3-4D80-835D-872BA275FD3B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of mixed ductal and papillary invasive carcinoma, TNM staging of T2N0M0, and IHC results showing high positivity for estrogen and progesterone receptors with no HER2/neu gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The tumor's hormone receptor positivity suggests potential benefit from hormonal therapies, and the absence of HER2/neu amplification indicates a less aggressive disease course, despite the moderate TNM staging."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JT-01Z-00-DX1.F278C419-E405-4BDA-BA50-BFBA08801168-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JT-01Z-00-DX1.F278C419-E405-4BDA-BA50-BFBA08801168.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of mixed ductal and papillary invasive carcinoma, TNM staging of T2N0M0, and IHC results showing high positivity for estrogen and progesterone receptors with no HER2/neu gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The tumor's hormone receptor positivity suggests potential benefit from hormonal therapies, and the absence of HER2/neu amplification indicates a less aggressive disease course, despite the moderate TNM staging."
      }
    ]
  },
  {
    "id": "TCGA-S3-A6ZF-01Z-00-DX1.E50205A0-63CA-49DE-8831-2A8916DEF403-1",
    "image": "TCGA-BRCA/TCGA-S3-A6ZF-01Z-00-DX1.E50205A0-63CA-49DE-8831-2A8916DEF403.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing high estrogen receptor positivity with equivocal HER-2/neu status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally favorable. The cancer is moderately differentiated with no lymph node involvement (N0), and high estrogen receptor positivity suggests potential effectiveness of hormone therapy, despite the equivocal HER-2/neu status."
      }
    ]
  },
  {
    "id": "TCGA-A7-A4SC-01Z-00-DX1.171E89D2-2D64-4C3F-A42C-B1167654858B-1",
    "image": "TCGA-BRCA/TCGA-A7-A4SC-01Z-00-DX1.171E89D2-2D64-4C3F-A42C-B1167654858B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, grade 1, TNM staging MXT3N0, and IHC findings of negative progesterone receptors and equivocal HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low-grade tumor, the advanced local stage (T3) and negative progesterone receptor status suggest a more challenging outcome, while equivocal HER2 complicates potential treatment avenues."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0WY-01Z-00-DX1.FA103E02-3BDC-47DC-BA6E-59FCC58866D1-1",
    "image": "TCGA-BRCA/TCGA-B6-A0WY-01Z-00-DX1.FA103E02-3BDC-47DC-BA6E-59FCC58866D1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal adenocarcinoma with histologic grade 2 to 3, TNM staging of T3N1M0, and IHC results showing positive estrogen receptor and negative progesterone receptor, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The higher histologic grade (2 to 3) and the advanced TNM stage (T3N1) indicate aggressive disease and lymph node involvement, though the positive estrogen receptor status may offer some hormonal therapy benefit."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JS-01Z-00-DX1.76C592B0-DC6D-401A-9533-C9FE5B6CA08D-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JS-01Z-00-DX1.76C592B0-DC6D-401A-9533-C9FE5B6CA08D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive papillary carcinoma, TNM staging of T1CN0, and IHC results showing high hormone receptor positivity, negative HER2, and Ki67 at 20%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early-stage (T1C) with no lymph node involvement (N0), high hormone receptor positivity, and negative HER2 suggests favorable outcomes with potential hormonal therapy effectiveness."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IG-01Z-00-DX1.C894EEA1-708A-4043-8C60-3BCA98AA751E-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IG-01Z-00-DX1.C894EEA1-708A-4043-8C60-3BCA98AA751E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 2, TNM staging of T2N1M0, and IHC results showing positive ER and PR with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade (SBR Grade 2) and lymph node involvement (N1) suggest concern, but positive hormone receptors allow for effective hormonal therapy, despite negative HER2."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JI-01Z-00-DX1.9BDB647F-EEAB-4235-BE44-A3815A48CCE0-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JI-01Z-00-DX1.9BDB647F-EEAB-4235-BE44-A3815A48CCE0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with Nottingham Grade 2, TNM staging of MXT1CN1A, and IHC results showing partial estrogen receptor positivity, high progesterone receptor positivity, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade and TNM staging indicate a somewhat challenging outlook, yet the hormone receptor positivity offers potential benefits from hormone therapy, while negative HER2 suggests a less aggressive disease pattern."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JI-01Z-00-DX2.E688E270-26C9-43EC-BC26-86BF8B74A31D-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JI-01Z-00-DX2.E688E270-26C9-43EC-BC26-86BF8B74A31D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with Nottingham Grade 2, TNM staging of MXT1CN1A, and IHC results showing partial estrogen receptor positivity, high progesterone receptor positivity, and negative HER2 protein, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade and TNM staging indicate a somewhat challenging outlook, yet the hormone receptor positivity offers potential benefits from hormone therapy, while negative HER2 suggests a less aggressive disease pattern."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AI-01Z-00-DX1.5EF2A589-4284-45CF-BF0C-169E3A85530C-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AI-01Z-00-DX1.5EF2A589-4284-45CF-BF0C-169E3A85530C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of medullary carcinoma, TNM staging of T2N0M0, and IHC results with positive Cytokeratin stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. Medullary carcinoma generally has a better prognosis compared to other breast cancer types, and the T2N0M0 staging indicates localized disease without lymph node involvement, suggesting a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JN-01Z-00-DX1.3B02989C-CEA0-4EDD-A6DC-21C3A957C640-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JN-01Z-00-DX1.3B02989C-CEA0-4EDD-A6DC-21C3A957C640.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma with Nottingham Histologic Grade 2 (total score 6 out of 9), TNM staging of MXT3N3A, and IHC results showing 75% positivity for estrogen receptors, 10% positivity for progesterone receptors, and HER2 score of 2+ pending FISH verification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The advanced TNM staging (T3N3A) indicates a significant tumor size with extensive regional lymph node involvement, which is associated with a more aggressive disease and lower survival rates, despite the presence of estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24H-01Z-00-DX1.5CFC7E16-3F38-4531-968C-A4E4C9D00659-1",
    "image": "TCGA-BRCA/TCGA-AR-A24H-01Z-00-DX1.5CFC7E16-3F38-4531-968C-A4E4C9D00659.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive lobular carcinoma, Nottingham Grade 2, TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The intermediate histologic grade and absence of lymph node involvement, coupled with positive hormone receptors, suggest a favorable response to hormonal therapy and a relatively less aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-AR-A1AN-01Z-00-DX1.1118F9FE-6DF2-4496-B102-D3A10D332EC0-1",
    "image": "TCGA-BRCA/TCGA-AR-A1AN-01Z-00-DX1.1118F9FE-6DF2-4496-B102-D3A10D332EC0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of Nottingham grade II infiltrating ductal carcinoma, TNM staging of T2N0M0, and pending HER-2/neu results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade (Nottingham grade II) and absence of metastasis with no lymph node involvement (N0) suggest an average risk, though final prognosis depends on HER-2/neu status, which is still pending."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JG-01Z-00-DX1.BA6D5CC7-3A9B-4D17-A86A-B159D345A216-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JG-01Z-00-DX1.BA6D5CC7-3A9B-4D17-A86A-B159D345A216.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 2, TNM staging of T2N0M0, and IHC results showing HER2 protein score of 2+ with no HER2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate histologic grade (Nottingham Grade 2) and the TNM staging indicating no lymph node involvement (N0) suggest a moderate disease course, while the absence of HER2 gene amplification reduces the likelihood of aggressive cancer behavior."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1II-01Z-00-DX1.7F782477-0F92-4C57-8735-A1E3F95A6B94-1",
    "image": "TCGA-BRCA/TCGA-E2-A1II-01Z-00-DX1.7F782477-0F92-4C57-8735-A1E3F95A6B94.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated invasive ductal carcinoma (SBR Grade 3) with a TNM staging of M0T1CN0, and immunohistochemistry results showing mixed positivity for Cytokeratin AE1/3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) indicates an aggressive nature of the cancer despite the lower TNM staging (T1N0M0), which typically suggests limited spread. Mixed positivity for Cytokeratin AE1/3 does not significantly improve this prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0C3-01Z-00-DX1.14D3210D-0CBE-4DCA-A986-A26AE5382502-1",
    "image": "TCGA-BRCA/TCGA-BH-A0C3-01Z-00-DX1.14D3210D-0CBE-4DCA-A986-A26AE5382502.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of moderately differentiated invasive ductal carcinoma (Nottingham Histologic Grade 2), TNM staging of T1N0M0, and IHC results showing positive estrogen receptor, but negative progesterone receptor, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderate differentiation, low TNM stage, and positive estrogen receptor status suggest favorable outcomes with potential hormone therapy benefits, despite the negative progesterone receptor."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5D7-01Z-00-DX1.A4A45393-9AE1-4370-8B92-CB85CDB04934-1",
    "image": "TCGA-BRCA/TCGA-OL-A5D7-01Z-00-DX1.A4A45393-9AE1-4370-8B92-CB85CDB04934.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, SBR grade III, TNM staging of T2N0MX, and IHC results showing no reactivity for ER and PR, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high SBR grade and T2 staging indicate aggressive disease. The lack of hormone receptor reactivity limits treatment options, contributing to an unfavorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0EA-01Z-00-DX1.85FF2B48-2AF7-4C15-A7E6-FCA68CAB76C7-1",
    "image": "TCGA-BRCA/TCGA-BH-A0EA-01Z-00-DX1.85FF2B48-2AF7-4C15-A7E6-FCA68CAB76C7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with focal tubular features, moderately differentiated, Nottingham Histologic Grade 2 (NHG2), TNM staging of M0T1CN1A, and IHC results showing ER Positive, PR Positive, and HER-2/neu Positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate to slightly adverse. While the moderately differentiated status and hormone receptor positivity are favorable, the involved lymph node (N1A) and positive HER-2/neu suggest a higher potential for aggressive behavior and recurrence, slightly worsening the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IN-01Z-00-DX1.F63F004F-847D-41B0-BAEF-3189D4965838-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IN-01Z-00-DX1.F63F004F-847D-41B0-BAEF-3189D4965838.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Modified Scarff-Bloom-Richardson Grade 3, TNM staging of M0T1CN0, and IHC results showing ER positive, PR positive, and HER2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is fair to moderate. Despite the high histological grade indicating aggressive potential, the small tumor size (T1), absence of metastasis (M0), and lymph node involvement (N0), along with positive hormone receptor status, suggest that hormonal therapy may be effective."
      }
    ]
  },
  {
    "id": "TCGA-A7-A3IZ-01Z-00-DX1.7437130B-DF49-40C8-ABCD-FF9364B9B1B0-1",
    "image": "TCGA-BRCA/TCGA-A7-A3IZ-01Z-00-DX1.7437130B-DF49-40C8-ABCD-FF9364B9B1B0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of histologic grade 2 invasive lobular carcinoma, TNM staging of T2N0M0 (I+), and IHC findings showing rare isolated cytokeratin positive cells (pX0i+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The absence of metastasis (M0), no lymph node involvement (N0), and intermediate grade suggest a less aggressive disease, though isolated cell presence reflects minimal invasive potential."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0WX-01Z-00-DX1.1C4F7BCC-8423-4941-9490-0F35038E1878-1",
    "image": "TCGA-BRCA/TCGA-B6-A0WX-01Z-00-DX1.1C4F7BCC-8423-4941-9490-0F35038E1878.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, TNM staging of T3N1M0, and IHC results showing negative estrogen and progesterone receptors with low HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor size (T3) and lymph node involvement (N1) indicate a more aggressive disease. Additionally, the lack of hormone receptor expression and low HER2/neu expression limit targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0X0-01Z-00-DX1.5D67D9D5-C2F0-40BE-A661-E25B6A6287A2-1",
    "image": "TCGA-BRCA/TCGA-B6-A0X0-01Z-00-DX1.5D67D9D5-C2F0-40BE-A661-E25B6A6287A2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with a histologic grade of 2, TNM staging of T1N0M0, and positive estrogen and progesterone receptor IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer's moderate histologic grade, early TNM stage, and positive hormone receptors suggest a favorable outcome with potential effectiveness of hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1-1",
    "image": "TCGA-BRCA/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive mixed ductal and lobular carcinoma, Grade 2, TNM staging of T2N1M0, and IHC results showing high positivity for estrogen and progesterone receptors, but negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The cancer is intermediate grade (Grade 2) and has some lymph node involvement (N1), which warrants caution. However, the high positivity for hormone receptors suggests that hormonal therapy could be very effective, while the negative HER2/neu indicates a lower aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24T-01Z-00-DX1.3B325D54-38EC-4E16-BDE1-628894CC15AA-1",
    "image": "TCGA-BRCA/TCGA-AR-A24T-01Z-00-DX1.3B325D54-38EC-4E16-BDE1-628894CC15AA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith an infiltrating lobular carcinoma diagnosis, Nottingham grade I, TNM staging of T3N3M0, and pending HER-2/neu results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the low Nottingham grade indicating less aggressive cancer, the TNM stage of T3N3 suggests an advanced local and nodal spread, which typically portends a more challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JU-01Z-00-DX1.355D93B4-E69E-417C-B3D1-3E1AAF1E02FE-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JU-01Z-00-DX1.355D93B4-E69E-417C-B3D1-3E1AAF1E02FE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of M0T1CN0, and IHC results showing 75% positivity for estrogen and progesterone receptors with negative HER2 protein expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early TNM staging (T1, N0, M0), combined with strong positivity for hormone receptors and negative HER2 expression, generally indicates a lower likelihood of aggressive disease and favorable response to hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-A2-A3XY-01Z-00-DX1.E57FC9BF-411E-4028-AC10-8BCA5D0C8472-1",
    "image": "TCGA-BRCA/TCGA-A2-A3XY-01Z-00-DX1.E57FC9BF-411E-4028-AC10-8BCA5D0C8472.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of grade 3 invasive ductal carcinoma with a Nottingham score of 9/9, TNM staging of T2N1M0, and IHC results showing negative estrogen and progesterone receptors and negative HER2 by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade, high Nottingham score, and lymph node involvement indicate aggressive disease. The triple-negative status limits treatment options and is often associated with worse outcomes."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1J9-01Z-00-DX2.E1C59487-9563-4501-845F-2067A0C5C59B-1",
    "image": "TCGA-BRCA/TCGA-D8-A1J9-01Z-00-DX2.E1C59487-9563-4501-845F-2067A0C5C59B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T1CN0M0, and IHC results showing moderate estrogen receptor presence, absent progesterone receptors, and positive HER2 overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate. The intermediate grade, low TNM stage, and HER2 positivity suggest potential benefit from targeted therapies, though absent progesterone receptors may limit some hormonal treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1J9-01Z-00-DX1.F81FA9EF-8129-4E17-A9AD-2B850782CC18-1",
    "image": "TCGA-BRCA/TCGA-D8-A1J9-01Z-00-DX1.F81FA9EF-8129-4E17-A9AD-2B850782CC18.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T1CN0M0, and IHC results showing moderate estrogen receptor presence, absent progesterone receptors, and positive HER2 overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively moderate. The intermediate grade, low TNM stage, and HER2 positivity suggest potential benefit from targeted therapies, though absent progesterone receptors may limit some hormonal treatment options."
      }
    ]
  },
  {
    "id": "TCGA-B6-A1KN-01Z-00-DX1.E769FD65-E5CE-4CA4-8BBE-6FC54A2ED870-1",
    "image": "TCGA-BRCA/TCGA-B6-A1KN-01Z-00-DX1.E769FD65-E5CE-4CA4-8BBE-6FC54A2ED870.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, histologic grade 3, TNM staging of T4BN1M0, and IHC results showing positive estrogen receptor status and negative progesterone receptor status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade, advanced tumor stage (T4B), and lymph node involvement (N1) indicate aggressive disease, despite the positive estrogen receptor suggesting some hormonal treatment options."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA15-01Z-00-DX2.915A4F90-25CB-4535-99C7-D0D0CFC90412-1",
    "image": "TCGA-BRCA/TCGA-S3-AA15-01Z-00-DX2.915A4F90-25CB-4535-99C7-D0D0CFC90412.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Histologic Grade 3 (NHG3), TNM staging of CM0 (I+)T2N1A, and IHC results negative for keratins AE1/AE3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (NHG3) and TNM staging indicating a relatively advanced tumor with lymph node involvement (N1A) suggest a more aggressive disease course, and the negative keratin markers indicate a lack of certain features typically seen in carcinomas."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA15-01Z-00-DX1.A2456A4A-E6E8-4429-8F09-B997AA497BB0-1",
    "image": "TCGA-BRCA/TCGA-S3-AA15-01Z-00-DX1.A2456A4A-E6E8-4429-8F09-B997AA497BB0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Histologic Grade 3 (NHG3), TNM staging of CM0 (I+)T2N1A, and IHC results negative for keratins AE1/AE3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (NHG3) and TNM staging indicating a relatively advanced tumor with lymph node involvement (N1A) suggest a more aggressive disease course, and the negative keratin markers indicate a lack of certain features typically seen in carcinomas."
      }
    ]
  },
  {
    "id": "TCGA-LL-A9Q3-01Z-00-DX1.94FA76F5-008A-401B-BFDC-817804BAE5F6-1",
    "image": "TCGA-BRCA/TCGA-LL-A9Q3-01Z-00-DX1.94FA76F5-008A-401B-BFDC-817804BAE5F6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of pleomorphic infiltrating lobular carcinoma with Nottingham Histologic Grade 2, TNM staging MXT3N3A, and IHC results showing strong estrogen receptor positivity and low progesterone receptor positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high tumor size (T3), significant lymph node involvement (N3), and aggressive pleomorphic subtype suggest a more challenging disease course despite strong estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1IU-01Z-00-DX1.E2F24814-24BA-4158-8841-F27A8E100589-1",
    "image": "TCGA-BRCA/TCGA-E2-A1IU-01Z-00-DX1.E2F24814-24BA-4158-8841-F27A8E100589.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, Nottingham Grade 1, TNM staging M0T1CN0 (MOL+), and IHC results showing ER and PR positivity but HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low Nottingham grade, early TNM stage, and positive hormone receptor status suggest effective treatment options and a favorable disease outlook."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA12-01Z-00-DX1.2A991B9F-E7E6-410B-B0BF-635E3CC40C7E-1",
    "image": "TCGA-BRCA/TCGA-S3-AA12-01Z-00-DX1.2A991B9F-E7E6-410B-B0BF-635E3CC40C7E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Grade 2 invasive ductal carcinoma with a TNM staging of MXT3N1A and IHC results showing 99% positivity for estrogen receptors, <1% positivity for progesterone receptors, and a HER-2/neu score of 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate grade (Grade 2), advanced TNM staging (with regional lymph node involvement and locally advanced tumor), and the lack of progesterone receptor positivity, along with negative HER-2/neu, suggest a more challenging disease course, despite the high estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA12-01Z-00-DX2.4F0A4F18-41C7-4497-A7B8-5DCE610E08AD-1",
    "image": "TCGA-BRCA/TCGA-S3-AA12-01Z-00-DX2.4F0A4F18-41C7-4497-A7B8-5DCE610E08AD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Grade 2 invasive ductal carcinoma with a TNM staging of MXT3N1A and IHC results showing 99% positivity for estrogen receptors, <1% positivity for progesterone receptors, and a HER-2/neu score of 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate grade (Grade 2), advanced TNM staging (with regional lymph node involvement and locally advanced tumor), and the lack of progesterone receptor positivity, along with negative HER-2/neu, suggest a more challenging disease course, despite the high estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-EW-A423-01Z-00-DX2.5EF1CF39-600A-4ED3-A5A2-AF4435A5F8B5-1",
    "image": "TCGA-BRCA/TCGA-EW-A423-01Z-00-DX2.5EF1CF39-600A-4ED3-A5A2-AF4435A5F8B5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma with a Nottingham grade of 2, TNM staging of MXT2N0, and IHC results showing high positivity for estrogen receptors, low positivity for progesterone receptors, and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The intermediate grade (Nottingham 2), absence of distant metastasis (MX) and lymph node involvement (N0), along with high estrogen receptor positivity, suggest a likely benefit from hormonal therapies, although the low progesterone receptor positivity and HER-2/neu negativity may limit some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A423-01Z-00-DX1.31502D62-9C83-4A9C-9682-05A185486EAA-1",
    "image": "TCGA-BRCA/TCGA-EW-A423-01Z-00-DX1.31502D62-9C83-4A9C-9682-05A185486EAA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma with a Nottingham grade of 2, TNM staging of MXT2N0, and IHC results showing high positivity for estrogen receptors, low positivity for progesterone receptors, and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The intermediate grade (Nottingham 2), absence of distant metastasis (MX) and lymph node involvement (N0), along with high estrogen receptor positivity, suggest a likely benefit from hormonal therapies, although the low progesterone receptor positivity and HER-2/neu negativity may limit some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-E9-A5FL-01Z-00-DX1.FB810D6A-303E-45DF-BEF1-D9CE83B4417E-1",
    "image": "TCGA-BRCA/TCGA-E9-A5FL-01Z-00-DX1.FB810D6A-303E-45DF-BEF1-D9CE83B4417E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metaplastic squamous cell carcinoma, TNM staging of T3N0M0, and IHC results showing negative ER, PR, and Her-2/neu with a Ki-67 index of 30%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metaplastic squamous cell carcinoma, combined with a high TNM stage (T3), triple-negative hormone receptor status, and a relatively high Ki-67 index indicate a more aggressive and less responsive tumor, leading to a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27M-01Z-00-DX1.3020D223-2400-4A2D-8BFE-08A5B78FE13B-1",
    "image": "TCGA-BRCA/TCGA-D8-A27M-01Z-00-DX1.3020D223-2400-4A2D-8BFE-08A5B78FE13B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated invasive ductal carcinoma, NHG3 with TNM staging M0T1CN0, and negative results for estrogen receptors, progesterone receptors, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and NHG3 score indicate aggressive cancer behavior, while the triple-negative hormone receptor status limits targeted treatment options, despite the early TNM stage."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0H0-01Z-00-DX1.B3B394DD-1F4E-42CA-BB51-C002E423B3D0-1",
    "image": "TCGA-BRCA/TCGA-BH-A0H0-01Z-00-DX1.B3B394DD-1F4E-42CA-BB51-C002E423B3D0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of Nottingham grade 1 invasive ductal carcinoma, TNM stage T1CN0 (M0), and IHC showing positive estrogen, weakly positive progesterone, and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low Nottingham grade, early TNM stage, and positive hormone receptor status indicate favorable outcomes, while negative HER-2/neu reduces aggressive disease risk."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1OY-01Z-00-DX1.42AF5C9A-A90F-4A58-B5D4-B615F8CD4333-1",
    "image": "TCGA-BRCA/TCGA-EW-A1OY-01Z-00-DX1.42AF5C9A-A90F-4A58-B5D4-B615F8CD4333.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham grade III, TNM staging of MXT2N0, and IHC results showing positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade indicates aggressive disease, and the T2 stage suggests larger tumor size. Despite hormonal receptor positivity, the negative HER2 status limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A0U1-01Z-00-DX1.276433E7-E841-42D2-AF21-762F2FEA3B9B-1",
    "image": "TCGA-BRCA/TCGA-AR-A0U1-01Z-00-DX1.276433E7-E841-42D2-AF21-762F2FEA3B9B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade 3, TNM staging of T2N1M0, and pending HER-2/neu results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham grade 3) and TNM staging with lymph node involvement (N1) suggest a more aggressive disease behavior, while pending HER-2/neu results may further influence therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CX-01Z-00-DX1.F07C75AB-E568-45CB-B497-37C712490393-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CX-01Z-00-DX1.F07C75AB-E568-45CB-B497-37C712490393.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated Nottingham Grade III infiltrating ductal carcinoma, TNM staging of T2N0M0, and IHC results showing positive HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade and larger tumor size (T2) suggest aggressive behavior, while HER2/neu positivity, despite offering targeted therapy options, signifies a more aggressive cancer type overall."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D-1",
    "image": "TCGA-BRCA/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive carcinoma with Nottingham Histologic Grade 3, TNM staging of T2N0M0, and IHC results showing negative estrogen and progesterone receptors with HER-2/neu score 0, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade and lack of hormone receptor expression, combined with negative HER-2/neu, suggest limited treatment options and a more aggressive disease profile."
      }
    ]
  },
  {
    "id": "TCGA-E9-A5FK-01Z-00-DX1.3F002C99-B4CA-4068-A816-EAC370A2E8C4-1",
    "image": "TCGA-BRCA/TCGA-E9-A5FK-01Z-00-DX1.3F002C99-B4CA-4068-A816-EAC370A2E8C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive lobular carcinoma (G2), TNM staging of T2N3M0, and IHC results showing 85% ER positivity, 70% PR positivity, negative HER-2/neu, and Ki-67 at 18%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the tumor is moderately differentiated and has strong hormone receptor positivity, the high TNM stage, indicating significant lymph node involvement (N3), suggests a more advanced and higher risk of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-LQ-A4E4-01Z-00-DX1.CF422C39-614F-4F14-813B-95BB7B171977-1",
    "image": "TCGA-BRCA/TCGA-LQ-A4E4-01Z-00-DX1.CF422C39-614F-4F14-813B-95BB7B171977.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma, Nottingham grade 1 with TNM staging of MXT3N1a, and negative e-Cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low histologic grade, the T3N1a staging indicates a larger tumor with lymph node involvement, and negative e-Cadherin is typical for invasive lobular carcinoma, which can be more challenging to treat."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0H7-01Z-00-DX1.21502FEA-DB37-4630-BA42-778DDF3A6D17-1",
    "image": "TCGA-BRCA/TCGA-BH-A0H7-01Z-00-DX1.21502FEA-DB37-4630-BA42-778DDF3A6D17.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of multifocal infiltrating ductal carcinoma, Nottingham Grade 2, TNM staging of T1N2M0, with positive progesterone receptors and low HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The multifocal nature, lymph node involvement (N2), and moderate tumor grade suggest a higher chance of recurrence and aggressive behavior, despite the positive hormone receptor status."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1OW-01Z-00-DX1.97888686-EBB6-4B13-AB5D-452F475E865B-1",
    "image": "TCGA-BRCA/TCGA-EW-A1OW-01Z-00-DX1.97888686-EBB6-4B13-AB5D-452F475E865B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of poorly differentiated invasive mammary carcinoma with Nottingham grade 3 (8/9), TNM staging MXT2N0, and IHC results showing negative ER, PR, and HER2 with positive EGFR and p63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and lack of hormone receptor positivity limit treatment options, while EGFR positivity suggests an aggressive tumor behavior, impacting overall prognosis negatively."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1BD-01Z-00-DX1.A2AFF7AD-ED47-43E4-87FE-62882BAEB8DA-1",
    "image": "TCGA-BRCA/TCGA-E2-A1BD-01Z-00-DX1.A2AFF7AD-ED47-43E4-87FE-62882BAEB8DA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, Modified Scarff Bloom Richardson Grade 2 with a total score of 6, TNM staging of M0T2N0, and IHC results showing positive estrogen and progesterone receptors with negative HER2 by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderately differentiated grade indicates intermediate behavior, the TNM staging shows no lymph node involvement or metastasis (N0, M0), and the positive hormonal receptors provide effective therapeutic options, while the negative HER2 status suggests a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8-1",
    "image": "TCGA-BRCA/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of moderately differentiated infiltrating ductal carcinoma, TNM staging of T2N1M0, and IHC results showing high ER positivity, low PR positivity, and negative HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The moderately differentiated tumor and lymph node involvement (N1) suggest intermediate risk, while high ER positivity provides options for hormone therapy, balancing the lower PR expression and negative HER2 status."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1BC-01Z-00-DX1.FD19F2F8-497F-4D7D-97C6-271DC6B75173-1",
    "image": "TCGA-BRCA/TCGA-E2-A1BC-01Z-00-DX1.FD19F2F8-497F-4D7D-97C6-271DC6B75173.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive tubulolobular carcinoma with Scarff-Bloom-Richardson Grade 1, TNM staging of T1CN0M0, and IHC results showing positive ER and PR with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low-grade tumor, early-stage TNM classification, and positive hormone receptor status indicate effective hormonal therapy options, while negative HER2 suggests a less aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0H9-01Z-00-DX1.8AE869C6-5C78-4D52-AC8B-5B6FD5FD91AA-1",
    "image": "TCGA-BRCA/TCGA-BH-A0H9-01Z-00-DX1.8AE869C6-5C78-4D52-AC8B-5B6FD5FD91AA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma and DCIS with nuclear grade 3, Nottingham Histologic Grade 3, TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with weakly positive HER2/neu and no amplification by FISH analysis, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (nuclear grade 3, Nottingham Histologic Grade 3) indicates aggressive tumor behavior, and the TNM staging of T2N0 suggests significant tumor size without lymph node involvement. However, hormone receptor positivity offers some potential for hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA0Z-01Z-00-DX1.4D96156A-4067-41F2-90B8-41EF7ED794CF-1",
    "image": "TCGA-BRCA/TCGA-S3-AA0Z-01Z-00-DX1.4D96156A-4067-41F2-90B8-41EF7ED794CF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s invasive ductal carcinoma diagnosis, Nottingham grade 3, TNM staging of T2N1M0, and IHC results showing variable estrogen receptor positivity and equivocal HER-2/neu status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high tumor grade and lymph node involvement suggest aggressive disease, while weak hormone receptor positivity and equivocal HER-2/neu status limit some targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BG-01Z-00-DX1.0838FB7F-8C85-4687-9F70-D136A1063383-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BG-01Z-00-DX1.0838FB7F-8C85-4687-9F70-D136A1063383.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham grade 3 invasive ductal carcinoma with TNM staging of T1N0M0 and IHC results showing negative hormone receptors and HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (Nottingham grade 3) indicates aggressive disease, and the triple-negative status (negative for hormone receptors and HER-2/neu) limits targeted treatment options, increasing the risk of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-AR-A255-01Z-00-DX1.E67C081D-50C9-451C-814B-F097B2671300-1",
    "image": "TCGA-BRCA/TCGA-AR-A255-01Z-00-DX1.E67C081D-50C9-451C-814B-F097B2671300.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, Nottingham grade II (7/9), TNM staging of T1N0M0, and positive Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low TNM stage (T1N0M0) indicates localized cancer without lymph node involvement, and the intermediate grade suggests moderate differentiation, which usually corresponds to a more favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CV-01Z-00-DX1.B02D017A-61CD-45FE-BB31-705CD127DDAB-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CV-01Z-00-DX1.B02D017A-61CD-45FE-BB31-705CD127DDAB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma with ductal carcinoma in situ, TNM staging of T2N1M0, and IHC results showing negative HER2 and strong positivity for both estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status and TNM staging with lymph node involvement (N1) suggest more aggressive disease, although positive hormone receptors may allow effective hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18H-01Z-00-DX1.4EC9108F-04C2-4B28-BD74-97A414C9A536-1",
    "image": "TCGA-BRCA/TCGA-BH-A18H-01Z-00-DX1.4EC9108F-04C2-4B28-BD74-97A414C9A536.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient's diagnosis of invasive ductal carcinoma, Nottingham grade 2, TNM staging of T1BN0M0, and IHC results showing strong positivity for hormone receptors and negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The tumor's intermediate grade, early stage, strong hormone receptor positivity, and negative HER-2/neu suggest less aggressive behavior and responsive hormonal treatment options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0AZ-01Z-00-DX1.E20051E8-DEEF-48E5-B519-40777DDBC96B-1",
    "image": "TCGA-BRCA/TCGA-BH-A0AZ-01Z-00-DX1.E20051E8-DEEF-48E5-B519-40777DDBC96B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T3N1A CM0 (I+), and IHC results showing positive estrogen and progesterone receptors with equivocal HER-2/neu score and non-amplified HER-2 by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a larger tumor size (T3) and lymph node involvement (N1A), which are associated with a more advanced disease stage, despite favorable hormone receptor status and non-amplified HER-2."
      }
    ]
  },
  {
    "id": "TCGA-EW-A6SC-01Z-00-DX1.C2D50E7C-3AD0-4038-9A1C-CAE54A3FBE2F-1",
    "image": "TCGA-BRCA/TCGA-EW-A6SC-01Z-00-DX1.C2D50E7C-3AD0-4038-9A1C-CAE54A3FBE2F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive lobular carcinoma, Nottingham Histologic Grade 2 with a total score of 6, TNM staging of T2N0M0, and IHC results showing ER and PR positivity and HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The cancer\u2019s moderate differentiation, absence of lymph node involvement (N0), and positivity for hormone receptors (ER and PR) suggest that the disease is likely responsive to hormonal therapies, despite a larger tumor size (T2) and HER2 negativity."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DL-01Z-00-DX1.553F0021-1FC2-4675-810D-BBD9785D065E-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DL-01Z-00-DX1.553F0021-1FC2-4675-810D-BBD9785D065E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma and ductal carcinoma in situ (DCIS), Nottingham Histologic Grade 3, TNM staging of T2N0M0, and IHC results showing positive estrogen receptor, negative progesterone receptor, and HER2/neu score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham grade 3) and the intermediate TNM stage (T2N0M0) indicate a more aggressive tumor. The mixed receptor status, with a positive estrogen receptor but negative progesterone receptor, and the equivocal HER2/neu status (score 2+) further complicate the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-EW-A6SD-01Z-00-DX1.32D8240E-2076-492B-BB95-300A9FCA96E7-1",
    "image": "TCGA-BRCA/TCGA-EW-A6SD-01Z-00-DX1.32D8240E-2076-492B-BB95-300A9FCA96E7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, Nottingham Grade 3, TNM staging of T2N1M0, and IHC results showing minimal estrogen and progesterone receptor positivity but positive HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (Nottingham grade 3), lymph node involvement (N1), and minimal hormone receptor positivity indicate a more aggressive cancer. Though HER2/neu positivity allows for targeted therapy, it also signifies a more aggressive form of the disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with cribriform and solid types, Nottingham Histologic Grade 2 with a total score of 6 out of 9, TNM staging of M0T1CN0, and IHC results showing positive estrogen and progesterone receptors and negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The intermediate grade (Nottingham Histologic Grade 2), lower TNM stage, and positive hormone receptors indicate a favorable response to hormonal therapies, and the negative HER2/neu suggests a lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB-1",
    "image": "TCGA-BRCA/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of SBR grade II invasive lobular carcinoma, TNM staging of T3N3MX, and IHC results showing moderate to strong expression of estrogen receptors (ER) in 80% of tumor cells, no progesterone receptor (PR) expression, and non-amplified HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The advanced TNM stage indicating a large primary tumor and multiple lymph node involvement (T3N3) suggests a more aggressive disease, despite the moderate to strong ER expression, which provides some hormonal therapy options. The lack of PR expression and non-amplified HER2 further complicate potential treatment efficacy."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0ES-01Z-00-DX1.5652EE30-48C1-4EC1-AD77-8C72DFCB9A97-1",
    "image": "TCGA-BRCA/TCGA-A2-A0ES-01Z-00-DX1.5652EE30-48C1-4EC1-AD77-8C72DFCB9A97.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated infiltrating lobular carcinoma with a Nottingham score of 6 out of 9, TNM staging of M0T2N0 (I-), and immunohistochemistry results showing 95% positivity for estrogen receptors, negative progesterone receptors, and weakly positive HER2/neu by immunohistochemistry but negative by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The moderately differentiated status and the TNM staging of T2N0 indicate a localized disease without lymph node involvement, while the high estrogen receptor positivity suggests potential effectiveness of hormonal therapy, despite the negative progesterone receptors and equivocal HER2 status."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18T-01Z-00-DX1.90123A74-F631-4538-AB2E-4076486ADF88-1",
    "image": "TCGA-BRCA/TCGA-BH-A18T-01Z-00-DX1.90123A74-F631-4538-AB2E-4076486ADF88.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of poorly differentiated, grade 3 infiltrating ductal carcinoma, TNM staging of T2N0M0, and IHC findings of negative hormone receptors with weak HER-2/neu positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade suggests aggressive behavior, and the lack of hormone receptor expression limits hormonal therapy options. The weak HER-2/neu positivity presents uncertain potential for targeted therapy."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A-1",
    "image": "TCGA-BRCA/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T1N0M0, and a negative HER-2/neu overexpression, but with pending hormone receptor status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (NHG3) indicates aggressive tumor behavior. Despite low TNM stage N0M0 suggesting limited spread, incomplete receptor status prevents full assessment of hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-LL-A50Y-01Z-00-DX1.7F08413F-2C59-4322-9296-84F8CD3DF619-1",
    "image": "TCGA-BRCA/TCGA-LL-A50Y-01Z-00-DX1.7F08413F-2C59-4322-9296-84F8CD3DF619.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated invasive lobular carcinoma, Nottingham Histologic Grade 2, TNM staging of MXT2N0, and IHC results showing positive ER and PR with equivocal HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate grade, absence of lymph node involvement, and strong hormone receptor positivity suggest potential responsiveness to hormonal therapy, though the equivocal HER2 status may require further testing for targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-LL-A6FP-01Z-00-DX1.6261398A-7288-4924-BBE2-FC1949256E40-1",
    "image": "TCGA-BRCA/TCGA-LL-A6FP-01Z-00-DX1.6261398A-7288-4924-BBE2-FC1949256E40.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, pleomorphic type, Nottingham Histologic Grade 2, TNM staging of MXT2NX, and IHC results showing high estrogen receptor positivity, moderate progesterone receptor positivity, equivocal HER-2 status, and non-amplified FISH results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate grade, high estrogen receptor positivity, and moderate progesterone receptor positivity indicate responsiveness to hormonal therapies, though the unknown metastatic status adds some uncertainty. The non-amplified HER-2 suggests lower aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-AQ-A04H-01Z-00-DX1.5AC1E459-EF27-401D-98FD-0AC16559AF17-1",
    "image": "TCGA-BRCA/TCGA-AQ-A04H-01Z-00-DX1.5AC1E459-EF27-401D-98FD-0AC16559AF17.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis for a patient with infiltrating ductal carcinoma with micropapillary features, Nottingham Histologic Grade 3, TNM staging MXT2N2A, and IHC showing positive estrogen and progesterone receptors and indeterminate HER2/neu, good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade, significant lymph node involvement (N2), and indeterminate HER2 status contribute to a more aggressive cancer behavior, despite positive hormone receptor status."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC-1",
    "image": "TCGA-BRCA/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with apocrine features, Nottingham Histologic Grade 3, TNM staging of T2N1M0, and IHC results showing ER positive, PR positive, and HER-2/neu positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3), presence of lymph node involvement (N1), and HER-2/neu positivity suggest a more aggressive cancer, despite the hormone receptor positivity which typically aids in treatment options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HI-01Z-00-DX1.89DB9F79-0DCC-4C65-831E-96AE026C2C4E-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HI-01Z-00-DX1.89DB9F79-0DCC-4C65-831E-96AE026C2C4E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Nottingham Grade 2 invasive ductal carcinoma with TNM staging of T1N0M0 and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early TNM stage (T1N0M0) and positive hormone receptor status suggest favorable hormone therapy responses, while the negative HER-2/neu indicates a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669-1",
    "image": "TCGA-BRCA/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, Nottingham Grade 1 with a total score of 5 out of 9, TNM staging of M0T1CN0, and IHC results showing positive estrogen and progesterone receptors with HER2/neu expression at zero or 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low grade (Nottingham Grade 1), early stage (T1N0M0), and positive hormone receptors suggest a favorable outlook and responsiveness to hormonal therapy, while the absence of HER2/neu overexpression indicates a lower risk for aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-AO-A03N-01Z-00-DX1.79A8816D-961F-4D79-90B4-341919297A90-1",
    "image": "TCGA-BRCA/TCGA-AO-A03N-01Z-00-DX1.79A8816D-961F-4D79-90B4-341919297A90.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis for a patient with histologic grade 2/3 invasive ductal carcinoma, TNM staging M0T2N1A, and IHC results showing ER positivity, weak PR staining, and negative HER2/neu good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate tumor grade and lymph node involvement indicate a higher risk, but substantial ER positivity suggests potential hormonal therapy benefits. Negative HER2/neu points to less aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18S-01Z-00-DX1.B36FC684-0010-4ABB-9E25-303C8DF1C4E2-1",
    "image": "TCGA-BRCA/TCGA-BH-A18S-01Z-00-DX1.B36FC684-0010-4ABB-9E25-303C8DF1C4E2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, mucinous type, TNM staging of T1CN0M0, and IHC results showing positive estrogen and progesterone receptors, with negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The mucinous type is typically less aggressive, the low TNM stage indicates limited disease spread, and the positive hormone receptors suggest responsiveness to hormonal therapies, while the negative HER-2/neu further reduces the likelihood of aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1J1-01Z-00-DX1.FFC2D5DB-E6D0-4143-A1E7-0A2027846C8C-1",
    "image": "TCGA-BRCA/TCGA-EW-A1J1-01Z-00-DX1.FFC2D5DB-E6D0-4143-A1E7-0A2027846C8C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, Nottingham grade 3, TNM staging of T2N1M0, and IHC results showing positivity for estrogen and progesterone receptors but negative immunoperoxidase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Nottingham grade and lymph node involvement (N1) indicate aggressive disease, despite hormone receptor positivity providing some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated invasive ductal carcinoma, Grade III/III, TNM staging of T2N0M0, and IHC results showing negative estrogen and HER2/neu receptors with focally positive progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high tumor grade and negative hormone and HER2/neu receptor status limit treatment options and suggest more aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D-1",
    "image": "TCGA-BRCA/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of high-grade invasive lobular carcinoma, TNM staging of MXT3N0, and IHC results showing strong positivity for estrogen and progesterone receptors but negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and T3 tumor size indicate aggressive potential, while the absence of positive HER2 status limits some treatment avenues, despite the favorable hormone receptor status."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HN-01Z-00-DX1.4997F641-C593-41F6-82ED-6A0E4EFA55F3-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HN-01Z-00-DX1.4997F641-C593-41F6-82ED-6A0E4EFA55F3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham Grade 2, with a TNM staging of T1CN0 (M0) and IHC results showing positive estrogen and progesterone receptors but HER-2/neu score of 2+ with negative FISH amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The cancer's low stage (T1CN0), hormone receptor positivity, and negative HER-2/neu FISH amplification indicate less aggressive disease and more effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C-1",
    "image": "TCGA-BRCA/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR Grade 1, with TNM staging of M0T1CN2A, and IHC results showing ER and PR positivity with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately poor. While the cancer's low grade (SBR Grade 1) and hormone receptor positivity indicate a generally less aggressive disease, the significant lymph node involvement (N2) seen in the TNM staging suggests a higher risk of disease spread, thereby worsening the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18-1",
    "image": "TCGA-BRCA/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham grade 2 with a total score of 7 out of 9, TNM staging of CM0 (I+)T1CN1A, and IHC results showing membranous reactivity for both E-cadherin and P20 in invasive tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate Nottingham grade and TNM stage indicating involvement of lymph nodes (N1) suggest a potentially more aggressive disease, while the membranous reactivity for E-cadherin and P20 supports the tumor's invasive characteristics."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EN-01Z-00-DX1.F43A5D17-9267-4963-993A-93AC91BDC031-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EN-01Z-00-DX1.F43A5D17-9267-4963-993A-93AC91BDC031.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, TNM staging of T2N0M0 (I+), and IHC results showing positive estrogen and progesterone receptors with HER2/neu not amplified, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The absence of lymph node involvement (N0), positive hormone receptor status, and non-amplified HER2/neu indicate a lower likelihood of aggressive behavior and better responsiveness to hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-AO-A03T-01Z-00-DX1.8B75E203-6DC8-4AC9-A256-6FCB818DA0DD-1",
    "image": "TCGA-BRCA/TCGA-AO-A03T-01Z-00-DX1.8B75E203-6DC8-4AC9-A256-6FCB818DA0DD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of grade III invasive ductal carcinoma, TNM staging of T2N1M0, and moderate positivity for estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade and TNM staging with lymph node involvement (N1) indicate aggressive behavior, while moderate hormone receptor positivity offers some treatment potential, the negative HER2/neu limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1OV-01Z-00-DX1.93698123-5B34-4163-848B-2D75A5F7B001-1",
    "image": "TCGA-BRCA/TCGA-EW-A1OV-01Z-00-DX1.93698123-5B34-4163-848B-2D75A5F7B001.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging MXT2N1MI, and IHC results negative for ER, PR, HER-2, CK5/6, and EGFR, but positive for P-cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated tumor, lymph node involvement, and negative hormonal and HER-2 receptor status limit treatment options and indicate more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DX-01Z-00-DX1.45C27E71-9A0A-400E-93A9-5CE7780F3C5E-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DX-01Z-00-DX1.45C27E71-9A0A-400E-93A9-5CE7780F3C5E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T1bN0M0, and IHC results showing positive estrogen receptor, weakly positive progesterone receptor, and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The moderately differentiated grade and early TNM stage indicate less aggressive disease, while positive hormone receptors suggest responsiveness to hormonal therapy, despite the weak progesterone positivity."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BA-01Z-00-DX1.579E11C9-437C-4D49-8811-DD94D8454712-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BA-01Z-00-DX1.579E11C9-437C-4D49-8811-DD94D8454712.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of mixed ductal and lobular carcinoma, Nottingham Histologic Grade 2 (NHG 2), TNM staging of T3N3M0, and IHC results showing positive estrogen and progesterone receptors but negative HER-2/neu (Score +1), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a larger tumor size and extensive lymph node involvement (N3), which implies a higher risk of metastasis despite the intermediate histologic grade and positive hormone receptor status."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CP-01Z-00-DX1.ECFD263C-BB17-4ADA-8F2C-654C2AA4C45F-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CP-01Z-00-DX1.ECFD263C-BB17-4ADA-8F2C-654C2AA4C45F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated infiltrating ductal carcinoma, Bloom-Richardson grade 4, TNM staging of T1CN0 (I-), and IHC results showing 40% positivity for estrogen receptors and 80% positivity for progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer\u2019s well-differentiated status, low TNM stage (T1CN0), and significant positivity for progesterone receptors suggest favorable outcomes and effective hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DQ-01Z-00-DX1.5A98747C-52D9-45AD-BC84-934A96F069EB-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DQ-01Z-00-DX1.5A98747C-52D9-45AD-BC84-934A96F069EB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T2N1M0, and IHC results showing positive ER and PR but negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated grade and lymph node involvement suggest a potential risk, but the positive hormone receptor status offers favorable treatment options, balancing the negative HER2/neu for a cautiously positive outlook."
      }
    ]
  },
  {
    "id": "TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6-1",
    "image": "TCGA-BRCA/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of infiltrating ductal carcinoma, Nottingham grade III, TNM staging of T2N1M0, and IHC results showing negativity for estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (Nottingham grade III) and TNM staging with lymph node involvement (N1) suggest aggressive disease, while negative hormone receptor status limits hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C-1",
    "image": "TCGA-BRCA/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive lobular carcinoma, TNM staging of T2N3M0, and IHC showing positive Cytokeratin AE1/3 at the margin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage, specifically N3 indicating extensive lymph node involvement, and positive margins suggest a higher risk of residual disease and recurrence, leading to a challenging clinical scenario."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18G-01Z-00-DX1.DB2B5819-CE83-4E07-BD03-2CD9CF2E246C-1",
    "image": "TCGA-BRCA/TCGA-BH-A18G-01Z-00-DX1.DB2B5819-CE83-4E07-BD03-2CD9CF2E246C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, Nottingham grade 3 with a total score of 9/9, TNM staging of T1N0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low TNM stage and positive hormone receptors indicating therapy options, the high Nottingham grade suggests aggressive disease potential."
      }
    ]
  },
  {
    "id": "TCGA-Z7-A8R5-01Z-00-DX1.3BDB407F-514C-4131-B058-FA1E69154276-1",
    "image": "TCGA-BRCA/TCGA-Z7-A8R5-01Z-00-DX1.3BDB407F-514C-4131-B058-FA1E69154276.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated infiltrating lobular carcinoma with a modified Bloom-Richardson score of 5/9, TNM staging of MXT3N1A, and IHC results showing positive estrogen and progesterone receptors, aneuploid DNA index, intermediate Ki-67, and negative HER2/neu and p53, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of both metastatic potential (MX), a tumor size of T3, and lymph node involvement (N1A) suggest a more advanced disease stage, while the positive hormone receptors and negative HER2/neu are favorable factors, the overall outlook is tempered by these advanced features."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27K-01Z-00-DX1.25AF7928-046B-45BF-BAD6-F34156203F5A-1",
    "image": "TCGA-BRCA/TCGA-D8-A27K-01Z-00-DX1.25AF7928-046B-45BF-BAD6-F34156203F5A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, moderately differentiated, Nottingham Histologic Grade 2 with a total score of 4, TNM staging of M0T2N1A, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate to fair. While the moderately differentiated grade and positive hormone receptor status are favorable for treatment response, the TNM staging indicating some lymph node involvement suggests a higher risk of recurrence compared to lower-stage disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0H6-01Z-00-DX1.0CF7253A-B42C-4778-B1C6-17EC78A039ED-1",
    "image": "TCGA-BRCA/TCGA-BH-A0H6-01Z-00-DX1.0CF7253A-B42C-4778-B1C6-17EC78A039ED.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive carcinoma and ductal carcinoma in situ (DCIS), TNM staging of M0T1BNX, and IHC results showing positive estrogen and progesterone receptors with HER2/neu zero or 1+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The early stage (T1B), positive hormone receptor status, and low HER2/neu expression suggest favorable outcomes and potential responsiveness to hormone therapy."
      }
    ]
  },
  {
    "id": "TCGA-LL-A5YP-01Z-00-DX1.ADA978DF-6625-4C4D-AE0C-F589B2BA4897-1",
    "image": "TCGA-BRCA/TCGA-LL-A5YP-01Z-00-DX1.ADA978DF-6625-4C4D-AE0C-F589B2BA4897.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with high-grade DCIS and extensive tumor necrosis, Nottingham Histologic Grade 3, TNM staging of T2N1M0, and IHC results with ER-positive, PR-negative, HER2 2+ (but not amplified by FISH), and negative HER2 (1+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (Nottingham Grade 3), TNM staging indicating lymph node involvement (T2N1), and limited hormone receptor positivity (weak ER) along with HER2 negative status suggest a more aggressive disease with fewer targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0DV-01Z-00-DX1.2F0B5FB3-40F0-4D27-BFAC-390FB9A42B39-1",
    "image": "TCGA-BRCA/TCGA-BH-A0DV-01Z-00-DX1.2F0B5FB3-40F0-4D27-BFAC-390FB9A42B39.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with lobular features, Nottingham Histologic Grade 1 with a total score of 5 out of 9, TNM staging of T2N2M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low histologic grade and hormone receptor positivity which favor better outcomes, the TNM staging of T2N2M0 indicating significant lymph node involvement (N2) suggests a more advanced disease with a higher risk of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BO-01Z-00-DX1.1A704471-FEB3-40F9-9838-3E347A18285F-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BO-01Z-00-DX1.1A704471-FEB3-40F9-9838-3E347A18285F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated infiltrating ductal carcinoma, Nottingham Histologic Grade 2 with TNM staging of T1bN0M0, and IHC results showing positivity for estrogen and progesterone receptors and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated status, low TNM stage, and positive hormone receptor status suggest favorable responses to hormonal therapy, while the negative HER-2/neu indicates a lower likelihood of aggressive disease progression."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1OX-01Z-00-DX1.9B19CBEE-E592-4A4D-839F-CECDCA20F4B1-1",
    "image": "TCGA-BRCA/TCGA-EW-A1OX-01Z-00-DX1.9B19CBEE-E592-4A4D-839F-CECDCA20F4B1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma, colloid type, low nuclear grade, Nottingham Histologic Grade 1, TNM staging of MXT2N0, and IHC results showing positivity for ER and PR but negative for HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The low nuclear grade and histologic grade indicate a less aggressive tumor, while the hormone receptor positivity suggests effective hormone therapy options. The absence of lymph node involvement (N0) and negative HER2 status also contribute to a more favorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0GY-01Z-00-DX1.E1AEAA36-94FA-41ED-851F-7BB11DD3C06D-1",
    "image": "TCGA-BRCA/TCGA-BH-A0GY-01Z-00-DX1.E1AEAA36-94FA-41ED-851F-7BB11DD3C06D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma with TNM staging of T2N1M0 and positive results for both estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. While the TNM stage indicates some lymph node involvement (N1), the positive estrogen and progesterone receptors suggest hormonal treatment can be effective, improving overall outcomes."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27L-01Z-00-DX1.6572593C-B015-4F9A-8C9B-B634CAA0D3B4-1",
    "image": "TCGA-BRCA/TCGA-D8-A27L-01Z-00-DX1.6572593C-B015-4F9A-8C9B-B634CAA0D3B4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with Nottingham Grade 1, TNM stage T1CN2A, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. While the low histologic grade and hormone receptor positivity are favorable, the TNM stage indicates more advanced lymph node involvement (N2), impacting the overall outlook negatively."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CL-01Z-00-DX1.5342E971-DCD2-42C4-B4FF-E6942A95829E-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CL-01Z-00-DX1.5342E971-DCD2-42C4-B4FF-E6942A95829E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with Nottingham Histologic Grade 3, TNM staging of M0T3N2A, and IHC results showing 20% positivity for estrogen receptors, negative progesterone receptors, and negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG3) and TNM staging indicating large tumor size (T3) and significant lymph node involvement (N2) suggest a more aggressive disease. Additionally, low estrogen receptor positivity and negative HER2/neu overexpression limit therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EU-01Z-00-DX1.13335BEB-63D4-469B-A389-8A079A096129-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EU-01Z-00-DX1.13335BEB-63D4-469B-A389-8A079A096129.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of multifocal infiltrating ductal carcinoma, Nottingham Grade III, TNM staging of T1C N0 M0, and IHC showing positive hormone receptors and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite low TNM staging and strong hormone receptor positivity, the high grade (Nottingham Grade III) indicates an aggressive tumor behavior, which can affect the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18R-01Z-00-DX1.07E6FA7F-5072-4327-9982-A40F010B7532-1",
    "image": "TCGA-BRCA/TCGA-BH-A18R-01Z-00-DX1.07E6FA7F-5072-4327-9982-A40F010B7532.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of ductal carcinoma in situ, non-comedo type, poor grade, with TNM staging M0T2BN1, and IHC results showing positive estrogen receptor, negative progesterone receptor, and positive HER-2/Neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poor grade, presence of lymph node metastasis with extracapsular extension, and high HER-2/Neu positivity indicate a more aggressive disease and limit the effectiveness of certain treatments, contributing to a less favorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-AO-A03O-01Z-00-DX1.054BBC89-69F4-4311-814D-E343472CD2C0-1",
    "image": "TCGA-BRCA/TCGA-AO-A03O-01Z-00-DX1.054BBC89-69F4-4311-814D-E343472CD2C0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, NOS type, histological grade II, TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The histological grade II suggests a moderate differentiation, and the absence of lymph node involvement (N0) is favorable, but the T2 stage shows a larger tumor size. The positivity for estrogen and progesterone receptors is beneficial for hormone therapy, while the negative HER2/neu indicates a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HO-01Z-00-DX1.D3D66547-F5D4-40F5-B737-2FECEEB35ACB-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HO-01Z-00-DX1.D3D66547-F5D4-40F5-B737-2FECEEB35ACB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, Ham Grade 2, TNM staging of T1cN1M0, and IHC results showing strong positivity for estrogen and progesterone receptors but negative HER-2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The cancer's moderate grade and lymph node involvement indicate a risk, but strong hormone receptor positivity allows for effective hormonal therapy, while the negative HER-2 suggests a less aggressive disease profile."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1B5-01Z-00-DX1.AB19FF3D-5C42-4D49-ABEA-D2315709B6EA-1",
    "image": "TCGA-BRCA/TCGA-E2-A1B5-01Z-00-DX1.AB19FF3D-5C42-4D49-ABEA-D2315709B6EA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of SBR Grade 2 invasive lobular carcinoma, TNM staging of T2N0M0, and IHC results showing positivity for estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally favorable. The moderate grade, absence of lymph node involvement (N0), and strong hormone receptor positivity indicate effective hormonal treatment options, while negative HER2 suggests a less aggressive tumor."
      }
    ]
  },
  {
    "id": "TCGA-LL-A7SZ-01Z-00-DX1.4DAF6421-6A1D-41C8-BFD6-859FE10CB8CC-1",
    "image": "TCGA-BRCA/TCGA-LL-A7SZ-01Z-00-DX1.4DAF6421-6A1D-41C8-BFD6-859FE10CB8CC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of high-grade invasive ductal carcinoma, Nottingham Histologic Grade 3 with a total score of 8, TNM staging of MXT2N1A, and IHC results showing 99% positivity for both estrogen and progesterone receptors but negative Immunoperoxidase studies (1+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (NHG3) and the TNM staging indicating lymph node involvement (N1) suggest a more aggressive cancer, despite the high positivity for hormone receptors, which does offer some therapeutic targets."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0BZ-01Z-00-DX1.45EB3E93-A871-49C6-9EAE-90D98AE01913-1",
    "image": "TCGA-BRCA/TCGA-BH-A0BZ-01Z-00-DX1.45EB3E93-A871-49C6-9EAE-90D98AE01913.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma, Nottingham Histologic Grade 3, TNM staging of T3N1M0, and IHC results showing positive estrogen and progesterone receptors with HER-2/neu negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade and significant tumor size with lymph node involvement suggest aggressive behavior. Despite hormonal receptor positivity, the negative HER-2/neu decreases options for targeted therapy."
      }
    ]
  },
  {
    "id": "TCGA-BH-A18U-01Z-00-DX1.63940315-59BC-462B-87A8-2BBB33C9503E-1",
    "image": "TCGA-BRCA/TCGA-BH-A18U-01Z-00-DX1.63940315-59BC-462B-87A8-2BBB33C9503E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of NHG3 infiltrating ductal carcinoma, TNM staging M0T2N2A, and IHC results showing ER and PR positivity with strong HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade, significant lymph node involvement (N2), and strong HER-2/neu positivity indicate a more aggressive disease, though targeted therapies might offer some benefit."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0CK-01Z-00-DX1.C3226BD1-11B0-4034-946A-BAB42958CE85-1",
    "image": "TCGA-BRCA/TCGA-A2-A0CK-01Z-00-DX1.C3226BD1-11B0-4034-946A-BAB42958CE85.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating lobular carcinoma with TNM staging of T3N2M0 and IHC results showing negative HER2/neu overexpression and ER/PR negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with significant lymph node involvement (N2) indicates aggressive disease, and the negativity for ER/PR and HER2/neu limits targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-LL-A6FQ-01Z-00-DX1.D4FEEC16-FC67-4C4A-A4B1-F8BA34ECBCBD-1",
    "image": "TCGA-BRCA/TCGA-LL-A6FQ-01Z-00-DX1.D4FEEC16-FC67-4C4A-A4B1-F8BA34ECBCBD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma (NOS), moderately differentiated, Nottingham Histologic Grade 2 with a total score of 6 out of 9, TNM staging of MXT2N2A, and IHC results showing 100% positivity for estrogen receptor but only 2% positivity for progesterone receptor, high Ki-67 score, and negative Her2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated tumor with NHG2, significant lymph node involvement (N2), and high Ki-67 score indicate higher proliferative activity and aggressiveness, despite strong estrogen receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0AU-01Z-00-DX1.E852F218-B15C-4CF8-8FD0-F284043834C4-1",
    "image": "TCGA-BRCA/TCGA-BH-A0AU-01Z-00-DX1.E852F218-B15C-4CF8-8FD0-F284043834C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with equivocal HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The intermediate grade (Nottingham Grade 2) and TNM staging indicating no lymph node involvement (N0) are positive factors, while the strong hormone receptor positivity suggests potential effectiveness of hormonal therapy. The equivocal HER-2/neu status may necessitate further testing to clarify target therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27P-01Z-00-DX1.EF426996-D0DC-4418-BEC4-F7CE3C82C869-1",
    "image": "TCGA-BRCA/TCGA-D8-A27P-01Z-00-DX1.EF426996-D0DC-4418-BEC4-F7CE3C82C869.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive ductal carcinoma, Nottingham grade 1 with TNM stage T1CN0M0 and IHC results showing 75% estrogen receptor positivity, 10% progesterone receptor positivity, and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low grade and stage indicate less aggressive disease, and the high estrogen receptor positivity suggests responsiveness to hormonal therapy, while negative HER2 indicates a lower risk of aggressive growth."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HA-01Z-00-DX1.5A2F5C86-E1E7-445D-A4E3-29980FA37708-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HA-01Z-00-DX1.5A2F5C86-E1E7-445D-A4E3-29980FA37708.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal adenocarcinoma, Nottingham Grade I with a TNM staging of T1N0M0, and IHC findings of positive estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The well-differentiated Grade I tumor, low TNM stage, and positive hormone receptors support favorable outcomes, while the negative HER2 status suggests lower aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-OL-A66O-01Z-00-DX1.5F1E4C60-5CE8-41B4-A94D-4AA80D9253F9-1",
    "image": "TCGA-BRCA/TCGA-OL-A66O-01Z-00-DX1.5F1E4C60-5CE8-41B4-A94D-4AA80D9253F9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, TNM staging of MXT2N1A, and IHC showing strong ER and PR expression with non-amplified HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. While strong hormone receptor positivity suggests responsiveness to hormonal therapy, the T2N1 staging indicates lymph node involvement, which can lead to a more challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2-1",
    "image": "TCGA-BRCA/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham grade 3, TNM staging of T2N2MX, and IHC results showing positive estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade and significant lymph node involvement (N2) indicate aggressive disease, despite the positive hormone receptors that may offer some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80-1",
    "image": "TCGA-BRCA/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive lobular carcinoma with a Nottingham Histologic Grade 2, TNM staging of MXT2N1A, and IHC results showing ER positivity (92% of tumor cells), PR negativity, and HER2 positivity (score 3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate grade (Grade 2) combined with lymph node involvement (N1) indicates a more aggressive disease. Additionally, HER2 positivity (score 3+) suggests a higher risk of aggressive behavior, though it opens up potential targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-EW-A6SB-01Z-00-DX1.D56E1922-01A9-4AEE-AB95-D69447DD13EE-1",
    "image": "TCGA-BRCA/TCGA-EW-A6SB-01Z-00-DX1.D56E1922-01A9-4AEE-AB95-D69447DD13EE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive ductal carcinoma, TNM staging of T2N0M0, and negative results for hormone receptors and HER2/neu with positive EGFR, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade, moderate tumor size without lymph node involvement, negative hormone and HER2/neu receptors, and positive EGFR indicate a more aggressive cancer with limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014-1",
    "image": "TCGA-BRCA/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, SBR grade III, TNM staging of MXT1CN0, and IHC results showing negative ER and PR receptors with non-amplified HER2/neu antigen, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade (SBR grade III) indicates aggressive cancer, while negative hormone receptors (ER and PR) and non-amplified HER2/neu reduce the effectiveness of common hormonal and targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-AC-A23C-01Z-00-DX1.0E67C785-83D3-49AF-B600-FB5B909AE6ED-1",
    "image": "TCGA-BRCA/TCGA-AC-A23C-01Z-00-DX1.0E67C785-83D3-49AF-B600-FB5B909AE6ED.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of Nottingham grade 1 invasive ductal carcinoma, TNM staging MXT2N1, and IHC results showing low estrogen receptor positivity, high progesterone receptor positivity, and high Ki-67 index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low histologic grade, the positive lymph node involvement (N1), low estrogen receptor positivity, and high Ki-67 index indicate a more aggressive behavior and potential recurrence."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27W-01Z-00-DX1.CE2D4FEA-284C-44AF-A70F-7956D91CCB29-1",
    "image": "TCGA-BRCA/TCGA-D8-A27W-01Z-00-DX1.CE2D4FEA-284C-44AF-A70F-7956D91CCB29.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive mucinous carcinoma, Nottingham Histologic Grade 3, TNM staging of T4BN0, and IHC findings showing high estrogen receptor positivity with low progesterone receptor expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade (NHG3) and advanced local tumor size (T4B) contribute to a more aggressive disease course, despite high estrogen receptor positivity which suggests potential hormone therapy responsiveness."
      }
    ]
  },
  {
    "id": "TCGA-D8-A27W-01Z-00-DX2.4E0D2E4E-5662-4305-8FC2-C651CDDA4998-1",
    "image": "TCGA-BRCA/TCGA-D8-A27W-01Z-00-DX2.4E0D2E4E-5662-4305-8FC2-C651CDDA4998.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive mucinous carcinoma, Nottingham Histologic Grade 3, TNM staging of T4BN0, and IHC findings showing high estrogen receptor positivity with low progesterone receptor expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade (NHG3) and advanced local tumor size (T4B) contribute to a more aggressive disease course, despite high estrogen receptor positivity which suggests potential hormone therapy responsiveness."
      }
    ]
  },
  {
    "id": "TCGA-OL-A66H-01Z-00-DX1.E54AF3FA-E59E-404C-BB83-A6FC6FC9B312-1",
    "image": "TCGA-BRCA/TCGA-OL-A66H-01Z-00-DX1.E54AF3FA-E59E-404C-BB83-A6FC6FC9B312.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma with mucinous features, TNM staging MXT1CN1MI, and IHC results showing strong ER/PR expression and negative HER2 score, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is cautiously optimistic. The mucinous features often indicate a less aggressive cancer, and strong ER/PR expression suggests hormonal therapy options, though nodal involvement (N1) and indeterminate metastasis (MI) present challenges."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0B8-01Z-00-DX1.380ABAE9-EA83-4E9B-BFB2-6476A86C1ADD-1",
    "image": "TCGA-BRCA/TCGA-BH-A0B8-01Z-00-DX1.380ABAE9-EA83-4E9B-BFB2-6476A86C1ADD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating ductal carcinoma with a Nottingham histologic score of 6/9, TNM staging of T1BN0M0 (I-), and IHC results showing positive estrogen and progesterone receptors with weakly positive HER-2/neu (Score 2+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The intermediate histologic score, low TNM stage, and positivity for hormone receptors indicate that the cancer is likely to respond well to hormonal therapies, and the weakly positive HER-2/neu suggests a relatively lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1EV-01Z-00-DX1.106CF220-1D7D-40DD-88B2-A7F00B758F8F-1",
    "image": "TCGA-BRCA/TCGA-BH-A1EV-01Z-00-DX1.106CF220-1D7D-40DD-88B2-A7F00B758F8F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating and intraductal carcinoma, TNM staging of M0T3N1B, and IHC results showing positive c-erbB2 (HER-2/Neu) with a score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T3N1B indicates a larger tumor size and some lymph node involvement, while the positive HER-2/Neu status suggests a more aggressive cancer subtype."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15O-01Z-00-DX1.4D0F3975-93EA-4DC2-AD0C-A76A24C3AE0C-1",
    "image": "TCGA-BRCA/TCGA-E2-A15O-01Z-00-DX1.4D0F3975-93EA-4DC2-AD0C-A76A24C3AE0C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of Scarff-Bloom-Richardson Grade 2 invasive ductal carcinoma, TNM staging of M0T1CNX, and IHC results showing ER and PR positive, with HER2 negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low tumor size (T1), positive hormone receptor status, and absence of detectable metastasis (M0) suggest favorable outcomes, though node status (NX) is not specified."
      }
    ]
  },
  {
    "id": "TCGA-AC-A3QP-01Z-00-DX1.4B97E53E-1069-40C5-A062-C988663B37DD-1",
    "image": "TCGA-BRCA/TCGA-AC-A3QP-01Z-00-DX1.4B97E53E-1069-40C5-A062-C988663B37DD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of Grade 2 invasive lobular carcinoma with TNM staging of MXT2N1MI and IHC results showing variable Cytokeratin 7/E3 expression in sentinel lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate grade, combined with lymph node involvement (N1) and distant metastasis indicator (MI), suggests a more challenging disease course despite the limited IHC positivity."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SD-01Z-00-DX1.DB17BFA9-D951-42A8-91D2-F4C2EBC6EB9F-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SD-01Z-00-DX1.DB17BFA9-D951-42A8-91D2-F4C2EBC6EB9F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, grade 2 SBR total score 6, TNM staging M0T2N0, and IHC showing positive estrogen and progesterone receptors with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The moderate grade and absence of lymph node involvement, combined with strong hormone receptor positivity, suggest effective hormone therapy options, and the negative HER2/neu indicates a less aggressive cancer type."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15H-01Z-00-DX1.E3A9DFDC-204D-4F03-98D9-97BBBB74E840-1",
    "image": "TCGA-BRCA/TCGA-E2-A15H-01Z-00-DX1.E3A9DFDC-204D-4F03-98D9-97BBBB74E840.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR Grade 2, TNM staging M0T1CN1MI, and IHC results showing positive ER, PR, and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The intermediate grade and lymph node involvement suggest a more cautious outlook, but the positive hormonal receptors and HER2 positivity provide targeted therapy options that may effectively manage the disease."
      }
    ]
  },
  {
    "id": "TCGA-E9-A54X-01Z-00-DX1.9BF3DE15-FA5A-459D-9B2E-8EB92F34228D-1",
    "image": "TCGA-BRCA/TCGA-E9-A54X-01Z-00-DX1.9BF3DE15-FA5A-459D-9B2E-8EB92F34228D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated (G2) mucinous carcinoma, TNM staging of T1BN0 (I-), and IHC results showing high positivity for estrogen and progesterone receptors, negative HER-2/neu reaction, and a Ki67 index of 12%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated cancer (G2), early TNM stage (T1BN0), high positivity for hormone receptors, and low Ki67 index indicate a less aggressive disease profile with favorable response to hormonal therapies."
      }
    ]
  },
  {
    "id": "TCGA-A7-A0CG-01Z-00-DX1.D77019C2-96B1-4EF5-A61E-5F2D5B8D9852-1",
    "image": "TCGA-BRCA/TCGA-A7-A0CG-01Z-00-DX1.D77019C2-96B1-4EF5-A61E-5F2D5B8D9852.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating ductal carcinoma and lobular carcinoma with an overall grade of 1, TNM staging of M0T2N0, and positive Pankeratin on sentinel lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low overall grade (1) and absence of lymph node metastasis or distant spread (N0, M0) suggest a favorable outlook, despite the tumor size (T2)."
      }
    ]
  },
  {
    "id": "TCGA-A7-A0CG-01Z-00-DX2.81138E90-373A-4C12-B9CA-6EEF5F84A5B5-1",
    "image": "TCGA-BRCA/TCGA-A7-A0CG-01Z-00-DX2.81138E90-373A-4C12-B9CA-6EEF5F84A5B5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of infiltrating ductal carcinoma and lobular carcinoma with an overall grade of 1, TNM staging of M0T2N0, and positive Pankeratin on sentinel lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low overall grade (1) and absence of lymph node metastasis or distant spread (N0, M0) suggest a favorable outlook, despite the tumor size (T2)."
      }
    ]
  },
  {
    "id": "TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C-1",
    "image": "TCGA-BRCA/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of infiltrating pleomorphic lobular carcinoma, TNM staging of T2N0M0, and IHC results showing negative for estrogen receptor, progesterone receptor, and HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The infiltrating pleomorphic lobular carcinoma type, combined with the lack of positivity for hormone receptors and HER-2/neu, limits effective targeted therapy options, contributing to a more challenging treatment landscape."
      }
    ]
  },
  {
    "id": "TCGA-WT-AB44-01Z-00-DX1.B6ECEA7C-DA26-4B34-88CE-6834631DFA35-1",
    "image": "TCGA-BRCA/TCGA-WT-AB44-01Z-00-DX1.B6ECEA7C-DA26-4B34-88CE-6834631DFA35.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of moderately differentiated invasive lobular carcinoma, TNM staging MXT1CN0 (I-), and IHC findings with negative pancytokeratin and diagnosis-supported smooth muscle myosin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally intermediate. The moderately differentiated tumor (NHG2) and TNM stage indicating some local advancement (T1C) without confirmed distant metastasis suggest a balanced risk profile."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1F2-01Z-00-DX1.17E2FD6F-0DCF-425B-864B-21ADCDAE734B-1",
    "image": "TCGA-BRCA/TCGA-BH-A1F2-01Z-00-DX1.17E2FD6F-0DCF-425B-864B-21ADCDAE734B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of invasive ductal carcinoma, TNM staging of T4bN1bM0, and IHC results showing HER2 positivity (Score 3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The advanced tumor size and regional lymph node involvement (T4bN1b) indicate an aggressive disease, despite HER2 positivity allowing for targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A13Y-01Z-00-DX1.02321E77-A11E-41A5-95FE-BB897EA5CE58-1",
    "image": "TCGA-BRCA/TCGA-D8-A13Y-01Z-00-DX1.02321E77-A11E-41A5-95FE-BB897EA5CE58.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 (NHG 3), TNM staging of T1CN0M0, and IHC results showing 10-75% positivity for estrogen and progesterone receptors with negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG 3) suggests aggressive tumor behavior, which is not fully offset by the intermediate hormone receptor positivity and negative HER2 status. Although the TNM stage is low, the high grade remains a significant prognostic concern."
      }
    ]
  },
  {
    "id": "TCGA-D8-A13Y-01Z-00-DX2.0043D2BB-B04D-4A44-AAB1-1CAAD97AC246-1",
    "image": "TCGA-BRCA/TCGA-D8-A13Y-01Z-00-DX2.0043D2BB-B04D-4A44-AAB1-1CAAD97AC246.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 (NHG 3), TNM staging of T1CN0M0, and IHC results showing 10-75% positivity for estrogen and progesterone receptors with negative HER2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade (NHG 3) suggests aggressive tumor behavior, which is not fully offset by the intermediate hormone receptor positivity and negative HER2 status. Although the TNM stage is low, the high grade remains a significant prognostic concern."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SJ-01Z-00-DX1.C196FA66-C376-4016-86BC-3D8E745B3A51-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SJ-01Z-00-DX1.C196FA66-C376-4016-86BC-3D8E745B3A51.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of Nottingham grade III invasive ductal carcinoma, TNM staging of T3N1M0, and IHC results showing positive estrogen and progesterone receptors with indeterminate HER2/neu status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade and TNM staging with lymph node involvement indicate aggressive disease, though positive hormone receptors provide some favorable treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AC-A5XS-01Z-00-DX1.E5F2481E-9314-4B20-84B7-370EF82AF4BB-1",
    "image": "TCGA-BRCA/TCGA-AC-A5XS-01Z-00-DX1.E5F2481E-9314-4B20-84B7-370EF82AF4BB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive lobular carcinoma, Nottingham grade 1, TNM staging of MXT2N0, and IHC results showing positive hormone receptors and negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The low-grade cancer, absence of lymph node involvement, and positive hormone receptors suggest favorable treatment responses, while negative HER2 indicates a lower risk of aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1EX-01Z-00-DX1.16B6A817-6729-446E-9FCF-A4A333C5295D-1",
    "image": "TCGA-BRCA/TCGA-BH-A1EX-01Z-00-DX1.16B6A817-6729-446E-9FCF-A4A333C5295D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated ductal carcinoma, Nottingham Histologic Grade 2 (NHG2), TNM staging of T2N1M0, and IHC results showing moderate positivity for estrogen and progesterone receptors with HER-2/neu score of 2+, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The moderately differentiated status and TNM stage with some lymph node involvement (N1) suggest an intermediate-level aggressiveness of the disease, while hormone receptor positivity provides some therapeutic options. The HER-2/neu score of 2+ indicates an equivocal status, which might require further assessment for targeted therapy suitability."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SM-01Z-00-DX1.AD503DBD-4D93-4476-B467-F091254FDF78-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SM-01Z-00-DX1.AD503DBD-4D93-4476-B467-F091254FDF78.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of grade 2 invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing low positivity for estrogen receptors, negative progesterone receptors, and positive HER2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate grade and presence of HER2/neu overexpression, despite low hormone receptor positivity, indicate a possibly more aggressive cancer behavior that necessitates specific targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1FB-01Z-00-DX1.9D778D1A-07F6-450D-B7AA-0E17B4D0A88C-1",
    "image": "TCGA-BRCA/TCGA-BH-A1FB-01Z-00-DX1.9D778D1A-07F6-450D-B7AA-0E17B4D0A88C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma cribriform type, Nottingham Histologic Grade 2, TNM staging of T2N1M0, and pending IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderate grade (NHG2) and TNM staging showing lymph node involvement (N1) indicate a need for close assessment once immunohistochemistry results are available to provide additional prognostic details."
      }
    ]
  },
  {
    "id": "TCGA-E2-A10B-01Z-00-DX1.148CFC4B-EE65-4A7E-918F-10C72F37CB0F-1",
    "image": "TCGA-BRCA/TCGA-E2-A10B-01Z-00-DX1.148CFC4B-EE65-4A7E-918F-10C72F37CB0F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR Grade 3, TNM staging of M0T2N1A, and IHC results showing ER and PR positivity with an equivocal HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) and TNM staging indicating lymph node involvement (N1) suggest a more aggressive disease, despite strong positivity for hormone receptors, which is favorable. The equivocal HER2 status adds uncertainty regarding the potential effectiveness of HER2-targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338-1",
    "image": "TCGA-BRCA/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive ductal carcinoma, SBR Grade 3, with a TNM staging of M0T1CN1MI and varied IHC results showing both negative and positive hormone receptor statuses as well as equivocal HER-2 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high Grade 3 indicates a more aggressive tumor, and the presence of lymph node involvement (N1) suggests some degree of metastasis. Additionally, the mixed hormone receptor statuses and equivocal HER-2 expression complicate the predictive assessment for treatment efficacy."
      }
    ]
  },
  {
    "id": "TCGA-AC-A6NO-01Z-00-DX1.61B7F48C-6D6E-4C1B-B236-DD130ECBDA9D-1",
    "image": "TCGA-BRCA/TCGA-AC-A6NO-01Z-00-DX1.61B7F48C-6D6E-4C1B-B236-DD130ECBDA9D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of intermediate grade multifocal invasive ductal carcinoma, TNM staging of MXT2N1A, and IHC results showing high positivity for estrogen and progesterone receptors with negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The intermediate grade and TNM staging indicating significant primary tumor size (T2) with lymph node involvement (N1) suggest a more aggressive disease. However, the positive hormone receptors provide some favorable treatment options with hormonal therapy."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y2-01Z-00-DX2.A563ABFE-18DE-4D78-BB66-9CD18D3CBE3A-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y2-01Z-00-DX2.A563ABFE-18DE-4D78-BB66-9CD18D3CBE3A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 (NHG3), TNM staging of MXT2N0, and IHC results showing high estrogen receptor positivity, low progesterone receptor positivity, and no HER-2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade nature (NHG3), the TNM staging indicating primary tumor size without metastasis information (MX), and the mixed hormone receptor status, along with the absence of HER-2 gene amplification, are indicative of a more aggressive disease with limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y2-01Z-00-DX1.77451A0F-00FD-44A9-A0D0-CB7A39CE74CC-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y2-01Z-00-DX1.77451A0F-00FD-44A9-A0D0-CB7A39CE74CC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3 (NHG3), TNM staging of MXT2N0, and IHC results showing high estrogen receptor positivity, low progesterone receptor positivity, and no HER-2 gene amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade nature (NHG3), the TNM staging indicating primary tumor size without metastasis information (MX), and the mixed hormone receptor status, along with the absence of HER-2 gene amplification, are indicative of a more aggressive disease with limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1FE-01Z-00-DX1.8FB57ECF-350B-44E4-8612-63E8374D3C4B-1",
    "image": "TCGA-BRCA/TCGA-BH-A1FE-01Z-00-DX1.8FB57ECF-350B-44E4-8612-63E8374D3C4B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with poor nuclear and histologic grade, TNM staging of T2N1M0, and IHC results showing negative ER, PR, and HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade features, TNM stage indicating lymph node involvement (N1), and triple-negative receptor status suggest a more aggressive cancer with limited hormone or targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-AO-A12A-01Z-00-DX1.4E9609A7-9AAD-40A8-8344-8369DF998006-1",
    "image": "TCGA-BRCA/TCGA-AO-A12A-01Z-00-DX1.4E9609A7-9AAD-40A8-8344-8369DF998006.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing 99% positivity for estrogen receptors, 30% positivity for progesterone receptors, and negative MENZ/RO, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The absence of metastasis (M0), no lymph node involvement (N0), and strong estrogen receptor positivity suggest favorable outcomes with hormonal therapy despite the intermediate tumor size (T2) and partial progesterone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-E2-A156-01Z-00-DX1.CEF32B4D-A676-4230-992D-45A046E4043A-1",
    "image": "TCGA-BRCA/TCGA-E2-A156-01Z-00-DX1.CEF32B4D-A676-4230-992D-45A046E4043A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of invasive ductal carcinoma, SBR Grade 2, TNM staging of M0T1CN0, and IHC results showing positive ER and PR with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low TNM stage, positive hormone receptors, and negative HER2 suggest a less aggressive cancer with effective hormone therapy options and a lower risk of metastasis."
      }
    ]
  },
  {
    "id": "TCGA-A7-A13H-01Z-00-DX2.6C937651-4D3E-475D-99F6-4A9FD25CD48B-1",
    "image": "TCGA-BRCA/TCGA-A7-A13H-01Z-00-DX2.6C937651-4D3E-475D-99F6-4A9FD25CD48B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of infiltrating lobular carcinoma, histologic grade 2, TNM staging of T2N1MX, and positive hormone receptors with equivocal HER2/neu status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The grade 2 tumor and lymph node involvement (N1) present an intermediate risk. Positive hormone receptors may allow effective hormonal therapy, while equivocal HER2/neu requires further testing to determine additional treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A7-A13H-01Z-00-DX1.FCB33A3C-6209-474C-83C1-02551F242937-1",
    "image": "TCGA-BRCA/TCGA-A7-A13H-01Z-00-DX1.FCB33A3C-6209-474C-83C1-02551F242937.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of infiltrating lobular carcinoma, histologic grade 2, TNM staging of T2N1MX, and positive hormone receptors with equivocal HER2/neu status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The grade 2 tumor and lymph node involvement (N1) present an intermediate risk. Positive hormone receptors may allow effective hormonal therapy, while equivocal HER2/neu requires further testing to determine additional treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AO-A12H-01Z-00-DX1.C6CCBD9D-FB41-4F6C-84FB-A43E0A77E696-1",
    "image": "TCGA-BRCA/TCGA-AO-A12H-01Z-00-DX1.C6CCBD9D-FB41-4F6C-84FB-A43E0A77E696.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma with mucinous differentiation, TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with HER-2/neu positivity (3+), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite hormone receptor positivity suggesting responsiveness to hormonal therapy, the HER-2/neu positivity (3+) indicates a more aggressive cancer which generally results in a poorer prognosis, even with no lymph node involvement (N0) and no metastasis (M0)."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5RZ-01Z-00-DX1.6394C05E-1C34-4F4B-8859-F5E961E7EFF9-1",
    "image": "TCGA-BRCA/TCGA-OL-A5RZ-01Z-00-DX1.6394C05E-1C34-4F4B-8859-F5E961E7EFF9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, SBR grade III with high nuclear grade DCIS and central necrosis, TNM staging of MXT1BN0, and IHC results showing weak ER expression in 30% of cells, no PR expression, and Ki-67 proliferation index of 10-20%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high-grade nature (SBR grade III) combined with DCIS with central necrosis, the weak hormone receptor expression, and the intermediate Ki-67 index are indicators of a more aggressive disease course. The pending HER2 status may further influence the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SQ-01Z-00-DX1.36071264-3407-4224-BCBB-2ED00294569A-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SQ-01Z-00-DX1.36071264-3407-4224-BCBB-2ED00294569A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with mucinous features, moderate differentiation, and a total modified Bloom\u2013Richardson score of 6 (grade 2), TNM staging of MXT2N1, and IHC results showing strong positivity for estrogen and progesterone receptors with negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The moderate grade (2), strong hormone receptor positivity, and HER2/neu negativity suggest a good response to hormonal therapies, although the presence of lymph node involvement (N1) indicates a need for more careful disease management."
      }
    ]
  },
  {
    "id": "TCGA-D8-A73U-01Z-00-DX2.91F571C8-303C-463D-952C-263FAA5097DF-1",
    "image": "TCGA-BRCA/TCGA-D8-A73U-01Z-00-DX2.91F571C8-303C-463D-952C-263FAA5097DF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of moderately differentiated invasive ductal carcinoma with a Nottingham Histologic Grade 2 (NHG2), TNM staging of T2N0M0, and immunohistochemistry results showing 75% positivity for estrogen and progesterone receptors, negative HER2, and 15% Ki-67 proliferation index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated status (NHG2), lack of lymph node involvement (N0), and strong hormone receptor positivity suggest favorable treatment responses, while the negative HER2 status and moderate Ki-67 index indicate a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-D8-A73U-01Z-00-DX1.6ECEF7C0-00CC-4AC2-87BD-DBFB6E0DC042-1",
    "image": "TCGA-BRCA/TCGA-D8-A73U-01Z-00-DX1.6ECEF7C0-00CC-4AC2-87BD-DBFB6E0DC042.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of moderately differentiated invasive ductal carcinoma with a Nottingham Histologic Grade 2 (NHG2), TNM staging of T2N0M0, and immunohistochemistry results showing 75% positivity for estrogen and progesterone receptors, negative HER2, and 15% Ki-67 proliferation index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated status (NHG2), lack of lymph node involvement (N0), and strong hormone receptor positivity suggest favorable treatment responses, while the negative HER2 status and moderate Ki-67 index indicate a lower likelihood of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-AC-A3W7-01Z-00-DX1.189BB448-ECBA-4042-8A35-4B787271E8FE-1",
    "image": "TCGA-BRCA/TCGA-AC-A3W7-01Z-00-DX1.189BB448-ECBA-4042-8A35-4B787271E8FE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of grade 1 invasive lobular carcinoma with a cumulative Nottingham score of 5 out of 9, TNM staging of MXT2N1A, and IHC results showing positive estrogen receptors (99-100%), negative progesterone receptors, negative HER2/neu, and an intermediate K-67 proliferative index (11%), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The grade 1 status and high estrogen receptor positivity suggest a better response to hormonal therapy, although lymph node involvement (N1) and an intermediate K-67 index indicate a somewhat increased risk of recurrence."
      }
    ]
  },
  {
    "id": "TCGA-A7-A0CH-01Z-00-DX1.48ADDD0B-527A-404C-B794-7D7D35BF861F-1",
    "image": "TCGA-BRCA/TCGA-A7-A0CH-01Z-00-DX1.48ADDD0B-527A-404C-B794-7D7D35BF861F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, histologic grade 1 (total score of 5 out of 9), TNM staging of T2N0M0 (I-), and IHC results showing negative Keratin (AE1/AE3), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The low histologic grade suggests a slower-growing tumor, and the absence of lymph node involvement (N0) and metastasis (M0) indicate a more favorable outcome, despite the tumor size of T2."
      }
    ]
  },
  {
    "id": "TCGA-A7-A0CH-01Z-00-DX2.81DDF423-FCA8-46CA-83A4-2E80B611844D-1",
    "image": "TCGA-BRCA/TCGA-A7-A0CH-01Z-00-DX2.81DDF423-FCA8-46CA-83A4-2E80B611844D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, histologic grade 1 (total score of 5 out of 9), TNM staging of T2N0M0 (I-), and IHC results showing negative Keratin (AE1/AE3), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The low histologic grade suggests a slower-growing tumor, and the absence of lymph node involvement (N0) and metastasis (M0) indicate a more favorable outcome, despite the tumor size of T2."
      }
    ]
  },
  {
    "id": "TCGA-A2-A04R-01Z-00-DX1.BE3661A3-A2A0-4248-B7D5-D8986E529B6C-1",
    "image": "TCGA-BRCA/TCGA-A2-A04R-01Z-00-DX1.BE3661A3-A2A0-4248-B7D5-D8986E529B6C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated infiltrating ductal carcinoma, TNM staging of T1N0M0, and IHC results showing high positivity for estrogen and progesterone receptors with weak HER2 positivity (2+) but not amplified by FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer is moderately differentiated and at an early stage (T1N0M0), combined with high positivity for hormone receptors, offering effective hormonal therapy options. The weak and non-amplified HER2 status further supports a less aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-AC-A2BM-01Z-00-DX1.162A9FA9-6E61-48BF-B0A5-C6C7640ABD9B-1",
    "image": "TCGA-BRCA/TCGA-AC-A2BM-01Z-00-DX1.162A9FA9-6E61-48BF-B0A5-C6C7640ABD9B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, Nottingham Histologic Grade 3, TNM staging of T2N1MX, and IHC results showing positive estrogen and progesterone receptors with non-amplified HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high histologic grade and lymph node involvement (N1) suggest more aggressive disease, despite positive hormone receptors. The non-amplified HER2 limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15G-01Z-00-DX1.BAA5235E-1022-463B-A852-586ED7CA75FF-1",
    "image": "TCGA-BRCA/TCGA-E2-A15G-01Z-00-DX1.BAA5235E-1022-463B-A852-586ED7CA75FF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive mixed (ductal/lobular) carcinoma, SBR Grade 1, TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low SBR grade, absence of metastatic disease, and positive hormone receptor status suggest that the cancer is less aggressive and likely responsive to hormonal therapies, despite the tumor size."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SK-01Z-00-DX1.A44D70FA-4D96-43F4-9DD7-A61535786297-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SK-01Z-00-DX1.A44D70FA-4D96-43F4-9DD7-A61535786297.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of neuroendocrine carcinoma, large cell type, high grade, SBR grade 3 with a total grade score of 8, TNM staging of M0T2N0 (I-), and IHC results showing patchy positivity for Keratin cocktail, positive CD56 and PAX-5, but negative LCA, Chromogranin, Synaptophysin, and E-Cadherin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade large cell neuroendocrine carcinoma with an SBR grade 3 and a total grade score of 8 indicates a highly aggressive form of cancer, and although the regional lymph nodes are not involved (T2N0), the overall aggressive nature of the tumor contributes to an adverse prognosis."
      }
    ]
  },
  {
    "id": "TCGA-A2-A04U-01Z-00-DX1.06D17357-46A8-4DC3-A22B-2F4EB6EE3F79-1",
    "image": "TCGA-BRCA/TCGA-A2-A04U-01Z-00-DX1.06D17357-46A8-4DC3-A22B-2F4EB6EE3F79.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated, Bloom and Richardson Grade 3 infiltrating ductal carcinoma with a TNM staging of M0T2N0(I+), and IHC results showing negative hormone receptors and HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and lack of hormone receptor positivity, combined with negative HER2 status, suggest aggressive disease with fewer targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-GI-A2C8-01Z-00-DX1.09BD8AC9-645A-4C8B-9B36-77D833BDBA09-1",
    "image": "TCGA-BRCA/TCGA-GI-A2C8-01Z-00-DX1.09BD8AC9-645A-4C8B-9B36-77D833BDBA09.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, TNM staging of MXT4BN0, and IHC results showing positive ER and PR with negative HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high T4 stage indicates advanced local growth, although the absence of lymph node involvement (N0) is favorable. Positive hormone receptor status offers potential treatment avenues, but the overall advanced stage suggests a challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1EY-01Z-00-DX1.25C3DE1F-C702-4959-8DFA-69EF78AD9307-1",
    "image": "TCGA-BRCA/TCGA-BH-A1EY-01Z-00-DX1.25C3DE1F-C702-4959-8DFA-69EF78AD9307.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing HER-2/neu score 0, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately good. The absence of lymph node involvement (N0) and a negative HER-2/neu status indicate a less aggressive disease, despite the moderately differentiated tumor and T2 size."
      }
    ]
  },
  {
    "id": "TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A-1",
    "image": "TCGA-BRCA/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating lobular carcinoma, TNM staging of T2N2M0, and IHC results showing high positivity for estrogen and progesterone receptors, negative HER-2/neu overexpression, and a low Ki-67 index, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T2N2 indicates significant tumor size and notable lymph node involvement, which are concerning factors. However, the high positivity for hormone receptors and low Ki-67 index suggest a less aggressive tumor biology."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SB-01Z-00-DX1.B34C267B-CAAA-4AB6-AD5C-276C26F997A1-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SB-01Z-00-DX1.B34C267B-CAAA-4AB6-AD5C-276C26F997A1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of adenoid cystic carcinoma, histologic grade 1, TNM staging of M0T1CN0, and IHC results with ER positivity and HER2/neu negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The low histologic grade, early TNM stage, and absence of distant metastasis suggest a less aggressive disease, while ER positivity may offer some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E-1",
    "image": "TCGA-BRCA/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of infiltrating ductal carcinoma with TNM staging M0T2N0 (I-) and IHC results showing negative ER, PR, and Her-2/neu but positive B-cell and other markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The lack of hormone receptor status and Her-2/neu negativity limits targeted therapy options, while the presence of other positive markers indicates a potentially atypical, aggressive tumor behavior."
      }
    ]
  },
  {
    "id": "TCGA-LL-A441-01Z-00-DX1.33B13078-BB14-4C42-88A6-7460AD2BCD00-1",
    "image": "TCGA-BRCA/TCGA-LL-A441-01Z-00-DX1.33B13078-BB14-4C42-88A6-7460AD2BCD00.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, poorly differentiated, Nottingham grade 3, TNM staging MXT1CN0, with negative ER and PR status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high-grade, poorly differentiated nature, TNM indicators of unspecified distant metastasis but evident tumor presence, and negative hormone receptor status are associated with aggressive disease and limited hormonal therapy options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0T0-01Z-00-DX1.51F904DA-A4B5-4451-8AEF-58E7EF7651DB-1",
    "image": "TCGA-BRCA/TCGA-A2-A0T0-01Z-00-DX1.51F904DA-A4B5-4451-8AEF-58E7EF7651DB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient\u2019s diagnosis of invasive poorly differentiated ductal adenocarcinoma with a Nottingham Histologic Grade of 3, TNM staging of T2N1M0, and IHC results showing non-amplified HER-2 and negative estrogen and progesterone receptors, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high histologic grade (3), significant TNM stage indicating lymph node involvement (N1), and negative hormone receptor status all point towards a more aggressive disease with fewer treatment options."
      }
    ]
  },
  {
    "id": "TCGA-A2-A4RX-01Z-00-DX1.E2C96C9D-5023-4F41-8CC8-24C6E015B252-1",
    "image": "TCGA-BRCA/TCGA-A2-A4RX-01Z-00-DX1.E2C96C9D-5023-4F41-8CC8-24C6E015B252.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metaplastic carcinoma (carcinosarcoma), TNM staging of T2N0M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the positive hormone receptor status, metaplastic carcinoma tends to be more aggressive and rare, and the T2 stage indicates a larger primary tumor, which complicates the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1EW-01Z-00-DX1.A6A5F9C5-FB97-4DA3-A1EA-1F84BC006681-1",
    "image": "TCGA-BRCA/TCGA-BH-A1EW-01Z-00-DX1.A6A5F9C5-FB97-4DA3-A1EA-1F84BC006681.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma, poorly differentiated, Nottingham Histologic Grade 3 with a total score of 9, TNM staging of M0T2N1B, and IHC results showing positive estrogen receptor, negative progesterone receptor, and weakly positive HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status (NHG3) and TNM staging indicating both tumor size (T2) and some lymph node involvement (N1B) suggest a more aggressive disease, while the hormone receptor status and weak HER-2/neu positivity complicate treatment options."
      }
    ]
  },
  {
    "id": "TCGA-AR-A5QQ-01Z-00-DX1.4185D6D2-498E-4E71-8CB3-EDB4739C6229-1",
    "image": "TCGA-BRCA/TCGA-AR-A5QQ-01Z-00-DX1.4185D6D2-498E-4E71-8CB3-EDB4739C6229.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated metaplastic carcinoma, TNM staging of T3N1M0, pending IHC results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T3N1M0 stage indicates a larger tumor with regional lymph node involvement, suggesting a more advanced disease. The pending IHC results may further clarify hormone receptor status and HER2 involvement, but the current staging itself presents challenges."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SE-01Z-00-DX1.04B09232-C6C4-46EF-AA2C-41D078D0A80A-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SE-01Z-00-DX1.04B09232-C6C4-46EF-AA2C-41D078D0A80A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive carcinoma, mixed ductal and lobular type, with Nottingham Histologic Grade 2 (NHG2), TNM staging of M0T1CN0 (I-), and IHC results showing high positivity for estrogen and progesterone receptors with negative HER2/neu expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated tumor, early TNM stage, and high positivity for hormone receptors suggest favorable outcomes with hormonal therapy, while the negative HER2/neu expression indicates a lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-AC-A3QQ-01Z-00-DX1.86463263-AB12-49FB-8967-D5FD1F7D221A-1",
    "image": "TCGA-BRCA/TCGA-AC-A3QQ-01Z-00-DX1.86463263-AB12-49FB-8967-D5FD1F7D221A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of Grade II invasive lobular carcinoma (Nottingham score 6), TNM staging of MXT1CN0, and IHC results showing high positivity for estrogen and progesterone receptors, positive HER-2 overexpression, and an elevated Ki-67 index of 46%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. While the high positivity for hormone receptors is favorable, the high HER-2 overexpression and elevated Ki-67 index indicate a more aggressive tumor with a higher potential for faster growth and recurrence."
      }
    ]
  },
  {
    "id": "TCGA-E9-A6HE-01Z-00-DX1.97514DBA-9BC0-4554-9A43-99C48C6B953A-1",
    "image": "TCGA-BRCA/TCGA-E9-A6HE-01Z-00-DX1.97514DBA-9BC0-4554-9A43-99C48C6B953A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive lobular carcinoma, pleomorphic type, with TNM staging of MXT3N3 and IHC results showing strong positivity for estrogen and progesterone receptors and negative HER-2/neu amplification, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T3N3) indicates a large tumor size with extensive lymph node involvement, while the pleomorphic type is typically more aggressive. Despite the hormone receptor positivity, the negative HER-2/neu amplification limits some treatment options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A150-01Z-00-DX1.55643D23-83E6-4058-8EA5-18AAA8547839-1",
    "image": "TCGA-BRCA/TCGA-E2-A150-01Z-00-DX1.55643D23-83E6-4058-8EA5-18AAA8547839.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of SBR Grade 3 invasive ductal carcinoma, TNM staging of T2N0M0, and IHC results showing negative estrogen and progesterone receptors (Allred Score: 0), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high SBR grade (3) indicates a more aggressive cancer, and the TNM staging (T2N0M0) denotes a tumor of substantial size without lymph node involvement. Additionally, the lack of hormone receptor positivity limits effective hormonal treatment options, contributing to a poorer prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BH-A5J0-01Z-00-DX1.73CFBC85-8449-48FF-86F8-D4D49A90498B-1",
    "image": "TCGA-BRCA/TCGA-BH-A5J0-01Z-00-DX1.73CFBC85-8449-48FF-86F8-D4D49A90498B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, Nottingham Grade 2, TNM staging of T1CN0, and IHC results showing positive estrogen receptor with weakly positive progesterone receptor and negative HER-2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The intermediate grade, low TNM stage, and hormone receptor positivity suggest responsiveness to hormonal therapies, while negative HER-2/neu indicates a lower risk of aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SP-01Z-00-DX1.20D689C6-EFA5-4694-BE76-24475A89ACC0-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SP-01Z-00-DX1.20D689C6-EFA5-4694-BE76-24475A89ACC0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIn the case of invasive ductal carcinoma grade 3, with TNM staging M0T2N0 and negative results for estrogen, progesterone receptors, and HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high grade and lack of hormone receptor and HER2/neu expression, coupled with T2 staging, suggest a more aggressive cancer type with fewer treatment options available."
      }
    ]
  },
  {
    "id": "TCGA-A2-A04N-01Z-00-DX1.9E9B7DB0-1CF1-4631-8292-A9DBCA0BD37C-1",
    "image": "TCGA-BRCA/TCGA-A2-A04N-01Z-00-DX1.9E9B7DB0-1CF1-4631-8292-A9DBCA0BD37C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the diagnosis of moderately differentiated invasive ductal carcinoma with a Bloom-Richardson score of 6, TNM staging of T1CN0M0, and strongly positive ER/PR with non-amplified HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The moderately differentiated status, low TNM stage with no lymph node involvement, and strong ER/PR positivity suggest effective hormonal therapy options and a lower risk of aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y3-01Z-00-DX1.8AA5F695-A06C-4DEA-AD71-16254A48B218-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y3-01Z-00-DX1.8AA5F695-A06C-4DEA-AD71-16254A48B218.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with massive vascular invasion, a Nottingham grade of 3, TNM staging of MXT2N2A, and IHC results showing high hormone receptor positivity with uncertain HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high Nottingham grade, significant lymph node involvement (N2), and massive vascular invasion suggest aggressive disease, despite high hormone receptor positivity. The uncertain HER2 status adds complexity."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA-1",
    "image": "TCGA-BRCA/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive ductal carcinoma with massive vascular invasion, a Nottingham grade of 3, TNM staging of MXT2N2A, and IHC results showing high hormone receptor positivity with uncertain HER2 status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high Nottingham grade, significant lymph node involvement (N2), and massive vascular invasion suggest aggressive disease, despite high hormone receptor positivity. The uncertain HER2 status adds complexity."
      }
    ]
  },
  {
    "id": "TCGA-E2-A15R-01Z-00-DX1.B58D2D9D-05EE-4D66-8DC0-9E5C6AD2E3D3-1",
    "image": "TCGA-BRCA/TCGA-E2-A15R-01Z-00-DX1.B58D2D9D-05EE-4D66-8DC0-9E5C6AD2E3D3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive ductal carcinoma, SBR Grade 2, TNM staging of M0T1CN1A, and IHC results showing positive estrogen and progesterone receptors with negative HER2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderately favorable. The medium grade (SBR Grade 2) and early tumor size (T1) are positive factors, while the lymph node involvement (N1A) and hormone receptor positivity suggest that hormonal therapy could be effective, although the negative HER2 status limits targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A5IZ-01Z-00-DX1.6C871030-82E1-463E-A67B-976A5F3DCDB2-1",
    "image": "TCGA-BRCA/TCGA-BH-A5IZ-01Z-00-DX1.6C871030-82E1-463E-A67B-976A5F3DCDB2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma, TNM staging of CM0 (I+)T2N1A, and IHC results showing positive estrogen receptor, negative progesterone receptor, and negative HER-2 FISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates moderate tumor size (T2) and regional lymph node involvement (N1), both of which contribute to a worse prognosis, while the mixed hormone receptor status and negative HER-2 reduce some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-OL-A5RU-01Z-00-DX1.A48CAF2D-9310-4611-B27D-400F3A324607-1",
    "image": "TCGA-BRCA/TCGA-OL-A5RU-01Z-00-DX1.A48CAF2D-9310-4611-B27D-400F3A324607.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated invasive ductal carcinoma with ductal carcinoma in situ (SBR Grade 2, 6/9), TNM staging of MXT1CN1, and IHC results with strong positive expression for ER and PR receptors, and non-amplified HER2/neu, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is intermediate. The moderately differentiated status and lymph node involvement (N1) suggest a somewhat aggressive disease, but the strong positive expression of hormone receptors and non-amplified HER2/neu indicate potentially effective hormonal therapy options, balancing the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-E2-A10C-01Z-00-DX1.29A2B20B-29C6-4491-ADAB-0584C772EF25-1",
    "image": "TCGA-BRCA/TCGA-E2-A10C-01Z-00-DX1.29A2B20B-29C6-4491-ADAB-0584C772EF25.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive ductal carcinoma with SBR Grade 3, TNM staging of T2N1M0, and IHC results showing ER and PR positivity but HER2 negativity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The high grade (SBR Grade 3) and TNM staging with lymph node involvement (N1) suggest a more aggressive disease, although hormone receptor positivity provides some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1FC-01Z-00-DX1.B816A21B-1559-42F5-902A-A1532E59C015-1",
    "image": "TCGA-BRCA/TCGA-BH-A1FC-01Z-00-DX1.B816A21B-1559-42F5-902A-A1532E59C015.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of poorly differentiated infiltrating medullary carcinoma, TNM staging of T1N1M0, and IHC results showing positive estrogen and progesterone receptors with negative HER-2/neu overexpression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated nature and lymph node involvement (N1) suggest a more aggressive disease, despite the positive hormone receptors offering some therapeutic options."
      }
    ]
  },
  {
    "id": "TCGA-E2-A159-01Z-00-DX1.C8DC3356-CAE9-4E7A-AEFF-ABB4BE38192B-1",
    "image": "TCGA-BRCA/TCGA-E2-A159-01Z-00-DX1.C8DC3356-CAE9-4E7A-AEFF-ABB4BE38192B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith a diagnosis of SBR grade 3 invasive ductal carcinoma with necrosis and lymphoid infiltrate, TNM staging of T2N0M0, and IHC results showing triple negative status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high SBR grade, absence of hormone receptors, and triple negative status suggest a more aggressive cancer that lacks targeted hormone therapies, despite no lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-DT-5265-01Z-00-DX1.563f09af-8bbe-45cd-9c6d-85a96255e67f-1",
    "image": "TCGA-READ/TCGA-DT-5265-01Z-00-DX1.563f09af-8bbe-45cd-9c6d-85a96255e67f.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of leiomyosarcoma, TNM staging of T3N0M0, and IHC results showing negativity for ER, PR, HER-2/neu, and various other markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Leiomyosarcoma at T3 indicates a large tumor size, and the lack of hormone receptor positivity limits potential targeted therapies, which is generally associated with a more challenging treatment scenario."
      }
    ]
  },
  {
    "id": "TCGA-DC-6683-01Z-00-DX1.e1324f2d-db88-4416-adff-fffd9b361326-1",
    "image": "TCGA-READ/TCGA-DC-6683-01Z-00-DX1.e1324f2d-db88-4416-adff-fffd9b361326.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of moderately differentiated adenocarcinoma, TNM staging of T3N1bM0, and IHC results showing staining present for MLH1, MSH2, MSH6, and PMS2 in the tumor, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicating a locally advanced tumor with regional lymph node involvement (N1b) outweighs the moderately differentiated status and intact mismatch repair proteins, suggesting a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-DC-6155-01Z-00-DX1.1a582653-3865-42d5-bf6c-2a05126e90ef-1",
    "image": "TCGA-READ/TCGA-DC-6155-01Z-00-DX1.1a582653-3865-42d5-bf6c-2a05126e90ef.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma, TNM staging of T2N1bM0, and IHC results showing positive staining for MLH1, MSH2, MSH6, and PMS2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a primary tumor with regional lymph node involvement (N1b), which suggests a more advanced disease. However, positive staining for MLH1, MSH2, MSH6, and PMS2 indicates proficiency in mismatch repair proteins, which is generally a favorable molecular feature."
      }
    ]
  },
  {
    "id": "TCGA-AH-6544-01Z-00-DX1.bdb13901-92a8-48ed-aaa0-a6cf476b7ee9-1",
    "image": "TCGA-READ/TCGA-AH-6544-01Z-00-DX1.bdb13901-92a8-48ed-aaa0-a6cf476b7ee9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T3N1M1, and IHC results showing normal expression of hMLH1, hMSH2, hMSH6, and hPMS2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with distant metastasis (M1) and lymph node involvement (N1) indicates a more aggressive disease and a lower likelihood of favorable outcomes despite the normal mismatch repair protein expression."
      }
    ]
  },
  {
    "id": "TCGA-DC-4745-01Z-00-DX1.f5aa77b0-aa9b-4f0c-a007-5d507daed69a-1",
    "image": "TCGA-READ/TCGA-DC-4745-01Z-00-DX1.f5aa77b0-aa9b-4f0c-a007-5d507daed69a.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated adenocarcinoma, TNM staging of T3N1M0, and IHC results showing absent MLH1 and PMS2 staining with present MSH2 and MSH6 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status combined with TNM staging indicating lymph node involvement (N1) and the absence of MLH1 and PMS2, which is associated with mismatch repair deficiency, suggest a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-SN-A84X-01Z-00-DX1.52C9004C-E88F-47EC-AFBA-08A5872B62CA-1",
    "image": "TCGA-TGCT/TCGA-SN-A84X-01Z-00-DX1.52C9004C-E88F-47EC-AFBA-08A5872B62CA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of a mixed germ cell tumor consisting of embryonal carcinoma, yolk sac tumor, mature teratoma, immature teratoma, and seminoma, TNM staging of T2M0NX, and IHC result indicating CD117 highlighting the seminomatous component, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The mixed histology and T2 stage indicate a more complex and potentially aggressive disease, while the seminomatous component that is CD117 positive can be responsive to radiation and chemotherapy."
      }
    ]
  },
  {
    "id": "TCGA-SN-A84X-01Z-00-DX2.6E86250D-DD50-4925-9935-B5A7A6AD25B8-1",
    "image": "TCGA-TGCT/TCGA-SN-A84X-01Z-00-DX2.6E86250D-DD50-4925-9935-B5A7A6AD25B8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of a mixed germ cell tumor consisting of embryonal carcinoma, yolk sac tumor, mature teratoma, immature teratoma, and seminoma, TNM staging of T2M0NX, and IHC result indicating CD117 highlighting the seminomatous component, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. The mixed histology and T2 stage indicate a more complex and potentially aggressive disease, while the seminomatous component that is CD117 positive can be responsive to radiation and chemotherapy."
      }
    ]
  },
  {
    "id": "TCGA-SN-A84Y-01Z-00-DX1.B0B2C279-EBA0-45E9-9798-A30C7424FCEC-1",
    "image": "TCGA-TGCT/TCGA-SN-A84Y-01Z-00-DX1.B0B2C279-EBA0-45E9-9798-A30C7424FCEC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of a mixed germ cell tumor, TNM staging of T2M0NX, and IHC results showing strong staining for CD117, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T2 stage indicates that the tumor is of a significant size and/or has local extension, and the CD117 positivity is common in more aggressive germ cell tumors, although metastasis has not been assessed (NX)."
      }
    ]
  },
  {
    "id": "TCGA-XY-A8S3-01Z-00-DX1.18AA1B33-C612-4EBD-BE4A-8BA78139E722-1",
    "image": "TCGA-TGCT/TCGA-XY-A8S3-01Z-00-DX1.18AA1B33-C612-4EBD-BE4A-8BA78139E722.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of mixed germ cell tumor with TNM staging of T2M0NX and IHC results highlighting embryonal carcinoma, yolk sac tumor, and small foci of choriocarcinoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2 staging indicates a tumor that is moderately advanced, and the presence of multiple aggressive tumor components such as embryonal carcinoma and choriocarcinoma suggests a higher risk of poor outcomes."
      }
    ]
  },
  {
    "id": "TCGA-XE-A8H1-01Z-00-DX1.75D3D52F-4C79-463C-99D2-4E43F1B8DEC6-1",
    "image": "TCGA-TGCT/TCGA-XE-A8H1-01Z-00-DX1.75D3D52F-4C79-463C-99D2-4E43F1B8DEC6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of embryonal carcinoma, TNM staging of T2M0NX, and IHC results showing positive Pancytokeratin (AE1/AE3), CD30, and PLAP with negative hCG, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Embryonal carcinoma is an aggressive type of testicular cancer, and the T2 stage indicates greater tumor extension beyond the testis, potentially involving blood or lymphatic vessels, suggesting a more challenging prognosis despite no distant metastasis detected."
      }
    ]
  },
  {
    "id": "TCGA-XE-AAO6-01Z-00-DX1.C4176415-F3D2-4E37-88F9-59F7656AB5E6-1",
    "image": "TCGA-TGCT/TCGA-XE-AAO6-01Z-00-DX1.C4176415-F3D2-4E37-88F9-59F7656AB5E6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of seminoma, TNM staging of T1M0NX, and IHC results showing negative HCG and negative CAM 5.2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The T1 stage indicates the tumor is limited to the testis without metastasis, and seminomas typically have a favorable response to treatment options despite the incomplete nodal information (NX)."
      }
    ]
  },
  {
    "id": "TCGA-S6-A8JX-01Z-00-DX1.C44E5FBF-10BA-43C4-980C-C6280B9ECFE9-1",
    "image": "TCGA-TGCT/TCGA-S6-A8JX-01Z-00-DX1.C44E5FBF-10BA-43C4-980C-C6280B9ECFE9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of seminoma, TNM staging of T2M0NX, and IHC results showing positive placental alkaline phosphatase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Seminomas are typically responsive to treatment, and even with a T2 stage, the absence of distant metastasis (M0) and positive placental alkaline phosphatase, a common marker for seminoma, support a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-ZM-AA0E-01Z-00-DX1.D673EF20-56BB-4CBB-96E7-CDE7E38058BF-1",
    "image": "TCGA-TGCT/TCGA-ZM-AA0E-01Z-00-DX1.D673EF20-56BB-4CBB-96E7-CDE7E38058BF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of seminoma, TNM staging of T1M0NX, and IHC results showing CD117 positive and partially PLAP positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. Seminoma generally has a favorable outcome, and early-stage disease (T1) with the presence of CD117 positivity, which is typical for seminomas, suggests better treatment response."
      }
    ]
  },
  {
    "id": "TCGA-ZM-AA05-01Z-00-DX1.906300AF-5585-4921-9711-2F4C5C536CFE-1",
    "image": "TCGA-TGCT/TCGA-ZM-AA05-01Z-00-DX1.906300AF-5585-4921-9711-2F4C5C536CFE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of seminoma, TNM staging of T2M0NX, and IHC results showing PLAP positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Seminomas are highly responsive to treatment, even at T2 staging, and the PLAP positivity supports the diagnosis, which typically correlates with a favorable response to therapy."
      }
    ]
  },
  {
    "id": "TCGA-XE-AAOD-01Z-00-DX1.F78C46BD-FD97-4B34-8100-0D143B9E4CB9-1",
    "image": "TCGA-TGCT/TCGA-XE-AAOD-01Z-00-DX1.F78C46BD-FD97-4B34-8100-0D143B9E4CB9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of mixed germ cell tumor with seminoma and choriocarcinoma elements, TNM staging of T2M0NX, and IHC results showing strong positivity for HCG and CAMS.2 in choriocarcinoma, and cn Kit positivity in seminoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of choriocarcinoma, a more aggressive element, along with a T2 stage indicates a higher risk of advanced disease, despite seminoma typically having a more favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-XE-AAO3-01Z-00-DX1.ADEEB1FA-BA6B-4907-A643-F0F021702C7E-1",
    "image": "TCGA-TGCT/TCGA-XE-AAO3-01Z-00-DX1.ADEEB1FA-BA6B-4907-A643-F0F021702C7E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of seminoma, TNM staging of T2M0NX, and IHC results showing positive PLAP with negative CAM 5.2 and AE1/AE3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Seminomas are typically highly responsive to therapy, and the absence of metastasis (M0) supports a favorable outcome, despite the localized tumor size (T2)."
      }
    ]
  },
  {
    "id": "TCGA-XE-AAOB-01Z-00-DX1.28368FE5-BD13-4225-AA5C-910C3829753A-1",
    "image": "TCGA-TGCT/TCGA-XE-AAOB-01Z-00-DX1.28368FE5-BD13-4225-AA5C-910C3829753A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of mixed germ cell tumor, TNM staging of T1M0NX, and IHC results showing small focal tubular areas of strong positivity for AFP and HCG, and strongly positive CD30 in embryonal carcinoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early-stage (T1) indicates limited local spread, and these tumors generally respond well to treatment despite their mixed composition. The positive markers aid in targeted therapeutic approaches."
      }
    ]
  },
  {
    "id": "TCGA-WZ-A8D5-01Z-00-DX1.652349A8-0C7A-4D0F-AF39-EA1548701F9D-1",
    "image": "TCGA-TGCT/TCGA-WZ-A8D5-01Z-00-DX1.652349A8-0C7A-4D0F-AF39-EA1548701F9D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of a mixed germ cell tumor with TNM staging of T3M0NX and positive CD30 on immunohistochemistry, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor staging (T3) indicates a large primary tumor, and the unknown lymph node involvement (NX) adds uncertainty. Although CD30 positivity can be a favorable marker for treatment response, the overall assessment remains guarded."
      }
    ]
  },
  {
    "id": "TCGA-ZM-AA0N-01Z-00-DX1.22F4C6EB-C784-4493-9DC5-18D5A1DC6CD5-1",
    "image": "TCGA-TGCT/TCGA-ZM-AA0N-01Z-00-DX1.22F4C6EB-C784-4493-9DC5-18D5A1DC6CD5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of seminoma, TNM staging of T2M0NX, and IHC results showing positive PLAP in all tumor cells and in unclassified intratubular germ cell neoplasia, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. Seminomas are generally highly sensitive to radiation and chemotherapy. The T2 staging without metastasis (M0) and the PLAP positivity, which is indicative of seminoma, suggest a favorable response to standard treatments."
      }
    ]
  },
  {
    "id": "TCGA-V5-A7RE-01Z-00-DX1.71360DC3-F66C-4C4D-86CA-7964D56974FB-1",
    "image": "TCGA-ESCA/TCGA-V5-A7RE-01Z-00-DX1.71360DC3-F66C-4C4D-86CA-7964D56974FB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma with areas of ulceration, TNM staging of T1N0M0, and IHC results showing positive p16, positive p53, and 40% Ki-67, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early-stage TNM classification (T1N0M0) favors a better outcome, despite the positive p53 and moderately high Ki-67, which indicate a higher proliferation rate."
      }
    ]
  },
  {
    "id": "TCGA-LN-A49S-01Z-00-DX1.F9A7F5B3-8E02-4873-B193-EB0056AD286C-1",
    "image": "TCGA-ESCA/TCGA-LN-A49S-01Z-00-DX1.F9A7F5B3-8E02-4873-B193-EB0056AD286C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated sarcoma, Grade 2, with TNM staging of T3M0N0, and IHC results showing negative ER, PR, HER-2/neu, B-cell marker, and T-cell marker, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature, high tumor size (T3), and absence of hormone receptors or specific markers contribute to a more aggressive disease and limit targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-LN-A49V-01Z-00-DX1.FD93D99F-F318-4D08-9E0C-CF17455529F3-1",
    "image": "TCGA-ESCA/TCGA-LN-A49V-01Z-00-DX1.FD93D99F-F318-4D08-9E0C-CF17455529F3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma with TNM staging of T3N0M0 and IHC results showing negative for estrogen receptor, progesterone receptor, HER-2/neu, B-cell marker, T-cell marker, and other markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced T stage (T3) and lack of positive hormone or HER-2/neu receptor status suggest a more aggressive cancer with limited targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-JY-A6FB-01Z-00-DX1.8BCAB739-0AEE-41C1-B45B-07C615677DBB-1",
    "image": "TCGA-ESCA/TCGA-JY-A6FB-01Z-00-DX1.8BCAB739-0AEE-41C1-B45B-07C615677DBB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T1N0M0, and IHC results showing positivity for C117 (cKIT) and SMA, but negative for S100, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The cancer's moderate differentiation and early TNM stage (T1N0M0) suggest a less aggressive disease, while the specific IHC results provide useful targets for treatment strategies."
      }
    ]
  },
  {
    "id": "TCGA-JY-A6FE-01Z-00-DX1.BB3951AD-AA8D-4B2A-86E5-E0C4AA90E7AC-1",
    "image": "TCGA-ESCA/TCGA-JY-A6FE-01Z-00-DX1.BB3951AD-AA8D-4B2A-86E5-E0C4AA90E7AC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated squamous cell carcinoma, TNM staging of T3N1M0, and IHC results showing patchy positivity for pan-CK and CK7, and diffuse positivity for p63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status, advanced T3 staging, and lymph node involvement (N1) suggest a more aggressive and challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-LN-A4A2-01Z-00-DX1.41B9C9F4-C350-4FDF-A894-F23DDD6D3898-1",
    "image": "TCGA-ESCA/TCGA-LN-A4A2-01Z-00-DX1.41B9C9F4-C350-4FDF-A894-F23DDD6D3898.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of adenocarcinoma, TNM staging of T3N0M0, and IHC results showing positivity for ER, PR, Her-2/neu, Marker 1, and Marker 2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3 stage indicates a larger tumor size, and Her-2/neu positivity suggests more aggressive disease behavior despite the hormone receptor positivity."
      }
    ]
  },
  {
    "id": "TCGA-LN-A4A5-01Z-00-DX1.375EC417-663F-4E58-9369-C50BD2385C20-1",
    "image": "TCGA-ESCA/TCGA-LN-A4A5-01Z-00-DX1.375EC417-663F-4E58-9369-C50BD2385C20.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of adenocarcinoma with TNM staging of T2N0M0 and all negative immunohistochemistry results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a moderately advanced primary tumor size without lymph node or distant metastasis, but the lack of positive markers in the IHC results suggests limited options for targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-LN-A4MR-01Z-00-DX1.A27F1932-A134-48AE-ACB5-9A1C2EF823A9-1",
    "image": "TCGA-ESCA/TCGA-LN-A4MR-01Z-00-DX1.A27F1932-A134-48AE-ACB5-9A1C2EF823A9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of lymphocytic leukocytoclastic vasculitis, TNM staging of T2N0M0, and the negative immunohistochemistry results for EBV, HBV, HCV, HIV, CA 15-3, CA 19-9, AFP, and PSA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Lymphocytic leukocytoclastic vasculitis with TNM staging T2N0M0 and negative findings for various markers suggest a localized condition without significant involvement of major organs or systemic spread."
      }
    ]
  },
  {
    "id": "TCGA-JY-A939-01Z-00-DX1.BD1BA160-929F-442B-8080-71B2725A7ED1-1",
    "image": "TCGA-ESCA/TCGA-JY-A939-01Z-00-DX1.BD1BA160-929F-442B-8080-71B2725A7ED1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated (G3) adenocarcinoma, TNM staging of T1N1M0, and IHC results showing patchy positivity for CK7, CK20, and CDX2 with negative Chromogranin and Synaptophysin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status (G3) indicates a more aggressive tumor, and the presence of lymph node involvement (N1) suggests a higher likelihood of disease progression."
      }
    ]
  },
  {
    "id": "TCGA-BB-A6UM-01Z-00-DX1.403D4D0A-83F4-4D2F-9CBB-C7A1470AC565-1",
    "image": "TCGA-HNSC/TCGA-BB-A6UM-01Z-00-DX1.403D4D0A-83F4-4D2F-9CBB-C7A1470AC565.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis good or poor for a patient diagnosed with infiltrating squamous cell carcinoma, TNM staging of T1MXN2, and IHC results showing positive p16 and positive HPV16?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Although the T1 stage indicates a small primary tumor and p16 and HPV16 positivity are favorable markers, the N2 stage indicates significant regional lymph node involvement, impacting the overall prognosis negatively."
      }
    ]
  },
  {
    "id": "TCGA-KU-A6H7-01Z-00-DX1.AFBBE7A7-6261-499F-AEC3-31AEFF1AB651-1",
    "image": "TCGA-HNSC/TCGA-KU-A6H7-01Z-00-DX1.AFBBE7A7-6261-499F-AEC3-31AEFF1AB651.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive squamous cell carcinoma, TNM staging of T2N2aM0, and IHC results showing diffuse positivity for p16 in both the cytoplasm and nucleus, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging of T2N2aM0 indicates significant lymph node involvement, which is a factor in a more advanced disease stage, despite the moderately differentiated status and positive p16 expression suggesting HPV-related disease with somewhat better outlook."
      }
    ]
  },
  {
    "id": "TCGA-BA-A8YP-01Z-00-DX1.03B95E63-2639-49F6-B8DD-AC2C2FA872B1-1",
    "image": "TCGA-HNSC/TCGA-BA-A8YP-01Z-00-DX1.03B95E63-2639-49F6-B8DD-AC2C2FA872B1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive moderately differentiated squamous cell carcinoma, TNM staging of T4AN3M0, and IHC results showing negative P16 and high-risk HPV ISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4AN3M0) indicates a large primary tumor with significant lymph node involvement, and the negative P16 and high-risk HPV ISH results suggest fewer potential targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-QK-A8ZA-01Z-00-DX1.D169F19F-99A3-4A8C-9AE8-24C529B2CE12-1",
    "image": "TCGA-HNSC/TCGA-QK-A8ZA-01Z-00-DX1.D169F19F-99A3-4A8C-9AE8-24C529B2CE12.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of moderately differentiated invasive squamous cell carcinoma, TNM staging of T2N2bMX, and IHC results showing strong diffuse positivity for P16, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a larger tumor size with significant regional lymph node involvement, which suggests a higher risk for metastasis, despite the generally favorable indicator of P16 positivity."
      }
    ]
  },
  {
    "id": "TCGA-CN-A63T-01Z-00-DX1.6AF3A8E6-373B-4D7C-AEDC-CFFC3D6E0FE8-1",
    "image": "TCGA-HNSC/TCGA-CN-A63T-01Z-00-DX1.6AF3A8E6-373B-4D7C-AEDC-CFFC3D6E0FE8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated invasive squamous cell carcinoma, TNM staging of T3MXN2B, and IHC results showing numerous positive plasma cells and marked proliferating cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status of the invasive squamous cell carcinoma and the advanced TNM stage (T3MXN2B) indicate a more aggressive disease with significant lymph node involvement and likely systemic spread."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DA-01Z-00-DX1.8BFA179A-8E8A-45DC-A036-77A7D6ABB7EA-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DA-01Z-00-DX1.8BFA179A-8E8A-45DC-A036-77A7D6ABB7EA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive squamous cell carcinoma (moderately differentiated), TNM staging of T4A N2C M0, and IHC results showing positive P16 with negative high-risk HPV (ISH), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4A N2C M0) indicates significant local invasion and extensive lymph node involvement, overshadowing the moderately differentiated status and positive P16 marker."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DF-01Z-00-DX1.AAA638F5-C794-441B-A034-30AD8CC72573-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DF-01Z-00-DX1.AAA638F5-C794-441B-A034-30AD8CC72573.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of moderately differentiated squamous cell carcinoma, TNM staging of T4aN0M0, and IHC results showing weakly positive P16 and negative HR HPV ISH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T4a) indicates a large primary tumor, and the negative HR HPV ISH with only weak P16 positivity suggest fewer favorable molecular features, associated with more aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-H7-A76A-01Z-00-DX1.E4D824E3-2076-4E46-83F8-9BF5283FCDEE-1",
    "image": "TCGA-HNSC/TCGA-H7-A76A-01Z-00-DX1.E4D824E3-2076-4E46-83F8-9BF5283FCDEE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of focally keratinizing squamous cell carcinoma, moderately differentiated, TNM staging of TXMXN2B, and IHC results showing positive p16 and HPV high risk (16/18), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The unknown primary tumor size and metastasis status (TXMX) combined with significant lymph node involvement (N2B) suggest advanced disease. However, the presence of HPV high-risk type can offer some therapeutic benefits."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DI-01Z-00-DX1.4EB42174-5219-43A3-AD93-64446DCE37CF-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DI-01Z-00-DX1.4EB42174-5219-43A3-AD93-64446DCE37CF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive moderately differentiated keratinizing squamous cell carcinoma with TNM staging of TXM0NX, and IHC results showing negative p16 and negative high-risk HPV, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderate differentiation and the negative status for both p16 and high-risk HPV suggest a more aggressive behavior and limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-T2-A6X2-01Z-00-DX1.8A72CC59-D322-4C0B-AD52-ACF91CC3B72F-1",
    "image": "TCGA-HNSC/TCGA-T2-A6X2-01Z-00-DX1.8A72CC59-D322-4C0B-AD52-ACF91CC3B72F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive well-differentiated keratinizing squamous cell carcinoma, TNM staging of T3MXN0, and IHC results showing strong and diffuse positivity for EGFR, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The large tumor size (T3), perineural invasion, and bone involvement together suggest more aggressive disease, despite the lack of lymph node metastasis and strong EGFR positivity."
      }
    ]
  },
  {
    "id": "TCGA-HD-8224-01Z-00-DX1.2b08e329-bb26-4605-bb3b-b257cef561b2-1",
    "image": "TCGA-HNSC/TCGA-HD-8224-01Z-00-DX1.2b08e329-bb26-4605-bb3b-b257cef561b2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of diffusely infiltrating squamous cell carcinoma, TNM staging of T3N2M0, and pending P16 immunostain results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with significant lymph node involvement (N2) and large tumor size (T3) generally indicate a more aggressive disease with a higher risk of poor outcomes."
      }
    ]
  },
  {
    "id": "TCGA-CN-6023-01Z-00-DX1.abfbc2c7-109b-4b72-8645-8e4135d00306-1",
    "image": "TCGA-HNSC/TCGA-CN-6023-01Z-00-DX1.abfbc2c7-109b-4b72-8645-8e4135d00306.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of invasive squamous cell carcinoma, TNM staging of T3N2M0, and IHC results indicating no evidence of additional metastatic papillary thyroid carcinoma with TTF1 and CAM 5.2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T3N2M0) indicates a large primary tumor with significant regional lymph node involvement, which complicates treatment and reduces overall survival chances."
      }
    ]
  },
  {
    "id": "TCGA-CN-6024-01Z-00-DX1.c5791a72-1ded-4723-a33a-68da0685c80b-1",
    "image": "TCGA-HNSC/TCGA-CN-6024-01Z-00-DX1.c5791a72-1ded-4723-a33a-68da0685c80b.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated squamous cell carcinoma, TNM staging of T4AN2M0, and IHC results showing negative p16 and negative HPV status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T4A with significant lymph node involvement N2) and negative HPV status indicate a more aggressive disease and limited response to HPV-related treatment options."
      }
    ]
  },
  {
    "id": "TCGA-F7-A624-01Z-00-DX1.5626052F-EA0A-43E0-B011-43276FA282C5-1",
    "image": "TCGA-HNSC/TCGA-F7-A624-01Z-00-DX1.5626052F-EA0A-43E0-B011-43276FA282C5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of squamous cell carcinoma, TNM staging of T2M0NX, and IHC results indicating positive Vimentin, HMW cytokeratins, CK7, and high Ki-67 index (90%), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The intermediate tumor size (T2) and high Ki-67 index suggest a high proliferative rate, indicating a more aggressive behavior of the carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-QK-A6V9-01Z-00-DX1.0D202E91-5205-4888-A40D-381F7534B34A-1",
    "image": "TCGA-HNSC/TCGA-QK-A6V9-01Z-00-DX1.0D202E91-5205-4888-A40D-381F7534B34A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated squamous cell carcinoma, TNM staging of T2M0NX, and IHC results showing strong p16 positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is cautiously optimistic. The moderately differentiated status and p16 positivity, which often correlates with HPV-associated cancers, generally suggest better responsiveness to treatment, even though complete staging information is pending."
      }
    ]
  },
  {
    "id": "TCGA-CV-A463-01Z-00-DX1.5391495E-FADF-4F35-AA41-17CF8D80E102-1",
    "image": "TCGA-HNSC/TCGA-CV-A463-01Z-00-DX1.5391495E-FADF-4F35-AA41-17CF8D80E102.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive hybrid verrucous and conventional squamous cell carcinoma, TNM staging of T4AM0N0, and IHC results showing strongly positive p53, focal rare positivity for p16, and negative in situ hybridization for high-risk HPV, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4A) indicates extensive local invasion, and the combination of p53 positivity with low p16 positivity and negative high-risk HPV suggests a more aggressive tumor biology."
      }
    ]
  },
  {
    "id": "TCGA-CN-5359-01Z-00-DX1.30a19cad-c2b0-4c5f-bd5d-89aa8ac2bb91-1",
    "image": "TCGA-HNSC/TCGA-CN-5359-01Z-00-DX1.30a19cad-c2b0-4c5f-bd5d-89aa8ac2bb91.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of moderately differentiated squamous cell carcinoma, TNM staging of T4AM0N2B, and IHC results showing positive EGFR and negative P16, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4A and N2B) indicates extensive local invasion and significant lymph node involvement, despite the EGFR positivity, which may provide some targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-4P-AA8J-01Z-00-DX1.5B44796F-D099-4076-9CAF-B40C2B83F432-1",
    "image": "TCGA-HNSC/TCGA-4P-AA8J-01Z-00-DX1.5B44796F-D099-4076-9CAF-B40C2B83F432.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of grade 2 keratinizing squamous cell carcinoma, TNM staging of T2MXN2C, and negative p16 IHC result, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated grade, lymph node involvement (N2), and p16 negativity, which often indicates a non-HPV-related tumor, are associated with a more challenging clinical outlook."
      }
    ]
  },
  {
    "id": "TCGA-RS-A6TP-01Z-00-DX1.C8674492-472E-4EAC-8DBC-B1004C30BD9C-1",
    "image": "TCGA-HNSC/TCGA-RS-A6TP-01Z-00-DX1.C8674492-472E-4EAC-8DBC-B1004C30BD9C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of squamous cell carcinoma, TNM staging of T2N0M0, and IHC results showing strongly and diffusely positive p16 and positive high-risk HPV by in-situ hybridization, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The positive p16 and high-risk HPV status are generally associated with better treatment response and overall outcomes in squamous cell carcinoma, despite the tumor size (T2)."
      }
    ]
  },
  {
    "id": "TCGA-CN-A63W-01Z-00-DX1.57F5E8BA-E352-4AC9-A800-21DF745474B8-1",
    "image": "TCGA-HNSC/TCGA-CN-A63W-01Z-00-DX1.57F5E8BA-E352-4AC9-A800-21DF745474B8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated squamous cell carcinoma, TNM staging of T4AMXN2C, and negative IHC results for p16 and HPV, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4A, N2C) indicates extensive local invasion and significant regional lymph node involvement, and the negative p16 and HPV status are associated with worse outcomes in squamous cell carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DL-01Z-00-DX1.A2E13153-88A9-411B-AA0F-56314E72E2CB-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DL-01Z-00-DX1.A2E13153-88A9-411B-AA0F-56314E72E2CB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of invasive moderately differentiated squamous cell carcinoma, TNM staging of T0N0M0, and IHC results showing negative P16 protein expression and negative high-risk HPV by in situ hybridization, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The TNM staging of T0N0M0 indicates no detectable primary tumor or metastatic spread, which is favorable despite the moderate differentiation and negative HPV status."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DE-01Z-00-DX1.3279D372-4A92-4CFA-9E52-19197934378D-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DE-01Z-00-DX1.3279D372-4A92-4CFA-9E52-19197934378D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive squamous cell carcinoma, TNM staging of T2N0M0, and immunohistochemistry results showing negative P16 and negative HR and HPV ISH status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated status, along with a higher T stage (T2) and negative P16 and HPV ISH status, suggest a more aggressive disease with fewer targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DB-01Z-00-DX1.6EC4113A-D48B-4F83-84EF-1A811C67FDFE-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DB-01Z-00-DX1.6EC4113A-D48B-4F83-84EF-1A811C67FDFE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated invasive keratinizing squamous cell carcinoma, TNM staging of T1N0M0, and IHC results showing negative P16 and HR HPV ISH status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The well-differentiated status and early TNM stage (T1N0M0) suggest a relatively favorable outcome, despite the negative P16 and HR HPV status."
      }
    ]
  },
  {
    "id": "TCGA-CN-A63Y-01Z-00-DX1.27C0793B-B61B-4329-8909-F42D8B50EA24-1",
    "image": "TCGA-HNSC/TCGA-CN-A63Y-01Z-00-DX1.27C0793B-B61B-4329-8909-F42D8B50EA24.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of invasive squamous cell carcinoma, TNM staging of T2MXN0, and IHC results showing positive immunoperoxidase stain for p16 and in-situ hybridization for human Papillomavirus, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The presence of HPV and p16 positivity is typically associated with a better response to treatment and improved survival outcomes in squamous cell carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DD-01Z-00-DX1.5B67DD6F-811C-4DE2-894E-C8FE4CF7FBE7-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DD-01Z-00-DX1.5B67DD6F-811C-4DE2-894E-C8FE4CF7FBE7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated invasive squamous cell carcinoma, TNM staging of T4AM0N2C, and IHC results showing negative P16 and HR HPV, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4AN2C) indicates significant local invasion and lymph node involvement, and the negative P16 and HR HPV status are associated with a less favorable response to treatment."
      }
    ]
  },
  {
    "id": "TCGA-HD-A4C1-01Z-00-DX1.AAE02372-CA5D-463D-937B-B88A1C5321F9-1",
    "image": "TCGA-HNSC/TCGA-HD-A4C1-01Z-00-DX1.AAE02372-CA5D-463D-937B-B88A1C5321F9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of well-differentiated infiltrating squamous cell carcinoma, TNM staging of T4AMXN2B, and IHC results showing negative P16 (HPV surrogate marker), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high TNM stage (T4AN2B) indicates extensive local invasion and significant lymph node involvement, while the negative P16 status suggests the absence of HPV-related, potentially less aggressive tumor behavior."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DJ-01Z-00-DX1.F83A347E-4442-4F06-9715-32E4C4E1A4FA-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DJ-01Z-00-DX1.F83A347E-4442-4F06-9715-32E4C4E1A4FA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of invasive moderately differentiated keratinizing squamous cell carcinoma, TNM staging of T4AM0N2C, and IHC results showing negative p16 and HR HPV ISH status, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T4A, N2c) indicates extensive local invasion and significant lymph node involvement, and the negative p16 and HR HPV ISH status are associated with a less favorable prognosis in squamous cell carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-KO-8413-01Z-00-DX1.592BC1BB-35B9-4CE1-ACD2-76DD4C4FE7A4-1",
    "image": "TCGA-KICH/TCGA-KO-8413-01Z-00-DX1.592BC1BB-35B9-4CE1-ACD2-76DD4C4FE7A4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of chromophobe renal cell carcinoma with Fuhrman's nuclear grade 3, TNM staging of T1N0M0, and IHC results showing focal positivity for Cytokeratin 7 and CD10 with negative Vimentin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The early TNM stage (T1N0M0) indicates localized disease, which is generally associated with better outcomes, despite the higher Fuhrman grade."
      }
    ]
  },
  {
    "id": "TCGA-KO-8406-01Z-00-DX1.F9FDAB2C-9EEC-41D0-A29C-530107B96AC2-1",
    "image": "TCGA-KICH/TCGA-KO-8406-01Z-00-DX1.F9FDAB2C-9EEC-41D0-A29C-530107B96AC2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of chromophobe renal cell carcinoma, TNM staging of T1N0M0, and IHC results showing positive Keratin and EMA with negative CD10, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Chromophobe renal cell carcinoma with a low TNM stage (T1N0M0) typically has a favorable outcome as it is often less aggressive and more responsive to surgical treatment."
      }
    ]
  },
  {
    "id": "TCGA-KO-8411-01Z-00-DX1.57A47A81-003C-4F34-B8FA-D1313114892F-1",
    "image": "TCGA-KICH/TCGA-KO-8411-01Z-00-DX1.57A47A81-003C-4F34-B8FA-D1313114892F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nIs the prognosis good or poor for a patient with chromophobe renal cell carcinoma, Fuhrman's nuclear grade 3, TNM staging of T1BM0NX, and IHC results showing positive CK, negative CD10, and negative Vimentin?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. Chromophobe renal cell carcinoma generally has a favorable outcome, and the T1B stage indicates a localized tumor. However, the uncertain node status (NX) and higher nuclear grade suggest a need for more caution."
      }
    ]
  },
  {
    "id": "TCGA-KO-8416-01Z-00-DX1.AA58FA3E-02A6-4696-A4F6-2B11C5B0C0E8-1",
    "image": "TCGA-KICH/TCGA-KO-8416-01Z-00-DX1.AA58FA3E-02A6-4696-A4F6-2B11C5B0C0E8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of renal cell carcinoma, chromophobe type, Fuhrman Grade 3, TNM staging of T3A N0 M0, and IHC results showing positive Cytokeratin 7, CD117, and weak diffuse cytoplasmic positivity for CD10, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The Fuhrman Grade 3 indicates a higher grade tumor, and T3A staging suggests an advanced local disease. These factors generally lead to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-KO-8417-01Z-00-DX1.E145D87F-24DC-4336-98BD-2D142079D73D-1",
    "image": "TCGA-KICH/TCGA-KO-8417-01Z-00-DX1.E145D87F-24DC-4336-98BD-2D142079D73D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of chromophobe renal cell carcinoma (RCC), TNM staging of T1M0N0, and IHC results showing positive CKT and c-kit, partially positive AMACR, and negative vimentin and CD10, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early-stage tumor (T1M0N0) and favorable histological subtype (chromophobe RCC) are associated with a typically less aggressive behavior and better outcomes."
      }
    ]
  },
  {
    "id": "TCGA-KO-8405-01Z-00-DX1.DB2F9FFE-B562-4D52-A4DF-E939DE99B5F7-1",
    "image": "TCGA-KICH/TCGA-KO-8405-01Z-00-DX1.DB2F9FFE-B562-4D52-A4DF-E939DE99B5F7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of chromophobe renal cell carcinoma, eosinophilic type, with a TNM staging of T3aN0M0, and immunohistochemistry results showing strong positivity for Cytokeratin 7, negative Vimentin, and predominantly cytoplasmic and focally membranous CD10 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3a stage indicates local advancement of the tumor, which complicates treatment and tends to be associated with a lower overall survival rate compared to earlier stages."
      }
    ]
  },
  {
    "id": "TCGA-KM-8477-01Z-00-DX1.5419F74B-EE1C-47C3-A5A7-B22768E613A8-1",
    "image": "TCGA-KICH/TCGA-KM-8477-01Z-00-DX1.5419F74B-EE1C-47C3-A5A7-B22768E613A8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of chromophobe renal cell carcinoma with TNM staging of T1aMXNX and IHC results showing positive c-kit (CD117), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Chromophobe renal cell carcinoma typically has a favorable outcome compared to other renal cell carcinoma subtypes, especially given the early stage (T1a), and the absence of confirmed metastasis or lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-ER-A42L-06Z-00-DX1.EFC23C96-F0A5-4ADA-BE77-11B967531BEC-1",
    "image": "TCGA-SKCM/TCGA-ER-A42L-06Z-00-DX1.EFC23C96-F0A5-4ADA-BE77-11B967531BEC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma with TNM staging of T3M0N0 and IHC results showing positive S100 and HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma, despite the T3M0N0 staging, indicates advanced disease spread, and while the positive S100 and HMB45 confirm the melanoma diagnosis, these markers do not offer therapeutic advantages."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2M5-01Z-00-DX1.8F00BDE7-5445-49BB-98FA-694C197BD3CF-1",
    "image": "TCGA-SKCM/TCGA-EE-A2M5-01Z-00-DX1.8F00BDE7-5445-49BB-98FA-694C197BD3CF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2N0M0, and IHC results showing S100 positivity with equivocal Melan A and Cytokeratin results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Although the TNM staging indicates no distant metastasis or lymph node involvement, the diagnosis of metastatic melanoma and the IHC findings suggest an aggressive disease with limited effective treatment options."
      }
    ]
  },
  {
    "id": "TCGA-WE-A8K5-06Z-00-DX1.88DA18DD-8CB6-4214-97C8-CCE566619649-1",
    "image": "TCGA-SKCM/TCGA-WE-A8K5-06Z-00-DX1.88DA18DD-8CB6-4214-97C8-CCE566619649.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma with TNM staging of T2AM1CN3 and IHC results showing negative BRAF immunostain but a BRAF mutation in codon 600, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic status (M1C), high nodal involvement (N3), and presence of a BRAF mutation indicate an advanced disease with aggressive potential."
      }
    ]
  },
  {
    "id": "TCGA-D9-A4Z3-01Z-00-DX1.DD40CC06-5F33-4C8D-BE76-80189D969EBE-1",
    "image": "TCGA-SKCM/TCGA-D9-A4Z3-01Z-00-DX1.DD40CC06-5F33-4C8D-BE76-80189D969EBE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of malignant melanoma, nodular type, ulcerated, with Clark level V and a Breslow thickness of 75 mm, TNM staging of T4BM0N1B, and IHC results showing HMB45 positivity in few cells, negative MelanA, negative CKAE1/3, and a Ki67 of 50%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced stage (T4B), presence of regional lymph node involvement (N1B), ulceration, high Breslow thickness, and high Ki67 index collectively indicate a more aggressive disease with a higher risk of progression."
      }
    ]
  },
  {
    "id": "TCGA-EE-A184-01Z-00-DX1.66D44004-A355-42FA-A21B-2911C132B0CE-1",
    "image": "TCGA-SKCM/TCGA-EE-A184-01Z-00-DX1.66D44004-A355-42FA-A21B-2911C132B0CE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma with TNM staging of T2AM0N0 and immunohistochemistry results showing patchy positive staining for S-100, HMB-45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the low T2A staging and no lymph node involvement, the metastatic nature of the melanoma significantly worsens the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2A0-06Z-00-DX1.270C855C-3B9F-4927-ABDA-35829213FFDF-1",
    "image": "TCGA-SKCM/TCGA-EE-A2A0-06Z-00-DX1.270C855C-3B9F-4927-ABDA-35829213FFDF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma, TNM staging of T3AM0N0, and IHC results showing positivity for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the melanoma, despite the negative lymph node involvement (N0) and absence of distant metastasis (M0), suggests advanced disease with a higher risk of spreading and recurrence."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2MP-01Z-00-DX1.4A7DAF7C-078D-4068-A443-049D702098FF-1",
    "image": "TCGA-SKCM/TCGA-EE-A2MP-01Z-00-DX1.4A7DAF7C-078D-4068-A443-049D702098FF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2M0N0, and IHC results showing strong S100, positive Melan A, and focal strong HMB45 staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the absence of metastasis and lymph node involvement (M0 and N0), the diagnosis of metastatic melanoma typically indicates aggressive disease behavior, and the positivity for melanoma markers confirms the diagnosis."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2MM-01Z-00-DX1.8EBF6AD7-6812-4779-932A-665F898E18AA-1",
    "image": "TCGA-SKCM/TCGA-EE-A2MM-01Z-00-DX1.8EBF6AD7-6812-4779-932A-665F898E18AA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T2M0N0, and immunohistochemistry results showing positive S100 and Melan-A with negative HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the primary tumor size (T2) and absence of distant metastasis (M0) or lymph node involvement (N0), the diagnosis of metastatic malignant melanoma inherently indicates a more aggressive and challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-GN-A9SD-06Z-00-DX1.B013023E-1764-4607-B86E-CE984CBBFB1B-1",
    "image": "TCGA-SKCM/TCGA-GN-A9SD-06Z-00-DX1.B013023E-1764-4607-B86E-CE984CBBFB1B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma with extranodal extension, TNM staging of T1AM0NX, and IHC results showing negative HMB 45 and MART-1 (Melan-A), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastatic melanoma with extranodal extension and negative IHC markers HMB 45 and MART-1 complicates the ability to identify and target tumor cells effectively, suggesting a more challenging clinical scenario."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2A6-01Z-00-DX1.9897318F-B858-4036-9F4B-4AF92D357859-1",
    "image": "TCGA-SKCM/TCGA-EE-A2A6-01Z-00-DX1.9897318F-B858-4036-9F4B-4AF92D357859.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T1AM0N0, and IHC results showing positive S100, Melan-A, and HMB-45 with negative CD45 and Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the early TNM stage, the diagnosis of metastatic melanoma inherently indicates a serious condition with a significant risk of spread and recurrence."
      }
    ]
  },
  {
    "id": "TCGA-D3-A2JL-06Z-00-DX1.3258F79C-866E-4AC5-BB16-F4DF65E9DFC2-1",
    "image": "TCGA-SKCM/TCGA-D3-A2JL-06Z-00-DX1.3258F79C-866E-4AC5-BB16-F4DF65E9DFC2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N0, and IHC results showing diffuse reactivity for the pan-melanoma cocktail (HMB-45 and anti-MART 1) strongly supporting the diagnosis of melanoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Metastatic melanoma, even with no current evidence of distant metastasis (TXM0N0), typically indicates advanced disease and is associated with a higher risk of recurrence and progression."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2MQ-01Z-00-DX1.9EDA37BD-21FD-4CED-8375-5D8FFD2D6CA0-1",
    "image": "TCGA-SKCM/TCGA-EE-A2MQ-01Z-00-DX1.9EDA37BD-21FD-4CED-8375-5D8FFD2D6CA0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant melanoma with TNM staging of T3AN2M0, and IHC results showing positive S100, patchy positivity for HMB45, negative MelanA, and negative pan-cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (N2 indicating multiple lymph node involvement) and mixed IHC results suggest a more aggressive and advanced disease, leading to a less favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-GF-A4EO-01Z-00-DX1.A895033F-BC64-4871-8292-BCEB4FF5B9DE-1",
    "image": "TCGA-SKCM/TCGA-GF-A4EO-01Z-00-DX1.A895033F-BC64-4871-8292-BCEB4FF5B9DE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma, TNM staging of T0M0N3, and IHC results including positive CD20, CD5, and CD3, with negative Cyclin D1 in lymphoid cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Metastatic melanoma with TNM staging indicating extensive lymph node involvement (N3) typically suggests advanced disease with a higher likelihood of aggressive behavior and limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D3-A2JE-06Z-00-DX1.71482107-04E7-4DB6-873A-F68DC4F8C0D1-1",
    "image": "TCGA-SKCM/TCGA-D3-A2JE-06Z-00-DX1.71482107-04E7-4DB6-873A-F68DC4F8C0D1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of renal cell carcinoma, clear cell type with metastatic melanoma as a secondary tumor, TNM staging of TXM0N3, and IHC results with positive S-100 protein, vimentin, and panmelanoma cocktail, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastatic melanoma, nodal involvement (N3), and the positive IHC markers for melanoma indicate a more advanced and aggressive disease, leading to a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-ER-A19K-01Z-00-DX1.C7AAFCAE-F735-43A7-958A-EF162BAECB77-1",
    "image": "TCGA-SKCM/TCGA-ER-A19K-01Z-00-DX1.C7AAFCAE-F735-43A7-958A-EF162BAECB77.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma, focally ulcerated, Level V, with TNM staging of T4BM0N0 and IHC results showing no tumor cells nor lymph nodes seen, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor thickness indicated by T4B and the presence of ulceration contribute to a higher risk of aggressive disease and poor outcomes, despite no visible tumor cells in the IHC results."
      }
    ]
  },
  {
    "id": "TCGA-DA-A95X-01Z-00-DX1.F66442E6-F0C9-4528-B000-E47FCAA964FD-1",
    "image": "TCGA-SKCM/TCGA-DA-A95X-01Z-00-DX1.F66442E6-F0C9-4528-B000-E47FCAA964FD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2AM0N0, and IHC results showing HMB-45, Negative Control, and S-100 Protein all at 2, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Although the TNM staging indicates no distant metastasis and no lymph node involvement, the diagnosis of metastatic melanoma itself signifies that the cancer has already spread beyond the primary site, suggesting an aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-ER-A19E-01Z-00-DX1.50204A2E-4F44-4F34-848A-6C649FFF5C36-1",
    "image": "TCGA-SKCM/TCGA-ER-A19E-01Z-00-DX1.50204A2E-4F44-4F34-848A-6C649FFF5C36.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated metastatic neoplasm compatible with malignant melanoma, TNM staging of T2A N0 M0, and IHC results showing positive S100 and NK1-C3 but negative for markers like Melan A, Tyrosinase, and HMB-45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and metastatic nature of the melanoma, along with the lack of expression of several common melanoma markers, suggest a more aggressive disease with limited targeted treatment options."
      }
    ]
  },
  {
    "id": "TCGA-EE-A29S-01Z-00-DX1.C53935B6-2B30-47B6-B051-0360C8C9B774-1",
    "image": "TCGA-SKCM/TCGA-EE-A29S-01Z-00-DX1.C53935B6-2B30-47B6-B051-0360C8C9B774.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of melanoma, TNM staging of T3aN0M0, and IHC results showing positive S-100, Melan A, and HMB-45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM stage of T3a indicates a thicker primary tumor, which is a significant risk factor for a worse outcome in melanoma, despite the lack of nodal or distant metastasis."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3JA-06Z-00-DX1.616ADF60-1EBE-4082-97D8-25AFEF393429-1",
    "image": "TCGA-SKCM/TCGA-EE-A3JA-06Z-00-DX1.616ADF60-1EBE-4082-97D8-25AFEF393429.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T2AM0N0, and IHC results showing S100 (2-3+ cytoplasmic) and Melan A (2+ cytoplasmic), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic malignant melanoma, even with no distant or lymph node involvement (M0, N0), indicates a more severe disease given its metastatic nature."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3JH-01Z-00-DX1.C1558CB7-A35E-4EC2-A615-219D6FB0E06B-1",
    "image": "TCGA-SKCM/TCGA-EE-A3JH-01Z-00-DX1.C1558CB7-A35E-4EC2-A615-219D6FB0E06B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2N0M0, and IHC results strongly positive for HMB45, S-100, and Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. While the TNM staging indicates localized disease without distant metastasis, the diagnosis of metastatic melanoma typically denotes a more aggressive and less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-ER-A195-01Z-00-DX1.90F626B4-B6B2-45FB-AABC-1E984AE08237-1",
    "image": "TCGA-SKCM/TCGA-ER-A195-01Z-00-DX1.90F626B4-B6B2-45FB-AABC-1E984AE08237.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N0, and IHC results showing positive S100, Tyrosinase, and MelanA with negative Pankeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma indicates a high potential for spreading, and even though TNM staging does not show current metastasis or nodal involvement, the metastatic nature signifies a severe prognosis."
      }
    ]
  },
  {
    "id": "TCGA-DA-A95W-01Z-00-DX1.8E28AD5A-F851-47A6-835D-A0F3DA1DFCE3-1",
    "image": "TCGA-SKCM/TCGA-DA-A95W-01Z-00-DX1.8E28AD5A-F851-47A6-835D-A0F3DA1DFCE3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N1B, and IHC results showing positive Melan-A and S100, with negative Pan keratin and TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma and the TNM staging indicating lymph node involvement (N1B) suggest a higher risk of disease progression. Positive Melan-A and S100 confirm melanoma presence, but these findings do not significantly alter the poor prognosis."
      }
    ]
  },
  {
    "id": "TCGA-EE-A29G-01Z-00-DX1.8123979A-EF7A-4EB7-A323-94B4F7E77547-1",
    "image": "TCGA-SKCM/TCGA-EE-A29G-01Z-00-DX1.8123979A-EF7A-4EB7-A323-94B4F7E77547.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of metastatic melanoma with a TNM staging of T4A, N2A, M0 and IHC results showing positivity for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage, indicating a large tumor size and significant lymph node involvement without distant metastasis, combined with the metastatic nature of melanoma, suggests a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-ER-A19D-01Z-00-DX1.14682B98-9080-48C5-96D0-C4678456D80D-1",
    "image": "TCGA-SKCM/TCGA-ER-A19D-01Z-00-DX1.14682B98-9080-48C5-96D0-C4678456D80D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2AM0N0, and IHC results showing negative MelanA, Tyrosinase, and HMB45 but positive S100 and CD68, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma and overall IHC results indicate aggressive disease despite the absence of distant metastatic spread (M0) or nodal involvement (N0), given the limitations of the marker profile for targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-FR-A8YC-06Z-00-DX1.C74DAE48-0901-4858-A47B-CAF5ED89C5D0-1",
    "image": "TCGA-SKCM/TCGA-FR-A8YC-06Z-00-DX1.C74DAE48-0901-4858-A47B-CAF5ED89C5D0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T3BM0N0, and IHC results showing positive MART-1 and HMB-45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Metastatic melanoma (stage IV indicated by T3B) generally indicates a spread beyond the primary site, and even with positive MART-1 and HMB-45, which confirm melanoma, it suggests a more challenging disease course."
      }
    ]
  },
  {
    "id": "TCGA-EE-A29N-01Z-00-DX1.9842217A-23B9-40CA-91CE-D83F8DFD7A0B-1",
    "image": "TCGA-SKCM/TCGA-EE-A29N-01Z-00-DX1.9842217A-23B9-40CA-91CE-D83F8DFD7A0B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N0, and IHC results showing positive Melan and HMB45, weakly positive S100, and negative CK, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma indicates the presence of cancer spread beyond the initial site, despite the TNM staging showing no detectable metastasis or lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-FR-A8YD-06Z-00-DX1.AF90C1E6-94CB-48ED-BDED-F2AC6183153F-1",
    "image": "TCGA-SKCM/TCGA-FR-A8YD-06Z-00-DX1.AF90C1E6-94CB-48ED-BDED-F2AC6183153F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma with TNM staging of T4BM0N0 and IHC results showing positive S-100 and MART-1 with negative Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high primary tumor thickness (T4B) and positive metastatic markers (S-100 and MART-1) indicate advanced melanoma, which is associated with a lower likelihood of favorable outcomes."
      }
    ]
  },
  {
    "id": "TCGA-EE-A20F-01Z-00-DX1.78401458-3FDA-4D9D-8567-878E6D28EF5C-1",
    "image": "TCGA-SKCM/TCGA-EE-A20F-01Z-00-DX1.78401458-3FDA-4D9D-8567-878E6D28EF5C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma with TNM staging of T1M0N0 and IHC results showing positive S100, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the T1 stage indicating a smaller primary tumor, the diagnosis of metastatic malignant melanoma indicates the disease has spread, which typically worsens the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-WE-AA9Y-06Z-00-DX1.83813BA4-04FA-4AEA-A50D-B962A753A59E-1",
    "image": "TCGA-SKCM/TCGA-WE-AA9Y-06Z-00-DX1.83813BA4-04FA-4AEA-A50D-B962A753A59E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of metastatic malignant melanoma, TNM staging of T2aN3M0, and IHC results showing S-100 positivity, focal Melan-A positivity, and negative BRAF, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with significant lymph node involvement (N3) and the negative BRAF mutation, which limits targeted therapy options, contribute to a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-D3-A3C6-06Z-00-DX1.AEAFE336-C5BC-4EC0-A869-14DCB44700CD-1",
    "image": "TCGA-SKCM/TCGA-D3-A3C6-06Z-00-DX1.AEAFE336-C5BC-4EC0-A869-14DCB44700CD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2AM0N0, and IHC results showing positive anti-melanocytic cocktail (HMB45, anti-MART1, and anti-tyrosinase), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the T2A stage indicating a thicker primary tumor without ulceration and no metastasis to lymph nodes or distant sites, the diagnosis of metastatic melanoma inherently carries a more serious outlook."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3AD-01Z-00-DX1.43458789-DF9D-4CF4-8CE6-C6C4112B89D0-1",
    "image": "TCGA-SKCM/TCGA-EE-A3AD-01Z-00-DX1.43458789-DF9D-4CF4-8CE6-C6C4112B89D0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of metastatic melanoma, with a TNM staging of T0N1bM0, and IHC results showing strong positivity for S100, HMB-45, and Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic status indicated by N1b suggests regional lymph node involvement, which is associated with a more advanced and aggressive disease, despite the strong positivity of melanoma markers."
      }
    ]
  },
  {
    "id": "TCGA-GF-A3OT-01Z-00-DX1.014B8884-EE9D-4F3A-81BB-9DCAC92CC2AE-1",
    "image": "TCGA-SKCM/TCGA-GF-A3OT-01Z-00-DX1.014B8884-EE9D-4F3A-81BB-9DCAC92CC2AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T3M0N3, and IHC results showing positive S100, melanA, HMB45, and tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic melanoma diagnosis, advanced TNM stage with significant lymph node involvement (N3), and positivity for several melanoma markers indicate aggressive disease with a higher likelihood of poor outcomes."
      }
    ]
  },
  {
    "id": "TCGA-GN-A26C-01Z-00-DX1.E6395A6B-21CA-4994-9F01-738B915ADFB8-1",
    "image": "TCGA-SKCM/TCGA-GN-A26C-01Z-00-DX1.E6395A6B-21CA-4994-9F01-738B915ADFB8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of ulcerated malignant melanoma, spindle cell type, Clark's Level V, TNM staging of T4bM0N2b, and IHC results with intense S100 positivity, rare HMB45 positivity, negative MelanA, and weak SMA background staining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced Clark's Level V, high TNM stage indicating deep invasion and regional lymph node involvement, along with IHC findings typical of aggressive melanoma, suggest a more unfavorable disease outlook."
      }
    ]
  },
  {
    "id": "TCGA-ER-A2NF-01Z-00-DX1.1468DD2D-6AC8-4657-A02E-E520668C676F-1",
    "image": "TCGA-SKCM/TCGA-ER-A2NF-01Z-00-DX1.1468DD2D-6AC8-4657-A02E-E520668C676F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive melanoma with TNM staging of T3BM0N3 and IHC results showing positive Melan-A immunostains in malignant cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high TNM stage, evidence of metastasis to lymph nodes, and involvement of deep and lateral margins suggest an advanced and aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-ER-A2NF-01Z-00-DX2.01ACC455-4161-4EF1-8478-3C4DF709F6D6-1",
    "image": "TCGA-SKCM/TCGA-ER-A2NF-01Z-00-DX2.01ACC455-4161-4EF1-8478-3C4DF709F6D6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive melanoma with TNM staging of T3BM0N3 and IHC results showing positive Melan-A immunostains in malignant cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high TNM stage, evidence of metastasis to lymph nodes, and involvement of deep and lateral margins suggest an advanced and aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-RP-A694-01Z-00-DX1.31B4F597-0CDA-4A3B-B34E-881ADCAB17DF-1",
    "image": "TCGA-SKCM/TCGA-RP-A694-01Z-00-DX1.31B4F597-0CDA-4A3B-B34E-881ADCAB17DF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM1CNX, and IHC results showing positive S-100 and Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic stage (M1) indicates that the melanoma has spread to distant sites, which is associated with a higher risk and lower survival rates despite the positive expression of melanoma markers S-100 and Melan-A."
      }
    ]
  },
  {
    "id": "TCGA-DA-A1I7-01Z-00-DX1.EC6BB67F-9AEF-47EA-AF5D-508352639DD4-1",
    "image": "TCGA-SKCM/TCGA-DA-A1I7-01Z-00-DX1.EC6BB67F-9AEF-47EA-AF5D-508352639DD4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma, TNM staging of T0M0N2B, and positive S-100 on immunohistochemistry, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Metastatic melanoma with lymph node involvement (N2B) suggests an advanced stage of the disease, despite the lack of evidence for a primary tumor (T0), which typically correlates with a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-D3-A8GQ-06Z-00-DX1.5D8925EC-7571-4842-8763-0D8077D2FC68-1",
    "image": "TCGA-SKCM/TCGA-D3-A8GQ-06Z-00-DX1.5D8925EC-7571-4842-8763-0D8077D2FC68.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma and cecal tubulovillous adenoma with focal high-grade dysplasia, TNM staging of T3M0N0, and IHC results showing negative neuroendocrine markers with positive CK 5/6, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the malignant melanoma indicates advanced disease with a high risk of further spread, and the focal high-grade dysplasia present in the cecal adenoma suggests potential progression to invasive carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-D3-A51K-06Z-00-DX1.CBDB017A-31B3-430E-B69B-5789F79504B2-1",
    "image": "TCGA-SKCM/TCGA-D3-A51K-06Z-00-DX1.CBDB017A-31B3-430E-B69B-5789F79504B2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of melanoma in situ and metastatic melanoma with a TNM staging of TISM0N2B, and IHC results showing reactivity for pan melanocytic cocktail, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastatic melanoma (N2B) indicates significant disease spread, despite the in situ component, suggesting a more advanced and aggressive condition."
      }
    ]
  },
  {
    "id": "TCGA-W3-A828-06Z-00-DX1.1617E01C-D0E8-49F9-9FE1-5D912E9C024A-1",
    "image": "TCGA-SKCM/TCGA-W3-A828-06Z-00-DX1.1617E01C-D0E8-49F9-9FE1-5D912E9C024A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of spindle cell malignant neoplasm consistent with metastatic desmoplastic malignant melanoma, TNM staging of T3M0N0, and IHC results showing positive vimentin and negative S-100 protein and cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic desmoplastic malignant melanoma and the T3 stage indicate a high-risk and aggressive disease with limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D3-A51E-06Z-00-DX1.819FF689-47EB-468E-A9C1-5205951F69C0-1",
    "image": "TCGA-SKCM/TCGA-D3-A51E-06Z-00-DX1.819FF689-47EB-468E-A9C1-5205951F69C0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T2M0N0, and IHC results showing no evidence of metastatic melanoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is cautiously optimistic. While the primary cancer is confirmed (T2), the absence of detectable metastases (N0, M0) by IHC suggests limited disease spread, which is generally associated with a better prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D3-A8GE-06Z-00-DX1.757AE9F7-823E-4167-B12C-F6DA031B21D1-1",
    "image": "TCGA-SKCM/TCGA-D3-A8GE-06Z-00-DX1.757AE9F7-823E-4167-B12C-F6DA031B21D1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant spindle cell neoplasm, TNM staging of TXM1BN0, and IHC results showing strong positivity for S100, Sox-9, and CD34, with negative results for the anti-melanocytic cocktail and MITF, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor due to the presence of distant metastasis (M1B), which typically indicates advanced disease and worsens the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-WE-A8JZ-06Z-00-DX1.071CA5D6-D02C-4B69-AFA8-A43654FECAEA-1",
    "image": "TCGA-SKCM/TCGA-WE-A8JZ-06Z-00-DX1.071CA5D6-D02C-4B69-AFA8-A43654FECAEA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma, TNM staging of T4BM0N1A, and IHC result showing negative BRAF immunostaining, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage with thick tumor and regional lymph node involvement, along with the negative BRAF immunostaining, indicates limited targeted therapy options and a more aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-DA-A1I1-01Z-00-DX1.08A88C76-48C4-4724-AF64-24F99B7D33AD-1",
    "image": "TCGA-SKCM/TCGA-DA-A1I1-01Z-00-DX1.08A88C76-48C4-4724-AF64-24F99B7D33AD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma with TNM staging of T0M0N2A and IHC results showing positive S100 and Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the melanoma and the involvement of multiple regional lymph nodes (N2A) indicate advanced disease, despite no primary tumor (T0) or distant metastasis (M0)."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2M6-01Z-00-DX1.78D26DB4-610E-46E8-87C6-192A1E4741BC-1",
    "image": "TCGA-SKCM/TCGA-EE-A2M6-01Z-00-DX1.78D26DB4-610E-46E8-87C6-192A1E4741BC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma, TNM staging of T1N0M0, and IHC results showing focal 2+ positive staining for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The early stage indicated by T1N0M0 suggests that the melanoma is localized without evidence of spread, and the positive staining for melanocytic markers supports the diagnosis."
      }
    ]
  },
  {
    "id": "TCGA-WE-A8K1-06Z-00-DX1.78AB8C19-41B2-4BAB-AD11-48051A2E4C78-1",
    "image": "TCGA-SKCM/TCGA-WE-A8K1-06Z-00-DX1.78AB8C19-41B2-4BAB-AD11-48051A2E4C78.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of malignant melanoma, TNM staging of T3BM0N3, and IHC results showing positive HMB45 and S100 with negative BRAF, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging with significant lymph node involvement (N3) and the negative BRAF mutation indicate a more aggressive form of melanoma with fewer targeted therapy options."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2MS-06Z-00-DX1.76FF55CE-10D0-4A93-AB1D-81AFB910410B-1",
    "image": "TCGA-SKCM/TCGA-EE-A2MS-06Z-00-DX1.76FF55CE-10D0-4A93-AB1D-81AFB910410B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of metastatic malignant melanoma with TNM staging of T3aM0N0 and IHC results showing S100 positivity, focal HMB45 positivity, and scattered Melan A positivity, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic malignant melanoma and the TNM staging indicating T3a tumor depth with metastasis suggest a serious condition, despite some positive IHC markers, which indicate melanoma."
      }
    ]
  },
  {
    "id": "TCGA-FR-A728-01Z-00-DX1.FF67AF45-E879-449F-BAA1-73B3DB4D79FA-1",
    "image": "TCGA-SKCM/TCGA-FR-A728-01Z-00-DX1.FF67AF45-E879-449F-BAA1-73B3DB4D79FA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of superficial spreading melanoma, TNM staging of T4BM0N2A, and the provided immunohistochemistry results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The high tumor thickness (T4), regional lymph node involvement (N2A), and the presence of ulceration (indicated by \"B\") suggest a more advanced and aggressive melanoma, which typically correlates with a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2GS-01Z-00-DX1.77D6F0AA-5D58-4863-BC0C-362B3063756D-1",
    "image": "TCGA-SKCM/TCGA-EE-A2GS-01Z-00-DX1.77D6F0AA-5D58-4863-BC0C-362B3063756D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic amelanotic melanoma, TNM staging of T2AM0N0, and IHC results showing strong positivity for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the absence of distant metastases (M0) or lymph node involvement (N0), the metastatic nature of amelanotic melanoma and its aggressive biological behavior usually indicate a more challenging prognosis."
      }
    ]
  },
  {
    "id": "TCGA-QB-AA9O-01Z-00-DX1.DC862486-1A25-4351-A091-C4626713FCB6-1",
    "image": "TCGA-SKCM/TCGA-QB-AA9O-01Z-00-DX1.DC862486-1A25-4351-A091-C4626713FCB6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N3, and IHC results showing strong diffuse positivity for Melan A and MITF with patchy positivity for AE1/3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Metastatic melanoma with significant lymph node involvement (N3) suggests advanced disease, despite the strong melanocyte markers indicated by the IHC results."
      }
    ]
  },
  {
    "id": "TCGA-ER-A1A1-06Z-00-DX1.CD88FBDD-AD5B-4063-8223-DDBA8A1F721B-1",
    "image": "TCGA-SKCM/TCGA-ER-A1A1-06Z-00-DX1.CD88FBDD-AD5B-4063-8223-DDBA8A1F721B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N3, and IHC results showing negative Pankeratin cytokeratin, positive S100/S100a, and focally positive Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma with significant lymph node involvement (N3) indicates advanced disease, which is associated with a lower survival rate despite specific immunohistochemical markers."
      }
    ]
  },
  {
    "id": "TCGA-FR-A729-01Z-00-DX1.90FA96F1-549C-4E9A-B9EC-F7EBA35FCC0D-1",
    "image": "TCGA-SKCM/TCGA-FR-A729-01Z-00-DX1.90FA96F1-549C-4E9A-B9EC-F7EBA35FCC0D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the patient's diagnosis of metastatic melanoma, TNM staging of T1N0M0, and IHC results showing positive S100 and Melan A staining in block A1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The low TNM stage (T1N0M0) indicates limited tumor size and no evidence of regional lymph node or distant metastasis, despite the metastatic nature of the melanoma."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2A2-01Z-00-DX1.D527C2E8-7AF4-484E-A0A5-1EB44EDAF00E-1",
    "image": "TCGA-SKCM/TCGA-EE-A2A2-01Z-00-DX1.D527C2E8-7AF4-484E-A0A5-1EB44EDAF00E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of metastatic melanoma, TNM staging of T4BM0N1B, and IHC results showing positive for S-100, HMB-45, and Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage indicates a high tumor burden with regional lymph node involvement, and while the IHC markers confirm melanoma, they do not change the overall outlook."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2A5-01Z-00-DX1.96AC91D6-1BED-4F64-BF07-A8EA5B6C92F9-1",
    "image": "TCGA-SKCM/TCGA-EE-A2A5-01Z-00-DX1.96AC91D6-1BED-4F64-BF07-A8EA5B6C92F9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma, TNM staging of T2aN0M0, and IHC results showing positivity for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is reasonably good. The melanoma is at an intermediate thickness (T2a) with no regional lymph node involvement (N0) and no distant metastasis (M0), which are favorable indicators for a better outcome."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2MR-01Z-00-DX1.F5AB5CC6-0D9A-4438-804D-FA4636D966F2-1",
    "image": "TCGA-SKCM/TCGA-EE-A2MR-01Z-00-DX1.F5AB5CC6-0D9A-4438-804D-FA4636D966F2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma and basal cell carcinoma, TNM staging of T2M0N0, and IHC results showing negative Melan A and Tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the malignant melanoma and the TNM staging indicating significant tumor presence (T2) contribute to an unfavorable outcome, and the negative IHC markers may complicate treatment strategies."
      }
    ]
  },
  {
    "id": "TCGA-D3-A2JF-06Z-00-DX1.1AD134CC-6844-45CC-BEC2-46F487356703-1",
    "image": "TCGA-SKCM/TCGA-D3-A2JF-06Z-00-DX1.1AD134CC-6844-45CC-BEC2-46F487356703.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of melanoma with TNM staging of T1aN0M0 and IHC results showing scattered tumor cell labeling for HMB45, Anti-MART1, and Anti-tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early-stage melanoma (T1aN0M0) indicates a small tumor size without lymph node involvement or metastasis, which is typically associated with a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2M7-01Z-00-DX1.9BC4B066-11FD-4606-8D2D-66757BD5C0AD-1",
    "image": "TCGA-SKCM/TCGA-EE-A2M7-01Z-00-DX1.9BC4B066-11FD-4606-8D2D-66757BD5C0AD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T3AM0N0, and IHC results showing positive S100 and negative HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the melanoma and the TNM staging indicating a tumor thickness (T3a) without lymph node involvement but potential for distant spread contribute to a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-W3-AA1V-01Z-00-DX1.86F0DF30-1FB8-4316-8126-0C6CCF82A06E-1",
    "image": "TCGA-SKCM/TCGA-W3-AA1V-01Z-00-DX1.86F0DF30-1FB8-4316-8126-0C6CCF82A06E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T3M0N0, and IHC results showing strong positivity for S100 protein and weak focal staining for HMB-45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic malignant melanoma, despite the TNM staging indicating no distant metastasis or lymph node involvement, generally leads to a more challenging clinical outcome."
      }
    ]
  },
  {
    "id": "TCGA-EE-A17Y-06Z-00-DX1.0D310813-3A45-4B49-8338-8146F9760BE4-1",
    "image": "TCGA-SKCM/TCGA-EE-A17Y-06Z-00-DX1.0D310813-3A45-4B49-8338-8146F9760BE4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of melanoma, TNM staging of T3BM0N1A, and IHC results showing positive S100, HMB45, and Melan-A with negative Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a T3 tumor with regional lymph node involvement (N1A), suggesting a higher risk of disease progression despite the positive melanoma markers."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2GI-01Z-00-DX1.3555691F-4DCF-45E9-9360-A7F34361B7AA-1",
    "image": "TCGA-SKCM/TCGA-EE-A2GI-01Z-00-DX1.3555691F-4DCF-45E9-9360-A7F34361B7AA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of metastatic melanoma with a TNM staging of T1AM0N0 and IHC results showing positivity for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low TNM stage (T1A), the diagnosis of metastatic melanoma inherently indicates disease spread beyond the primary site, which generally portends a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2GN-01Z-00-DX1.CC2B5420-6636-4CC3-AD84-AE8B2751675D-1",
    "image": "TCGA-SKCM/TCGA-EE-A2GN-01Z-00-DX1.CC2B5420-6636-4CC3-AD84-AE8B2751675D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of melanoma with TNM staging of T2BM0N0 and immunohistochemistry results showing S100 patchy strong nuclear staining, HMB45 positive, and Melan A positive, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The tumor thickness indicated by T2B and ulceration denotes a more advanced local disease, despite no regional lymph node involvement or distant metastasis (N0M0)."
      }
    ]
  },
  {
    "id": "TCGA-EB-A5UN-06Z-00-DX1.A3554E02-198F-48CA-A055-FF9D617C2B11-1",
    "image": "TCGA-SKCM/TCGA-EB-A5UN-06Z-00-DX1.A3554E02-198F-48CA-A055-FF9D617C2B11.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T4BM0NX, and IHC results showing positive S100 and MART1, negative Cytokeratin, and patchy positive HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma with high tumor thickness (T4B) and lack of M0 lymph node status indicates advanced disease, which is typically aggressive and challenging to treat effectively."
      }
    ]
  },
  {
    "id": "TCGA-EE-A2GU-01Z-00-DX1.72DD2321-B321-4A18-88FF-04B179B4C297-1",
    "image": "TCGA-SKCM/TCGA-EE-A2GU-01Z-00-DX1.72DD2321-B321-4A18-88FF-04B179B4C297.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma with TNM staging of T1AM0N0 and IHC results showing positive S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the T1A stage indicating a small primary tumor and no regional lymph node involvement, metastatic melanoma generally has a less favorable outlook, especially considering its aggressive nature and potential distant spread."
      }
    ]
  },
  {
    "id": "TCGA-FR-A3R1-01Z-00-DX1.D6EB7ABD-9AD8-44B8-9055-782C272A65F4-1",
    "image": "TCGA-SKCM/TCGA-FR-A3R1-01Z-00-DX1.D6EB7ABD-9AD8-44B8-9055-782C272A65F4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of nodular melanoma with TNM staging of T4BM0N0 and IHC results showing negative Melan A and S100 protein in multiple sentinel lymph nodes and the skin excision, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T4B classification indicates a thick melanoma with ulceration, which is associated with a higher risk of recurrence and metastasis, despite negative sentinel lymph node involvement."
      }
    ]
  },
  {
    "id": "TCGA-EE-A29W-01Z-00-DX1.5C3B9CDC-43EB-4E9E-85D2-7B83BE7AB6F0-1",
    "image": "TCGA-SKCM/TCGA-EE-A29W-01Z-00-DX1.5C3B9CDC-43EB-4E9E-85D2-7B83BE7AB6F0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T1SM0N0, and IHC results showing positive S-100, negative HMB-45, and negative Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Metastatic melanoma by definition involves distant spread, and the IHC profile, although positive for S-100, does not alter the fact that metastatic melanoma typically has a poor overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-EE-A29P-01Z-00-DX1.E4E718E1-C5C3-477E-8073-F30C4D0A52C3-1",
    "image": "TCGA-SKCM/TCGA-EE-A29P-01Z-00-DX1.E4E718E1-C5C3-477E-8073-F30C4D0A52C3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma, TNM staging of T4BM0N0, and positive immunohistochemistry results for S100, HMB45, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the malignant melanoma (T4B) and the positive markers indicating aggressive and advanced disease contribute to this assessment."
      }
    ]
  },
  {
    "id": "TCGA-WE-A8ZO-06Z-00-DX1.6679C145-BB41-4696-96FE-94646701122F-1",
    "image": "TCGA-SKCM/TCGA-WE-A8ZO-06Z-00-DX1.6679C145-BB41-4696-96FE-94646701122F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma, TNM staging of T3aN1bM0, and negative BRAF immunostain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging indicates a thicker tumor with lymph node involvement (N1b), and the negative BRAF result limits treatment options involving targeted therapies."
      }
    ]
  },
  {
    "id": "TCGA-D3-A3MV-06Z-00-DX1.C06EECC4-8DA7-4432-8FEC-7A5ED82E21CB-1",
    "image": "TCGA-SKCM/TCGA-D3-A3MV-06Z-00-DX1.C06EECC4-8DA7-4432-8FEC-7A5ED82E21CB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma with TNM staging T2BM0N2A and IHC results showing strong positivity for HMB45, Anti-MART1, and Anti-tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging indicates regional lymph node involvement (N2A) and no distant metastasis (M0), which together with the metastatic nature of melanoma, suggest a more aggressive disease course."
      }
    ]
  },
  {
    "id": "TCGA-ER-A196-01Z-00-DX1.54FAFEC7-851D-4D8A-9F25-B334F52548D4-1",
    "image": "TCGA-SKCM/TCGA-ER-A196-01Z-00-DX1.54FAFEC7-851D-4D8A-9F25-B334F52548D4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of ulcerated nodular melanoma, acral lentiginous type, TNM staging of T4BM0N0, and IHC results showing negative HM 45, S100, Melan A, CD68, and tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The T4B classification indicates a large and ulcerated primary tumor, which is associated with a higher risk of metastasis and poorer survival outcomes, compounded by the lack of positive immunohistochemical markers typically associated with melanomas."
      }
    ]
  },
  {
    "id": "TCGA-EE-A20C-01Z-00-DX1.48BAD79E-DFC8-44A7-92F8-09C7C0545455-1",
    "image": "TCGA-SKCM/TCGA-EE-A20C-01Z-00-DX1.48BAD79E-DFC8-44A7-92F8-09C7C0545455.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TISM0N0, and IHC results showing weak positivity for S100, negative HMB45, and Ki67 positivity in 2-20% of tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma indicates that the cancer has spread, and the weak S100 positivity along with variable Ki67 expression suggests a difficulty in achieving effective treatment response."
      }
    ]
  },
  {
    "id": "TCGA-ER-A19O-01Z-00-DX1.41972CD4-68BF-4815-A362-74A1038241C9-1",
    "image": "TCGA-SKCM/TCGA-ER-A19O-01Z-00-DX1.41972CD4-68BF-4815-A362-74A1038241C9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma, TNM staging of T3BM0N1B, and IHC results showing all melanoma markers negative except for CD68 in macrophages and S100 in dendritic cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastatic melanoma with regional lymph node involvement (N1B) and a high tumor burden (T3B) points to a more advanced and aggressive disease."
      }
    ]
  },
  {
    "id": "TCGA-EE-A29L-01Z-00-DX1.63E1EE2B-FC39-4E41-9C48-6E6371055411-1",
    "image": "TCGA-SKCM/TCGA-EE-A29L-01Z-00-DX1.63E1EE2B-FC39-4E41-9C48-6E6371055411.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T4BM0N3, and IHC results showing positive S100 and HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4B indicating a large tumor, and N3 indicating significant lymph node involvement) and the diagnosis of metastatic melanoma indicate a high risk of disease spread and reduced overall survival."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3J5-06Z-00-DX1.47202780-2B18-4661-AD4E-2AF8D1A7C9E5-1",
    "image": "TCGA-SKCM/TCGA-EE-A3J5-06Z-00-DX1.47202780-2B18-4661-AD4E-2AF8D1A7C9E5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma, TNM staging of T4AM0N1, and IHC results showing positive S100 and HMB-45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis (N1) and high tumor thickness (T4A) indicate advanced disease, and although the IHC results confirm the diagnosis, they do not improve the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-ER-A19A-01Z-00-DX1.75490B10-9604-4846-96BA-E932489E51AB-1",
    "image": "TCGA-SKCM/TCGA-ER-A19A-01Z-00-DX1.75490B10-9604-4846-96BA-E932489E51AB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of TXM1N0, and IHC results showing negativity for S100, HMB45, Tyrosinase, CD68, and Melan A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis (M1) in TNM staging indicates advanced disease, and the negative IHC markers complicate the diagnosis and potential targeted treatment strategies."
      }
    ]
  },
  {
    "id": "TCGA-EE-A20B-01Z-00-DX1.BAA59F59-B286-4DAF-BB9E-0FCCD09E67C4-1",
    "image": "TCGA-SKCM/TCGA-EE-A20B-01Z-00-DX1.BAA59F59-B286-4DAF-BB9E-0FCCD09E67C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of melanoma, TNM staging of T3N0M0, and IHC results showing positive tumor cells for S-100, HMB-45, and Melan-A with no evidence of malignancy in the sentinel lymph node, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is moderate. Although the tumor is at a more advanced stage (T3), the absence of lymph node involvement (N0) and distant metastasis (M0) are positive indicators."
      }
    ]
  },
  {
    "id": "TCGA-ER-A197-01Z-00-DX1.43CE44D7-E3C1-4D61-8319-D9614F898047-1",
    "image": "TCGA-SKCM/TCGA-ER-A197-01Z-00-DX1.43CE44D7-E3C1-4D61-8319-D9614F898047.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of melanoma, TNM staging of T4BM0N1A, and IHC results showing positivity for S100, HMB45, and vimentin with negative epithelial markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage, including deep tumor invasion (T4B) and lymph node involvement (N1), combined with the typical melanoma markers, indicates a more aggressive and advanced disease."
      }
    ]
  },
  {
    "id": "TCGA-ER-A3PL-01Z-00-DX1.D8724F60-92DD-4727-943E-51C89E219813-1",
    "image": "TCGA-SKCM/TCGA-ER-A3PL-01Z-00-DX1.D8724F60-92DD-4727-943E-51C89E219813.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma with extensive vascular permeation, TNM staging of T3BM1AN0, and IHC results showing positive S100, Melan-A, and Tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis (M1A) along with extensive vascular permeation indicates advanced and aggressive disease, which significantly impacts the overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-D3-A5GU-06Z-00-DX1.17B59BCE-262E-4575-ABDE-7F01BDAEAF1E-1",
    "image": "TCGA-SKCM/TCGA-D3-A5GU-06Z-00-DX1.17B59BCE-262E-4575-ABDE-7F01BDAEAF1E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma with TNM staging of T1BM0N0 and IHC results strongly reacting to the panmelanocytic cocktail (HMB45, anti-Mart-1, anti-tyrosinase), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the early TNM stage, the diagnosis of metastatic melanoma typically indicates a more aggressive disease course and a higher risk of spread, suggesting a less favorable overall prognosis."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3JD-01Z-00-DX1.D4E5B644-C7EF-442D-91FB-594685CEBFD8-1",
    "image": "TCGA-SKCM/TCGA-EE-A3JD-01Z-00-DX1.D4E5B644-C7EF-442D-91FB-594685CEBFD8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of TXM0N2B, and IHC results showing strongly positive S100, negative HMB45, very focally positive Melan-A, and focal weak staining for Pancytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic nature of the melanoma (N2B indicating significant lymph node involvement) and the IHC pattern suggest an aggressive disease with limited treatment options."
      }
    ]
  },
  {
    "id": "TCGA-FW-A3R5-01Z-00-DX1.701DF0D8-5D3A-4FEA-BA55-0F8CB3961E81-1",
    "image": "TCGA-SKCM/TCGA-FW-A3R5-01Z-00-DX1.701DF0D8-5D3A-4FEA-BA55-0F8CB3961E81.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of metastatic malignant melanoma, TNM staging of TXM0N2, and IHC results showing strong positivity for S-100 with negative Melan A and HMB45 stains, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of regional lymph node metastasis (N2) with metastatic malignant melanoma generally indicates a more advanced and aggressive disease, despite negative distant metastasis (M0)."
      }
    ]
  },
  {
    "id": "TCGA-DA-A95Z-01Z-00-DX1.E34FE26D-097D-4469-8ED3-5AA2EA346033-1",
    "image": "TCGA-SKCM/TCGA-DA-A95Z-01Z-00-DX1.E34FE26D-097D-4469-8ED3-5AA2EA346033.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma, TNM staging of TXM1AN0, and IHC results showing positivity for Melan A and practically negative HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of distant metastasis (M1A) indicates advanced disease, despite the lack of regional lymph node involvement (N0), and the diagnosis of malignant melanoma carries a high risk of aggressiveness."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3AG-01Z-00-DX1.75BA8FFE-82A0-4FE0-B538-2451561DA164-1",
    "image": "TCGA-SKCM/TCGA-EE-A3AG-01Z-00-DX1.75BA8FFE-82A0-4FE0-B538-2451561DA164.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic malignant melanoma, TNM staging of T0N2M0, and IHC results showing positive S100, focally positive Melan A, and focally positive HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis to regional lymph nodes (N2) in malignant melanoma, despite a T0 classification, indicates a higher disease burden and greater likelihood of aggressive disease behavior."
      }
    ]
  },
  {
    "id": "TCGA-ER-A2ND-01Z-00-DX1.F2F060DC-995C-467C-8C5C-2C041BB13AD0-1",
    "image": "TCGA-SKCM/TCGA-ER-A2ND-01Z-00-DX1.F2F060DC-995C-467C-8C5C-2C041BB13AD0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of malignant melanoma, TNM staging of T1BM0N3, and immunohistochemistry results showing positive S100 and HMB 45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging of T1BM0N3 indicates a high level of lymph node involvement (N3), which is associated with a higher risk of metastasis and poorer outcomes in malignant melanoma despite the positive IHC markers."
      }
    ]
  },
  {
    "id": "TCGA-ER-A2NC-06Z-00-DX1.A7FE889C-F0D4-44BD-9373-96577D33C6FF-1",
    "image": "TCGA-SKCM/TCGA-ER-A2NC-06Z-00-DX1.A7FE889C-F0D4-44BD-9373-96577D33C6FF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T2AM0N0, and IHC results showing positive staining for S100, HMB45, and Melan-A with negative Cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma typically indicates a more advanced disease, even with no regional lymph node involvement (N0) and no distant metastasis (M0)."
      }
    ]
  },
  {
    "id": "TCGA-GN-A4U5-01Z-00-DX1.809E353D-07E7-4AC7-9ABD-8D59E59E4897-1",
    "image": "TCGA-SKCM/TCGA-GN-A4U5-01Z-00-DX1.809E353D-07E7-4AC7-9ABD-8D59E59E4897.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of malignant melanoma with a TNM staging of T2aM0NX and IHC results showing mixed results for A103 and S-100 markers, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2a classification indicates a thicker melanoma, and inconsistent IHC results can complicate the assessment of the tumor\u2019s behavior and potential treatment responses, increasing uncertainty in managing the disease."
      }
    ]
  },
  {
    "id": "TCGA-ER-A2NB-01Z-00-DX1.323F02C6-D07A-41B6-BEE3-DE212F657A3E-1",
    "image": "TCGA-SKCM/TCGA-ER-A2NB-01Z-00-DX1.323F02C6-D07A-41B6-BEE3-DE212F657A3E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of nodular malignant melanoma, TNM staging of T4BM0N2, and IHC results showing positive S100, MelanA, and Tyrosinase with negative Cytokeratin AE1/3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4B, N2) indicates a large primary tumor with lymph node involvement, suggesting an aggressive disease course, despite positive melanoma markers."
      }
    ]
  },
  {
    "id": "TCGA-EE-A3AH-01Z-00-DX1.681D7F88-B3C6-4F5B-9AE5-3692543583E5-1",
    "image": "TCGA-SKCM/TCGA-EE-A3AH-01Z-00-DX1.681D7F88-B3C6-4F5B-9AE5-3692543583E5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma with TNM staging of T3BM0N0 and IHC results showing positivity for S-100, HMB-45, and Melan-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of metastatic melanoma (stage IV), indicated by T3BM0N0, is associated with advanced disease and a higher likelihood of recurrence despite positive IHC markers, which primarily confirm the diagnosis."
      }
    ]
  },
  {
    "id": "TCGA-GN-A269-01Z-00-DX1.8DEB7375-C896-48F9-903F-5BA1384B10D7-1",
    "image": "TCGA-SKCM/TCGA-GN-A269-01Z-00-DX1.8DEB7375-C896-48F9-903F-5BA1384B10D7.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant melanoma, superficial spreading type with an ulcerated vertical growth phase at Clark's Level V, TNM staging of T4BM0N3, and IHC results showing positive S-100 and HMB-45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM stage (T4B with nodal involvement N3), the presence of ulceration, and the deep Clark's Level V indicate a high-risk, aggressive form of melanoma."
      }
    ]
  },
  {
    "id": "TCGA-GN-A4U4-06Z-00-DX1.A9927319-9AE2-46A1-B68D-435E47CA2E09-1",
    "image": "TCGA-SKCM/TCGA-GN-A4U4-06Z-00-DX1.A9927319-9AE2-46A1-B68D-435E47CA2E09.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T2BM0NX, and IHC results showing negative A103 and MELAN-A, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastatic disease coupled with the negative IHC markers A103 and MELAN-A, typically used to identify melanoma cells, indicate a more challenging situation in terms of disease management and treatment efficacy."
      }
    ]
  },
  {
    "id": "TCGA-D3-A3C3-06Z-00-DX1.E5A8F232-C772-461D-A997-BF97599E4E66-1",
    "image": "TCGA-SKCM/TCGA-D3-A3C3-06Z-00-DX1.E5A8F232-C772-461D-A997-BF97599E4E66.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TXM0N0, and IHC results showing tumor cells positive for HMB45, anti-MART1, and anti-tyrosinase, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The diagnosis of metastatic melanoma indicates that the cancer has spread beyond the primary site, which is generally associated with a more aggressive disease course and lower overall survival rates."
      }
    ]
  },
  {
    "id": "TCGA-D3-A8GR-06Z-00-DX1.B5B05EF4-7ECC-435C-BEFE-F0D9786B6D4B-1",
    "image": "TCGA-SKCM/TCGA-D3-A8GR-06Z-00-DX1.B5B05EF4-7ECC-435C-BEFE-F0D9786B6D4B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of TISM0N0, and IHC results showing positivity for S-100 and Pan-mel, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis (indicated by TIS) in melanoma typically signifies advanced disease, despite the absence of additional distant metastasis (M0) and lymph node involvement (N0)."
      }
    ]
  },
  {
    "id": "TCGA-W3-A825-06Z-00-DX1.0C817E5E-BD62-4476-A5C0-DDFA8F41681E-1",
    "image": "TCGA-SKCM/TCGA-W3-A825-06Z-00-DX1.0C817E5E-BD62-4476-A5C0-DDFA8F41681E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of metastatic melanoma, TNM staging of T3M0N0, and IHC results showing negative S-100 and HMB-45 for tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the lack of distant metastasis (M0) and regional lymph node involvement (N0), the advanced tumor stage (T3) and negative IHC markers (S-100 and HMB-45) complicate the assessment and suggest more challenging treatment options."
      }
    ]
  },
  {
    "id": "TCGA-D3-A8GI-06Z-00-DX1.CF5E4553-D092-40DD-A610-A1879563C4AC-1",
    "image": "TCGA-SKCM/TCGA-D3-A8GI-06Z-00-DX1.CF5E4553-D092-40DD-A610-A1879563C4AC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T1AM0N0, and IHC results showing negative BRAF-V600E, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the low TNM stage (T1AM0N0), the diagnosis of metastatic melanoma and negative BRAF-V600E status limit some targeted treatment options, suggesting a more challenging clinical scenario."
      }
    ]
  },
  {
    "id": "TCGA-D3-A8GN-06Z-00-DX1.B946963A-067D-4823-878C-DB46EC2ACAEF-1",
    "image": "TCGA-SKCM/TCGA-D3-A8GN-06Z-00-DX1.B946963A-067D-4823-878C-DB46EC2ACAEF.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of TXM0N0, and IHC results showing negative HMB45 and anti-MART1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. Despite the absence of distant metastasis (M0), the genetic variability and aggressive nature of metastatic malignant melanoma, combined with negative markers for HMB45 and anti-MART1, suggest limited treatment options and potential for disease progression."
      }
    ]
  },
  {
    "id": "TCGA-D3-A51T-06Z-00-DX1.90803497-46D5-4967-91D3-CB294605772E-1",
    "image": "TCGA-SKCM/TCGA-D3-A51T-06Z-00-DX1.90803497-46D5-4967-91D3-CB294605772E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of metastatic melanoma, TNM staging of T4BM0N1B, and IHC results showing a failure to reveal metastatic melanoma with the anti-melanocytic cocktail, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced TNM staging (T4B, N1B) indicates a high tumor burden and lymph node involvement, characteristic of aggressive disease progression, despite the negative IHC results."
      }
    ]
  },
  {
    "id": "TCGA-DA-A3F3-01Z-00-DX1.8F546F95-2071-41E5-A0D4-66AB7B46DCFD-1",
    "image": "TCGA-SKCM/TCGA-DA-A3F3-01Z-00-DX1.8F546F95-2071-41E5-A0D4-66AB7B46DCFD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic melanoma, TNM staging of T0N2bM0, and IHC results showing positive Melan-A and HMB45, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The metastatic status indicated by N2b staging suggests significant lymph node involvement, and while the positive IHC markers confirm the diagnosis, they do not mitigate the advanced stage of the disease."
      }
    ]
  },
  {
    "id": "TCGA-FR-A2OS-01Z-00-DX1.9F35411B-FFCE-4BD7-8161-68DE08C67AB8-1",
    "image": "TCGA-SKCM/TCGA-FR-A2OS-01Z-00-DX1.9F35411B-FFCE-4BD7-8161-68DE08C67AB8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of malignant melanoma with TNM staging of T4BM0N0 and IHC results mentioning the use of S100 and MART-1 without specifying their results, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The advanced tumor size (T4B) indicates a high tumor burden despite no distant metastasis or lymph node involvement (M0N0), which is typically associated with a worse outcome in malignant melanoma."
      }
    ]
  },
  {
    "id": "TCGA-D3-A1Q1-06Z-00-DX1.7E87AE47-8145-464D-AFBC-82DEAC42F492-1",
    "image": "TCGA-SKCM/TCGA-D3-A1Q1-06Z-00-DX1.7E87AE47-8145-464D-AFBC-82DEAC42F492.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic malignant melanoma, TNM staging of T1BM0N3, and IHC results showing positive Pan-Mel and negative Keratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The TNM staging indicates metastasis to distant lymph nodes (N3), and despite the positive Pan-Mel confirming melanoma, the advanced metastatic stage significantly worsens the outlook."
      }
    ]
  },
  {
    "id": "TCGA-D3-A51G-06Z-00-DX1.4AE56306-4049-4854-82FD-8445F872D05F-1",
    "image": "TCGA-SKCM/TCGA-D3-A51G-06Z-00-DX1.4AE56306-4049-4854-82FD-8445F872D05F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of metastatic melanoma with TNM staging TISN0M0 and IHC results showing positivity for a pan-melanocytic cocktail (anti-MART1, anti-tyrosinase, HMB45), is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the localized staging indicated by TIS, the diagnosis of metastatic melanoma generally suggests a high potential for disease spread and poorer outcomes."
      }
    ]
  },
  {
    "id": "TCGA-EL-A3T9-01Z-00-DX1.E2795595-E82F-4DFC-A6AC-A4AA45753A00-1",
    "image": "TCGA-THCA/TCGA-EL-A3T9-01Z-00-DX1.E2795595-E82F-4DFC-A6AC-A4AA45753A00.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated papillary thyroid carcinoma, TNM staging of T4MXN1, and IHC results showing positivity for TTF-1 and CK-19, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and TNM staging indicating extensive local invasion (T4) and regional lymph node involvement (N1), combined with the undetermined metastatic status (MX), suggest a more aggressive disease and poorer outcome."
      }
    ]
  },
  {
    "id": "TCGA-IM-A41Z-01Z-00-DX1.BEB9E1F0-75E7-418D-921A-0B28268F52FE-1",
    "image": "TCGA-THCA/TCGA-IM-A41Z-01Z-00-DX1.BEB9E1F0-75E7-418D-921A-0B28268F52FE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, follicular variant, a TNM staging of T1bNXN0, and IHC results showing positive Galectin 3, CK19, Cyclin D1, negative HBME, and a proliferative index of less than 5%, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The early TNM stage (T1b) with no evidence of lymph node or distant metastasis (NX, N0), along with a low proliferative index, suggests a less aggressive cancer with a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-EM-A3O6-01Z-00-DX1.D6CB7107-7A56-4C76-A65C-033FD214EBA5-1",
    "image": "TCGA-THCA/TCGA-EM-A3O6-01Z-00-DX1.D6CB7107-7A56-4C76-A65C-033FD214EBA5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma, follicular variant, TNM staging of T2MXNX, and IHC results with diffuse weak positivity for CK19 and negative HBME-1 and Galectin-3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Papillary carcinoma, follicular variant, typically has a favorable outcome, and although the TNM staging reflects an uncertain nodal and metastatic status, the weak positivity for CK19 suggests a less aggressive tumor behavior."
      }
    ]
  },
  {
    "id": "TCGA-EL-A4KI-01Z-00-DX1.D906569B-AA2A-46FE-B094-AE05F8CDEF4C-1",
    "image": "TCGA-THCA/TCGA-EL-A4KI-01Z-00-DX1.D906569B-AA2A-46FE-B094-AE05F8CDEF4C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of papillary thyroid carcinoma with higher-grade insular areas and necrosis, TNM staging of T3MXN0, and IHC results showing positive TTF-1 and negative PTH, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of higher-grade insular areas and necrosis indicates a more aggressive variant of papillary thyroid carcinoma, and the T3 stage suggests the tumor has grown significantly in size."
      }
    ]
  },
  {
    "id": "TCGA-EM-A3O8-01Z-00-DX1.B164A20B-7433-420A-B947-C78CEB49B7D2-1",
    "image": "TCGA-THCA/TCGA-EM-A3O8-01Z-00-DX1.B164A20B-7433-420A-B947-C78CEB49B7D2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma, follicular variant with TNM staging of T1BMXN0, and IHC results showing thyroglobulin positivity in the dominant nodule and negative for calcitonin, monoclonal CEA, and chromogranin in the dominant nodule, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. The small tumor size (T1B), absence of lymph node involvement (N0), and the IHC profile characteristic of less aggressive disease support a favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-EM-A3FN-01Z-00-DX1.B93AB1DC-1F4A-46FE-A269-0BEC3256E76F-1",
    "image": "TCGA-THCA/TCGA-EM-A3FN-01Z-00-DX1.B93AB1DC-1F4A-46FE-A269-0BEC3256E76F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of multifocal papillary carcinoma, follicular variant, TNM staging of T3MXN0, and IHC results showing regional membranous positivity for Cytokeratin 19 with negative HBME-1 and Galectin 3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The multifocal nature of the papillary carcinoma and the T3 stage indicate a more advanced and potentially aggressive disease, even though lymph nodes have not been assessed definitively (MX)."
      }
    ]
  },
  {
    "id": "TCGA-BJ-A0YZ-01Z-00-DX1.FFDC24FB-D8A1-40F8-89CD-DDB0ED010870-1",
    "image": "TCGA-THCA/TCGA-BJ-A0YZ-01Z-00-DX1.FFDC24FB-D8A1-40F8-89CD-DDB0ED010870.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of encapsulated papillary thyroid carcinoma, follicular variant, with TNM staging of T2N0M0, and IHC results showing positive PPARg, focally positive Galectin-9, negative HBME-1, and positive Calcitonin and CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Encapsulated papillary thyroid carcinoma, particularly the follicular variant, typically has a favorable outcome, and the TNM staging of T2N0M0 indicates no metastasis, which contributes to a better prognosis."
      }
    ]
  },
  {
    "id": "TCGA-BJ-A0Z0-01Z-00-DX1.65834934-8E06-426D-A20A-B0D20A0C7C7A-1",
    "image": "TCGA-THCA/TCGA-BJ-A0Z0-01Z-00-DX1.65834934-8E06-426D-A20A-B0D20A0C7C7A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of papillary thyroid carcinoma, follicular variant, with TNM staging of T2MXN0, and IHC results showing positive H&E staining with lymph nodes negative for TTF, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. Papillary thyroid carcinoma generally has a favorable prognosis, and the follicular variant with no lymph node involvement (N0) and a moderate tumor size (T2) further supports this positive outlook."
      }
    ]
  },
  {
    "id": "TCGA-ET-A40T-01Z-00-DX1.09910804-5BB5-471E-9EA3-CC6FCDF6E26A-1",
    "image": "TCGA-THCA/TCGA-ET-A40T-01Z-00-DX1.09910804-5BB5-471E-9EA3-CC6FCDF6E26A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma with focal solid areas, TNM staging of T2MXN1A, and IHC results showing individual metastatic carcinoma cells highlighted by Cytokeratin and a few metastatic cells labeled by TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicates a larger tumor size (T2) and regional lymph node involvement (N1A), suggesting a higher risk of disease spread and recurrence."
      }
    ]
  },
  {
    "id": "TCGA-EL-A3TA-01Z-00-DX1.272C4B72-AB1F-4ADB-83FF-98D301B22977-1",
    "image": "TCGA-THCA/TCGA-EL-A3TA-01Z-00-DX1.272C4B72-AB1F-4ADB-83FF-98D301B22977.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient's diagnosis of papillary carcinoma, TNM staging of T2M0N0, and IHC results showing metastatic carcinoma in lymph nodes associated with the isthmus, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The presence of metastatic carcinoma in the lymph nodes (despite an M0 designation) suggests a higher likelihood of disease spread and a more challenging treatment course."
      }
    ]
  },
  {
    "id": "TCGA-EM-A3O9-01Z-00-DX1.D875DF72-EBDE-43FD-9FAE-3F696D4C0F03-1",
    "image": "TCGA-THCA/TCGA-EM-A3O9-01Z-00-DX1.D875DF72-EBDE-43FD-9FAE-3F696D4C0F03.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of multifocal papillary carcinoma, dominant oncocytic follicular variant, TNM staging of T3MXN0, and IHC results showing calcitonin stains with focal mild reactive C-cell hyperplasia, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM stage T3 suggests a larger tumor size with potential local advancement, and the multifocal nature of the carcinoma can complicate treatment outcomes."
      }
    ]
  },
  {
    "id": "TCGA-DJ-A3VK-01Z-00-DX1.27EC85CB-86A8-4E18-A6F6-0B1540E9B7F0-1",
    "image": "TCGA-THCA/TCGA-DJ-A3VK-01Z-00-DX1.27EC85CB-86A8-4E18-A6F6-0B1540E9B7F0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary microcarcinoma with nodular hyperplasia, TNM staging of T3N0M0, and IHC results showing positive staining for thyroglobulin and negative staining for calcitonin, chromogranin, and synaptophysin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. Papillary microcarcinoma generally has a favorable outcome, and the absence of metastasis (N0M0) supports this. Additionally, positive thyroglobulin suggests well-differentiated thyroid tissue presence, which is typically less aggressive."
      }
    ]
  },
  {
    "id": "TCGA-EM-A22O-01Z-00-DX1.54357B5E-FDE4-4C7A-B2D9-3E26B4D9DDD2-1",
    "image": "TCGA-THCA/TCGA-EM-A22O-01Z-00-DX1.54357B5E-FDE4-4C7A-B2D9-3E26B4D9DDD2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the patient\u2019s diagnosis of multifocal papillary carcinoma with focal dedifferentiation and tall cell change, and medullary carcinoma, TNM staging of T4AMXN1A, and IHC results showing medullary carcinoma stains positive for calcitonin, CEA, chromogranin, and TTF1 and papillary carcinoma stains positive for thyroglobulin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The combination of multifocal papillary carcinoma with dedifferentiation and tall cell change, advanced TNM staging (T4A with lymph node involvement N1A), and presence of medullary carcinoma indicates a more aggressive disease and higher risk of adverse outcomes."
      }
    ]
  },
  {
    "id": "TCGA-IM-A3EB-01Z-00-DX1.2E9C1C0E-99BC-4BA3-BF97-2AD737D37E4B-1",
    "image": "TCGA-THCA/TCGA-IM-A3EB-01Z-00-DX1.2E9C1C0E-99BC-4BA3-BF97-2AD737D37E4B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, TNM staging of T3MXN1A, and IHC results showing positive cytokeratin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3 stage indicates a larger tumor with possible extension beyond the thyroid, and N1A shows regional lymph node involvement, both of which are associated with a worse prognosis in papillary thyroid carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-BJ-A28R-01Z-00-DX1.604684C7-A61F-4EA5-9E6E-545CE8420B73-1",
    "image": "TCGA-THCA/TCGA-BJ-A28R-01Z-00-DX1.604684C7-A61F-4EA5-9E6E-545CE8420B73.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, conventional type, with TNM staging of T1N0M0, and immunohistochemistry results showing HBME-1 and Galectin-3 both negative, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is good. Papillary thyroid carcinoma generally has an excellent prognosis, especially at an early stage (T1N0M0), and the lack of HBME-1 and Galectin-3 positivity does not significantly alter this outlook."
      }
    ]
  },
  {
    "id": "TCGA-EM-A4FH-01Z-00-DX1.6EB7BADA-ADC1-47A9-A915-4034BA055777-1",
    "image": "TCGA-THCA/TCGA-EM-A4FH-01Z-00-DX1.6EB7BADA-ADC1-47A9-A915-4034BA055777.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma, follicular variant for the thyroid lesion, and intravascular fasciitis for the spindle cell lesion, with TNM staging of T3MXNX, and IHC results showing positive SMA and negative for Caldesmon, Desmin, and CD34, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The papillary carcinoma\u2019s T3 stage indicates locally advanced disease. The IHC results suggest that the primary tumor and spindle cells have limited therapeutic targets, complicating treatment options."
      }
    ]
  },
  {
    "id": "TCGA-L6-A4EQ-01Z-00-DX1.F8E576B5-ADA7-44DB-AC79-C3429F2B33E2-1",
    "image": "TCGA-THCA/TCGA-L6-A4EQ-01Z-00-DX1.F8E576B5-ADA7-44DB-AC79-C3429F2B33E2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of papillary thyroid carcinoma, TNM staging T2N1A, and IHC results showing positive thyroglobulin and negative calcitonin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Papillary thyroid carcinoma typically has a favorable outcome, and although there is lymph node involvement (N1A), the absence of distant metastasis (M0) and the positive thyroglobulin support a better prognosis."
      }
    ]
  },
  {
    "id": "TCGA-EM-A1YD-01Z-00-DX1.476300DE-BEE0-4B66-8128-2C06A2A25D0A-1",
    "image": "TCGA-THCA/TCGA-EM-A1YD-01Z-00-DX1.476300DE-BEE0-4B66-8128-2C06A2A25D0A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of papillary carcinoma, follicular variant, with TNM staging of T2MXN0, and IHC results showing negative AE1/AE3 immunostaining in the right paratracheal lymph nodes, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Papillary carcinoma, follicular variant, typically has a favorable outcome, and the TNM staging (T2N0) indicates no lymph node involvement. The negative AE1/AE3 in the lymph nodes suggests no metastatic spread in the sampled nodes."
      }
    ]
  },
  {
    "id": "TCGA-DO-A2HM-01Z-00-DX1.20D6ED5E-AD06-464B-9311-8D470E236931-1",
    "image": "TCGA-THCA/TCGA-DO-A2HM-01Z-00-DX1.20D6ED5E-AD06-464B-9311-8D470E236931.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, TNM staging of T1BMXN1B, and IHC results showing positive HBME within tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM staging indicating lymph node involvement (N1B) suggests a higher risk of metastasis and recurrence, despite the generally favorable nature of papillary thyroid carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-BJ-A0ZE-01Z-00-DX1.8D51B2CD-3AB1-425D-AC80-C22B592A847F-1",
    "image": "TCGA-THCA/TCGA-BJ-A0ZE-01Z-00-DX1.8D51B2CD-3AB1-425D-AC80-C22B592A847F.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of encapsulated follicular variant of papillary carcinoma, TNM staging of T3M0N0, and IHC results showing positive focal membranous staining for HBME-1 in the lesion, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T3 staging indicates a larger tumor burden, and while the encapsulated variant generally has a better prognosis, the higher T stage suggests a more advanced local disease."
      }
    ]
  },
  {
    "id": "TCGA-EM-A3FL-01Z-00-DX1.8B0828AC-4EFF-4C9A-8B11-B249C97C6F59-1",
    "image": "TCGA-THCA/TCGA-EM-A3FL-01Z-00-DX1.8B0828AC-4EFF-4C9A-8B11-B249C97C6F59.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma, follicular variant, multifocal, TNM staging of T1BMXNX, and IHC results showing negative Galectin-3, focally positive Cytokeratin 19, and few cells positive for HBME-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The small tumor size (T1b) and the relatively low-risk IHC profile, combined with multifocality, suggest a less aggressive behavior typical of papillary carcinoma variants."
      }
    ]
  },
  {
    "id": "TCGA-EM-A3O3-01Z-00-DX1.F1D69AEB-CBBD-49EE-A2F4-411A11E3B3AC-1",
    "image": "TCGA-THCA/TCGA-EM-A3O3-01Z-00-DX1.F1D69AEB-CBBD-49EE-A2F4-411A11E3B3AC.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of widely invasive papillary thyroid carcinoma with TNM staging T2MXN1A and IHC results showing positive Thyroglobulin, TTF-1, HBME-1, Vimentin, and focal monoclonal CEA, along with negative CD31, CD5, and Calcitonin, and less than 3% p53 expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The widely invasive nature and lymph node involvement (N1A) indicate a more aggressive disease and potential for spread, despite the typical markers for papillary thyroid carcinoma."
      }
    ]
  },
  {
    "id": "TCGA-DO-A1JZ-01Z-00-DX1.CD2D8D52-8E7A-4187-A5BA-DF3E0FA7984A-1",
    "image": "TCGA-THCA/TCGA-DO-A1JZ-01Z-00-DX1.CD2D8D52-8E7A-4187-A5BA-DF3E0FA7984A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, follicular variant, TNM staging of T2MXNX, and IHC results with negative GALECTIN 3 and HBME, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Papillary thyroid carcinoma, even the follicular variant, tends to have a favorable outcome, and while the exact extent of metastasis is unknown (MX), its usual indolent behavior supports a positive outlook."
      }
    ]
  },
  {
    "id": "TCGA-DO-A1JZ-01Z-00-DX2.0AFF242D-24B6-4A84-BA67-9C6BF870DA3A-1",
    "image": "TCGA-THCA/TCGA-DO-A1JZ-01Z-00-DX2.0AFF242D-24B6-4A84-BA67-9C6BF870DA3A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, follicular variant, TNM staging of T2MXNX, and IHC results with negative GALECTIN 3 and HBME, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Papillary thyroid carcinoma, even the follicular variant, tends to have a favorable outcome, and while the exact extent of metastasis is unknown (MX), its usual indolent behavior supports a positive outlook."
      }
    ]
  },
  {
    "id": "TCGA-H2-A2K9-01Z-00-DX1.4FA56AC1-CC13-43B4-A8D8-06EDC96D0968-1",
    "image": "TCGA-THCA/TCGA-H2-A2K9-01Z-00-DX1.4FA56AC1-CC13-43B4-A8D8-06EDC96D0968.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of papillary carcinoma, papillary and follicular variant, TNM staging of T2MXN1B, and IHC results showing Pankeratin highlighting metastatic cells in blocks 81 through 83 with the largest focus measuring 3-5 mm, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2MXN1B stage indicates a larger tumor with regional lymph node involvement, suggesting a more advanced disease that could complicate treatment and affect outcomes."
      }
    ]
  },
  {
    "id": "TCGA-ET-A3BX-01Z-00-DX1.237EA6E4-435A-4918-9BC0-1471352FB1A9-1",
    "image": "TCGA-THCA/TCGA-ET-A3BX-01Z-00-DX1.237EA6E4-435A-4918-9BC0-1471352FB1A9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma, TNM staging of T3MXN1A, and IHC results showing one of four lymph nodes positive for carcinoma, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally poor. The advanced tumor size (T3), the involvement of regional lymph nodes (N1A), and the presence of carcinoma cells in the lymph nodes suggest a higher risk of disease progression and metastasis."
      }
    ]
  },
  {
    "id": "TCGA-DJ-A3UZ-01Z-00-DX1.5F80B690-1CF1-49FF-93D0-8C0E9A532C2C-1",
    "image": "TCGA-THCA/TCGA-DJ-A3UZ-01Z-00-DX1.5F80B690-1CF1-49FF-93D0-8C0E9A532C2C.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of well-differentiated papillary carcinoma, TNM staging of T3N0M0, and IHC results with negative Chromogranin, Synaptophysin, CEA-M, and Calcitonin as well as a negative Congo Red Stain, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively good. The well-differentiated status and lack of metastasis (M0) or lymph node involvement (N0) favor a positive outlook, despite the tumor's larger size (T3)."
      }
    ]
  },
  {
    "id": "TCGA-J8-A3O2-01Z-00-DX1.685865AB-D824-4107-9842-25FBD02957A3-1",
    "image": "TCGA-THCA/TCGA-J8-A3O2-01Z-00-DX1.685865AB-D824-4107-9842-25FBD02957A3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of well-differentiated papillary carcinoma, classical type, TNM staging of T3N1bM0, and IHC results showing positivity for CD3 and TdT, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the well-differentiated status, the TNM staging indicates larger tumor size (T3) and significant lymph node involvement (N1b), which contribute to a more serious outlook."
      }
    ]
  },
  {
    "id": "TCGA-EM-A22M-01Z-00-DX1.3E4CFB51-A1A5-48B5-96BC-F3EE763C7C5A-1",
    "image": "TCGA-THCA/TCGA-EM-A22M-01Z-00-DX1.3E4CFB51-A1A5-48B5-96BC-F3EE763C7C5A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma in the thyroid with characteristics of both columnar cell and classical variants, TNM staging of T1BMXN0, and IHC results showing positive HBME-1, Cytokeratin 19, and Galectin-3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The low TNM stage (T1BMXN0) suggests a localized tumor without lymph node involvement or known metastasis, and typical immunohistochemistry markers associated with papillary thyroid carcinoma support a favorable outlook."
      }
    ]
  },
  {
    "id": "TCGA-FE-A232-01Z-00-DX1.523A20E6-A15F-4081-A12F-B089A92CE0D2-1",
    "image": "TCGA-THCA/TCGA-FE-A232-01Z-00-DX1.523A20E6-A15F-4081-A12F-B089A92CE0D2.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of well-differentiated papillary thyroid carcinoma with oncocytic features, TNM staging of T3MXNX, and IHC results showing negative Calcitonin, positive Thyroglobulin, and positive TTF-1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Despite the T3 stage indicating a larger tumor, the well-differentiated nature of papillary thyroid carcinoma and positive Thyroglobulin suggest favorable outcomes with appropriate treatment."
      }
    ]
  },
  {
    "id": "TCGA-BJ-A190-01Z-00-DX1.9095091E-77EE-42FB-B3EB-D12BD29335FA-1",
    "image": "TCGA-THCA/TCGA-BJ-A190-01Z-00-DX1.9095091E-77EE-42FB-B3EB-D12BD29335FA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of encapsulated follicular variant of papillary thyroid carcinoma, TNM staging of T2MXN0, and IHC results showing focal HBME-1 staining and negative Galectin 3, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. The encapsulated follicular variant of papillary thyroid carcinoma typically has a favorable outcome, and the absence of lymph node involvement (N0) supports this positive prognosis, despite the unknown metastasis status (MX)."
      }
    ]
  },
  {
    "id": "TCGA-EM-A2CQ-01Z-00-DX1.DD22D5B4-3638-44B3-8127-03458B2ABC4D-1",
    "image": "TCGA-THCA/TCGA-EM-A2CQ-01Z-00-DX1.DD22D5B4-3638-44B3-8127-03458B2ABC4D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary carcinoma, follicular variant, TNM staging of T1BMXN1A, and IHC results showing positive TTF1 and CK in perithyroidal lymph node deposits, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The lymph node involvement (N1A) indicates a higher stage and more extensive disease, which generally correlates with a less favorable outcome."
      }
    ]
  },
  {
    "id": "TCGA-EM-A2CK-01Z-00-DX1.DAB0A75D-45B9-41F3-8358-CAC283D10EA9-1",
    "image": "TCGA-THCA/TCGA-EM-A2CK-01Z-00-DX1.DAB0A75D-45B9-41F3-8358-CAC283D10EA9.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of metastatic papillary thyroid carcinoma, classical variant, with TNM staging of T2MXN1B and IHC results showing positive CK19, variable Galectin, and positive HBME 1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of metastasis to lymph nodes (N1B) and inconsistent IHC markers indicate a more challenging and potentially aggressive form of the disease."
      }
    ]
  },
  {
    "id": "TCGA-EM-A2CL-01Z-00-DX1.32F1BCF4-7F07-4653-A859-056DE18DE6CE-1",
    "image": "TCGA-THCA/TCGA-EM-A2CL-01Z-00-DX1.32F1BCF4-7F07-4653-A859-056DE18DE6CE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of papillary carcinoma, follicular variant, a TNM staging of T2MXNX, and IHC results showing CK-19 positivity, focal HBME-1 positivity, and negative Galectin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is generally good. Papillary carcinoma, follicular variant, typically has a favorable outcome, especially with localized tumor (T2) and specific IHC profile indications, though the complete staging information is unknown."
      }
    ]
  },
  {
    "id": "TCGA-BJ-A191-01Z-00-DX1.E65056B8-C7D0-46A6-98B8-067E25548912-1",
    "image": "TCGA-THCA/TCGA-BJ-A191-01Z-00-DX1.E65056B8-C7D0-46A6-98B8-067E25548912.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of papillary thyroid carcinoma, columnar cell variant, confined within the thyroid tissue, with lymph-vascular invasion, TNM staging of T1BM0N0, and IHC results showing cytoplasmic beta-catenin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the limited size (T1) and lack of metastasis (M0, N0), the columnar cell variant and presence of lymph-vascular invasion are associated with a higher risk of recurrence and potentially aggressive behavior."
      }
    ]
  },
  {
    "id": "TCGA-2W-A8YY-01Z-00-DX1.2BEC2531-DA98-429B-83BB-3428D3B6FB1E-1",
    "image": "TCGA-CESC/TCGA-2W-A8YY-01Z-00-DX1.2BEC2531-DA98-429B-83BB-3428D3B6FB1E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of adenosquamous carcinoma, TNM staging of T2A2M0N0, and IHC results showing no reactivity for Vimentin and Estrogen Receptor, with patchy expression for p16 and CEA, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The T2A2 staging indicates a moderate-sized tumor, and the lack of estrogen receptor reactivity limits hormonal therapy options, while patchy expression of p16 and CEA suggests variable tumor behavior."
      }
    ]
  },
  {
    "id": "TCGA-HG-A9SC-01Z-00-DX1.7C75026C-7A7B-4129-87AF-643B68857837-1",
    "image": "TCGA-CESC/TCGA-HG-A9SC-01Z-00-DX1.7C75026C-7A7B-4129-87AF-643B68857837.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated adenosquamous carcinoma, TNM staging of T2BMXN0, and IHC results showing positive stains for multiple markers including MUCIN, Cytokeratin AE1/3, Cytokeratin 5/6, P63, CAM52, P40, and P16, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the adenosquamous carcinoma and the intermediate TNM staging (T2B) indicate an aggressive form of cancer, despite the absence of lymph node involvement (N0)."
      }
    ]
  },
  {
    "id": "TCGA-DS-A7WF-01Z-00-DX1.35D29A85-846A-435E-8D51-83381C6D52E6-1",
    "image": "TCGA-CESC/TCGA-DS-A7WF-01Z-00-DX1.35D29A85-846A-435E-8D51-83381C6D52E6.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated grade III primary cervical adenosquamous carcinoma, TNM staging of T1B2MXN0, and IHC results all negative for Pancytokeratin, Synaptophysin, and Chromogranin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated grade III status indicates a more aggressive tumor, and the T1B2MXN0 staging suggests a relatively significant local tumor size, contributing to a less favorable prognosis."
      }
    ]
  },
  {
    "id": "TCGA-JX-A3Q8-01Z-00-DX1.4995F70C-BDBE-4435-B57B-C6ACC27B0E91-1",
    "image": "TCGA-CESC/TCGA-JX-A3Q8-01Z-00-DX1.4995F70C-BDBE-4435-B57B-C6ACC27B0E91.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive poorly differentiated adenocarcinoma of the endocervix, TNM staging of T1B1MXN0, and IHC results showing diffuse positivity for p16, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status of the adenocarcinoma, even with a lower TNM stage, suggests a more aggressive tumor, and the uncertain metastatic status (MX) further complicates the prognosis."
      }
    ]
  },
  {
    "id": "TCGA-JW-A5VG-01Z-00-DX1.59D9AE20-FE48-44E4-B139-91BF9FD3CBD1-1",
    "image": "TCGA-CESC/TCGA-JW-A5VG-01Z-00-DX1.59D9AE20-FE48-44E4-B139-91BF9FD3CBD1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the diagnosis of poorly differentiated invasive squamous cell carcinoma, TNM staging of T2AMXNX, and IHC results showing CK5/6 highlighting tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated status and the indeterminate nodal/metastasis status (MXNX) signify a potentially aggressive and advanced disease, and CK5/6 positivity does not alter this assessment."
      }
    ]
  },
  {
    "id": "TCGA-JW-A69B-01Z-00-DX1.1C01BC3B-4DC2-4589-8940-10DFCCB2CF22-1",
    "image": "TCGA-CESC/TCGA-JW-A69B-01Z-00-DX1.1C01BC3B-4DC2-4589-8940-10DFCCB2CF22.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the diagnosis of adenocarcinoma favoring endocervical origin, TNM staging of T1B2MXNX, and IHC results showing strong diffuse positivity for p16, patchy positivity for CEA, and negativity for ER and Vimentin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. Despite the early tumor stage (T1B2), the uncertain metastatic and nodal status (MXNX) and negative ER expression limit favorable treatment options, which can affect disease management."
      }
    ]
  },
  {
    "id": "TCGA-EA-A556-01Z-00-DX1.08D384ED-C0AF-429B-8E7E-0B2BEAB2E90A-1",
    "image": "TCGA-CESC/TCGA-EA-A556-01Z-00-DX1.08D384ED-C0AF-429B-8E7E-0B2BEAB2E90A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated endometrioid adenocarcinoma, TNM staging of T1B1M0N0, and IHC results showing multiple positive markers including CA125 and low PR expression, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status of the tumor and low PR expression indicate more aggressive disease behavior, despite the early TNM stage."
      }
    ]
  },
  {
    "id": "TCGA-FU-A770-01Z-00-DX1.67C6E3B1-22BC-41C6-B841-2C01DF1D5071-1",
    "image": "TCGA-CESC/TCGA-FU-A770-01Z-00-DX1.67C6E3B1-22BC-41C6-B841-2C01DF1D5071.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately differentiated adenocarcinoma, TNM staging of T2A2MXN1, and IHC results showing positive p16 and negative WT1, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The moderately differentiated adenocarcinoma and TNM staging indicating lymph node involvement (N1) suggest a more advanced and potentially aggressive disease, despite the positive p16 marker."
      }
    ]
  },
  {
    "id": "TCGA-EX-A8YF-01Z-00-DX1.79A4FEAD-3D6A-4D15-BDA8-CD100A411302-1",
    "image": "TCGA-CESC/TCGA-EX-A8YF-01Z-00-DX1.79A4FEAD-3D6A-4D15-BDA8-CD100A411302.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of poorly differentiated squamous cell carcinoma, TNM staging of T2A1M0N0, and IHC results showing isolated tumor cells in one sentinel lymph node with no tumor seen in another, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The poorly differentiated nature of the squamous cell carcinoma and the presence of isolated tumor cells in the lymph node suggest a more aggressive disease with potential for further spread."
      }
    ]
  },
  {
    "id": "TCGA-JW-A5VK-01Z-00-DX1.828A50C3-1C95-4552-8C37-CA9556DF4B94-1",
    "image": "TCGA-CESC/TCGA-JW-A5VK-01Z-00-DX1.828A50C3-1C95-4552-8C37-CA9556DF4B94.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of poorly differentiated, papillary-type invasive squamous cell carcinoma with TNM staging of T1B2MXNX and IHC results showing negative CK20, focally positive CK, and positive P16, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The poorly differentiated status and uncertain metastasis (MX) alongside TNM staging complications indicate an aggressive cancer type, despite the positive P16 which suggests a cervical origin."
      }
    ]
  },
  {
    "id": "TCGA-Q1-A73S-01Z-00-DX1.D74CFF58-A032-45D2-98FA-4B4D9AB90069-1",
    "image": "TCGA-CESC/TCGA-Q1-A73S-01Z-00-DX1.D74CFF58-A032-45D2-98FA-4B4D9AB90069.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the diagnosis of moderately differentiated invasive adenosquamous carcinoma, TNM staging of T1B1MXN1, and IHC results showing strong positivity for p16 and mCEA, positive CK7, and negative p63, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively poor. The TNM stage indicating lymph node involvement (N1), coupled with moderately differentiated tumor status and mixed IHC results, suggest a potential for more aggressive behavior and complex treatment needs."
      }
    ]
  },
  {
    "id": "TCGA-MA-AA42-01Z-00-DX1.060491AB-E11F-44DC-91CA-0AE68DE8C900-1",
    "image": "TCGA-CESC/TCGA-MA-AA42-01Z-00-DX1.060491AB-E11F-44DC-91CA-0AE68DE8C900.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient's diagnosis of squamous cell carcinoma, TNM staging of T2BM0N0, and IHC results with negative EBV and HPV, but positive CK 5/6, p63, and p16, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is relatively favorable. The TNM staging indicates localized disease without lymph node involvement or metastasis, and the positive p16 expression suggests a potentially better response to therapy despite the negative EBV and HPV status."
      }
    ]
  },
  {
    "id": "TCGA-MA-AA43-01Z-00-DX1.ABDB39DC-D3A5-4B34-B573-C918D9783FFA-1",
    "image": "TCGA-CESC/TCGA-MA-AA43-01Z-00-DX1.ABDB39DC-D3A5-4B34-B573-C918D9783FFA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of invasive poorly differentiated squamous cell carcinoma and invasive moderately differentiated adenocarcinoma, TNM staging of T3BMXNX, and IHC results showing positive P63, CK5/6, CEA, and strongly positive P16 with negative ER and Vimentin, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The presence of poorly differentiated squamous cell carcinoma, advanced TNM stage (T3), and multiple types of carcinoma suggest a more aggressive disease with complicated management challenges."
      }
    ]
  },
  {
    "id": "TCGA-FU-A5XV-01Z-00-DX1.42E46204-02C8-4BD4-B14C-4A77895EECA5-1",
    "image": "TCGA-CESC/TCGA-FU-A5XV-01Z-00-DX1.42E46204-02C8-4BD4-B14C-4A77895EECA5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the patient\u2019s diagnosis of moderately to poorly differentiated squamous cell carcinoma, TNM staging of T1B2MXN1, and IHC results showing WT1 positive for endosalpingiosis, focally positive monoclonal CEA, p16 strongly positive in carcinoma, p63 positive in tumor cells, and CK7 negative in tumor cells, is the prognosis good or poor?"
      },
      {
        "from": "gpt",
        "value": "The prognosis is poor. The moderately to poorly differentiated squamous cell carcinoma and lymph node involvement (N1) indicate a more aggressive disease, contributing to a less favorable outlook."
      }
    ]
  }
]